<SEC-DOCUMENT>0001213900-21-017601.txt : 20210325
<SEC-HEADER>0001213900-21-017601.hdr.sgml : 20210325
<ACCEPTANCE-DATETIME>20210324212734
ACCESSION NUMBER:		0001213900-21-017601
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		53
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210325
DATE AS OF CHANGE:		20210324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tuscan Holdings Corp.
		CENTRAL INDEX KEY:			0001760689
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				832530757
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38826
		FILM NUMBER:		21769900

	BUSINESS ADDRESS:	
		STREET 1:		135 E 57TH STREET, 18TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(917) 208-6200

	MAIL ADDRESS:	
		STREET 1:		135 E 57TH STREET, 18TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>f10k2020_tuscanhold.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Mar 24 20:36:19 EDT 2021 -->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:thcb="http://thcb.com/20201231" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml"><head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">10-K</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric>&#160;<b>Annual
Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the year ended <ix:nonNumeric contextRef="c0" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 31, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2020</ix:nonNumeric></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-38826</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b>TUSCAN HOLDINGS CORP.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top"> <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="font-size: 10pt"><b>Delaware</b></span></ix:nonNumeric></td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber"><span style="font-size: 10pt"><b>83-2530757</b></span></ix:nonNumeric></td></tr>
<tr style="vertical-align: top"> <td style="text-align: center"><span style="font-size: 10pt">(State or Other Jurisdiction<br/>
of Incorporation)</span></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt">(I.R.S. Employer<br/>
Identification No.)</span></td></tr>
<tr style="vertical-align: top"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr>
<tr> <td style="vertical-align: top; border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">135 E. 57th St.</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2">18th Floor</ix:nonNumeric></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></b></p></td> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode"><span style="font-size: 10pt"><b>10022</b></span></ix:nonNumeric></td></tr>
<tr style="vertical-align: top"> <td style="text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt">(zip code)</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">(646)</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">948-7100</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Issuer&#8217;s Telephone Number, Including
Area Code)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section
12(b) of the Act:</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom"> <td style="width: 43%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Title of Each Class</b></span></td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b>&#160;</span></td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="width: 35%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Name of Each Exchange on Which Registered</b></span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><span style="font-size: 10pt">Units, each consisting of one share of common stock and one redeemable warrant</span></td> <td>&#160;</td> <td style="text-align: center"><span style="font-size: 10pt">THCBU</span></td> <td>&#160;</td> <td style="text-align: center"><span style="font-size: 10pt">The Nasdaq Stock Market LLC</span></td></tr>
<tr style="vertical-align: top; "> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle"><span style="font-size: 10pt">Common stock, par value $0.0001 per share</span></ix:nonNumeric></td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="font-size: 10pt">THCB</span></ix:nonNumeric></td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><span style="font-size: 10pt">The Nasdaq Stock Market LLC</span></ix:nonNumeric></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><span style="font-size: 10pt">Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share</span></td> <td>&#160;</td> <td style="text-align: center"><span style="font-size: 10pt">THCBW</span></td> <td>&#160;</td> <td style="text-align: center"><span style="font-size: 10pt">The Nasdaq Stock Market LLC</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section
12(g) of the Act:</b>&#160;None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant
is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
No <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-0">&#9746;</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant
is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
No <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-1">&#9746;</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the past 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement
for the past 90 days. Yes <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-2">&#9746;</span></span> No&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during
the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-3">&#9746;</span></span>
No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company.
See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;
and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top"> <td style="width: 51%; text-align: justify"><span style="font-size: 10pt">Large accelerated filer <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></span></td> <td style="width: 49%; text-align: justify"><span style="font-size: 10pt">Accelerated filer <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></span></td></tr>
<tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></span></td> <td style="text-align: justify"><span style="font-size: 10pt">Smaller reporting company <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify"><span style="font-size: 10pt">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared
or issued its audit report. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). <ix:nonNumeric contextRef="c0" format="ixt:booleantrue" name="dei:EntityShellCompany">Yes</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span>
No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate market value of the common
stock outstanding, other than shares held by persons who may be deemed affiliates of the registrant, computed by reference to the
closing price for the common stock as of the last business day of the registrant&#8217;s most recently completed second fiscal
quarter ($10.23 as of June 30, 2020), as reported on the Nasdaq Capital Market, was approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" unitRef="usd">282,348,000</ix:nonFraction>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 23, 2021, <ix:nonFraction contextRef="c1" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">35,483,802</ix:nonFraction> shares
of common stock, par value $0.0001 per share, were issued and outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Documents Incorporated by Reference: None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS; RISK FACTORS SUMMARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This annual report, including, without
limitation, statements under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of
Operations,&#8221; includes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E
of the Exchange Act. These forward-looking statements can be identified by the use of forward-looking terminology, including the
words &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;anticipates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221;
&#8220;plans,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;potential,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221;
&#8220;continue,&#8221; or &#8220;should,&#8221; or, in each case, their negative or other variations or comparable terminology.
There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not
limited to, any statements relating to our ability to consummate any acquisition or other business combination and any other statements
that are not statements of current or historical facts. These statements are based on management&#8217;s current expectations,
but actual results may differ materially due to various factors, including, but not limited to our:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">ability to complete our initial business combination;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">success in retaining or recruiting, or changes required in, our officers, key employees or directors following an initial business combination;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">potential ability to obtain additional financing to complete an initial business combination;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">pool of prospective target businesses;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">failure to maintain the listing on, or the delisting of our securities from, the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) or an inability to have our securities listed on Nasdaq or another national securities exchange following our initial business combination;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the ability of our officers and directors to generate a number of potential investment opportunities;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">potential change in control if we acquire one or more target businesses for stock;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">public securities&#8217; potential liquidity and trading;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">lack of a market for our securities;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">use of proceeds not held in the trust account or available to us from interest income on the trust account balance; or</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.75pt; text-indent: -30.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our financial performance.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The forward-looking statements contained
in this annual report are based on our current expectations and beliefs concerning future developments and their potential effects
on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number
of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance
to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include,
but are not limited to, those factors described under the heading &#8220;<i>Item 1A, Risk Factors</i>.&#8221; Should one or more
of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material
respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities
laws. These risks and others described under &#8220;<i>Item 1A, Risk Factors</i>&#8221; may not be exhaustive.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By their nature, forward-looking statements
involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.
We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations,
financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in
or suggested by the forward-looking statements contained in this annual report. In addition, even if our results or operations,
financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking
statements contained in this annual report, those results or developments may not be indicative of results or developments in subsequent
periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risk Factors Summary</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investors should consider
the risks and uncertainties described below that may affect our business and future financial performance. These and other risks
and uncertainties are more fully described in &#8220;<i>Item 1A, Risk Factors</i>&#8221; in this Form 10-K. Additional risks not
presently known to us or that we currently deem immaterial may also affect us. If any of these risks occur, our business, financial
condition or results of operations could be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As more fully set forth
under &#8220;<i>Item 1A, Risk Factors</i>&#8221; in this Form 10-K, principal risks and uncertainties that may affect our business,
financial condition or results of operations include the following risks:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We may not be able to complete our initial business combination by April 30, 2021 (or such later date as may be approved by
our stockholders), in which case we would cease all operations except for the purpose of winding up, and we would redeem our public
shares for a pro rata portion of the funds in the trust account, and we would liquidate. In such event, our warrants would expire
worthless.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise
of your right to convert your shares to cash.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Tuscan Holdings Acquisition LLC, our Sponsor, controls a substantial
interest in us and thus may influence certain actions requiring a stockholder vote.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">The ability of our public stockholders to exercise their conversion rights or sell their shares to us in a tender offer may
not allow us to effectuate the most desirable business combination or optimize our capital structure.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">We may require stockholders who wish to convert their shares in connection with a proposed business combination to comply with
specific requirements for conversion that may make it more difficult for them to exercise their conversion rights.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">We may issue additional shares of capital stock or debt securities to complete a business combination, which would reduce the
equity interest of our stockholders and likely cause a change in control of our ownership.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">We may be unable to obtain additional financing, if required, to complete a business combination or to fund the operations
and growth of the target business.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">We may not obtain a fairness opinion with respect to the target business that we seek to acquire and therefore you may be relying
solely on the judgment of our board of directors in approving a proposed business combination.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent
attempts to locate and acquire or merge with another business.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Our search for a business combination, and any target business with which we ultimately consummate a business combination,
may be materially adversely affected by the recent coronavirus (COVID-19) outbreak and other events, and the status of debt and
equity markets.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">We may have a limited ability to assess the management of a prospective target business and, as a result, may complete our
initial business combination with a target business whose management may not have the skills, qualifications or abilities to manage
a public company.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">If we consummate a business combination with a target company with assets located outside of the United States, our results
of operations and prospects could be subject to the economic, political, and legal policies, developments, and conditions in the
country in which we operate. Further, exchange rate fluctuations and currency policies may cause our ability to succeed in the
international markets to be diminished.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 3 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td>There may be tax consequences to our business combinations that may adversely affect us.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Our officers and directors presently have fiduciary or contractual obligations to other entities and, accordingly, may have
conflicts of interest in determining to which entity a particular business opportunity should be presented.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Our officers and directors may have interests in a potential business combination that are different than yours, which may
create conflicts of interest.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by a
majority of the then outstanding warrants.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your
warrants worthless.</td></tr>                             <tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td></tr>
</table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Nasdaq may delist our securities from trading on its exchange, which could limit investors&#8217; ability to make transactions
in our securities and subject us to additional trading restrictions.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">If third parties bring claims against us, and if our directors decide not to enforce the indemnification obligations of the
Sponsor, or if the Sponsor does not have the funds to indemnify us, the proceeds held in the trust account could be reduced and
the per-share&#160;redemption amount received by stockholders may be less than $10.00 per share.</td></tr>                                                                                                          <tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td></tr>
</table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Provisions in our amended and restated certificate of incorporation and bylaws and Delaware law may inhibit a takeover of us,
which could limit the price investors might be willing to pay in the future for our common stock and could entrench management.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Our amended and restated certificate of incorporation provides, subject to limited exceptions, that the Court of Chancery of
the State of Delaware is the sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholders&#8217;
ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or stockholders.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Our stockholders may be held liable for claims by third parties against us to the extent of distributions received by them
upon redemption of their shares.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">We are a newly formed company with no operating history, and, accordingly, you have no basis on which to evaluate our ability
to achieve our business objective.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance
requirements and our activities may be restricted, which may make it difficult for us to complete our initial business combination.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">We are an emerging growth company and smaller reporting company within the meaning of the Securities Act, and if we take advantage
of certain exemptions from disclosure requirements available to emerging growth companies, this could make our securities less
attractive to investors and may make it more difficult to compare our performance with other public companies.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM 10-K</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 10%"><a href="#a_001"><span style="font-size: 10pt">PART I</span></a></td>
    <td style="vertical-align: top; width: 82%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 8%; text-align: center">1</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 1.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_002"><span style="font-size: 10pt">Business.</span></a></td>
    <td style="vertical-align: top; text-align: center">1</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 1A.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_003"><span style="font-size: 10pt">Risk Factors.</span></a></td>
    <td style="vertical-align: top; text-align: center">12</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 1B.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_004"><span style="font-size: 10pt">Unresolved Staff Comments.</span></a></td>
    <td style="vertical-align: top; text-align: center">28</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 2.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_005"><span style="font-size: 10pt">Properties.</span></a></td>
    <td style="vertical-align: top; text-align: center">28</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 3.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_006"><span style="font-size: 10pt">Legal Proceedings.</span></a></td>
    <td style="vertical-align: top; text-align: center">28</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 4.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_007"><span style="font-size: 10pt">Mine Safety Disclosures.</span></a></td>
    <td style="vertical-align: top; text-align: center">28</td></tr>
<tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><a href="#a_008"><span style="font-size: 10pt">PART II</span></a></td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">29</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 5.</span></td>
    <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><a href="#a_009"><span style="font-size: 10pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></a></td>
    <td style="vertical-align: top; text-align: center">29</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 6.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_010"><span style="font-size: 10pt">Selected Financial Data.</span></a></td>
    <td style="vertical-align: top; text-align: center">29</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 7.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_011"><span style="font-size: 10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></a></td>
    <td style="vertical-align: top; text-align: center">30</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 7A.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_012"><span style="font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk.</span></a></td>
    <td style="vertical-align: top; text-align: center">34</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 8.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_013"><span style="font-size: 10pt">Financial Statements and Supplementary Data.</span></a></td>
    <td style="vertical-align: top; text-align: center">34</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 9.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_014"><span style="font-size: 10pt">Changes in and Disagreements with Accountants on Accounting and Financial Disclosures.</span></a></td>
    <td style="vertical-align: top; text-align: center">34</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 9A.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_015"><span style="font-size: 10pt">Controls and Procedures.</span></a></td>
    <td style="vertical-align: top; text-align: center">35</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 9B.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_016"><span style="font-size: 10pt">Other Information.</span></a></td>
    <td style="vertical-align: top; text-align: center">35</td></tr>
<tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><a href="#a_017"><span style="font-size: 10pt">PART III</span></a></td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">36</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 10.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_018"><span style="font-size: 10pt">Directors, Executive Officers and Corporate Governance.</span></a></td>
    <td style="vertical-align: top; text-align: center">36</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 11.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_019"><span style="font-size: 10pt">Executive Compensation.</span></a></td>
    <td style="vertical-align: top; text-align: center">40</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 12.</span></td>
    <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><a href="#a_020"><span style="font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></a></td>
    <td style="vertical-align: top; text-align: center">41</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 13.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_021"><span style="font-size: 10pt">Certain Relationships and Related Transactions, and Director Independence.</span></a></td>
    <td style="vertical-align: top; text-align: center">42</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 14.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_022"><span style="font-size: 10pt">Principal Accounting Fees and Services.</span></a></td>
    <td style="vertical-align: top; text-align: center">44</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">PART IV</span></td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 15.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_023"><span style="font-size: 10pt">Exhibits and Financial Statement Schedules.</span></a></td>
    <td style="vertical-align: top; text-align: center">44</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 9pt"><span style="font-size: 10pt">Item 16.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_024"><span style="font-size: 10pt">Form 10-K Summary.</span></a></td>
    <td style="vertical-align: top; text-align: center">45</td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART I</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 1. BUSINESS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>In this Annual Report
on Form 10-K (the &#8220;Form 10-K&#8221;), references to &#8220;Tuscan,&#8221; the &#8220;Company&#8221; and to &#8220;we,&#8221;
&#8220;us,&#8221; and &#8220;our&#8221; refer to Tuscan Holdings Corp.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a blank check
company formed under the laws of the State of Delaware on November 5, 2018. We were formed for the purpose of entering into a merger,
share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with
one or more businesses or entities. On February 1, 2021, we entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;)
with Microvast, Inc., a Delaware corporation (&#8220;Microvast&#8221;) and TSCN Merger Sub Inc., a newly formed Delaware corporation
and wholly owned subsidiary of ours (&#8220;Merger Sub&#8221;). The terms of the Merger Agreement are discussed in more detail
below. Prior to executing the Merger Agreement, our activities were limited to organization activities, the completion of our initial
public offering, and the evaluation of possible business combination candidates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Formation and Initial
Public Offering</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November 2018, we
issued an aggregate of 5,750,000 shares (&#8220;founders&#8217; shares&#8221;) of our common stock, par value $0.0001 per share
(&#8220;common stock&#8221;) for an aggregate purchase price of $25,000, or approximately $0.004 per share, to our initial stockholders.
In March 2019, we effectuated a stock dividend of 0.2 shares of common stock for each outstanding share of common stock, resulting
in our initial stockholders holding an aggregate of 6,900,000 founders&#8217; shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November 2018, we
also issued to designees of EarlyBirdCapital, Inc., the representative of the underwriters in our initial public offering (&#8220;IPO&#8221;),
an aggregate of 300,000 shares of common stock (after giving effect to the stock dividend referred to above) (&#8220;representative
shares&#8221;) at a price of $0.0001 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 7, 2019, we
consummated the IPO of 24,000,000 units. Each unit consists of one share of common stock and one redeemable warrant, with each
warrant entitling the holder to purchase one share of common stock at a price of $11.50 per share. The units were sold at an offering
price of $10.00 per unit, generating gross proceeds of $240,000,000. We refer to the shares underlying the units sold in our IPO
as our &#8220;Public Shares.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Simultaneously with
the consummation of the IPO, we consummated the private placement (&#8220;Private Placement&#8221;) of 615,000 Units (&#8220;Private
Units&#8221;) at a price of $10.00 per Private Unit, generating total proceeds of $6,150,000. The Private Units were sold to Tuscan
Holdings Acquisition LLC, our Sponsor, and EarlyBirdCapital and its designees. The Private Units are identical to the units sold
in the IPO, except that the warrants underlying the Private Units are non-redeemable and may be exercised on a cashless basis,
in each case so long as they continue to be held by the initial purchasers or their permitted transferees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 12, 2019,
we consummated the sale of an additional 3,600,000 units that were subject to the underwriters&#8217; over-allotment option at
$10.00 per Unit, generating gross proceeds of $36,000,000. Simultaneously with the closing of the sale of additional units, we
consummated the sale of an additional 72,000 Private Units at $10.00 per Private Unit, generating total proceeds of $720,000. Following
the closing of the over-allotment option and sale of additional Private Units, an aggregate amount of $276,000,000 has been placed
in the trust account established in connection with the IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Proposed Business
Combination</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 1, 2021,
Tuscan entered into the Merger Agreement with Microvast and Merger Sub. Pursuant to the Merger Agreement, Merger Sub will merge
with and into Microvast and Microvast will survive the merger and become a wholly owned subsidiary of Tuscan. Under the Merger
Agreement, all of the equity interests of Microvast will be converted into an aggregate of 210,000,000 shares of common stock (&#8220;closing
shares&#8221;). The Microvast shareholders and the investors in Microvast&#8217;s majority-owned subsidiary, Microvast Power System
(Houzhou) Co. Ltd. (&#8220;MPS&#8221;), will also have the ability to earn an additional 20,000,000 shares of common stock (&#8220;earnout
shares&#8221;) if the daily volume weighted average price of the common stock is greater than or equal to $18.00 for any 20 trading
days within a 30 trading day period (or a change of control occurs that results in the holders of common stock receiving a per
share price equal to or in excess of $18.00), during the period commencing on the closing date and ending on the third anniversary
of the closing date. Concurrently with the execution of the Merger Agreement, Tuscan and Microvast will jointly acquire 100% ownership
of MPS and will discharge certain convertible loans of MPS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the Merger
Agreement provides that Tuscan will issue an aggregate of 6,736,111&#160;shares of common stock upon conversion (the &#8220;Bridge
Notes Conversion&#8221;) of an aggregate of $57,500,000 outstanding promissory notes issued by Microvast.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, on February&#160;1,
2021, Tuscan, the Sponsor, Microvast and certain stockholders of Tuscan entered into the Sponsor Support Agreement (the &#8220;Sponsor
Support Agreement&#8221;), pursuant to which the Sponsor and certain officers and directors of Tuscan (collectively, the &#8220;Sponsor
Group&#8221;) agreed, among other things, to vote all equity interests of Tuscan held by such member of the Sponsor Group in favor
of the approval and adoption of the proposed business combination with Microvast. Additionally, such members of the Sponsor Group
have agreed not to (a) transfer any of their equity interests in the Company (or enter into any arrangement with respect thereto)
other than as set forth therein or (b) exercise any conversion rights of any equity interests held by such member of the Sponsor
Group in connection with the approval of the proposed business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sponsor also agreed
that, to the extent that certain expenses of Tuscan are in excess of $46,000,000 (unless such expenses shall have been approved
by Microvast), the Sponsor will either (i) pay any such excess amount in cash or (ii) forfeit to Tuscan such number of shares of
common stock held by the Sponsor that would have a value equal to such excess. The Sponsor also agreed to amend the escrow agreement
to make certain adjustments to the terms of the escrow of its shares of common stock as set forth in the Sponsor Support Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Contemporaneously with
the execution of the Merger Agreement, certain investors entered into subscription agreements (the &#8220;Subscription Agreements&#8221;),
pursuant to which such investors subscribed for an aggregate value of $482,500,000, representing 48,250,000 shares of Tuscan common
stock at a purchase price of $10.00 per share in a private placement (the &#8220;PIPE Financing&#8221;) to be consummated immediately
prior to the consummation of the Transactions. Affiliates of InterPrivate Capital LLC (&#8220;InterPrivate&#8221;), a co-sponsor
of Tuscan, subscribed to purchase 6.5 million shares in the PIPE Financing for an aggregate purchase price of $65 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immediately following
the Closing, the former equityholders of Microvast will hold approximately 69.9% of the issued and outstanding shares of common
stock and the current stockholders of Tuscan will hold approximately 9.2% of the issued and outstanding shares of common stock,
which pro forma ownership (1)&#160;assumes no holder of the common stock sold in Tuscan&#8217;s initial public offering (such persons,
the &#8220;Public Stockholders&#8221;) exercises its conversion rights in connection with the business combination, and (2)&#160;reflects
the issuance of an aggregate of 48,250,000&#160;shares of Common Stock in the PIPE Financing and 6,736,111&#160;shares of common
stock in the Bridge Notes Conversion, but does not include the effect of any other financing of Tuscan. If the maximum number of
Public Shares are converted into cash such that Microvast does not have the right to terminate the Merger Agreement (i.e., Tuscan
has at least $5,000,001 of net tangible assets immediately prior to or upon consummation of the business combination), such percentages
will be approximately 76.8% and 0.2%, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Consummation of the
proposed business combination is subject to customary conditions and covenants of the respective parties, including approval of
Tuscan&#8217;s stockholders and Tuscan having available cash of at least $250,000,000. Further information regarding the proposed
business combination, the proposed business of the combined company following consummation of the merger and the risks related
to the proposed business of the combined company following consummation of the merger can be found in Tuscan&#8217;s Current Report
on Form 8-K filed with the SEC on February 5, 2021, the preliminary proxy statement filed by Tuscan with the SEC on February 16,
2021, and the definitive proxy statement to be filed by Tuscan with the SEC. Unless otherwise indicated, the information in this
Form 10-K assumes we will not consummate the proposed business combination with Microvast, and that we will secure a further extension
to consummate an initial business combination and then seek to find an alternative target with which to consummate an initial business
combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Extension Amendment</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;3,
2020, Tuscan received stockholder approval to amend its amended and restated certificate of incorporation (&#8220;charter&#8221;)
to extend the date by which it must complete an initial business combination from December&#160;7, 2020 to April&#160;30, 2021.
In connection with such extension, holders of 3,198 Public Shares exercised their right to convert their shares into cash at a
conversion price of approximately $10.22 per share, for an aggregate conversion amount of approximately $32,684.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 12, 2021,
Tuscan filed a preliminary proxy statement seeking approval from its stockholders to amend Tuscan&#8217;s charter to extend the
date by which Tuscan is required to complete its initial business combination from April 30, 2021 to July 31, 2021 and to hold an annual meeting for the election of directors
in accordance with Nasdaq listing rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Nasdaq Compliance</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;6,
2021, we received a notice from the Listing Qualifications Department of The Nasdaq Stock Market stating that we failed to hold
an Annual Meeting of stockholders within 12&#160;months after our fiscal year ended December&#160;31, 2019, as required by Nasdaq
Listing Rule&#160;5620(a). In accordance with Nasdaq Listing Rule&#160;5810(c)(2)(G), we submitted a plan to regain compliance
on February&#160;4, 2021. Nasdaq accepted our plan and granted us an extension through June 29, 2021 to hold an annual meeting.
Nasdaq&#8217;s decision is subject to certain conditions, including that we provide periodic updates with respect to our proposed
business combination with Microvast.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effecting a Business Combination</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sources of Target Businesses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have evaluated a
number of target businesses, including Microvast. When evaluating each prospective target business, we conducted a thorough due
diligence review that encompassed, among other things, meetings with incumbent management and employees, document reviews, and
a review of financial and other information made available to us. We engaged EarlyBirdCapital, Inc. to provide services in connection
with our initial business combination and, upon consummation of our initial business combination, we must pay that firm a fee in
an amount equal to $9,660,000 (exclusive of any applicable finders&#8217; fees which might become payable); provided that up to
30% of the fee may be allocated at the Company&#8217;s sole discretion to other FINRA members that assist the Company in identifying
and consummating a business combination. We engaged Morgan Stanley &amp; Co. LLC (&#8220;Morgan Stanley&#8221;) to provide financial
advisory services in connection with the Microvast business combination, and, upon consummation of the transaction with Microvast,
we must pay that firm a transaction fee of $5.5 million, plus expenses. Morgan Stanley also acted as placement agent in connection
with the PIPE Financing, and we are obligated to pay Morgan Stanley a placement fee equal to (i) 3.5% of the sum of (x) the aggregate
gross proceeds raised in the PIPE Financing up to $300 million (not including funds from the sale of certain excluded securities)
and (y) any borrowings pursuant to a bridge financing provided in connection with the proposed business combination by investors
introduced by Morgan Stanley, and (ii) 2.5% of the aggregate gross proceeds raised in the PIPE Financing above $300 million. In
addition, Mr. Vogel and our Sponsor entered into an agreement with InterPrivate pursuant to which InterPrivate would advise us
with respect to our evaluation of business combination transactions. Pursuant to the agreement, the Sponsor granted InterPrivate
a profits interest attributable to a portion of the securities of Tuscan held by the Sponsor, subject to the consummation of our
initial business combination. We may engage other firms or other individuals in the future, in which event we may pay a finder&#8217;s
fee, consulting fee, or other compensation to be determined in an arm&#8217;s length negotiation based on the terms of the transaction.
In no event, however, will our sponsor, officers, directors, or their respective affiliates be paid any finder&#8217;s fee, consulting
fee, or other compensation prior to, or for any services they render in order to effectuate our initial business combination, other
than the monthly administrative services fee of $10,000, the repayment of working capital loans, and reimbursement of out-of-pocket
expenses, however, such repayment may be limited in connection with negotiations with a prospective target.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not restricted
from entering into any such transactions with a target business that is affiliated with any of our officers, directors, and sponsor,
and may do so if (i) such transaction is approved by a majority of our disinterested independent directors and (ii) we obtain an
opinion from an independent investment banking firm, or another independent entity that commonly renders valuation opinions, that
the business combination is fair to our unaffiliated stockholders from a financial point of view. Microvast is not affiliated with
any of our officers, directors, or sponsor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Selection of Target Business and Structuring of a Business
Combination</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the limitations
that a target business have a fair market value of at least 80% of the balance in the trust account (excluding taxes payable on
the income earned on the trust account) at the time of the execution of a definitive agreement for our initial business combination,
as described below in more detail, and that we must acquire a controlling interest in the target business, our management has virtually
unrestricted flexibility in identifying and selecting a prospective target business. We have not established any specific attributes
or criteria (financial or otherwise) for prospective target businesses. In evaluating a prospective target business, our management
may consider a variety of factors, including one or more of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">financial condition and results of operation;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">growth potential;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">brand recognition and potential;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">experience and skill of management and availability of additional personnel;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">capital requirements;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">competitive position;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">barriers to entry;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">stage of development of the products, processes or services;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">existing distribution and potential for expansion;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">degree of current or potential market acceptance of the products, processes or services;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">proprietary aspects of products and the extent of intellectual property or other protection for products or formulas;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">impact of regulation on the business;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">regulatory environment of the industry;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the target business&#8217;s compliance with U.S. federal law, including the Controlled Substances Act;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">costs associated with effecting the business combination;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">industry leadership, sustainability of market share and attractiveness of market industries in which a target business participates; and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">macro competitive dynamics in the industry within which the company competes.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These criteria are
not intended to be exhaustive. Any evaluation relating to the merits of a particular business combination will be based, to the
extent relevant, on the above factors as well as other considerations deemed relevant by our management in effecting a business
combination consistent with our business objective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any costs incurred with respect to the identification and evaluation of a prospective target business
with which a business combination is not ultimately completed will result in a loss to us and reduce the amount of capital available
to otherwise complete a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fair Market Value of Target Business</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nasdaq listing rules
require that the target business or businesses that we acquire must collectively have a fair market value equal to at least 80%
of the balance of the funds in the trust account (excluding taxes payable on the income earned on the trust account) at the time
of the execution of a definitive agreement for our initial business combination, although we may acquire a target business whose
fair market value significantly exceeds 80% of the trust account balance. Notwithstanding the foregoing, if we are not then listed
on Nasdaq for whatever reason, we would no longer be required to meet the foregoing 80% fair market value test.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have
structured the proposed business combination with Microvast so that we will acquire 100% of the equity interests or assets of
Microvast. We are not limited to this structure, however, and may structure our initial business combination where we merge
directly with the target business or where we acquire less than 100% of such interests or assets of the target business in
order to meet certain objectives of the target management team or shareholders or for other reasons, but we will only
complete such business combination if the post-transaction&#160;company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be
required to register as an investment company under the Investment Company Act. Even if the post-transaction&#160;company
owns or acquires 50% or more of the voting securities of the target, our stockholders prior to the business combination may
collectively own a minority interest in the post-transaction&#160;company, depending on valuations ascribed to the target and
us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number
of new shares in exchange for all of the outstanding capital stock of a target. In this case, we could acquire a 100%
controlling interest in the target; however, as a result of the issuance of a substantial number of new shares, our
stockholders immediately prior to our initial business combination could own less than a majority of our outstanding shares
subsequent to our initial business combination. If less than 100% of the equity interests or assets of a target business or
businesses are owned or acquired by the post-transaction&#160;company, the portion of such business or businesses that is
owned or acquired is what will be valued for purposes of the 80% of trust account balance test.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair market value
of the target will be determined by our board of directors based upon one or more standards generally accepted by the financial
community (such as actual and potential sales, earnings, cash flow and/or book value). The proxy solicitation materials or tender
offer documents used by us in connection with any proposed transaction will provide public stockholders with our analysis of the
fair market value of the target business, as well as the basis for our determinations. If our board is not able to independently
determine that the target business has a sufficient fair market value, we will obtain an opinion from an unaffiliated, independent
investment banking firm, or another independent entity that commonly renders valuation opinions, with respect to the satisfaction
of such criteria. We will not be required to obtain an opinion from an investment banking firm as to the fair market value if our
board of directors independently determines that the target business complies with the 80% threshold.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lack of Business Diversification</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we do not
currently intend to effect a business combination with more than one target business, we may do so, and there is no required minimum
valuation standard for any single target at the time of such acquisition. Because we expect to complete only a single business
combination, at least initially, the prospects for our success would be entirely dependent upon the future performance of a single
business operation. Unlike other entities which may have the resources to complete several business combinations of entities operating
in multiple industries or multiple areas of a single industry, it is probable that we will not have the resources to diversify
our operations or benefit from the possible spreading of risks or offsetting of losses. By consummating a business combination
with only a single entity, our lack of diversification may:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">subject us to numerous economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact upon the particular industry in which we may operate subsequent to a business combination, and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">result in our dependency upon the performance of a single operating business or the development or market acceptance of a single or limited number of products, processes or services.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Limited Ability to Evaluate the Target
Business&#8217; Management</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we have scrutinized
the management of Microvast, we cannot assure you that our assessment of Microvast&#8217;s management will prove to be correct.
While we anticipate that Stephen Vogel will remain a director of ours following the business combination with Microvast, it is
unlikely that he will devote his full time efforts to our affairs subsequent to a business combination. Following a business combination,
we may seek to recruit additional personnel to supplement the incumbent management of the target business. We cannot assure you
that we will have the ability to recruit additional managers, or that any such additional managers we do recruit will have the
requisite skills, knowledge or experience necessary to enhance the incumbent management.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Stockholders May Not Have the Ability
to Approve an Initial Business Combination</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
any proposed business combination, we will either (1) seek stockholder approval of our initial business combination at a meeting
called for such purpose at which stockholders may seek to convert their shares, regardless of whether they vote for or against
the proposed business combination or don&#8217;t vote at all, into their pro rata share of the aggregate amount then on deposit
in the trust account (net of taxes payable), or (2) provide our stockholders with the opportunity to sell their shares to us by
means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount equal to their pro rata share of the
aggregate amount then on deposit in the trust account (net of taxes payable), in each case subject to the limitations described
herein. If we determine to engage in a tender offer, such tender offer will be structured so that each stockholder may tender all
of his, her or its shares rather than some pro rata portion of his, her or its shares. The decision as to whether we will seek
stockholder approval of a proposed business combination or will allow stockholders to sell their shares to us in a tender offer
will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction and
whether the terms of the transaction would otherwise require us to seek stockholder approval. Unlike other blank check companies
which require stockholder votes and conduct proxy solicitations in conjunction with their initial business combinations and related
conversions of public shares for cash upon consummation of such initial business combination even when a vote is not required by
law, we will have the flexibility to avoid such stockholder vote and allow our stockholders to sell their shares pursuant to Rule
13e-4&#160;and Regulation 14E of the Exchange Act which regulate issuer tender offers. In that case, we will file tender offer
documents with the SEC which will contain substantially the same financial and other information about the initial business combination
as is required under the SEC&#8217;s proxy rules. We will consummate our initial business combination only if we have net tangible
assets of at least $5,000,001 upon such consummation and, if we seek stockholder approval, a majority of the outstanding shares
of common stock voted are voted in favor of the business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We chose our net tangible
asset threshold of $5,000,001 to ensure that we would avoid being subject to Rule 419 promulgated under the Securities Act of 1933,
as amended. However, if we seek to consummate an initial business combination with a target business that imposes any type of working
capital closing condition or requires us to have a minimum amount of funds available from the trust account upon consummation of
such initial business combination, we may need to have more than $5,000,001 in net tangible assets upon consummation and this may
force us to seek third party financing which may not be available on terms acceptable to us or at all. As a result, we may not
be able to consummate such initial business combination and we may not be able to locate another suitable target within the applicable
time period, if at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Sponsor, initial
stockholders, officers and directors have agreed (1) to vote any shares of common stock owned by them in favor of any proposed
business combination, (2) not to convert any shares of common stock in connection with a stockholder vote to approve a proposed
initial business combination and (3) not sell any shares of common stock in any tender in connection with a proposed initial business
combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we hold a meeting
to approve a proposed business combination and a significant number of stockholders vote, or indicate an intention to vote, against
such proposed business combination, our officers, directors, Sponsor, initial stockholders or their affiliates could make purchases
of our securities in the open market or in private transactions in order to influence the vote. Notwithstanding the foregoing,
our officers, directors, Sponsor, initial stockholders and their affiliates will not make purchases of shares of common stock if
the purchases would violate Section 9(a)(2) or Rule 10b-5&#160;of the Exchange Act, which are rules designed to stop potential
manipulation of a company&#8217;s stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Conversion Rights</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any meeting called
to approve an initial business combination, public stockholders may seek to convert their shares, regardless of whether they vote
for or against the proposed business combination or do not vote at all, into their pro rata share of the aggregate amount then
on deposit in the trust account as of two business days prior to the consummation of the initial business combination, less any
taxes then due but not yet paid. Alternatively, we may provide our public stockholders with the opportunity to sell their shares
of our common stock to us through a tender offer (and thereby avoid the need for a stockholder vote) for an amount equal to their
pro rata share of the aggregate amount then on deposit in the trust account, less any taxes then due but not yet paid.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Sponsor, initial
stockholders and our officers and directors will not have conversion rights with respect to any shares of common stock owned by
them, directly or indirectly, whether acquired prior our IPO or purchased by them in the IPO or in the aftermarket. Additionally,
the holders of the representative shares will not have conversion rights with respect to the representative shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may require public
stockholders, whether they are a record holder or hold their shares in &#8220;street name,&#8221; to either (i) physically tender
their certificates to our transfer agent or (ii) deliver their shares to the transfer agent electronically using Depository Trust
Company&#8217;s DWAC (Deposit/Withdrawal At Custodian) System, at the holder&#8217;s option, in each case prior to a date set forth
in the proxy materials sent in connection with the proposal to approve the business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is a nominal
cost associated with the above-referenced&#160;delivery process and the act of certificating the shares or delivering them through
the DWAC System. The transfer agent will typically charge the tendering broker a nominal fee and it would be up to the broker whether
or not to pass this cost on to the holder. However, this fee would be incurred regardless of whether or not we require holders
seeking to exercise conversion rights. The need to deliver shares is a requirement of exercising conversion rights regardless of
the timing of when such delivery must be effectuated. However, in the event we require stockholders seeking to exercise conversion
rights prior to the consummation of the proposed business combination and the proposed business combination is not consummated
this may result in an increased cost to stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any proxy solicitation
materials we furnish to stockholders in connection with a vote for any proposed business combination will indicate whether we are
requiring stockholders to satisfy such certification and delivery requirements. Accordingly, a stockholder would have from the
time the stockholder received our proxy statement up until the vote on the proposal to approve the business combination to deliver
his shares if he wishes to seek to exercise his conversion rights. This time period varies depending on the specific facts of each
transaction. However, as the delivery process can be accomplished by the stockholder, whether or not he is a record holder or his
shares are held in &#8220;street name,&#8221; in a matter of hours by simply contacting the transfer agent or his broker and requesting
delivery of his shares through the DWAC System, we believe this time period is sufficient for an average investor. However, we
cannot assure you of this fact. Please see the risk factor titled &#8220;<i>In connection with any stockholder meeting called to
approve a proposed initial business combination, we may require stockholders who wish to convert their shares in connection with
a proposed business combination to comply with specific requirements for conversion that may make it more difficult for them to
exercise their conversion rights prior to the deadline for exercising their rights</i>&#8221; for further information on the risks
of failing to comply with these requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing is different
from the procedures historically used by some blank check companies. Traditionally, in order to perfect conversion rights in connection
with a blank check company&#8217;s business combination, the company would distribute proxy materials for the stockholders&#8217;
vote on an initial business combination, and a holder could simply vote against a proposed business combination and check a box
on the proxy card indicating such holder was seeking to exercise his conversion rights. After the business combination was approved,
the company would contact such stockholder to arrange for him to deliver his certificate to verify ownership. As a result, the
stockholder then had an &#8220;option window&#8221; after the consummation of the business combination during which he could monitor
the price of the company&#8217;s stock in the market. If the price rose above the conversion price, he could sell his shares in
the open market before actually delivering his shares to the company for cancellation. As a result, the conversion rights, to which
stockholders were aware they needed to commit before the stockholder meeting, would become a &#8220;continuing&#8221; right surviving
past the consummation of the business combination until the holder delivered its certificate. The requirement for physical or electronic
delivery prior to the meeting ensures that a holder&#8217;s election to convert his shares is irrevocable once the business combination
is approved.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any request to convert
such shares once made, may be withdrawn at any time up to the vote on the proposed business combination or the expiration of the
tender offer. Furthermore, if a holder of a public share of common stock delivered his certificate in connection with an election
of their conversion and subsequently decides prior to the applicable date not to elect to exercise such rights, he may simply request
that the transfer agent return the certificate (physically or electronically).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the initial business
combination is not approved or completed for any reason, then our public stockholders who elected to exercise their conversion
rights would not be entitled to convert their shares for the applicable pro rata share of the trust account as of two business
days prior to the consummation of the initial business combination. In such case, we will promptly return any shares delivered
by public holders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Liquidation if No Business Combination</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our charter provides
that we will have only until April 30, 2021 to complete an initial business combination (unless such time period is extended by
our stockholders, as provided in our charter). On March 12, 2021, we filed a preliminary proxy statement to seek stockholder approval
to extend our liquidation date from April 30, 2021 to July 31, 2021 and to hold an annual meeting for the election of directors
in accordance with Nasdaq listing rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we have not completed
an initial business combination by such date, or have not secured stockholder approval to extend such date, we will (i) cease all
operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,
redeem 100% of the outstanding public shares, at a per-share&#160;price, payable in cash, equal to the aggregate amount then on
deposit in the trust account, including any interest not previously released to us but net of taxes payable, divided by the number
of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders
(including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as
reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors,
dissolve and liquidate, subject (in the case of (ii) and (iii) above) to our obligations under Delaware law to provide for claims
of creditors and the requirements of other applicable law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Sponsor, initial
stockholders, officers and directors have agreed that they will not propose any amendment to our charter that would affect our
public stockholders&#8217; ability to convert or sell their shares to us in connection with a business combination as described
herein or affect the substance or timing of our obligation to redeem 100% of our public shares if we do not complete a business
combination by April 30, 2021 (or July 31, 2021, if the proposed extension is approved by our stockholders) unless we provide our
public stockholders with the opportunity to convert their shares of common stock upon such approval at a per-share&#160;price,
payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest not previously released
to us but net of franchise and income taxes payable, divided by the number of then outstanding public shares. This redemption right
shall apply in the event of the approval of any such amendment, whether proposed by our Sponsor, initial stockholders, executive
officers, directors or any other person.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Delaware
General Corporation Law, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions
received by them in a dissolution. The pro rata portion of our trust account distributed to our public stockholders upon the redemption
of 100% of our outstanding public shares in the event we do not complete our initial business combination within the required time
period may be considered a liquidation distribution under Delaware law. If the corporation complies with certain procedures set
forth in Section 280 of the Delaware General Corporation Law intended to ensure that it makes reasonable provision for all claims
against it, including a 60-day&#160;notice period during which any third-party&#160;claims can be brought against the corporation,
a 90-day period during which the corporation may reject any claims brought, and an additional 150-day&#160;waiting period before
any liquidating distributions are made to stockholders, any liability of stockholders with respect to a liquidating distribution
is limited to the lesser of such stockholder&#8217;s pro rata share of the claim or the amount distributed to the stockholder,
and any liability of the stockholder would be barred after the third anniversary of the dissolution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, if the
pro rata portion of our trust account distributed to our public stockholders upon the redemption of 100% of our public shares in
the event we do not complete our initial business combination within the required time period is not considered a liquidation distribution
under Delaware law and such redemption distribution is deemed to be unlawful, then pursuant to Section 174 of the Delaware General
Corporation Law, the statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution,
instead of three years, as in the case of a liquidation distribution. If we are unable to complete a business combination within
the prescribed time frame, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably
possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares, at a per-share&#160;price,
payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest but net of franchise
and income taxes payable, divided by the number of then outstanding public shares, which redemption will completely extinguish
public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject
to applicable law and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining
stockholders and our board of directors, dissolve and liquidate, subject (in the case of (ii) and (iii) above) to our obligations
under Delaware law to provide for claims of creditors and the requirements of other applicable law. Accordingly, it is our intention
to redeem our public shares as soon as reasonably possible following our 21<sup>st</sup>&#160;month, and, therefore, we do not
intend to comply with those procedures. As such, our stockholders could potentially be liable for any claims to the extent of distributions
received by them (but no more) and any liability of our stockholders may extend well beyond the third anniversary of such date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because we will not
be complying with Section 280 of the Delaware General Corporation Law, Section 281(b) of the Delaware General Corporation Law requires
us to adopt a plan, based on facts known to us at such time that will provide for our payment of all existing and pending claims
or claims that may be potentially brought against us within the subsequent ten years. However, because we are a blank check company,
rather than an operating company, and our operations will be limited to searching for prospective target businesses to acquire,
the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are required to
seek to have all third parties (including any vendors or other entities we engage) and any prospective target businesses enter
into agreements with us waiving any right, title, interest or claim of any kind they may have in or to any monies held in the trust
account. As a result, the claims that could be made against us will be limited, thereby lessening the likelihood that any claim
would result in any liability extending to the trust. We therefore believe that any necessary provision for creditors will be reduced
and should not have a significant impact on our ability to distribute the funds in the trust account to our public stockholders.
Nevertheless, Marcum LLP, our independent registered public accounting firm, and the underwriters of our IPO, will not execute
agreements with us waiving such claims to the monies held in the trust account. Furthermore, there is no guarantee that other vendors,
service providers and prospective target businesses will execute such agreements. Nor is there any guarantee that, even if they
execute such agreements with us, they will not seek recourse against the trust account. Our Sponsor has agreed that it will be
liable to ensure that the proceeds in the trust account are not reduced below $10.00 per share by the claims of target businesses
or claims of vendors or other entities that are owed money by us for services rendered or contracted for or products sold to us,
but we cannot assure you that it will be able to satisfy its indemnification obligations if it is required to do so. We have not
asked our Sponsor to reserve for such indemnification obligations, nor have we independently verified whether our Sponsor has sufficient
funds to satisfy its indemnity obligations and believe that our Sponsor&#8217;s only assets are securities of our company. Therefore,
we believe it is unlikely that our Sponsor will be able to satisfy its indemnification obligations if it is required to do so.
Additionally, the agreement our Sponsor entered into specifically provides for two exceptions to the indemnity it has given: it
will have no liability (1) as to any claimed amounts owed to a target business or vendor or other entity who has executed an agreement
with us waiving any right, title, interest or claim of any kind they may have in or to any monies held in the trust account, or
(2) as to any claims for indemnification by the underwriters of our IPO against certain liabilities, including liabilities under
the Securities Act. As a result, if we liquidate, the per-share&#160;distribution from the trust account could be less than $10.00
due to claims or potential claims of creditors. We will distribute to all of our public stockholders, in proportion to their respective
equity interests, an aggregate sum equal to the amount in the trust account, inclusive of any interest (subject to our obligations
under Delaware law to provide for claims of creditors as described below).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We anticipate notifying
the trustee of the trust account to begin liquidating such assets promptly after such date and anticipate it will take no more
than 10 business days to effectuate such distribution. The holders of the founders&#8217; shares and private shares have waived
their rights to participate in any liquidation distribution from the trust account with respect to such shares. There will be no
distribution from the trust account with respect to our warrants, which will expire worthless. We will pay the costs of any subsequent
liquidation from our remaining assets outside of the trust account. If such funds are insufficient, our Sponsor has contractually
agreed to advance us the funds necessary to complete such liquidation (currently anticipated to be no more than approximately $15,000)
and has contractually agreed not to seek repayment for such expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are unable to
complete an initial business combination and expend all of the net proceeds of the IPO, other than the proceeds deposited in the
trust account, and without taking into account interest, if any, earned on the trust account, the initial per-share&#160;redemption
price would be $10.00. The proceeds deposited in the trust account could, however, become subject to claims of our creditors that
are in preference to the claims of public stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our public stockholders
shall be entitled to receive funds from the trust account only in the event of our failure to complete a business combination within
the required time period, if the stockholders seek to have us convert or purchase their respective shares upon a business combination
which is actually completed by us or upon certain amendments to our charter prior to consummating an initial business combination.
In no other circumstances shall a stockholder have any right or interest of any kind to or in the trust account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are forced to
file a bankruptcy case or an involuntary bankruptcy case is filed against us which is not dismissed, the proceeds held in the trust
account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of
third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the trust account,
we cannot assure you we will be able to return to our public stockholders at least $10.00 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are forced to
file a bankruptcy case or an involuntary bankruptcy case is filed against us which is not dismissed, any distributions received
by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a &#8220;preferential transfer&#8221;
or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy court could seek to recover all amounts received by our stockholders.
Furthermore, because we intend to distribute the proceeds held in the trust account to our public stockholders promptly after April
30, 2021 (or July 31, 2021, if the proposed extension is approved by our stockholders), this may be viewed or interpreted as giving
preference to our public stockholders over any potential creditors with respect to access to or distributions from our assets.
Furthermore, our board may be viewed as having breached their fiduciary duties to our creditors and/or may have acted in bad faith,
and thereby exposing itself and our company to claims of punitive damages, by paying public stockholders from the trust account
prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Amended and Restated Certificate of Incorporation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated
certificate of incorporation contains certain requirements and restrictions relating to our IPO that will apply to us until the
consummation of our initial business combination. These provisions cannot be amended without the approval of a majority of our
stockholders. If we seek to amend any provisions of our amended and restated certificate of incorporation that would affect our
public stockholders&#8217; ability to convert or sell their shares to us in connection with a business combination as described
herein or affect the substance or timing of our obligation to redeem 100% of our public shares if we do not complete a business
combination by April 30, 2021 (or July 31, 2021, if the proposed extension is approved by our stockholders), we will provide dissenting
public stockholders with the opportunity to convert their public shares in connection with any such vote. This conversion right
shall apply in the event of the approval of any such amendment, whether proposed by our Sponsor, any executive officer, director
or director nominee, or any other person. Our Sponsor, officers and directors have agreed to waive any conversion rights with respect
to any founders&#8217; shares, private shares and any public shares they may hold in connection with any vote to amend our amended
and restated certificate of incorporation. Specifically, our amended and restated certificate of incorporation provides, among
other things, that:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we shall either (1) seek stockholder approval of our initial business combination at a meeting called for such purpose at which stockholders may seek to convert their shares, regardless of whether they vote for or against the proposed business combination or don&#8217;t vote at all, into their pro rata share of the aggregate amount then on deposit in the trust account (net of taxes payable), or (2) provide our stockholders with the opportunity to sell their shares to us by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the trust account (net of taxes payable), in each case subject to the limitations described herein;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we will consummate our initial business combination only if we have net tangible assets of at least $5,000,001 upon such consummation and, if we seek stockholder approval, a majority of the outstanding shares of common stock voted are voted in favor of the business combination;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">if our initial business combination is not consummated by April 30, 2021, and such date is not further extended, then we will redeem all of the outstanding public shares and thereafter liquidate and dissolve our company;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we may not consummate any other business combination, merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar transaction prior to our initial business combination; and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">prior to our initial business combination, we may not issue additional stock that participates in any manner in the proceeds of the trust account, or that votes as a class with the common stock sold in our IPO on an initial business combination.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Competition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In identifying, evaluating and selecting
a target business, we may encounter intense competition from other entities having a business objective similar to ours. Many of
these entities are well established and have extensive experience identifying and effecting business combinations directly or through
affiliates. Many of these competitors possess greater technical, human and other resources than us and our financial resources
will be relatively limited when contrasted with those of many of these competitors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following also may not be viewed favorably
by certain target businesses:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our obligation to seek stockholder approval of a business combination or engage in a tender offer may delay the completion of a transaction;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our obligation to convert or repurchase shares of common stock held by our public stockholders may reduce the resources available to us for a business combination; and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our outstanding warrants, and the potential future dilution they represent.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any of these factors may place us at a
competitive disadvantage in successfully negotiating a business combination. Our management believes, however, that our status
as a public entity and potential access to the United States public equity markets may give us a competitive advantage over privately-held&#160;entities
having a similar business objective as ours in acquiring a target business with significant growth potential on favorable terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we succeed in effecting a business combination,
there will be, in all likelihood, intense competition from competitors of the target business. We cannot assure you that, subsequent
to a business combination, we will have the resources or ability to compete effectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Facilities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently maintain our principal executive
offices at 135 E. 57th St., 18th Floor, New York, NY 10022. The cost for this space is included in the $10,000 per-month&#160;fee
Vogel Partners, LLP, an affiliate of our Chief Executive Officer, will charge us for general and administrative services. We consider
our current office space, combined with the other office space otherwise available to our executive officers, adequate for our
current operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have two executive officers. These individuals
are not obligated to devote any specific number of hours to our matters and intend to devote only as much time as they deem necessary
to our affairs. We do not have, and do not intend to have, any full time employees prior to the consummation of a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 1A. RISK FACTORS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>An investment in our securities involves
a high degree of risk. You should consider carefully the risks described below, which we believe represent the material risks related
to Tuscan, together with the other information contained in this Form 10-K, before making a decision to invest in Tuscan. The risks
set forth below do not include specific risks relating to our proposed business combination with Microvast, or the risks inherent
in Microvast&#8217;s business, which are included in the preliminary proxy statement which we filed with the SEC on February 16,
2021. The risks presented below assumes that we will not consummate the proposed business combination with Microvast, and that
we will secure a further extension to consummate an initial business combination and then seek to find an alternative target with
which to consummate an initial business combination.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>This Form 10-K also contains forward-looking
statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking
statements as a result of specific factors, including the risks described below.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to Searching for and
Consummating a Business Combination</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have no operating history and,
accordingly, you will not have any basis on which to evaluate our ability to achieve our business objective.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have no operating
results to date. Therefore, our ability to commence operations is dependent upon obtaining financing through the public offering
of our securities. Since we do not have an operating history, you will have no basis upon which to evaluate our ability to achieve
our business objective, which is to acquire an operating business. We will not generate any revenues until, at the earliest, after
the consummation of a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to consummate a
business combination, our public stockholders may be forced to wait until after April 30, 2021 (or July 31, 2021, if the proposed
extension is approved by our stockholders) before receiving distributions from the trust account.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our public stockholders
will be entitled to receive funds from the trust account only upon the earlier to occur of: (i) the consummation of our initial
business combination; (ii) the redemption of our public shares if we are unable to consummate a business combination by April 30,
2021 (or July 31, 2021, if the proposed extension is approved by our stockholders), subject to applicable law; (iii) the redemption
of any public shares properly tendered in connection with a stockholder vote to amend our amended and restated certificate of incorporation
to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business
combination by April 30, 2021 (or July 31, 2021). In addition, if our plan to redeem our public shares if we are unable to consummate
an initial business combination by April 30, 2021 (or July 31, 2021) is not consummated for any reason, Delaware law may require
that we submit a plan of dissolution to our then-existing stockholders for approval prior to the distribution of the proceeds held
in our trust account. In that case, public stockholders may be forced to wait beyond April 30, 2021 before they receive funds from
our trust account. In no other circumstances will a public stockholder have any right or interest of any kind in the trust account.
Accordingly, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The requirement that we complete
an initial business combination by April 30, 2021 (or such later date as may be approved by our stockholders) may give potential
target businesses leverage over us in negotiating a business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have until April
30, 2021 (or such later date as may be approved by our stockholders) to complete an initial business combination. Any potential
target business with which we enter into negotiations concerning a business combination will be aware of this requirement. Consequently,
such target business may obtain leverage over us in negotiating a business combination, knowing that if we do not complete a business
combination with that particular target business, we may be unable to complete a business combination with any other target business.
This risk will increase as we get closer to the time limit referenced above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our public stockholders may not be
afforded an opportunity to vote on our proposed business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will either (1)
seek stockholder approval of our initial business combination at a meeting called for such purpose at which public stockholders
may seek to convert their shares, regardless of whether they vote for or against the proposed business combination or don&#8217;t
vote at all, into their pro rata share of the aggregate amount then on deposit in the trust account (net of taxes payable), or
(2) provide our public stockholders with the opportunity to sell their shares to us by means of a tender offer (and thereby avoid
the need for a stockholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the trust
account (net of taxes payable). Accordingly, it is possible that we will consummate our initial business combination even if holders
of a majority of our public shares do not approve of the business combination we consummate. The decision as to whether we will
seek stockholder approval of a proposed business combination or will allow stockholders to sell their shares to us in a tender
offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction
and whether the terms of the transaction would otherwise require us to seek stockholder approval. For instance, Nasdaq rules currently
allow us to engage in a tender offer in lieu of a stockholder meeting but would still require us to obtain stockholder approval
if we were seeking to issue more than 20% of our outstanding shares to a target business as consideration in any business combination.
Therefore, if we were structuring a business combination that required us to issue more than 20% of our outstanding shares, we
would seek stockholder approval of such business combination instead of conducting a tender offer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Sponsor controls a substantial
interest in us and thus may influence certain actions requiring a stockholder vote.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Sponsor, Tuscan
Holdings Acquisition LLC, owns approximately 21% of our issued and outstanding shares of common stock. Our Sponsor, officers, directors,
initial stockholders or their affiliates could determine in the future to make purchases of our securities in the open market or
in private transactions, to the extent permitted by law, in order to influence the vote or magnitude of the number of shareholders
seeking to tender their shares to us. In connection with any vote for a proposed business combination, our initial stockholders,
as well as all of our officers and directors, have agreed to vote the shares of common stock owned by them immediately before our
IPO as well as any shares of common stock acquired in the IPO or in the aftermarket in favor of such proposed business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors
is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being
elected in each year. As a consequence of our &#8220;staggered&#8221; board of directors, only a minority of the board of directors
will be considered for election and our Sponsor, because of its ownership position, will have considerable influence regarding
the outcome. Accordingly, our initial stockholders will continue to exert control at least until the consummation of a business
combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>You may be unable to ascertain the
merits or risks of any particular target business&#8217; operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may pursue an acquisition
opportunity in any business industry or sector. Accordingly, there is no current basis for you to evaluate the possible merits
or risks of the particular industry in which we may ultimately operate or the target business which we may ultimately acquire.
To the extent we complete a business combination with a financially unstable company or an entity in its development stage, we
may be affected by numerous risks inherent in the business operations of those entities. If we complete a business combination
with an entity in an industry characterized by a high level of risk, we may be affected by the currently unascertainable risks
of that industry. Although our management will endeavor to evaluate the risks inherent in a particular industry or target business,
we cannot assure you that we will properly ascertain or assess all of the significant risk factors. We also cannot assure you that
an investment in our units will not ultimately prove to be less favorable to investors than a direct investment, if an opportunity
were available, in a target business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The ability of our stockholders to
exercise their conversion rights or sell their shares to us in a tender offer may not allow us to effectuate the most desirable
business combination or optimize our capital structure.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our business combination
requires us to use substantially all of our cash to pay the purchase price, because we will not know how many stockholders may
exercise conversion rights or seek to sell their shares to us in a tender offer, we may either need to reserve part of the trust
account for possible payment upon such conversion, or we may need to arrange third party financing to help fund our business combination.
In the event that the acquisition involves the issuance of our stock as consideration, we may be required to issue a higher percentage
of our stock to make up for a shortfall in funds. Raising additional funds to cover any shortfall may involve dilutive equity financing
or incurring indebtedness at higher than desirable levels. This may limit our ability to effectuate the most attractive business
combination available to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>In connection with any vote to approve
a business combination, we will offer each public stockholder the option to vote in favor of a proposed business combination and
still seek conversion of his, her or its shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
any vote to approve a business combination, we will offer each public stockholder (but not our Sponsor, officers or directors)
the right to have his, her or its shares of common stock converted to cash (subject to the limitations described elsewhere in this
Form 10-K) regardless of whether such stockholder votes for or against such proposed business combination or does not vote at all.
The ability to seek conversion while voting in favor of our proposed business combination may make it more likely that we will
consummate a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>In connection with any stockholder
meeting called to approve a proposed initial business combination or an amendment to our charter to extend the date by which we
must complete an initial business combination, we may require stockholders who wish to convert their shares in connection with
such proposal to comply with specific requirements for conversion that may make it more difficult for them to exercise their conversion
rights prior to the deadline for exercising their rights.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
any stockholder meeting called to approve a proposed initial business combination or an amendment to our charter to extend the
date by which we must complete an initial business combination, each public stockholder will have the right, regardless of whether
he is voting for or against such proposal or does not vote at all, to demand that we convert his shares into a pro rata share of
the trust account as of two business days prior to the consummation thereof. We may require public stockholders who wish to convert
their shares to either (i) tender their certificates to our transfer agent or (ii) deliver their shares to the transfer agent electronically
using the Depository Trust Company&#8217;s DWAC (Deposit/Withdrawal At Custodian) System, at the holders&#8217; option, in each
case prior to a date set forth in the tender offer documents or proxy materials sent in connection with the proposal. In order
to obtain a physical stock certificate, a stockholder&#8217;s broker and/or clearing broker, DTC and our transfer agent will need
to act to facilitate this request. It is our understanding that stockholders should generally allot at least two weeks to obtain
physical certificates from the transfer agent. However, because we do not have any control over this process or over the brokers
or DTC, it may take significantly longer than two weeks to obtain a physical stock certificate. While we have been advised that
it takes a short time to deliver shares through the DWAC System, we cannot assure you of this fact. Accordingly, if it takes longer
than we anticipate for stockholders to deliver their shares, stockholders who wish to convert may be unable to meet the deadline
for exercising their conversion rights and thus may be unable to convert their shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If, in connection with any stockholder
meeting called to approve a proposed business combination, we require public stockholders who wish to convert their shares to comply
with specific requirements for conversion, such converting stockholders may be unable to sell their securities when they wish to
in the event that the proposed business combination is not approved.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we require public
stockholders who wish to convert their shares to comply with specific requirements for conversion and such proposed business combination
is not consummated, we will promptly return such certificates to the tendering public stockholders. Accordingly, investors who
attempted to convert their shares in such a circumstance will be unable to sell their securities after the failed acquisition until
we have returned their securities to them. The market price for our shares of common stock may decline during this time and you
may not be able to sell your securities when you wish to, even while other stockholders that did not seek conversion may be able
to sell their securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because of our structure, other companies
may have a competitive advantage and we may not be able to consummate an attractive business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to encounter
intense competition from entities other than blank check companies having a business objective similar to ours, including venture
capital funds, leveraged buyout funds and operating businesses competing for acquisitions. Many of these entities are well established
and have extensive experience in identifying and effecting business combinations directly or through affiliates. Many of these
competitors possess greater technical, human and other resources than we do and our financial resources will be relatively limited
when contrasted with those of many of these competitors. While we believe that there are numerous potential target businesses that
we could acquire with the net proceeds of our IPO, our ability to compete in acquiring certain sizable target businesses will be
limited by our available financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition
of certain target businesses. Furthermore, seeking stockholder approval or engaging in a tender offer in connection with any proposed
business combination may delay the consummation of such a transaction. Additionally, our outstanding warrants, and the future dilution
they potentially represent, may not be viewed favorably by certain target businesses. Any of the foregoing may place us at a competitive
disadvantage in successfully negotiating a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because we must furnish our stockholders
with target business financial statements prepared in accordance with U.S. generally accepted accounting principles or international
financial reporting standards, we will not be able to complete a business combination with prospective target businesses unless
their financial statements are prepared in accordance with U.S. generally accepted accounting principles or international financial
reporting standards.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The federal proxy rules
require that a proxy statement with respect to a vote on a business combination meeting certain financial significance tests include
historical and/or pro forma financial statement disclosure in periodic reports. These financial statements may be required to be
prepared in accordance with, or be reconciled to, accounting principles generally accepted in the United States of America, or
GAAP, or international financial reporting standards, or IFRS, depending on the circumstances, and the historical financial statements
may be required to be audited in accordance with the standards of the Public Company Accounting Oversight Board (United States),
or PCAOB. We will include the same financial statement disclosure in connection with any tender offer documents we use, whether
or not they are required under the tender offer rules. Additionally, to the extent we furnish our stockholders with financial statements
prepared in accordance with IFRS, such financial statements will need to be audited in accordance with U.S. GAAP at the time of
the consummation of the business combination. These financial statement requirements may limit the pool of potential target businesses
we may acquire.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A provision of our warrant agreement
may make it more difficult for us to consummate an initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we issue additional shares of common stock or equity-linked&#160;securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.50 per share of common stock,</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the volume weighted average trading price of our common stock during the 20 trading day period starting on the trading day prior to the day on which we consummate our initial business combination (such price, the &#8220;Market Value&#8221;) is below $9.50 per share,</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">then the exercise price of the warrants
will be adjusted to be equal to 115% of the higher of the Market Value and the price at which we issue the additional shares of
common stock or equity-linked&#160;securities. This may make it more difficult for us to consummate an initial business combination
with a target business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may issue shares of our capital
stock or debt securities to complete a business combination, which would reduce the equity interest of our stockholders and likely
cause a change in control of our ownership.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated
certificate of incorporation authorizes the issuance of up to 65,000,000&#160;shares of common stock, par value $0.0001 per share,
and 1,000,000&#160;shares of preferred stock, par value $0.0001 per share. We may issue a substantial number of additional shares
of common stock or shares of preferred stock, or a combination of common stock and preferred stock, to complete a business combination.
The issuance of additional shares of common stock will not reduce the per-share&#160;conversion amount in the trust account. The
issuance of additional shares of common stock or preferred stock:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">may significantly reduce the equity interest of investors in our common stock;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">may subordinate the rights of holders of shares of common stock if we issue shares of preferred stock with rights senior to those afforded to our shares of common stock;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">may cause a change in control if a substantial number of shares of common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">may adversely affect prevailing market prices for our shares of common stock.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Similarly, if we issue debt securities,
it could result in:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">default and foreclosure on our assets if our operating revenues after a business combination are insufficient to repay our debt obligations;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we incur indebtedness, our lenders will
not have a claim on the cash in the trust account and such indebtedness will not decrease the per-share&#160;conversion amount
in the trust account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be unable to obtain additional
financing, if required, to complete a business combination or to fund the operations and growth of the target business, which could
compel us to restructure or abandon a particular business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we believe
that the net proceeds of our IPO, together with interest earned on the funds held in the trust account available to us, will be
sufficient to allow us to consummate a business combination, because we have not yet identified any prospective target business,
we cannot ascertain the capital requirements for any particular transaction. If the net proceeds of our IPO prove to be insufficient,
either because of the size of the business combination, the depletion of the available net proceeds in search of a target business,
or the obligation to convert into cash a significant number of shares from dissenting stockholders, we will be required to seek
additional financing. Such financing may not be available on acceptable terms, if at all. To the extent that additional financing
proves to be unavailable when needed to consummate a particular business combination, we would be compelled to either restructure
the transaction or abandon that particular business combination and seek an alternative target business candidate. In addition,
if we consummate a business combination, we may require additional financing to fund the operations or growth of the target business.
The failure to secure additional financing could have a material adverse effect on the continued development or growth of the target
business. None of our Sponsor, officers, directors or stockholders is required to provide any financing to us in connection with
or after a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not obtain a fairness opinion
with respect to the target business that we seek to acquire and therefore you may be relying solely on the judgment of our board
of directors in approving a proposed business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will only be required
to obtain a fairness opinion with respect to the target business that we seek to acquire if it is an entity that is affiliated
with any of our Sponsor, initial stockholders, officers, directors or their affiliates. In all other instances, we will have no
obligation to obtain an opinion. Accordingly, investors will be relying solely on the judgment of our board of directors in approving
a proposed business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Resources could be spent researching
acquisitions that are not consummated, which could materially adversely affect subsequent attempts to locate and acquire or merge
with another business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is anticipated that
the investigation of each specific target business and the negotiation, drafting, and execution of relevant agreements, disclosure
documents, and other instruments will require substantial management time and attention and substantial costs for accountants,
attorneys and others. If a decision is made not to complete a specific business combination, the costs incurred up to that point
for the proposed transaction likely would not be recoverable. Furthermore, even if an agreement is reached relating to a specific
target business, we may fail to consummate the business combination for any number of reasons including those beyond our control.
Any such event will result in a loss to us of the related costs incurred which could materially adversely affect subsequent attempts
to locate and acquire or merge with another business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may only be able to complete one
business combination with the proceeds from our IPO, which will cause us to be solely dependent on a single business which may
have a limited number of products or services.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is likely we will
consummate a business combination with a single target business, although we have the ability to simultaneously acquire several
target businesses. By consummating a business combination with only a single entity, our lack of diversification may subject us
to numerous economic, competitive and regulatory developments. Further, we would not be able to diversify our operations or benefit
from the possible spreading of risks or offsetting of losses, unlike other entities which may have the resources to complete several
business combinations in different industries or different areas of a single industry. Accordingly, the prospects for our success
may be:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">solely dependent upon the performance of a single business, or</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">dependent upon the development or market acceptance of a single or limited number of products, processes or services.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This lack of diversification
may subject us to numerous economic, competitive and regulatory developments, any or all of which may have a substantial adverse
impact upon the particular industry in which we may operate subsequent to a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Alternatively, if we
determine to simultaneously acquire several businesses and such businesses are owned by different sellers, we will need for each
of such sellers to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations,
which may make it more difficult for us, and delay our ability, to complete the business combination. With multiple business combinations,
we could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and
due diligence investigations (if there are multiple sellers) and the additional risks associated with the subsequent assimilation
of the operations and services or products of the acquired companies in a single operating business. If we are unable to adequately
address these risks, it could negatively impact our profitability and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our search for an initial business
combination, and any target business with which we ultimately consummate an initial business combination, may be materially adversely
affected by the recent coronavirus (COVID-19) outbreak and other events, and the status of debt and equity markets.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The COVID-19&#160;pandemic has adversely
affected, and other events (such as terrorist attacks, natural disasters or a significant outbreak of other infectious diseases)
could adversely affect, the economies and financial markets worldwide, and the business of any potential target business with which
we consummate an initial business combination could be materially and adversely affected. Furthermore, we may be unable to complete
an initial business combination if concerns relating to COVID-19&#160;continue to restrict travel, limit the ability to have meetings
with potential investors or the target company&#8217;s personnel, vendors and services providers are unavailable to negotiate and
consummate a transaction in a timely manner. The extent to which COVID-19&#160;impacts our search for an initial business combination
will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge
concerning the severity of COVID-19&#160;and the actions to contain COVID-19&#160;or treat its impact, among others. If the disruptions
posed by COVID-19&#160;or other events (such as terrorist attacks, natural disasters or a significant outbreak of other infectious
diseases) continue for an extensive period of time, our ability to consummate an initial business combination, or the operations
of a target business with which we ultimately consummate an initial business combination, may be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our ability to consummate
a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by COVID-19&#160;and other
events (such as terrorist attacks, natural disasters or a significant outbreak of other infectious diseases), including as a result
of increased market volatility, decreased market liquidity in third-party&#160;financing being unavailable on terms acceptable
to us or at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>As the number of special purpose
acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for
attractive targets. This could increase the cost of our initial business combination and could even result in our inability to
find a target or to consummate an initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In recent years and especially since the
fourth quarter of 2020, the number of special purpose acquisition companies that have been formed has increased substantially.
Many potential targets for special purpose acquisition companies have already entered into an initial business combination, and
there are still many special purpose acquisition companies seeking targets for their initial business combination, as well as many
such companies currently in registration. As a result, at times, fewer attractive targets may be available, and it may require
more time, more effort and more resources to identify a suitable target and to consummate an initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, because there are more special
purpose acquisition companies seeking to enter into an initial business combination with available targets, the competition for
available targets with attractive fundamentals or business models may increase, which could cause targets companies to demand improved
financial terms. Attractive deals could also become scarcer for other reasons, such as economic or industry sector downturns, geopolitical
tensions, or increases in the cost of additional capital needed to close business combinations or operate targets post-business&#160;combination.
This could increase the cost of, delay or otherwise complicate or frustrate our ability to find and consummate an initial business
combination, and may result in our inability to consummate an initial business combination on terms favorable to our investors
altogether.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in the market for directors
and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business
combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In recent months, the market for directors
and officers liability insurance for special purpose acquisition companies has changed. The premiums charged for such policies
have generally increased and the terms of such policies have generally become less favorable. There can be no assurance that these
trends will not continue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The increased cost and decreased availability
of directors and officers liability insurance could make it more difficult and more expensive for us to negotiate an initial business
combination. In order to obtain directors and officers liability insurance or modify its coverage as a result of becoming a public
company, the post-business&#160;combination entity might need to incur greater expense, accept less favorable terms or both. However,
any failure to obtain adequate directors and officers liability insurance could have an adverse impact on the post-business&#160;combination&#8217;s
ability to attract and retain qualified officers and directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, even after we were to complete
an initial business combination, our directors and officers could still be subject to potential liability from claims arising from
conduct alleged to have occurred prior to the initial business combination. As a result, in order to protect our directors and
officers, the post-business&#160;combination entity may need to purchase additional insurance with respect to any such claims (&#8220;run-off&#160;insurance&#8221;).
The need for run-off&#160;insurance would be an added expense for the post-business&#160;combination entity, and could interfere
with or frustrate our ability to consummate an initial business combination on terms favorable to our investors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to the Post-Business
Combination Company</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our ability to successfully effect
a business combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel, some of
whom may join us following a business combination. While we intend to closely scrutinize any individuals we engage after a business
combination, we cannot assure you that our assessment of these individuals will prove to be correct.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to successfully
effect a business combination is dependent upon the efforts of our key personnel. We believe that our success depends on the continued
service of our key personnel, at least until we have consummated our initial business combination. We cannot assure you that any
of our key personnel will remain with us for the immediate or foreseeable future. In addition, none of our officers are required
to commit any specified amount of time to our affairs and, accordingly, our officers will have conflicts of interest in allocating
management time among various business activities, including identifying potential business combinations and monitoring the related
due diligence. We do not have employment agreements with, or key-man&#160;insurance on the life of, any of our officers. The unexpected
loss of the services of our key personnel could have a detrimental effect on us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The role of our key
personnel after a business combination, however, cannot presently be ascertained. Although some of our key personnel may serve
in senior management or advisory positions following a business combination, it is likely that most, if not all, of the management
of the target business will remain in place. While we intend to closely scrutinize any individuals we engage after a business combination,
we cannot assure you that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with
the requirements of operating a public company which could cause us to have to expend time and resources helping them become familiar
with such requirements. This could be expensive and time-consuming&#160;and could lead to various regulatory issues which may adversely
affect our operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our officers and directors may not
have significant experience or knowledge regarding the jurisdiction or industry of the target business we may seek to acquire.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may consummate a
business combination with a target business in any geographic location or industry we choose, although we intend to focus on companies
or assets ancillary to the cannabis industry. We cannot assure you that our officers and directors will have enough experience
or have sufficient knowledge relating to the jurisdiction of the target or its industry to make an informed decision regarding
a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we do not conduct an adequate
due diligence investigation of a target business, we may be required to subsequently take write-downs or write-offs, restructuring,
and impairment or other charges that could have a significant negative effect on our financial condition, results of operations
and our stock price, which could cause you to lose some or all of your investment.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We must conduct a due
diligence investigation of the target businesses we intend to acquire. Intensive due diligence is time consuming and expensive
due to the operations, accounting, finance and legal professionals who must be involved in the due diligence process. Even if we
conduct extensive due diligence on a target business, this diligence may not reveal all material issues that may affect a particular
target business, and factors outside the control of the target business and outside of our control may later arise. If our diligence
fails to identify issues specific to a target business, industry or the environment in which the target business operates, we may
be forced to later write-down&#160;or write-off&#160;assets, restructure our operations, or incur impairment or other charges that
could result in our reporting losses. Even though these charges may be non-cash&#160;items and not have an immediate impact on
our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions about us or our common
stock. In addition, charges of this nature may cause us to violate net worth or other covenants to which we may be subject as a
result of assuming pre-existing&#160;debt held by a target business or by virtue of our obtaining post-combination&#160;debt financing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we effect a business combination
with a company located in a foreign jurisdiction, we would be subject to a variety of additional risks that may negatively impact
our operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are successful
in consummating a business combination with a target business in a foreign country, we would be subject to any special considerations
or risks associated with companies operating in the target business&#8217; home jurisdiction, including any of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">rules and regulations or currency conversion or corporate withholding taxes on individuals;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">tariffs and trade barriers;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">regulations related to customs and import/export matters;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">longer payment cycles;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">tax issues, such as tax law changes and variations in tax laws as compared to the United States;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">currency fluctuations and exchange controls;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">challenges in collecting accounts receivable;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">cultural and language differences;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">employment regulations;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">crime, strikes, riots, civil disturbances, terrorist attacks and wars; and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">deterioration of political relations with the United States.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot assure you
that we would be able to adequately address these additional risks. If we were unable to do so, our operations might suffer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we effect a business combination
with a company located outside of the United States, the laws applicable to such company will likely govern all of our material
agreements and we may not be able to enforce our legal rights.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we effect a business
combination with a company located outside of the United States, the laws of the country in which such company operates will govern
almost all of the material agreements relating to its operations. We cannot assure you that the target business will be able to
enforce any of its material agreements or that remedies will be available in this new jurisdiction. The system of laws and the
enforcement of existing laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States.
The inability to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business,
business opportunities or capital. Additionally, if we acquire a company located outside of the United States, it is likely that
substantially all of our assets would be located outside of the United States and some of our officers and directors might reside
outside of the United States. As a result, it may not be possible for investors in the United States to enforce their legal rights,
to effect service of process upon our directors or officers or to enforce judgments of United States courts predicated upon civil
liabilities and criminal penalties of our directors and officers under federal securities laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There may be tax consequences to
our business combinations that may adversely affect us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While we expect to
undertake any merger or acquisition so as to minimize taxes both to the acquired business and/or asset and us, such business combination
might not meet the statutory requirements of a tax-free&#160;reorganization, or the parties might not obtain the intended tax-free&#160;treatment
upon a transfer of shares or assets. A non-qualifying&#160;reorganization could result in the imposition of substantial taxes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to Potential Conflicts
of Interest of our Management, Directors, and Others</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our officers and directors will allocate
their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our
affairs. This could have a negative impact on our ability to consummate a business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our officers and directors
do not commit their full time to our affairs. We expect each of our officers and directors to devote such amount of time as they
reasonably believe is necessary to our business. We do not intend to have any full time employees prior to the consummation of
our initial business combination. The foregoing could have a negative impact on our ability to consummate our initial business
combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our officers and directors may have
a conflict of interest in determining whether a particular target business is appropriate for a business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Sponsor has waived
its right to convert its founders&#8217; shares or any other shares purchased in our IPO or thereafter, or to receive distributions
from the trust account with respect to its founders&#8217; shares upon our liquidation if we are unable to consummate a business
combination. Accordingly, the shares acquired prior to our IPO, as well as the private securities and any warrants purchased by
our officers or directors in the aftermarket, will be worthless if we do not consummate a business combination. The personal and
financial interests of our directors and officers may influence their motivation in timely identifying and selecting a target business
and completing a business combination. Consequently, our directors&#8217; and officers&#8217; discretion in identifying and selecting
a suitable target business may result in a conflict of interest when determining whether the terms, conditions and timing of a
particular business combination are appropriate and in our stockholders&#8217; best interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our officers and directors or their
affiliates have pre-existing fiduciary and contractual obligations and may in the future become affiliated with other entities
engaged in business activities similar to those intended to be conducted by us. Accordingly, they may have conflicts of interest
in determining to which entity a particular business opportunity should be presented.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our officers and directors
or their affiliates have pre-existing&#160;fiduciary and contractual obligations to other companies. Accordingly, they may participate
in transactions and have obligations that may be in conflict or competition with our consummation of our initial business combination.
As a result, a potential target business may be presented by our management team to another entity prior to its presentation to
us and we may not be afforded the opportunity to engage in a transaction with such target business. Additionally, our officers
and directors may in the future become affiliated with entities that are engaged in a similar business, including another blank
check company that may have acquisition objectives that are similar to ours. Accordingly, they may have conflicts of interest in
determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor
and a potential target business may be presented to other entities prior to its presentation to us, subject to our officers&#8217;
and directors&#8217; fiduciary duties under Delaware law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our key personnel may negotiate employment
or consulting agreements with a target business in connection with a particular business combination. These agreements may provide
for them to receive compensation following a business combination and as a result, may cause them to have conflicts of interest
in determining whether a particular business combination is the most advantageous.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our key personnel will
be able to remain with the company after the consummation of a business combination only if they are able to negotiate employment
or consulting agreements or other appropriate arrangements in connection with the business combination. Such negotiations would
take place simultaneously with the negotiation of the business combination and could provide for such individuals to receive compensation
in the form of cash payments and/or our securities for services they would render to the company after the consummation of the
business combination. The personal and financial interests of such individuals may influence their motivation in identifying and
selecting a target business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>EarlyBirdCapital may have a conflict
of interest in rendering services to us in connection with our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have engaged EarlyBirdCapital
to assist us in connection with our initial business combination. We will pay EarlyBirdCapital a cash fee for such services in
an aggregate amount equal to up to 3.5% of the total gross proceeds raised in our IPO only if we consummate our initial business
combination. The representative shares will also be worthless if we do not consummate an initial business combination. These financial
interests may result in EarlyBirdCapital having a conflict of interest when providing the services to us in connection with an
initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to our Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we do not file and maintain a
current and effective prospectus relating to the common stock issuable upon exercise of the warrants, holders will only be able
to exercise such warrants on a &#8220;cashless basis.&#8221;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we do not file and
maintain a current and effective prospectus relating to the common stock issuable upon exercise of the warrants at the time that
holders wish to exercise such warrants, they will only be able to exercise them on a &#8220;cashless basis&#8221; provided that
an exemption from registration is available. As a result, the number of shares of common stock that holders will receive upon exercise
of the warrants will be fewer than it would have been had such holder exercised his warrant for cash. Further, if an exemption
from registration is not available, holders would not be able to exercise on a cashless basis and would only be able to exercise
their warrants for cash if a current and effective prospectus relating to the common stock issuable upon exercise of the warrants
is available. Under the terms of the warrant agreement, we have agreed to use our best efforts to meet these conditions and to
file and maintain a current and effective prospectus relating to the common stock issuable upon exercise of the warrants until
the expiration of the warrants. However, we cannot assure you that we will be able to do so. If we are unable to do so, the potential
&#8220;upside&#8221; of the holder&#8217;s investment in our company may be reduced or the warrants may expire worthless.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>An investor will only be able to
exercise a warrant if the issuance of shares of common stock upon such exercise has been registered or qualified or is deemed exempt
under the securities laws of the state of residence of the holder of the warrants.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No warrants will be
exercisable and we will not be obligated to issue shares of common stock unless the shares of common stock issuable upon such exercise
has been registered or qualified or deemed to be exempt under the securities laws of the state of residence of the holder of the
warrants. If the shares of common stock issuable upon exercise of the warrants are not qualified or exempt from qualification in
the jurisdictions in which the holders of the warrants reside, the warrants may be deprived of any value, the market for the warrants
may be limited and they may expire worthless if they cannot be sold.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The private warrants included in
the Private Units may be exercised at a time when the public warrants may not be exercised.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once the private warrants
included in the Private Units become exercisable, such warrants may immediately be exercised on a cashless basis, at the holder&#8217;s
option, so long as they are held by the initial purchasers or their permitted transferees. The public warrants, however, will only
be exercisable on a cashless basis at the option of the holders if we fail to register the shares issuable upon exercise of the
warrants under the Securities Act within 90 days following the closing of our initial business combination. Accordingly, it is
possible that the holders of the private warrants could exercise such warrants at a time when the holders of public warrants could
not.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may amend the terms of the warrants
in a manner that may be adverse to holders with the approval by the holders of at least 50% of the then outstanding public warrants.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our warrants were issued
in registered form under a warrant agreement between Continental Stock Transfer &amp; Trust Company, as warrant agent, and us.
The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity
or correct any defective provision. The warrant agreement requires the approval by the holders of at least 50% of the then outstanding
public warrants in order to make any change that adversely affects the interests of the registered holders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If third parties bring claims against
us, the proceeds held in trust could be reduced and the per-share redemption price received by stockholders may be less than $10.00.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our placing of funds
in trust may not protect those funds from third party claims against us. Although we will seek to have all vendors and service
providers we engage and prospective target businesses we negotiate with execute agreements with us waiving any right, title, interest
or claim of any kind in or to any monies held in the trust account for the benefit of our public stockholders, they may not execute
such agreements. Furthermore, even if such entities execute such agreements with us, they may seek recourse against the trust account.
A court may not uphold the validity of such agreements. Accordingly, the proceeds held in trust could be subject to claims which
could take priority over those of our public stockholders. If we are unable to complete a business combination and distribute the
proceeds held in trust to our public stockholders, our Sponsor has agreed (subject to certain exceptions described elsewhere in
this Form 10-K) that it will be liable to ensure that the proceeds in the trust account are not reduced below $10.00 per share
by the claims of target businesses or claims of vendors or other entities that are owed money by us for services rendered or contracted
for or products sold to us. However, we have not asked our Sponsor to reserve for such indemnification obligations, nor have we
independently verified whether our Sponsor has sufficient funds to satisfy its indemnity obligations and believe that our Sponsor&#8217;s
only assets are securities of our company. Therefore, we believe it is unlikely that our Sponsor will be able to satisfy its indemnification
obligations if it is required to do so. As a result, the per-share&#160;distribution from the trust account may be less than $10.00,
plus interest, due to such claims.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, if we
are forced to file a bankruptcy case or an involuntary bankruptcy case is filed against us which is not dismissed, the proceeds
held in the trust account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject
to the claims of third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the
trust account, we may not be able to return to our public stockholders at least $10.00.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our stockholders may be held liable
for claims by third parties against us to the extent of distributions received by them.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated
certificate of incorporation provides that we will continue in existence only until April 30, 2021 (unless such date is extended
by our stockholders). If we have not completed a business combination by such date, we will (i) cease all operations except for
the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100%
of the outstanding public shares, at a per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in
the trust account, including any interest not previously released to us but net of franchise and income taxes payable, divided
by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights
as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board
of directors, dissolve and liquidate, subject (in the case of (ii) and (iii) above) to our obligations under Delaware law to provide
for claims of creditors and the requirements of other applicable law. We cannot assure you that we will properly assess all claims
that may be potentially brought against us. As such, our stockholders could potentially be liable for any claims to the extent
of distributions received by them (but no more) and any liability of our stockholders may extend well beyond the third anniversary
of the date of distribution. Accordingly, we cannot assure you that third parties will not seek to recover from our stockholders
amounts owed to them by us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are forced to
file a bankruptcy case or an involuntary bankruptcy case is filed against us which is not dismissed, any distributions received
by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a &#8220;preferential transfer&#8221;
or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy court could seek to recover all amounts received by our stockholders.
Furthermore, because we intend to distribute the proceeds held in the trust account to our public stockholders promptly after expiration
of the time we have to complete an initial business combination, this may be viewed or interpreted as giving preference to our
public stockholders over any potential creditors with respect to access to or distributions from our assets. Furthermore, our board
may be viewed as having breached their fiduciary duties to our creditors and/or may have acted in bad faith, and thereby exposing
itself and our company to claims of punitive damages, by paying public stockholders from the trust account prior to addressing
the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our directors may decide not to enforce
our Sponsor&#8217;s indemnification obligations, resulting in a reduction in the amount of funds in the trust account available
for distribution to our public stockholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the
proceeds in the trust account are reduced below $10.00 per public share and our Sponsor asserts that it is unable to satisfy its
obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine
whether to take legal action against our Sponsor to enforce such indemnification obligations. It is possible that our independent
directors in exercising their business judgment may choose not to do so in any particular instance. If our independent directors
choose not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution to
our public stockholders may be reduced below $10.00 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nasdaq may delist our securities
from quotation on its exchange which could limit investors&#8217; ability to make transactions in our securities and subject us
to additional trading restrictions.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our securities are
listed on Nasdaq, a national securities exchange. Although we expect to meet on a pro forma basis Nasdaq&#8217;s minimum initial
listing standards, which generally only requires that we meet certain requirements relating to stockholders&#8217; equity, market
capitalization, aggregate market value of publicly held shares and distribution requirements, we cannot assure you that our securities
will continue to be listed on Nasdaq in the future prior to an initial business combination. Further, we cannot assure you that
we will continue to meet Nasdaq&#8217;s corporate governance requirements. On January&#160;6, 2021, we received a notice from the
Listing Qualifications Department of The Nasdaq Stock Market stating that we failed to hold an Annual Meeting of stockholders within
12&#160;months after our fiscal year ended December&#160;31, 2019, as required by Nasdaq Listing Rule&#160;5620(a). In accordance
with Nasdaq Listing Rule&#160;5810(c)(2)(G), we submitted a plan to regain compliance on February&#160;4, 2021. Nasdaq accepted
our plan and granted us an extension through June 29, 2021 to hold an annual meeting. Nasdaq&#8217;s decision is subject to certain
conditions, including that we provide periodic updates with respect to our proposed business combination with Microvast. While
we expect to comply with such requirements, there can be no assurance that we will be able to do so.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, in connection
with our initial business combination, it is likely that Nasdaq will require us to file a new initial listing application and meet
its initial listing requirements as opposed to its more lenient continued listing requirements. We cannot assure you that we will
be able to meet those initial listing requirements at that time. Nasdaq will also have discretionary authority to not approve our
listing if Nasdaq determines that the listing of the company to be acquired is against public policy at that time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Nasdaq delists our
securities from trading on its exchange, or we are not listed in connection with our initial business combination, we could face
significant material adverse consequences, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a limited availability of market quotations for our securities;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">reduced liquidity with respect to our securities;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a determination that our shares of common stock are &#8220;penny stock&#8221; which will require brokers trading in our shares of common stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our shares of common stock;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a limited amount of news and analyst coverage for our company; and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a decreased ability to issue additional securities or obtain additional financing in the future.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The National Securities
Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain
securities, which are referred to as &#8220;covered securities.&#8221; Because our units, common stock and warrants are listed
on Nasdaq, our units, common stock and warrants will be covered securities. Although the states are preempted from regulating the
sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and,
if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular
case. While we are not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank
check companies, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten
to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed
on Nasdaq, our securities would not be covered securities and we would be subject to regulation in each state in which we offer
our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our outstanding warrants may have
an adverse effect on the market price of our common stock and make it more difficult to effect a business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We issued warrants
to purchase 27,600,000&#160;shares of common stock as part of the units offered in our IPO and private warrants to purchase 687,000&#160;shares
of common stock as part of the Private Units. We may also issue other units and warrants to our Sponsor, initial stockholders,
officers, directors or their affiliates in payment of working capital loans made to us. To the extent we issue shares of common
stock to effect a business combination, the potential for the issuance of a substantial number of additional shares upon exercise
of these warrants could make us a less attractive acquisition vehicle in the eyes of a target business. Such securities, when exercised,
will increase the number of issued and outstanding shares of common stock and reduce the value of the shares issued to complete
the business combination. Accordingly, our warrants may make it more difficult to effectuate a business combination or increase
the cost of acquiring the target business. Additionally, the sale, or even the possibility of sale, of the shares underlying the
warrants could have an adverse effect on the market price for our securities or on our ability to obtain future financing. If and
to the extent these warrants are exercised, you may experience dilution to your holdings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may redeem your unexpired warrants
prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have the ability
to redeem outstanding warrants (excluding the private warrants included in the Private Units and any warrants underlying additional
units issued to our Sponsor, officers or directors in payment of working capital loans made to us) at any time after they become
exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of the
common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations)
for any 20 trading days within a 30 trading-day&#160;period ending on the third business day prior to proper notice of such redemption
provided that on the date we give notice of redemption and during the entire period thereafter until the time we redeem the warrants,
we have an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise
of the warrants and a current prospectus relating to them is available. If and when the warrants become redeemable by us, we may
exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable
state securities laws. Redemption of the outstanding warrants could force you (i) to exercise your warrants and pay the exercise
price therefor at a time when it may be disadvantageous for you to do so, (ii) to sell your warrants at the then-current&#160;market
price when you might otherwise wish to hold your warrants or (iii) to accept the nominal redemption price which, at the time the
outstanding warrants are called for redemption, is likely to be substantially less than the market value of your warrants. None
of the private warrants included in the Private Units will be redeemable by us so long as they are held by the initial purchasers
or their permitted transferees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our management&#8217;s ability to
require holders of our warrants to exercise such warrants on a cashless basis will cause holders to receive fewer shares of common
stock upon their exercise of the warrants than they would have received had they been able to exercise their warrants for cash.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we call our public
warrants for redemption after the redemption criteria described elsewhere in this Form 10-K have been satisfied, our management
will have the option to require any holder that wishes to exercise his warrant (including any private warrants included in the
Private Units) to do so on a &#8220;cashless basis.&#8221; If our management chooses to require holders to exercise their warrants
on a cashless basis, the number of shares of common stock received by a holder upon exercise will be fewer than it would have been
had such holder exercised his warrant for cash. This will have the effect of reducing the potential &#8220;upside&#8221; of the
holder&#8217;s investment in our company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our security holders exercise
their registration rights, it may have an adverse effect on the market price of our shares of common stock and the existence of
these rights may make it more difficult to effect a business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Sponsor is entitled
to make a demand that we register the resale of the founders&#8217; shares at any time commencing three months prior to the date
on which their shares may be released from escrow. Additionally, the holders of representative shares, the private securities and
any units and warrants our Sponsor, initial stockholders, officers, directors, or their affiliates may be issued in payment of
working capital loans made to us, are entitled to demand that we register the resale of the representative shares, private securities
and any other units and warrants we issue to them (and the underlying securities) commencing at any time after we consummate an
initial business combination. The presence of these additional securities trading in the public market may have an adverse effect
on the market price of our securities. In addition, the existence of these rights may make it more difficult to effectuate a business
combination or increase the cost of acquiring the target business, as the stockholders of the target business may be discouraged
from entering into a business combination with us or will request a higher price for their securities because of the potential
effect the exercise of such rights may have on the trading market for our shares of common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Provisions in our amended and restated
certificate of incorporation and bylaws and Delaware law may inhibit a takeover of us, which could limit the price investors might
be willing to pay in the future for our common stock and could entrench management.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated
certificate of incorporation and bylaws contain provisions that may discourage unsolicited takeover proposals that stockholders
may consider to be in their best interests. Our board of directors is divided into three classes, each of which will generally
serve for a term of three years with only one class of directors being elected in each year. As a result, at a given annual meeting
only a minority of the board of directors may be considered for election. Since our &#8220;staggered board&#8221; may prevent our
stockholders from replacing a majority of our board of directors at any given annual meeting, it may entrench management and discourage
unsolicited stockholder proposals that may be in the best interests of stockholders. Moreover, our board of directors has the ability
to designate the terms of and issue new series of preferred stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also subject
to anti-takeover&#160;provisions under Delaware law, which could delay or prevent a change of control. Together these provisions
may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium
over prevailing market prices for our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our amended and restated certificate
of incorporation provides, subject to limited exceptions, that the Court of Chancery of the State of Delaware will be the sole
and exclusive forum for certain stockholder litigation matters, which could limit our stockholders&#8217; ability to obtain a favorable
judicial forum for disputes with us or our directors, officers, employees or stockholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated
certificate of incorporation requires, to the fullest extent permitted by law, that derivative actions brought in our name, actions
against directors, officers and employees for breach of fiduciary duty and other similar actions may be brought only in the Court
of Chancery in the State of Delaware and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have
consented to service of process on such stockholder&#8217;s counsel except any action (A) as to which the Court of Chancery in
the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery
(and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such
determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, (C) for
which the Court of Chancery does not have subject matter jurisdiction, or (D) any action arising under the Securities Act, as to
which the Court of Chancery and the federal district court for the District of Delaware shall have concurrent jurisdiction. Any
person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of
and consented to the forum provisions in our amended and restated certificate of incorporation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This choice of forum
provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with
us or any of our directors, officers or employees, which may discourage lawsuits with respect to such claims, although our stockholders
will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder and may
therefore bring a claim in another appropriate forum. We cannot be certain that a court will decide that this provision is either
applicable or enforceable, and if a court were to find the choice of forum provision contained in our amended and restated certificate
of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such
action in other jurisdictions, which could harm our business, operating results and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated
certificate of incorporation also provides that the exclusive forum provision will be applicable to the fullest extent permitted
by applicable law. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any
duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision
will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal
courts have exclusive jurisdiction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General Risks</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are an &#8220;emerging growth
company&#8221; and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make
our shares of common stock less attractive to investors.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an &#8220;emerging
growth company,&#8221; as defined in the JOBS Act. We will remain an &#8220;emerging growth company&#8221; for up to five years.
However, if our non-convertible&#160;debt issued within a three year period or revenues exceeds $1.07&#160;billion, or the market
value of our shares of common stock that are held by non-affiliates&#160;exceeds $700&#160;million on the last day of the second
fiscal quarter of any given fiscal year, we would cease to be an emerging growth company as of the following fiscal year. As an
emerging growth company, we are not required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley&#160;Act,
we have reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and we are
exempt from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden
parachute payments not previously approved. Additionally, as an emerging growth company, we have elected to delay the adoption
of new or revised accounting standards that have different effective dates for public and private companies until those standards
apply to private companies. As such, our financial statements may not be comparable to companies that comply with public company
effective dates. We cannot predict if investors will find our shares of common stock less attractive because we may rely on these
provisions. If some investors find our shares of common stock less attractive as a result, there may be a less active trading market
for our shares and our share price may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are deemed to be an investment
company, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make
it difficult for us to complete a business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A company that, among
other things, is or holds itself out as being engaged primarily, or proposes to engage primarily, in the business of investing,
reinvesting, owning, trading or holding certain types of securities would be deemed an investment company under the Investment
Company Act, as amended, or the Investment Company Act. Since the proceeds of our IPO held in the trust account have been invested
by us, it is possible that we could be deemed an investment company. Notwithstanding the foregoing, we do not believe that our
anticipated principal activities will subject us to the Investment Company Act. To this end, the proceeds held in trust may be
invested by the trustee only in United States &#8220;government securities&#8221; within the meaning of Section 2(a)(16) of the
Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7&#160;promulgated
under the Investment Company Act which invest only in direct U.S. government treasury obligations. By restricting the investment
of the proceeds to these instruments, we intend to meet the requirements for the exemption provided in Rule 3a-1&#160;promulgated
under the Investment Company Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are nevertheless
deemed to be an investment company under the Investment Company Act, we may be subject to certain restrictions that may make it
more difficult for us to complete a business combination, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">restrictions on the nature
of our investments; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">restrictions on the issuance
of securities.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we may
have imposed upon us certain burdensome requirements, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">registration as an investment
company;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">adoption of a specific
form of corporate structure; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">reporting, record keeping,
voting, proxy, compliance policies and procedures and disclosure requirements and other rules and regulations.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.25pt; text-indent: -23.25pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Compliance with these
additional regulatory burdens would require additional expense for which we have not allotted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in laws or regulations, or
a failure to comply with any laws and regulations, may adversely affect our business, investments and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to laws
and regulations enacted by national, regional and local governments. In particular, we are required to comply with certain SEC
and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming
and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes
could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with
applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business and results of
operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p><div>


</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 1B. UNRESOLVED STAFF COMMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 2. PROPERTY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently maintain
our principal executive offices at 135 E. 57th St., 18th Floor, New York, NY 10022. The cost for this space is included in the
$10,000 per-month fee Vogel Partners, LLP, an affiliate of Stephen A. Vogel, our Chief Executive Officer, charges us for general
and administrative services. We consider our current office space, combined with the other office space otherwise available to
our executive officers, adequate for our current operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 3. LEGAL PROCEEDINGS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 4. MINE SAFETY DISCLOSURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Information</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
units, common stock and warrants are listed on the Nasdaq Capital Markets (&#8220;Nasdaq&#8221;) under the symbols THCBU, THCB
and THCBW, respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Holders</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 23, 2021,
there were three holders of record of our units, twelve holders of record of our common stock and one holder of record of our warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any cash dividends on our shares of common stock to date and do not intend to pay cash dividends prior to the completion
of a business combination. The payment of cash dividends in the future will be contingent upon our revenues and earnings, if any,
capital requirements, and general financial condition subsequent to completion of a business combination. The payment of any dividends
subsequent to a business combination will be within the discretion of our then board of directors. It is the present intention
of our board of directors to retain all earnings, if any, for use in our business operations and, accordingly, our board does
not anticipate declaring any dividends in the foreseeable future. Further, if we incur any indebtedness in connection with our
initial business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection
therewith.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Authorized for Issuance under Equity Compensation Plans</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Sales of Unregistered Securities</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchases
of Equity Securities by Issuer and Affiliates</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
purchases of our equity securities have been made by us or affiliated purchasers within the fourth quarter of the fiscal year
ended December 31, 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
6. SELECTED FINANCIAL DATA</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion and analysis of the Company&#8217;s financial condition and results of operations should be read in conjunction
with our audited financial statements and the notes related thereto which are included in &#8220;Item 8. Financial Statements
and Supplementary Data&#8221; of this Form 10-K. Certain information contained in the discussion and analysis set forth below
includes forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking
statements as a result of many factors, including those set forth under &#8220;Special Note Regarding Forward-Looking Statements,&#8221;
&#8220;Item 1A. Risk Factors&#8221; and elsewhere in this Form 10-K.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a blank check company incorporated on November 5, 2018 as a Delaware corporation and formed for the purpose of entering into
a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination
with one or more businesses or entities. We intend to effectuate our initial business combination using cash from the proceeds
of the IPO and the sale of the private units, our capital stock, debt or a combination of cash, stock and debt.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
entire activity since inception relates to our formation, to prepare for our IPO, which was consummated on March 7, 2019, searching
for a business combination candidate, and activities in connection with the proposed acquisition of Microvast.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Microvast
Business Combination</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 1, 2021, Tuscan entered into the Merger Agreement with Microvast and Merger Sub. Pursuant to the Merger Agreement, Merger
Sub will merge with and into Microvast and Microvast will survive the merger and become a wholly owned subsidiary of Tuscan. Under
the Merger Agreement, all of the equity interests of Microvast will be converted into an aggregate of 210,000,000 shares of common
stock. The Microvast shareholders and the investors in Microvast&#8217;s majority-owned subsidiary, MPS, will also have the ability
to earn an additional 20,000,000 shares of common stock if the daily volume weighted average price of the common stock is greater
than or equal to $18.00 for any 20 trading days within a 30 trading day period (or a change of control occurs that results in
the holders of common stock receiving a per share price equal to or in excess of $18.00), during the period commencing on the
closing date and ending on the third anniversary of the closing date. Concurrently with the execution of the Merger Agreement,
Tuscan and Microvast will jointly acquire 100% ownership of MPS and will discharge certain convertible loans of MPS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Merger will be
accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of
America (&#8220;U.S. GAAP&#8221;). Under this method of accounting, Tuscan will be treated as the &#8220;acquired&#8221; company
for accounting purposes and the Business Combination will be treated as the equivalent of Microvast issuing stock for the net assets
of Tuscan, accompanied by a recapitalization. The net assets of Tuscan will be stated at historical cost, with no goodwill or other
intangible assets recorded.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the Merger Agreement provides that Tuscan will issue an aggregate of 6,736,111&#160;shares of common stock in connection with
the Bridge Note Conversion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
on February&#160;1, 2021, Tuscan, the Sponsor, Microvast and certain stockholders of Tuscan entered into the Sponsor Support Agreement,
pursuant to which the Sponsor Group agreed, among other things, to vote all equity interests of Tuscan held by such member of
the Sponsor Group in favor of the approval and adoption of the proposed business combination with Microvast. Additionally, such
members of the Sponsor Group have agreed not to (a) transfer any of their equity interests in the Company (or enter into any arrangement
with respect thereto) other than as set forth therein or (b) exercise any conversion rights of any equity interests held by such
member of the Sponsor Group in connection with the approval of the proposed business combination.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor also agreed that, to the extent that certain expenses of Tuscan are in excess of $46,000,000 (unless such expenses shall
have been approved by Microvast), the Sponsor will either (i) pay any such excess amount in cash or (ii) forfeit to Tuscan such
number of shares of common stock held by the Sponsor that would have a value equal to such excess. The Sponsor also agreed to
amend the escrow agreement to make certain adjustments to the terms of the escrow of its shares of common stock as set forth in
the Sponsor Support Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Contemporaneously with
the execution of the Merger Agreement, certain investors entered into Subscription Agreements pursuant to which such investors
subscribed for an aggregate value of $482,500,000, representing 48,250,000 shares of Tuscan common stock at a purchase price of
$10.00 per share in a private placement to be consummated immediately prior to the consummation of the Transactions. Affiliates
of InterPrivate, a co-sponsor of Tuscan, subscribed to purchase 6.5 million shares in the PIPE Financing for an aggregate purchase
price of $65 million.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the Closing, the former equityholders of Microvast will hold approximately 69.9% of the issued and outstanding shares
of common stock and the current stockholders of Tuscan will hold approximately 9.2% of the issued and outstanding shares of common
stock, which pro forma ownership (1)&#160;assumes no Public Stockholder exercises its conversion rights in connection with the
business combination, and (2)&#160;reflects the issuance of an aggregate of 48,250,000&#160;shares of Common Stock in the PIPE
Financing and 6,736,111&#160;shares of common stock in the Bridge Notes Conversion, but does not include the effect of any other
financing of Tuscan. If the maximum number of Public Shares are converted into cash such that Microvast does not have the right
to terminate the Merger Agreement (i.e., Tuscan has at least $5,000,001 of net tangible assets immediately prior to or upon consummation
of the business combination), such percentages will be approximately 76.8% and 0.2%, respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Extension
Amendment</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 3, 2020, Tuscan received stockholder approval to extend the date by which it must complete an initial business combination
from December 7, 2020 to April 30, 2021. In connection with such extension, holders of 3,198 Public Shares exercised their right
to convert their shares into cash at a conversion price of approximately $10.22 per share, for an aggregate conversion amount
of approximately $32,684.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 12, 2021,
Tuscan filed a preliminary proxy statement seeking approval from its stockholders to amend Tuscan&#8217;s charter to further extend
the date by which Tuscan is required to complete its initial business combination from April 30, 2021 to July 31, 2021 and to hold
an annual meeting for the election of directors in accordance with Nasdaq listing rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Commitment</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;12,
2021, the Sponsor extended a loan to Tuscan in the aggregate principal amount totaling $1.2&#160;million, of which $400,000 was
drawn upon on such date. This loan was in addition to the previous $200,000 drawn upon the $300,000 convertible note that was committed
by the Sponsor on April 21, 2020. As a result of the February&#160;12, 2021 commitment, the Sponsor had committed to the Company
a total of $1.5 million, of which a total of $600,000 has been drawn upon, with $400,000 of the drawn amount pursuant to the February&#160;12,
2021 note. The Sponsor intends to convert the $1.5 million total loan balance into 150,000 Units immediately prior to the closing
of the proposed business combination with Microvast. Such Units will have terms identical to the terms of the Company&#8217;s Private
Units and will consist of (i) 150,000&#160;shares of common stock and (ii) warrants to purchase 150,000&#160;shares of common stock
at an exercise price of $11.50 per share, subject to adjustment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nasdaq
Notification</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;6, 2021, we received a notice from the Listing Qualifications Department of The Nasdaq Stock Market stating that
we failed to hold an Annual Meeting of stockholders within 12&#160;months after our fiscal year ended December&#160;31, 2019,
as required by Nasdaq Listing Rule&#160;5620(a). In accordance with Nasdaq Listing Rule&#160;5810(c)(2)(G), we submitted a plan
to regain compliance on February&#160;4, 2021. Nasdaq accepted our plan and granted us an extension through June 29, 2021 to hold
an annual meeting. Nasdaq&#8217;s decision is subject to certain conditions, including that we provide periodic updates with respect
to our proposed business combination with Microvast. While we expect to comply with such requirements, there can be no assurance
that we will be able to do so.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
only activities from November 5, 2018 (inception) through December 31, 2020 were organizational activities, those necessary to
consummate the IPO, described below, and, after the IPO, searching for a target company for a business combination. We do not
expect to generate any operating revenues until after the completion of our business combination. We generate non-operating income
in the form of interest income on marketable securities held in the trust account. We incur expenses as a result of being a public
company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2020, we had net income of $1,375,461, which consisted of interest income on marketable securities
held in the Trust Account of $2,654,140 and an unrealized gain on marketable securities held in the Trust Account of $9,750 offset
by operating costs of $921,665 and a provision for income taxes of $366,764.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the year ended December 31, 2020, income
earned on the investment held in the trust account decreased $2,258,206, or 46.0% to $2,654,140 from $4,912,346 for the year ended
December 31, 2019.&#160; As a result of the Covid-19 pandemic, the average annual yield on the investment held in the trust account
dropped to 0.10% in the second quarter of 2020 down from an average of 1.73% for 2019 and the first quarter of 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2019, we had net income of $3,367,179, which consisted of interest income on marketable securities
held in the trust account of $4,912,346 and an unrealized gain on marketable securities held in the trust account of $128,899,
offset by operating costs of $778,815 and a provision for income taxes of $895,251.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 7, 2019, we consummated our IPO of 24,000,000 units, at a price of $10.00 per unit, generating gross proceeds of $240,000,000.
Simultaneously with the closing of the IPO, we consummated the sale of 615,000 private units to our Sponsor and EarlyBirdCapital
and its designee, generating gross proceeds of $6,150,000. On March 12, 2019, in connection with the underwriters&#8217; exercise
of their over-allotment option in full, we consummated the sale of an additional 3,600,000 units at a price of $10.00 per unit,
generating total gross proceeds of $36,000,000. In addition, we also consummated the sale of an additional 72,000 private units
to our Sponsor and EarlyBirdCapital and its designee at $10.00 per private unit, generating total gross proceeds of $720,000.
Following the IPO, the exercise of the over-allotment option and the sale of the private units, a total of $276,000,000 was placed
in the trust account. We incurred $6,059,098 in IPO related costs, including $5,520,000 of underwriting fees, and $539,098 of
other costs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31,
2020, we had marketable securities held in the Trust Account of $282,254,978 (including approximately $6,255,000 of interest income
and unrealized gains less interest withdrawn) consisting of U.S. treasury bills with a maturity of 180 days or less. Interest income
on the balance in the Trust Account may be used by us to pay taxes. Through December 31, 2020, we withdrew approximately $1,417,000
of interest earned on the Trust Account to pay our franchise and income tax obligations, of which approximately $479,000 was withdrawn
during the year ended December 31, 2020. &#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2020, cash used in operating activities was $705,994. Net income of $1,375,461 was affected by interest
earned on marketable securities held in the Trust Account of $2,654,140, an unrealized gain on marketable securities held in our
Trust Account of $9,750 and a deferred income tax benefit of $5,601. Changes in operating assets and liabilities provided $588,036
of cash from operating activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2019, cash used in operating activities was $1,634,432. Net income of $3,367,179 was affected by interest
earned on marketable securities held in the trust account of $4,912,346, an unrealized gain on marketable securities held in our
trust account of $128,899 and a deferred income tax provision of $27,069. Changes in operating assets and liabilities provided
$12,565 of cash from operating activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to use substantially
all of the funds held in the trust account, to acquire a target business and to pay our expenses relating thereto, including fees
payable to EarlyBirdCapital and Morgan Stanley, upon consummation of our initial business combination for assisting us in connection
with our initial business combination. To the extent that our capital stock is used in whole or in part as consideration to effect
a business combination, the remaining funds held in the trust account will be used as working capital to finance the operations
of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target
business&#8217; operations, for strategic acquisitions and for marketing, research and development of existing or new products.
Such funds could also be used to repay any operating expenses or finders&#8217; fees which we had incurred prior to the completion
of our business combination if the funds available to us outside of the trust account were insufficient to cover such expenses.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had cash of $135,961. We intend to use the funds held outside the trust account for identifying and evaluating
prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from
the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements
of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the business
combination.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;20, 2020, the Sponsor committed to provide us an aggregate of $500,000 in loans. The loans shall be non-interest&#160;bearing,
unsecured and due upon the consummation of a business combination. In the event that a business combination does not close, the
loans would be repaid only out of funds held outside the Trust Account to the extent such funds are available. Otherwise, all
amounts loaned to us would be forgiven.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;21, 2020,
we issued an unsecured promissory note to the Sponsor in the aggregate amount of $300,000 (the &#8220;Sponsor Note&#8221;), of
which $200,000 was drawn upon on such date. The Sponsor Note is non-interest&#160;bearing and payable upon the consummation of
a business combination. The Sponsor Note is convertible, at the lender&#8217;s option, into units of the post-business&#160;combination
entity at a price of $10.00 per unit. The units would be identical to the Private Units. If a business combination is not consummated,
the Sponsor Notes will not be repaid by us and all amounts owed thereunder by us will be forgiven except to the extent that we
have funds available to us outside of our Trust Account. As of December 31, 2020, there was $200,000 outstanding under the Sponsor
Note.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to fund working
capital deficiencies or finance transaction costs in connection with a business combination, the Sponsor or our officers and directors
or their affiliates may, but are not obligated to, loan us funds on a non-interest basis as may be required, except as described
above. If we complete our initial business combination, we will repay such loaned amounts. In the event that our initial business
combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts
but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of notes may be convertible into private
units, at a price of $10.00 per unit. The units would be identical to the private units.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As described above,
our Sponsor committed to loan us a total of $1.5 million (inclusive of amounts currently outstanding) in aggregate principal amount
prior to the consummation of the proposed business combination with Microvast. We will need to raise additional capital through
loans or additional investments from our Sponsor, stockholders, officers, directors, or third parties. Other than the $1.5 million
loan (inclusive of amounts currently outstanding) committed to us by our Sponsor, our Sponsor, officers, directors, or their affiliates
may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their
sole discretion, to meet our working capital needs. Accordingly, we may not be able to obtain additional financing. If we are
unable to raise such additional capital, we may be required to take additional measures to conserve liquidity, which could include,
but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead
expenses. We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all.
These conditions raise substantial doubt about our ability to continue as a going concern through April 30, 2021 (or July 31,
2021, if our stockholders approve an amendment to our charter), the date that we will be required to cease all operations, except
for the purpose of winding up, if a business combination is not consummated. The financial statements included in this Form 10-K
do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might
be necessary should we be unable to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Financing Arrangements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not have any off-balance sheet arrangements as of December 31, 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
Obligations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities other than an
agreement to pay an affiliate of our Sponsor a monthly fee of $10,000 for office space, utilities and secretarial and administrative
support. We began incurring these fees on March 5, 2019 and will continue to incur these fees monthly until the earlier of the
completion of the business combination and our liquidation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged EarlyBirdCapital to act as an advisor in connection with a business combination, to assist us in holding meetings
with our shareholders to discuss the potential business combination and the target business&#8217; attributes, introduce us to
potential investors that are interested in purchasing our securities in connection with a business combination, assist us in obtaining
shareholder approval for the business combination and assist us with our press releases and public filings in connection with
the business combination. We will pay EarlyBirdCapital a cash fee for such services upon the consummation of a business combination
in an amount equal to $9,660,000 (exclusive of any applicable finders&#8217; fees which might become payable); provided that up
to 30% of the fee may be allocated at our sole discretion to other FINRA members that assist us in identifying and consummating
a business combination.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt/107% Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0">We engaged Morgan Stanley to provide financial advisory
services in connection with the Microvast business combination, and, upon consummation of the transaction with Microvast, we must
pay that firm a transaction fee of $5.5 million, plus expenses. Morgan Stanley also acted as placement agent in connection with
the PIPE Financing, and we are obligated to pay Morgan Stanley a placement fee equal to (i) 3.5% of the sum of (x) the aggregate
gross proceeds raised in the PIPE Financing up to $300 million (not including funds from the sale of certain excluded securities)
and (y) any borrowings pursuant to a bridge financing provided in connection with the proposed business combination by investors
introduced by Morgan Stanley, and (ii) 2.5% of the aggregate gross proceeds raised in the PIPE Financing above $300 million.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the
United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income
and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the
following critical accounting policies:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Subject to Possible Redemption</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for our common stock subject to possible conversion in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption
is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common
stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified
as stockholders&#8217; equity. Our common stock features certain redemption rights that are considered to be outside of our control
and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders&#8217; equity section of our balance sheets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Net Income (Loss) Per Common Share</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our statement of operations
includes a presentation of income per share for common shares subject to possible redemption in a manner similar to the two-class
method of loss per share. Net income per common share, basic and diluted, for Common stock subject to possible redemption is calculated
by dividing the proportionate share of income on marketable securities held by the Trust Account, net of applicable franchise and
income taxes, by the weighted average number of Common stock subject to possible redemption outstanding since original issuance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net loss per share,
basic and diluted, for non-redeemable common stock is calculated by dividing the net income, adjusted for income on marketable
securities attributable to Common stock subject to possible redemption, by the weighted average number of non-redeemable common
stock outstanding for the period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Non-redeemable common
stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. Non-redeemable
common stock participates in the income on marketable securities based on non-redeemable common stock shares&#8217; proportionate
interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recent
Accounting Pronouncements</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have
a material effect on our financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
information appears following Item 16 of this Report and is incorporated herein by reference.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
9A. CONTROLS AND PROCEDURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Disclosure
Controls and Procedures</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed
in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods
specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated
and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding
required disclosure.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out
an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2020.
Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and
procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management&#8217;s
Annual Report on Internal Control Over Financial Reporting</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by SEC rules and regulations implementing Section&#160;404 of the Sarbanes-Oxley Act, our management is responsible for
establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting
is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial
statements for external reporting purposes in accordance with GAAP. Our internal control over financial reporting includes those
policies and procedures that:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0.5in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pertain
    to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions
    of the assets of our company,</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
    with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management
    and directors, and</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets
    that could have a material effect on the financial statements.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because of its inherent
limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial statements.
Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate. The Chief Executive
Officer and Chief Financial Officer assessed the effectiveness of our internal control over financial reporting at December 31,
2020. In making these assessments, the Chief Executive Officer and Chief Financial Officer used the criteria set forth by the Committee
of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control &#8212; Integrated Framework (2013). Based on
their assessments and those criteria, the Chief Executive Officer and Chief Financial Officer determined that we maintained effective
internal control over financial reporting as of December 31, 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Form 10-K does not include an attestation report of internal controls from our independent registered public accounting firm due
to our status as an emerging growth company under the JOBS Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in Internal Control over Financial Reporting</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of
the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
9B. OTHER INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
III</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors
and Executive Officers</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current directors and executive officers are as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 62%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen A. Vogel</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and Chief Executive Officer</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ruth Epstein</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Financial Officer and Director</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stefan M. Selig</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard O. Rieger</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy Butte</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stephen
A. Vogel</i></b>&#160;has served as Tuscan&#8217;s Chairman and Chief Executive Officer since its inception. He has also served
as Chairman and Chief Executive Officer of Tuscan Holdings Corp. II (&#8220;Tuscan II&#8221;), a blank check company like Tuscan
that is searching for a target business with which to consummate an initial business combination, since March&#160;2019. Mr.&#160;Vogel
has over 40&#160;years of operating and private equity experience. He has served as General Partner of Vogel Partners, LLP, a
private investment firm, since 1996. He served as President of Twelve Seas Investment Company, a blank check company, from May
2018 until the completion of its business combination with Brooge Holdings Limited in December 2019, and he has served as a director
of the company from June&#160;2018 until December 2019. From December&#160;2016 until February&#160;2018, Mr.&#160;Vogel was Executive
Chairman of Forum Merger Corporation, a blank check company that completed its initial public offering in April&#160;2017. Forum
completed its initial business combination in February&#160;2018 with C1 Investment Corp. and in connection with the consummation
of the business combination changed its name to ConvergeOne Holdings, Inc. (NASDAQ: CVON). Mr.&#160;Vogel began his career in
1971 as President, Chief Executive Officer and co-founder&#160;of Synergy Gas Corp., a retail propane distribution company. After
selling Synergy Gas Corp. to Northwestern Corp. in 1995, Mr.&#160;Vogel co-founded&#160;EntreCapital Partners, a private equity
firm that focused on companies facing operational or management challenges, and served until&#160;1999. Additionally, he was a
venture partner at EnerTech Capital Partners, an energy focused venture capital firm, from 1999 to 2002, and an operating partner
at Tri-Artisan&#160;Capital Partners, LLC, an investment bank, from 2004 to 2006. Mr.&#160;Vogel also served as Chief Executive
Officer of Grameen America, a not-for-profit&#160;organization that provides microloans to low-income&#160;borrowers in the United&#160;States,
from 2008 to 2013. He was on the board of Netspend (NASDAQ: NTSP), a leader for prepaid stored value platforms, from 2011 to 2013.
Mr.&#160;Vogel was a member of the Board of Trustees at Montefiore Medical Center and Children&#8217;s Hospital for over 20&#160;years
and served on the Board of Trustees at Lighthouse International, a non-profit&#160;organization. Mr.&#160;Vogel is a past Trustee
of the Horace Mann School and previously served on the Board of Directors of the National Propane Gas Association. Mr.&#160;Vogel
received a BS degree from Syracuse University School of Management. We believe Mr. Vogel is well-qualified to serve as a member
of the board due to his business experience, including prior blank check company experience and his contacts.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ruth
Epstein</i></b>&#160;has served as Tuscan&#8217;s President, Chief Financial Officer and a member of Tuscan&#8217;s board of directors
since November&#160;2018. Ms.&#160;Epstein has over 25&#160;years&#8217; experience providing financial and strategic advisory
services to companies across a wide range of mature and emerging growth industries. She has also been an active investor in, and
advisor to, companies operating in the legal cannabis industry. In 2017, she founded, and has since served as a Partner of, BGP
Advisors LLC, a financial and strategic advisory firm providing consulting and management services to companies in the emerging
legal cannabis industry. She has also been a registered representative at Pickwick Capital Partners since January&#160;2019. In
2018, Ms.&#160;Epstein served as Chief Financial Officer and Chief Operating Officer of Treez, Inc., California&#8217;s leading
provider of point of sale and retail management solutions to cannabis dispensaries. From 2014 through February&#160;2017, Ms.&#160;Epstein
served as Senior Vice President of Business Development for Holt Media Companies. From 2009 to 2013, Ms.&#160;Epstein served as
Chief Operating Officer for Arjewel Partners, LLC/ Bigelow Capital, LP, a long-short&#160;hedge fund. Prior to 2009, Ms.&#160;Epstein
raised an independent film fund and served as Executive Producer on several independent feature films. She began her career at
Goldman, Sachs&#160;&amp; Co. in the Investment Banking Division. During her ten-year&#160;tenure with Goldman, Ms.&#160;Epstein
served as Vice President in Corporate Finance, working on numerous IPOs, debt and equity offerings and M&amp;A transactions. Ms.&#160;Epstein
received a BA in Economics with Highest Honors from Wesleyan University and an MBA from Harvard Business School with First Year
Honors. We believe Ms. Epstein is well-qualified to serve as a member of the board due to her business experience.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stefan
M. Selig</i></b>&#160;has served as a member of Tuscan&#8217;s board of directors since November&#160;2018. Mr.&#160;Selig is
the founder and Managing Partner of BridgePark Advisors LLC, a firm formed in January&#160;2017 which provides personalized strategic
advice on a broad range of critical business and financial issues and transaction execution. Mr.&#160;Selig served as Under Secretary
of Commerce for International Trade at the U.S. Department of Commerce from June&#160;2014 to June&#160;2016, and during this
period headed the International Trade Administration, a global bureau of more than 2,200 trade and investment professionals. During
this period, he also served as the Executive Director of the U.S. Travel and Tourism Advisory Board, sat on the board of directors
of the Overseas Private Investment Corporation, was a Commissioner for the Congressional Executive Commission on China and was
the Executive Director of the President&#8217;s Advisory Council on Doing Business in Africa. Prior to that, he held various senior
level leadership positions at Bank of America Merrill Lynch beginning in 1999, including being the Executive Vice Chairman of
Global Corporate&#160;&amp; Investment Banking from 2009 to 2014, and prior to that, he was Vice Chairman of Global Investment
Banking and Global Head of Mergers&#160;&amp; Acquisitions. Mr.&#160;Selig currently serves on the board of directors of Simon
Property Group, Inc., Entercom Communications Corp. and Safehold Inc. Mr.&#160;Selig received an MBA from Harvard Business School
and a BA from Wesleyan University. We believe Mr. Selig is well-qualified to serve as a member of our board of directors due to
his business experience serving in prominent leadership roles in both the private and public sectors as well as his business contacts.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Richard
O. Rieger</i></b>&#160;has been a member of Tuscan&#8217;s board of directors since February&#160;2019. He has also served as
Chief Financial Officer of Tuscan II since June&#160;2019 and served as a director of Tuscan II from March&#160;2019 to June&#160;2019.
Mr.&#160;Rieger has over 33&#160;years of investment experience. Since January&#160;2016, he has served as the President of Inkblot
Capital, LLC, which is a family office. Prior to this, Mr.&#160;Rieger was a Principal, Member of the Executive Committee and
Co-Chief&#160;Investment Officer of Kingdon Capital Management LLC (&#8220;Kingdon&#8221;) from 1992 to September&#160;2014 and
then served as a consultant to Kingdon until December&#160;2015. He joined Kingdon in December&#160;1992 as a Portfolio Manager
and was named Co-Director&#160;of Domestic Equity Research in March&#160;1995 and the Chief Investment Officer in May&#160;2002.
From January&#160;1992 to December&#160;1992, Mr.&#160;Rieger worked as a securities Analyst and a Portfolio Manager for Glickenhaus&#160;&amp;
Co., an investment manager. Prior to this, Mr.&#160;Rieger served as an Analyst for several investment firms, including Ladenburg
Thalmann&#160;&amp; Co. Inc., Allen&#160;&amp; Company and Sloate, Weisman, Murray&#160;&amp; Co. Mr.&#160;Rieger is on the Photography
Committee at the Museum of Modern Art and the Investment Committee of Ethical Cultural Fieldston School. He previously served
on the board of the University Settlement House in New&#160;York City and was a trustee at the Ethical Cultural Fieldston School
and the Rippowam Cisqua School in Bedford NY. Mr. Rieger received a B.A. from the University of Michigan. We believe Mr. Rieger
is well-qualified to serve as a member of our board of directors due to his business experience as well as business contacts and
relationships.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Amy Butte</i></b>&#160;has
been a member of Tuscan&#8217;s board of directors since February&#160;2019. Ms.&#160;Butte has significant experience in leading
and advising companies through the IPO process. She spearheaded two public offerings as Chief Financial Officer, including the
public offering of the New&#160;York Stock Exchange in 2006. She has served as a Board Member and Audit Chair for Digital Ocean
Inc., a high-growth&#160;technology company, since 2018 and an Independent Director, Audit Chair and Risk Committee member for
BNP Paribas USA, Inc., an entity created to ensure compliance with Dodd-Frank&#160;regulations, since 2016. She has also served
as an advisor to the Long Term Stock Exchange, Inc., a Silicon Valley led start up creating a vision and marketplace for long-term&#160;investors,
issuers, and leaders, and Carbon38, Inc., an online athleisure destination, each since 2015, and previously served as an advisor
to other start-up&#160;companies. Previously, she was an Independent Director for the Fidelity Investments Strategic Advisors Funds
(2011 to 2017), a Board Member for Accion International, a global microfinance organization (2008 to 2016) and the founder of a
fintech startup, TILE Financial (2008 to 2012). From 2002 to 2008, Ms.&#160;Butte was CFO and Strategist for the Financial Services
Division of Credit Suisse First Boston, Inc., CFO and Executive Vice President at Nasdaq, and CFO of Man Financial, Inc. Between
1996 and 2002, Ms.&#160;Butte was an equity research analyst at Merrill Lynch&#160;&amp; Co. and Bear Stearns&#160;&amp; Co., where
she took part in multiple capital markets transactions. We believe Ms. Butte is well-qualified to serve as a member of our board
of directors due to her business experience, business contacts and relationships.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is divided into three classes with only one class of directors being elected in each year and each class serving
a three-year term. The term of office of the first class of directors, consisting of Amy Butte, will expire at our first annual
meeting of stockholders. The term of office of the second class of directors, consisting of Ruth Epstein and Richard O. Rieger,
will expire at the second annual meeting. The term of office of the third class of directors, consisting of Stephen A. Vogel and
Stefan M. Selig, will expire at the third annual meeting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
rules require that a majority of the board of directors of a company listed on Nasdaq must be composed of &#8220;independent directors.&#8221;
An &#8220;independent director&#8221; is defined generally as a person other than an officer or employee of the company or its
subsidiaries or any other individual having a relationship, which, in the opinion of the company&#8217;s board of directors, would
interfere with the director&#8217;s exercise of independent judgment in carrying out the responsibilities of a director. We have
determined that Stefan M. Selig, Amy Butte, and Richard O. Rieger are independent directors under the Nasdaq rules and Rule 10A-3
of the Exchange Act. Our independent directors have regularly scheduled meetings at which only independent directors are present.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
affiliated transactions will be on terms no less favorable to us than could be obtained from independent parties. Our board of
directors will review and approve all affiliated transactions with any interested director abstaining from such review and approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 5, 2019, we established an audit committee of the board of directors, in accordance with Section 3(a)(58)(A) of the Exchange
Act, which consists of Stefan M. Selig, Richard O. Rieger and Amy Butte, each of whom is an independent director under Nasdaq&#8217;s
listing standards. The audit committee&#8217;s duties, which are specified in our Audit Committee Charter, include, but are not
limited to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and discussing
    with management and the independent auditor the annual audited financial statements, and recommending to the board whether
    the audited financial statements should be&#160;included in our Form 10-K;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing with
    management and the independent auditor significant financial reporting issues and judgments made in connection with the preparation
    of our financial statements;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing with
    management major risk assessment and risk management policies;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring the independence
    of the independent auditor;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">verifying the rotation
    of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible
    for reviewing the audit as required by law;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and approving
    all related-party transactions;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inquiring and discussing
    with management our compliance with applicable laws and regulations;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-approving all
    audit services and permitted non-audit services to be performed by our independent auditor, including the fees and terms of
    the services to be performed;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing or replacing
    the independent auditor;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining the
    compensation and oversight of the work of the independent auditor (including resolution of disagreements between management
    and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related
    work;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing procedures
    for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or
    reports which raise material issues regarding our financial statements or accounting policies; and</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving reimbursement
    of expenses incurred by our management team in identifying potential target businesses.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
Experts on Audit Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee will at all times be composed exclusively of &#8220;independent directors&#8221; who are &#8220;financially literate&#8221;
as defined under Nasdaq&#8217;s listing standards. In addition, we must certify to Nasdaq that the committee has, and will continue
to have, at least one member who has past employment experience in finance or accounting, requisite professional certification
in accounting, or other comparable experience or background that results in the individual&#8217;s financial sophistication. The
board of directors has determined that Amy Butte qualifies as an &#8220;audit committee financial expert,&#8221; as defined under
rules and regulations of the SEC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 5, 2019, we established a nominating committee of the board of directors, which consists of Stefan M. Selig, Richard O.
Rieger and Amy Butte, each of whom is an independent director under Nasdaq&#8217;s listing standards. The nominating committee
is responsible for overseeing the selection of persons to be nominated to serve on our board of directors. The nominating committee
considers persons identified by its members, management, shareholders, investment bankers and others.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Guidelines
for Selecting Director Nominees</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
guidelines for selecting nominees, which are specified in the Nominating Committee Charter, generally provide that persons to
be nominated:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; ">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">should have demonstrated
    notable or significant achievements in business, education or public service;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">should possess the
    requisite intelligence, education and experience to make a significant contribution&#160;to the board of directors and bring
    a range of skills, diverse perspectives and backgrounds to its deliberations; and</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">should have the
    highest ethical standards, a strong sense of professionalism and intense dedication to&#160;serving the interests of the shareholders.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating Committee will consider a number of qualifications relating to management and leadership experience, background, and
integrity and professionalism in evaluating a person&#8217;s candidacy for membership on the board of directors. The nominating
committee may require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that
arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and diverse
mix of board members. The nominating committee does not distinguish among nominees recommended by shareholders and other persons.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no material changes to the procedures by which security holders may recommend nominees to our board of directors.<b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 5, 2019, we established a compensation committee of the board of directors, which consists of Stefan M. Selig and Richard
O. Rieger, each of whom is an independent director under Nasdaq&#8217;s listing standards. The compensation committee&#8217;s
duties, which are specified in our Compensation Committee Charter, include, but are not limited to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; ">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and approving
    on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer&#8217;s compensation, evaluating
    our Chief Executive Officer&#8217;s performance in light of such goals and objectives and determining and approving the remuneration
    (if any) of our Chief Executive Officer based on such evaluation;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and approving
    the compensation of all of our other executive officers;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing our executive
    compensation policies and plans;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">implementing and
    administering our incentive compensation equity-based remuneration plans;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting management
    in complying with our proxy statement and annual report disclosure requirements;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving all special
    perquisites, special cash payments and other special compensation and benefit&#160;arrangements for our executive officers
    and employees;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if required, producing
    a report on executive compensation to be included in our annual proxy statement; and</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing, evaluating,
    and recommending changes, if appropriate, to the remuneration for directors.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 5, 2019, we adopted a code of ethics that applies to all of our executive officers, directors, and employees. The code of
ethics codifies the business and ethical principles that govern all aspects of our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>&#160;</b></span></p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
11. EXECUTIVE COMPENSATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Compensation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
executive officer has received any cash compensation for services rendered to us. Until consummation of an initial business combination,
we will pay Vogel Partners, LLP, an affiliate of Mr. Vogel, an aggregate fee of $10,000 per month for providing us with office
space and certain office and secretarial services. However, this arrangement is solely for our benefit and is not intended to
provide Mr. Vogel compensation in lieu of a salary. We may also pay consulting, success or finder fees to our Sponsor, officers,
directors, initial stockholders or their affiliates in connection with the consummation of our initial business combination. They
will also receive reimbursement for any out-of-pocket expenses incurred by them in connection with activities on our behalf, such
as identifying potential target businesses, performing business due diligence on suitable target businesses and business combinations,
as well as traveling to and from the offices, plants, or similar locations of prospective target businesses to examine their operations.
There is no limit on the amount of out-of-pocket expenses reimbursable by us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
our initial business combination, members of our management team who remain with us may be paid consulting, management, or other
fees from the combined company with any and all amounts being fully disclosed to shareholders, to the extent then known, in the
proxy solicitation materials furnished to our shareholders. The amount of such compensation may not be known at the time of a
shareholder meeting held to consider an initial business combination, as it will be up to the directors of the post-combination
business to determine executive and director compensation. In this event, such compensation will be publicly disclosed at the
time of its determination in a Current Report on Form 8-K, as required by the SEC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our formation, we have not granted any stock options or stock appreciation rights or any other awards under long-term incentive
plans to any of our executive officers or directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding the beneficial ownership of our common stock by:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; ">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each person known
    by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of our officers
    and directors; and</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all of our officers
    and directors as a group.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all
shares of common stock beneficially owned by them. The following table does not reflect record of beneficial ownership of the
warrants included in the units offered in the IPO or the Private Units as the warrants are not exercisable within 60 days of the
date hereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Address of Beneficial Owner&#160;<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount and<br/> Nature of<br/>
    Beneficial<br/> Ownership</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Approximate<br/> Percentage&#160;of<br/>
    Outstanding<br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Officers and Directors:</i></span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Stephen A. Vogel</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,308,589</td><td style="width: 1%; text-align: left">(2)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20.77</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Ruth Epstein</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stefan M. Selig</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Amy Butte</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Richard O Rieger</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">All directors and executive officers as a group (six individuals)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,458,589</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21.02</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Five Percent Holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Tuscan Holdings Acquisition LLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,368,589</td><td style="text-align: left">(2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20.77</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Alpine Global Management, LLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,036,308</td><td style="text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.74</td><td style="text-align: left">%</td></tr>
</table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1%.</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise
    indicated, the business address of each of the individuals is 135 E. 57th St., 18th Floor, New York, NY 10022.</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents securities
    held by Tuscan Holdings Acquisition LLC, our Sponsor, of which Mr. Vogel is sole managing member. &#160;Mr.&#160;Vogel disclaims
    beneficial ownership of the reported shares other than to the extent of his ultimate pecuniary interest therein.</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does not include
    any securities held by Tuscan Holdings Acquisition LLC, of which each person is a member. Each such person disclaims beneficial
    ownership of the reported shares other than to the extent of his or her ultimate pecuniary interest therein.</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents shares
    held by Alpine Global Management, LLC (&#8220;Alpine Global&#8221;). Alpine Partners (BVI), L.P. (&#8220;Alpine Partners&#8221;)
    may be deemed to control the shares held by Alpine Global. The principal place of business of Alpine Global and Alpine Partners
    is 140 Broadway, 38th Floor, New York, NY 10005. Information derived from a Schedule 13G/A filed on February 24, 2021.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the founders&#8217; shares outstanding prior to the IPO have been placed in escrow with Continental Stock Transfer &amp; Trust
Company, as escrow agent, until (i) with respect to 50% of such shares, the earlier of one year after the date of the consummation
of our initial business combination and the date on which the closing price of our common stock equals or exceeds $12.50 per share
(as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading
day period commencing after our initial business combination and (ii) with respect to the remaining 50% of such shares, one year
after the date of the consummation of our initial business combination, or earlier if, subsequent to our initial business combination,
we consummate a liquidation, merger, stock exchange or other similar transaction which results in all of our stockholders having
the right to exchange their shares of common stock for cash, securities or other property.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the escrow period, the holders of these shares will not be able to sell or transfer their securities except for transfers, assignments
or sales (i) among our initial stockholders or to our initial stockholders&#8217; members, officers, directors, consultants or
their affiliates, (ii) to a holder&#8217;s stockholders or members upon its liquidation, (iii) by bona fide gift to a member of
the holder&#8217;s immediate family or to a trust, the beneficiary of which is the holder or a member of the holder&#8217;s immediate
family, for estate planning purposes, (iv) by virtue of the laws of descent and distribution upon death, (v) pursuant to a qualified
domestic relations order, (vi) to us for no value for cancellation in connection with the consummation of our initial business
combination, or (vii) in connection with the consummation of a business combination at prices no greater than the price at which
the shares were originally purchased, in each case (except for clause (vi) or with our prior consent) where the transferee agrees
to the terms of the escrow agreement and to be bound by these transfer restrictions, but will retain all other rights as our stockholders,
including, without limitation, the right to vote their shares of common stock and the right to receive cash dividends, if declared.
If dividends are declared and payable in shares of common stock, such dividends will also be placed in escrow. If we are unable
to effect a business combination and liquidate, there will be no liquidation distribution with respect to the founders&#8217;
shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers and our Sponsor are our &#8220;promoters,&#8221; as that term is defined under the federal securities laws.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif"><b>Equity
Compensation Plans</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had no compensation plans (including individual compensation arrangements) under which equity securities
of the registrant were authorized for issuance.</span>&#160;</p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Service Fee</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vogel
Partners, LLP, an affiliate of Mr.&#160;Vogel, has agreed that, until the earlier of the consummation of an initial business combination
or Tuscan&#8217;s liquidation, it will make available to Tuscan certain general and administrative services, including office
space, utilities and administrative support, as Tuscan may require from time to time. Tuscan has agreed to pay Vogel Partners,
LLP $10,000 per month for these services. Tuscan believes, based on rents and fees for similar services in the New&#160;York City
metropolitan area, that the fee charged by Vogel Partners, LLP is at least as favorable as it could have obtained from an unaffiliated
person.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Working
Capital Loans</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;20, 2020,
the Sponsor committed to provide us an aggregate of $500,000 in loans. The loans shall be non-interest&#160;bearing, unsecured
and due upon the consummation of a business combination. In the event that a business combination does not close, the loans would
be repaid only out of funds held outside the Trust Account to the extent such funds are available. Otherwise, all amounts loaned
to us would be forgiven. On April&#160;21, 2020, we issued an unsecured promissory note to the Sponsor in the aggregate amount
of $300,000, of which $200,000 was drawn upon on such date. Such note is non-interest&#160;bearing and payable upon the consummation
of a business combination, and convertible, at the lender&#8217;s option, into units of the post-business&#160;combination entity
at a price of $10.00 per unit.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;12,
2021, the Sponsor extended a loan to Tuscan in the aggregate principal amount totaling $1.2&#160;million, of which $400,000 was
drawn upon on such date. This loan was in addition to the previous $200,000 drawn upon the $300,000 convertible note that was committed
by the Sponsor on April 21, 2020. As a result of the February&#160;12, 2021 commitment, the Sponsor had committed to the Company
a total of $1.5 million, of which a total of $600,000 has been drawn upon, with $400,000 of the drawn amount pursuant to the February&#160;12,
2021 note. The Sponsor intends to convert the $1.5 million total loan balance into 150,000 Units immediately prior to the closing
of the proposed business combination with Microvast. Such units will have terms identical to the terms of the Company&#8217;s Private
Units and will consist of (i) 150,000&#160;shares of common stock and (ii) warrants to purchase 150,000&#160;shares of common stock
at an exercise price of $11.50 per share, subject to adjustment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the
loan commitments described above, in order to fund working capital deficiencies or finance transaction costs in connection with
a business combination, the Sponsor or our officers and directors or their affiliates may, but are not obligated to, loan us funds
on a non-interest basis as may be required. If we complete our initial business combination, we will repay such loaned amounts.
In the event that our initial business combination does not close, we may use a portion of the working capital held outside the
trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000
of notes may be convertible into private units, at a price of $10.00 per unit. The units would be identical to the private units.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Advance from Related Party</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s
Chief Executive Officer advanced the Company an aggregate of $86,748 to be used for the payment of costs related to the Initial
Public Offering. The advances were non-interest bearing, unsecured and due on demand. The advances were repaid upon the consummation
of the Initial Public Offering on March 7, 2019. As of December 31, 2020, the Company has an aggregate of $22,179 in outstanding
advances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the founders&#8217; shares, as well as the holders of the Private Units and any units the Sponsor, initial stockholders,
officers, directors or their affiliates may be issued in payment of working capital loans made to us (and all underlying securities),
are entitled to registration rights pursuant to an agreement signed in connection with the initial public offering. The holders
of a majority of these securities are entitled to make up to two demands that we register such securities. The holders of the
majority of the founders&#8217; shares can elect to exercise these registration rights at any time commencing three months prior
to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Units
and units issued in payment of working capital loans made to us (or underlying securities) can elect to exercise these registration
rights at any time after we consummate a business combination. In addition, the holders have certain &#8220;piggy-back&#8221;
registration rights with respect to registration statements filed subsequent to the consummation of a business combination. Tuscan
will bear the expenses incurred in connection with the filing of any such registration statements. In connection with the proposed
business combination with Microvast, Tuscan agreed to terminate this registration rights agreement and replace it with a Registration
Rights and Lock-Up&#160;Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Tuscan
Support Agreement</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the proposed business combination and concurrently with the execution of the Merger Agreement, the Sponsor, Tuscan&#8217;s
officers and directors, Tuscan and Microvast entered into the Tuscan Support Agreement, pursuant to which the Sponsor and Tuscan&#8217;s
officers and directors agreed to vote all shares of common stock held by them in favor of the proposed business combination and
each other proposal being submitted for the vote of Tuscan stockholders herein and abstain from exercising any conversion rights
that they may have in connection with the proposed business combination. The Sponsor also agreed to pay certain of Tuscan&#8217;s
transaction expenses that exceed a certain cap and to amend the Escrow Agreement to provide for forfeiture of an aggregate of
1,687,500&#160;shares of common stock currently held by it unless certain specified trading prices are met over certain trading
periods prior to the fifth anniversary of the closing of the proposed business combination.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Policy</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Code of Ethics, which we adopted upon consummation of the IPO, requires us to avoid, wherever possible, all related party transactions
that could result in actual or potential conflicts of interests, except under guidelines approved by the board of directors (or
the audit committee). Related-party transactions are defined as transactions in which (1) the aggregate amount involved will or
may be expected to exceed $120,000 in any calendar year, (2) we or any of our subsidiaries is a participant, and (3) any (a) executive
officer, director or nominee for election as a director, (b) greater than 5% beneficial owner of our shares of common stock, or
(c) immediate family member, of the persons referred to in clauses (a) and (b), has or will have a direct or indirect material
interest (other than solely as a result of being a director or a less than 10% beneficial owner of another entity). A conflict
of interest situation can arise when a person takes actions or has interests that may make it difficult to perform his or her
work objectively and effectively. Conflicts of interest may also arise if a person, or a member of his or her family, receives
improper personal benefits as a result of his or her position.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee, pursuant to its written charter, is responsible for reviewing and approving related-party transactions to the
extent we enter into such transactions. All ongoing and future transactions between us and any of our officers and directors or
their respective affiliates will be on terms believed by us to be no less favorable to us than are available from unaffiliated
third parties. Such transactions will require prior approval by our audit committee and a majority of our uninterested &#8220;independent&#8221;
directors, or the members of our board who do not have an interest in the transaction, in either case who had access, at our expense,
to our attorneys or independent legal counsel. We will not enter into any such transaction unless our audit committee and a majority
of our disinterested &#8220;independent&#8221; directors determine that the terms of such transaction are no less favorable to
us than those that would be available to us with respect to such a transaction from unaffiliated third parties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents
a conflict of interest on the part of a director, employee or officer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of fees paid or to be paid to Marcum LLP, or Marcum, for services rendered.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>Audit Fees</i>. Audit
fees consist of fees billed for professional services rendered for the audit of our year-end financial statements and services
that are normally provided by Marcum in connection with regulatory filings. The aggregate fees billed by Marcum for professional
services rendered for the audit of our annual financial statements, review of the financial information included in our Forms 10-Q
for the respective periods and other required filings with the SEC for the year ended December 31, 2020 and 2019 totaled $48,765
and $88,415, respectively. The above amounts include interim procedures and audit fees, as well as attendance at audit committee
meetings.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit-Related
Fees.</i> Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance
of the audit or review of our financial statements and are not reported under &#8220;Audit Fees.&#8221; These services include
attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting
standards. We did not pay Marcum for consultations concerning financial accounting and reporting standards for the year ended
December 31, 2020 and 2019.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>Tax Fees</i>. The aggregate
fees billed by Marcum for tax planning and tax advice for the year ended December 31, 2020 totaled $7,725. We did not pay Marcum
for tax planning and tax advice for the year ended December 31, 2019.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>All
Other Fees</i>. We did not pay Marcum for other services for the year ended December 31, 2020 and 2019.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Approval
Policy</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee was formed upon the consummation of our Initial Public Offering. As a result, the audit committee did not pre-approve
all of the foregoing services, although any services rendered prior to the formation of our audit committee were approved by our
board of directors. Since the formation of our audit committee, and on a going-forward basis, the audit committee has and will
pre-approve all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees
and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved
by the audit committee prior to the completion of the audit).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
15. EXHIBITS, FINANCIAL STATEMENTS, AND SCHEDULES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The following documents are filed as part of this report:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Financial Statements:&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; ">
    <td style="width: 90%; border-bottom: black 1.5pt solid; padding-left: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_001">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_002">Balance Sheets</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_003">Statements of Operations</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_004">Statements of Changes in Stockholders&#8217; Equity</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_005">Statements of Cash Flows</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="white-space: nowrap; padding-left: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_006">Notes to Financial Statements</a></span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7
    to F-17</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Financial Statement Schedules:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following Exhibits are filed as part of this report:</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 8%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 43%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 15%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Included</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 15%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 15%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003702/f8k030519ex1-2_tuscan.htm">Business Combination Marketing Agreement between Tuscan Holdings Corp. and EarlyBirdCapital, Inc.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    5, 2019</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003702/f8k030519ex3-1_tuscan.htm">Amended and Restated Certificate of Incorporation</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    5, 2019</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390020040684/ea130972ex3-1_tuscanhold.htm">Amendment to the Amended and Restated Certificate of Incorporation</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    3, 2020</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019002379/fs12019ex3-3_tuscanholding.htm">Bylaws</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    26, 2019</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003155/fs12018a1ex4-1_tuscanhold.htm">Specimen Unit Certificate</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    26, 2019</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003155/fs12018a1ex4-2_tuscanhold.htm">Specimen Common Stock Certificate</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    26, 2019</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003155/fs12018a1ex4-3_tuscanhold.htm">Specimen Warrant Certificate</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    26, 2019</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003702/f8k030519ex4-1_tuscan.htm">Warrant Agreement between Continental Stock Transfer &amp; Trust Company and Tuscan Holdings Corp.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    5, 2019</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><a href="f10k2020ex4-5_tuscanhold.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Securities</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herewith</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003155/fs12018a1ex10-1_tuscanhold.htm">Form of Letter Agreement from each of the initial stockholders, officers, and directors of Tuscan Holdings Corp.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    26, 2019</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003702/f8k030519ex10-1_tuscan.htm">Investment Management Trust Agreement between Continental Stock Transfer &amp; Trust Company and Tuscan Holdings Corp.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    5, 2019</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003702/f8k030519ex10-3_tuscan.htm">Registration Rights Agreement.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    5, 2019</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003155/fs12018a1ex10-5i_tuscanhold.htm">Subscription Agreement for Private Units between Tuscan Holdings Acquisition LLC and Tuscan Holdings Corp.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    26, 2019</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003155/fs12018a1ex10-5ii_tuscanhold.htm">Subscription Agreement for Private Units between EarlyBirdCapital, Inc. and Tuscan Holdings Corp.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    26, 2019</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390019003702/f8k030519ex10-2_tuscan.htm">Stock Escrow Agreement.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    5, 2019</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390020009923/ea120991ex10-1_tuscanhold.htm">Sponsor Commitment Letter, dated as of April 20, 2020.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    20, 2020</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390020009923/ea120991ex10-2_tuscanhold.htm">Convertible Promissory Note, dated as of April 21, 2020.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    20, 2020</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="f10k2020ex10-9_tuscanhold.htm">Convertible Promissory Note, dated as of February 12, 2021</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herewith</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390021007125/ea134382ex2-1_tuscanhold.htm">Agreement and Plan of Merger, dated as of February 1, 2021, by and among Tuscan Holdings Corp., TSCN Merger Sub Inc., and Microvast, Inc.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    1, 2021</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390021007125/ea134382ex10-1_tuscanhold.htm">Framework Agreement, dated as of February 1, 2021, by and among Tuscan Holdings Corp., Microvast, Inc., MVST SPV Inc., Microvast Power System (Huzhou) Co., Ltd., and the other parties thereto</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    1, 2021</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390021007125/ea134382ex10-2_tuscanhold.htm">Microvast Stockholder Support Agreement, dated as of February 1, 2021, by and among Tuscan Holdings Corp., Microvast, Inc., and certain stockholders of Microvast, Inc.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    1, 2021</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390021007125/ea134382ex10-3_tuscanhold.htm">Sponsor Support Agreement, dated as of February 1, 2021, by and among Tuscan Holdings Corp., Microvast, Inc., Tuscan Holdings Acquisition LLC, and certain other stockholders of Tuscan Holdings Corp.</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    1, 2021</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390021007125/ea134382ex10-4_tuscanhold.htm">Form of Subscription Agreement</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    1, 2021</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390021007125/ea134382ex10-5_tuscanhold.htm">Subscription Agreement, dated as of February 1, 2021, by and between Tuscan Holdings Corp. and Riheng HK Limited</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    1, 2021</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1760689/000121390021007125/ea134382ex10-6_tuscanhold.htm">Subscription Agreement, dated as of February 1, 2021, by and between Tuscan Holdings Corp. and Aurora Sheen Limited</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Reference</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    1, 2021</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="f10k2020ex21_tuscanhold.htm">List of Subsidiaries</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herewith</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><a href="f10k2020ex31-1_tuscanhold.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Principal Executive Officer and Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herewith</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="f10k2020ex31-2_tuscanhold.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Principal Financial Officer and Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herewith</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><a href="f10k2020ex32_tuscanhold.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herewith</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Instance Document</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Schema Document</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Calculation Linkbase Document</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Definition Linkbase Document</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Label Linkbase Document</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Presentation Linkbase Document</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
16. FORM 10-K SUMMARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Section 13 or 15 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized on the 24th&#160;day of March, 2021.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TUSCAN HOLDINGS CORP.</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Stephen A. Vogel</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen A. Vogel</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 32%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 43%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 21%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
<tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Stephen A. Vogel</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and Chief Executive Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 24, 2021</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen A. Vogel</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Ruth Epstein</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Financial Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 24, 2021</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Ruth Epstein</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)
    and Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Amy Butte&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 24, 2021</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy Butte</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Richard O. Rieger&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 24, 2021</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard O. Rieger</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TUSCAN
HOLDINGS CORP.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO FINANCIAL STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 88%; padding-left: 10pt; text-indent: -10pt"><a href="#f_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report
    of Independent Registered Public Accounting Firm</span></a></td>
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements:</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 13.5pt"><a href="#f_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance Sheets</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 13.5pt"><a href="#f_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Operations</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_004">Statements of Changes in Stockholders&#8217; Equity</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_005">Statements of Cash Flows</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_006">Notes to Financial Statements</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7 to F-17</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 52; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="f_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders and Board of Directors of<br/>
Tuscan Holdings Corp.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying balance sheets of Tuscan Holdings Corp. (the &#8220;Company&#8221;) as of December 31, 2020 and
2019, the related statements of operations, changes in stockholders&#8217; equity and cash flows for each of the years ended December
31, 2020, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and
the results of its operations and its cash flows for each of the years ended December 31, 2020, in conformity with accounting
principles generally accepted in the United States of America.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Explanatory Paragraph </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying financial statements have been prepared assuming
that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company&#8217;s business
plan is dependent on the completion of a business combination and the Company&#8217;s cash and working capital as of December 31,
2020 are not sufficient to complete its planned activities. These conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1. The financial
statements do not include any adjustments that might result from the outcome of this uncertainty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on
the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (the &#8220;PCAOB&#8221;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but
not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.
Accordingly, we express no such opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">/s/
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum LLP</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
<span style="font-variant: small-caps">LLP</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2018.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
24, 2021</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="f_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>TUSCAN
HOLDINGS CORP.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BALANCE
SHEETS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2020</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2019</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Current assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-indent: -9.1pt; padding-left: 18.15pt">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">135,961</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">140,303</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.1pt; padding-left: 18.15pt">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="0" unitRef="usd">69,818</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -9pt; padding-left: 0.25in">Prepaid expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd">22,499</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd">186,247</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 24.3pt">Total Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">158,460</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">396,368</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Cash and marketable securities held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd">282,254,978</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd">280,103,245</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">TOTAL ASSETS</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" unitRef="usd">282,413,438</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" unitRef="usd">280,499,613</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.1pt; padding-left: 18.15pt">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">320,978</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">269,055</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.1pt; padding-left: 18.15pt">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TaxesPayableCurrent" scale="0" unitRef="usd">302,547</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -9pt; padding-left: 0.25in">Advances from related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesCurrent" scale="0" unitRef="usd">22,179</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 24.3pt">Total Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">645,704</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">269,055</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible promissory note &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NotesPayableRelatedPartiesNoncurrent" scale="0" unitRef="usd">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Deferred tax liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="0" unitRef="usd">21,468</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="0" unitRef="usd">27,069</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">TOTAL LIABILITIES</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">867,172</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">296,124</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-indent: -9pt; padding-left: 9pt">Commitments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Common stock subject to possible redemption <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="thcb:CommonSharesSubjectToPossibleRedemption" scale="0" unitRef="shares">27,087,556</ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="thcb:CommonSharesSubjectToPossibleRedemption" scale="0" unitRef="shares">27,126,477</ix:nonFraction> at December 31, 2020 and 2019, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="0" unitRef="usd">276,546,264</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="0" unitRef="usd">275,203,480</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Stockholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Preferred stock, $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c4" decimals="4" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">1,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <span style="-sec-ix-hidden: hidden-fact-12"><span style="-sec-ix-hidden: hidden-fact-13"><span style="-sec-ix-hidden: hidden-fact-14"><span style="-sec-ix-hidden: hidden-fact-15">none</span></span></span></span> issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Common stock, $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c4" decimals="4" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">65,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">8,396,246</ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">8,360,523</ix:nonFraction></ix:nonFraction> shares issued and outstanding (excluding 27,087,556 and 27,126,477 shares subject to possible redemption) at December 31, 2020 and 2019, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd">840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd">836</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">257,314</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">1,632,786</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Retained earnings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" unitRef="usd">4,741,848</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" unitRef="usd">3,366,387</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Total Stockholders&#8217; Equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">5,000,002</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">5,000,009</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">282,413,438</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">280,499,613</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>&#160;&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="f_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TUSCAN
HOLDINGS CORP.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STATEMENTS
OF OPERATIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Operating and formation costs</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd">921,665</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd">778,815</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 9pt">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">921,665</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">778,815</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Interest earned on marketable securities held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeOther" scale="0" unitRef="usd">2,654,140</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeOther" scale="0" unitRef="usd">4,912,346</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Unrealized gain on marketable securities held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" scale="0" unitRef="usd">9,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" scale="0" unitRef="usd">128,899</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Other income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="0" unitRef="usd">2,663,890</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="0" unitRef="usd">5,041,245</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income before provision for income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="0" unitRef="usd">1,742,225</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="0" unitRef="usd">4,262,430</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Provision for income taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">366,764</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">895,251</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Net income</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">1,375,461</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">3,367,179</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:numdotdecimal" name="thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" scale="0" unitRef="shares">27,104,439</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:numdotdecimal" name="thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" scale="0" unitRef="shares">27,123,666</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Basic and diluted net income per share, Common stock subject to possible redemption</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:numdotdecimal" name="thcb:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:numdotdecimal" name="thcb:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Basic and diluted weighted average shares outstanding, Common stock</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" unitRef="shares">8,382,317</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" unitRef="shares">7,927,608</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Basic and diluted net loss per common share, Common stock</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" sign="-" unitRef="usdPershares">0.08</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" sign="-" unitRef="usdPershares">0.07</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements</i>.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="f_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TUSCAN
HOLDINGS CORP.<br/>
STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Common Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional Paid-in</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Retained Earnings/ (Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total Stockholders&#8217;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Deficit)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-indent: -9.05pt; padding-left: 9.05pt">Balance &#8211; January 1, 2019</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">7,200,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">720</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">25,480</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">792</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">25,408</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Sale of <ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="0" unitRef="usd">27,600,000</ix:nonFraction> Units, net of underwriting discount and offering expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:numdotdecimal" name="thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" scale="0" unitRef="shares">27,600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:numdotdecimal" name="thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" scale="0" unitRef="usd">2,760</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:numdotdecimal" name="thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" scale="0" unitRef="usd">269,938,142</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" scale="0" unitRef="usd">269,940,902</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-indent: -10.1pt; padding-left: 10.1pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Sale of <ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:SaleOfPrivateUnitAmount" scale="0" unitRef="usd">687,000</ix:nonFraction> Private Units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">687,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">68</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">6,869,932</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">6,870,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-indent: -8.65pt; padding-left: 8.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Common stock subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c10" decimals="INF" format="ixt:numdotdecimal" name="thcb:CommonStockSubjectToPossibleRedemptionShares" scale="0" sign="-" unitRef="shares">27,126,477</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:numdotdecimal" name="thcb:CommonStockSubjectToPossibleRedemption" scale="0" sign="-" unitRef="usd">2,712</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:numdotdecimal" name="thcb:CommonStockSubjectToPossibleRedemption" scale="0" sign="-" unitRef="usd">275,200,768</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:CommonStockSubjectToPossibleRedemption" scale="0" sign="-" unitRef="usd">275,203,480</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-indent: -8.65pt; padding-left: 8.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Net income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">3,367,179</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">3,367,179</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 8.65pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -8.65pt; padding-left: 8.65pt">Balance&#160;&#8211;&#160;December 31, 2019</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">8,360,523</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">836</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">1,632,786</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">3,366,387</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">5,000,009</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-indent: -8.65pt; padding-left: 8.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Change in value of common stock subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:numdotdecimal" name="thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" scale="0" unitRef="shares">35,723</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:numdotdecimal" name="thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemption" scale="0" unitRef="usd">4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c17" decimals="0" format="ixt:numdotdecimal" name="thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemption" scale="0" sign="-" unitRef="usd">1,375,472</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemption" scale="0" sign="-" unitRef="usd">1,375,468</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-indent: -8.65pt; padding-left: 8.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Net income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">1,375,461</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">1,375,461</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 8.65pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -8.65pt; padding-left: 8.65pt">Balance&#160;&#8211;&#160;December 31, 2020</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">8,396,246</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">840</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">257,314</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">4,741,848</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">5,000,002</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of the financial statements.&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span>&#160;</p><div>


</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="f_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TUSCAN
HOLDINGS CORP.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STATEMENTS
OF CASH FLOWS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cash Flows from Operating Activities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">1,375,461</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">3,367,179</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 8.1pt">Adjustments to reconcile net income to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 8.1pt">Interest earned on marketable securities held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:IncreaseDecreaseInMarketableSecurities" scale="0" unitRef="usd">2,654,140</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:IncreaseDecreaseInMarketableSecurities" scale="0" unitRef="usd">4,912,346</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 8.1pt">Unrealized gain on marketable securities held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:IncreaseDecreaseUnrealizedGainMarketableSecurities" scale="0" unitRef="usd">9,750</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:IncreaseDecreaseUnrealizedGainMarketableSecurities" scale="0" unitRef="usd">128,899</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 8.1pt">Deferred tax provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="0" sign="-" unitRef="usd">5,601</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="0" unitRef="usd">27,069</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 8.1pt">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 16.2pt">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" sign="-" unitRef="usd">163,748</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" unitRef="usd">186,222</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 16.2pt">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="0" sign="-" unitRef="usd">69,818</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="0" unitRef="usd">69,818</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 16.2pt">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">51,923</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">268,605</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 16.2pt">Income taxes payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" unitRef="usd">302,547</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 28.35pt">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">705,994</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">1,634,432</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Investing Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Investment of cash in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="0" unitRef="usd">276,000,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash withdrawn from Trust Account for redemptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:CashWithdrawnAccountForRedemptions" scale="0" unitRef="usd">32,684</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash withdrawn from Trust Account to pay income taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:CashWithdrawnFromTrustAccountToPayIncomeTaxes" scale="0" unitRef="usd">479,473</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:CashWithdrawnFromTrustAccountToPayIncomeTaxes" scale="0" unitRef="usd">938,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 28.35pt">Net cash provided by (used in) investing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" unitRef="usd">512,157</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">275,062,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Financing Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Proceeds from sale of Units, net of underwriting discounts paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-24">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:ProceedsFromSalesOfUnitsUnderwritingDiscount" scale="0" unitRef="usd">270,480,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from sale of Private Units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-25">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:ProceedsFromSaleOfPrivateUnits" scale="0" unitRef="usd">6,870,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Advances from related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="usd">25,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="usd">86,748</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Repayment of advances from related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" unitRef="usd">2,833</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" unitRef="usd">86,748</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Proceeds from convertible promissory note &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:ProceedsFromConvertiblePromissoryNoteRelatedParty" scale="0" unitRef="usd">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-26">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from promissory note &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-27">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:ProceedsFromPromissoryNotesRelatedparty" scale="0" unitRef="usd">15,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Repayment of promissory note &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:RepaymentOfPromissoryNoteRelatedParty" scale="0" unitRef="usd">90,342</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Payment of offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:PaymentOfOfferingCosts" scale="0" unitRef="usd">32,684</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:PaymentOfOfferingCosts" scale="0" unitRef="usd">455,423</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 28.35pt">Net cash provided by financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">189,495</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">276,819,235</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Net Change in Cash</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">4,342</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" unitRef="usd">122,803</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Cash &#8211; Beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">140,303</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">17,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Cash &#8211; End of period</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">135,961</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">140,303</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Supplemental cash flow information</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Cash paid for income taxes</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="0" unitRef="usd">938,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-Cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Initial classification of common stock subject to possible redemption</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:InitialClassificationOfCommonStockSubjectToRedemption" scale="0" unitRef="usd">271,835,860</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Change in value of common stock subject to possible redemption</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:ChangeInValueOfCommonStockSubjectToRedemption" scale="0" unitRef="usd">1,342,784</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:ChangeInValueOfCommonStockSubjectToRedemption" scale="0" unitRef="usd">3,367,620</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>


</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tuscan
Holdings Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on November 5, 2018. The Company was formed for the purpose
of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business
combination with one or more businesses or entities (the &#8220;Business Combination&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company
is focusing its search on companies in the cannabis industry.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one subsidiary, TSCN Merger Sub Inc., a wholly-owned subsidiary of the Company incorporated in Delaware on January
21, 2021 (&#8220;Merger Sub&#8221;) (see Note 10).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_5" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
activity through December 31, 2020 relates to the Company&#8217;s formation, the initial public offering (&#8220;Initial Public
Offering&#8221;), which is described below, identifying a target company for a Business Combination, activities in connection
with the proposed acquisition of Microvast, Inc., a Delaware corporation (&#8220;Microvast&#8221;) (see Note 10). The Company
will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates
non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_6" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering was declared effective on March 5, 2019. On March 7, 2019,
the Company consummated the Initial Public Offering of <ix:nonFraction contextRef="c22" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">24,000,000</ix:nonFraction> units (the &#8220;Units&#8221; and, with respect to the shares
of common stock included in the Units sold, the &#8220;Public Shares&#8221;) at $<ix:nonFraction contextRef="c23" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Unit, generating gross proceeds of
$<ix:nonFraction contextRef="c24" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">240,000,000</ix:nonFraction>, which is described in Note 3.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_7" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <ix:nonFraction contextRef="c25" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">615,000</ix:nonFraction> units (the &#8220;Private Units&#8221;)
at a price of $<ix:nonFraction contextRef="c26" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Private Unit in a private placement to Tuscan Holdings Acquisition LLC (the &#8220;Sponsor&#8221;) and
EarlyBirdCapital, Inc. (&#8220;EarlyBirdCapital&#8221;) and its designee, generating gross proceeds of $<ix:nonFraction contextRef="c27" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">6,150,000</ix:nonFraction>, which is described
in Note 4.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:nonNumeric contextRef="c0" name="thcb:IssuanceOfUnitsDescription"><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_8" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on March 7, 2019, an amount of $<ix:nonFraction contextRef="c28" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">240,000,000</ix:nonFraction> ($<ix:nonFraction contextRef="c3" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (&#8220;Trust
Account&#8221;) which are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment
Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 180 days or less or in any open-ended
investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company
Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), as determined by the Company, until the earlier of: (i) the
completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_9" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 12, 2019, the underwriters exercised their over-allotment option in full, resulting in the sale of an additional <ix:nonFraction contextRef="c29" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">3,600,000</ix:nonFraction>
Units for $<ix:nonFraction contextRef="c29" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">36,000,000</ix:nonFraction>, less the underwriters&#8217; discount of $<ix:nonFraction contextRef="c29" decimals="0" format="ixt:numdotdecimal" name="thcb:UnderwritersDiscount" scale="0" unitRef="usd">720,000</ix:nonFraction>. In connection with the underwriters&#8217; exercise
of their over-allotment option, the Company also consummated the sale of an additional <ix:nonFraction contextRef="c30" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">72,000</ix:nonFraction> Private Units at $<ix:nonFraction contextRef="c31" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Private
Unit, generating total gross proceeds of $<ix:nonFraction contextRef="c30" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">720,000</ix:nonFraction>. A total of $<ix:nonFraction contextRef="c32" decimals="0" format="ixt:numdotdecimal" name="thcb:AmountDepositInTrustAccount" scale="0" unitRef="usd">36,000,000</ix:nonFraction> was deposited into the Trust Account from the sale of
the additional Units pursuant to the over-allotment option and the additional sale of Private Units, bringing the aggregate proceeds
held in the Trust Account to $<ix:nonFraction contextRef="c30" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" scale="0" unitRef="usd">276,000,000</ix:nonFraction>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_10" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs amounted to $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">6,059,098</ix:nonFraction>, consisting of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" scale="0" unitRef="usd">5,520,000</ix:nonFraction> of underwriting fees and $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:OtherOfferingCosts" scale="0" unitRef="usd">539,098</ix:nonFraction> of other offering costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_11" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public
Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally
toward consummating a Business Combination. The Company&#8217;s Business Combination must be with one or more target businesses
that together have a fair market value of at least <ix:nonFraction contextRef="c0" decimals="2" format="ixt:numdotdecimal" name="thcb:PercentageOfTrustAccountRequiredForBusinessCombination" scale="-2" unitRef="pure">80</ix:nonFraction>% of the assets held in the Trust Account (excluding taxes payable on income
earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete
a Business Combination if the post-transaction company owns or acquires <ix:nonFraction contextRef="c3" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" unitRef="pure">50</ix:nonFraction>% or more of the outstanding voting securities of the
target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination
successfully.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_12" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide its holders of the outstanding Public Shares (the &#8220;public stockholders&#8221;) with the opportunity
to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with
a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether
the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely
in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro&#160;rata portion of the amount
then in the Trust Account ($<ix:nonFraction contextRef="c0" decimals="2" format="ixt:numdotdecimal" name="thcb:PublicSharePrice" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Public Share, plus any pro&#160;rata interest earned on the funds held in the Trust Account
and not previously released to the Company to pay its franchise and income tax obligations). There will be no redemption rights
upon the completion of a Business Combination with respect to the Company&#8217;s warrants. &#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_13" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will proceed with a Business Combination only if the Company has net tangible assets of at least $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" scale="0" unitRef="usd">5,000,001</ix:nonFraction> upon such
consummation of a Business Combination and, solely if the Company seeks stockholder approval, a majority of the shares voted are
voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold
a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of
Incorporation (the &#8220;Amended and Restated Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender
offer rules of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC prior
to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company
decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with
a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder
approval in connection with a Business Combination, the Company&#8217;s Sponsor and EarlyBirdCapital have agreed to vote their
Founder Shares (as defined in Note 5), Private Shares (as defined in Note 4) and any Public Shares purchased after the Initial
Public Offering in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote
to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination.
Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against
the proposed transaction or do not vote at all.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_14" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor and EarlyBirdCapital have agreed (a) to waive their rights to liquidating distributions from the Trust Account with respect
to the Founder Shares and Private Shares if the Company fails to consummate a Business Combination and (b) not to propose an amendment
to the Amended and Restated Certificate of Incorporation that would affect a public stockholders&#8217; ability to convert or
sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company&#8217;s
obligation to redeem <ix:nonFraction contextRef="c3" decimals="2" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure">100</ix:nonFraction>% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides
the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_15" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had until December 7, 2020 to complete a Business Combination (the &#8220;Combination Period&#8221;). On December 3,
2020, the Company held a special meeting pursuant to which the Company&#8217;s stockholders approved extending the
Combination Period from December 7, 2020 to April 30, 2021 (the &#8220;Extension Date&#8221;). In connection with the
approval of the extension, stockholders elected to redeem an aggregate of <ix:nonFraction contextRef="c33" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">3,198</ix:nonFraction> shares of the Company&#8217;s common stock.
As a result, an aggregate of approximately $<ix:nonFraction contextRef="c33" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" unitRef="usd">32,700</ix:nonFraction> (or approximately $<ix:nonFraction contextRef="c34" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.22</ix:nonFraction> per share) was released from the Company&#8217;s
Trust Account to pay such stockholders. Additionally, the Company has filed a preliminary proxy statement on March 12, 2021 seeking approval to
further extend date for which the Company is required to complete a business combination to July 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_16" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account
including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and
income taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders&#8217;
rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law,
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining
stockholders and the Company&#8217;s board of directors, dissolve and liquidate, subject in each case to the Company&#8217;s obligations
under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails
to complete a Business Combination within the Combination Period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_17" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent
any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which
the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $<ix:nonFraction contextRef="c3" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares">10.00</ix:nonFraction>
per Public Share, except as to any claims by a third party who executed an agreement with the Company waiving any right, title,
interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the
Company&#8217;s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under
the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Moreover, in the event that an executed waiver is deemed
to be unenforceable against a third party, the Insiders will not be responsible to the extent of any liability for such third-party
claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account by endeavoring
to have all vendors, service providers, prospective target businesses or other entities with which the Company does business,
execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust
Account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_18" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_19" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus
could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company,
the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i></i></b></span></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i></i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_20" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity and Going Concern</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_21" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account
outside of the Trust Account for working capital purposes. As of December 31, 2020, the Company had $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustCurrent" scale="0" unitRef="usd">135,961</ix:nonFraction> held outside of the
Trust Account. As of April 20, 2020, the Sponsor committed to provide an aggregate of $<ix:nonFraction contextRef="c35" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="0" unitRef="usd">500,000</ix:nonFraction> in loans to the Company. The loans
shall be non-interest bearing, unsecured and due upon the consummation of a Business Combination. In the event that a Business
Combination does not close, the loans would be repaid only out of funds held outside the Trust Account to the extent such funds
are available. Otherwise, all amounts loaned to the Company would be forgiven. On April 21, 2020, the Sponsor loaned the Company
an aggregate of $<ix:nonFraction contextRef="c36" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="0" unitRef="usd">200,000</ix:nonFraction> (see Note 5).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_22" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until the consummation
of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective
acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the
target business to acquire, and structuring, negotiating and consummating the Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will need
to raise further additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors,
or third parties. In addition to the loan commitment described herein (see Note 10), the Company&#8217;s officers, directors and
Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable
in their sole discretion, to meet the Company&#8217;s working capital needs. Accordingly, the Company may not be able to obtain
additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve
liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential
transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it
on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company&#8217;s ability to continue
as a going concern through April 30, 2021 (or July 31, 2021, if our stockholders approve an amendment to our amended and restated
certificate of incorporation), the current date that the Company will be required to cease all operations, except for the purpose
of winding up, if a Business Combination is not consummated. These financial statements do not include any adjustments relating
to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable
to continue as a going concern.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_EmergingGrowthPolicyTextBlock-c0_cont_1" escape="true" name="thcb:EmergingGrowthPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:continuation continuedAt="_EmergingGrowthPolicyTextBlock-c0_cont_2" id="_EmergingGrowthPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the
&#8220;Securities Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered
public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:continuation id="_EmergingGrowthPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:continuation continuedAt="_UseOfEstimates-c0_cont_2" id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_9" id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:continuation id="_UseOfEstimates-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could
differ significantly from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_10" id="_SignificantAccountingPoliciesTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Cash Equivalents</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_11" id="_SignificantAccountingPoliciesTextBlock-c0_cont_10"><ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of December 31, 2020 and 2019.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_12" id="_SignificantAccountingPoliciesTextBlock-c0_cont_11"><ix:nonNumeric contextRef="c0" continuedAt="_MarketableSecuritiesPolicy-c0_cont_1" escape="true" name="us-gaap:MarketableSecuritiesPolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Marketable Securities Held in Trust Account</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_13" id="_SignificantAccountingPoliciesTextBlock-c0_cont_12"><ix:continuation id="_MarketableSecuritiesPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">At
December 31, 2020 and 2019, the assets held in the Trust Account were substantially held in U.S. Treasury Bills. During the year
ended December 31, 2020 and 2019, the Company withdrew $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:CashWithdrawnFromTrustAccountToPayFranchise" scale="0" unitRef="usd">479,473</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:numdotdecimal" name="thcb:CashWithdrawnFromTrustAccountToPayFranchise" scale="0" unitRef="usd">938,000</ix:nonFraction> of interest income from the Trust Account, respectively,
to pay its franchise and income tax obligations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>



</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_14" id="_SignificantAccountingPoliciesTextBlock-c0_cont_13"><ix:nonNumeric contextRef="c0" continuedAt="_CommonStockSubjectToPossibleRedemptionPolicyTextBlock-c0_cont_1" escape="true" name="thcb:CommonStockSubjectToPossibleRedemptionPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Subject to Possible Redemption</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_15" id="_SignificantAccountingPoliciesTextBlock-c0_cont_14"><ix:continuation id="_CommonStockSubjectToPossibleRedemptionPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption
is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common
stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#8217; equity. The Company&#8217;s common stock features certain redemption rights that are
considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, common
stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders&#8217;
equity section of the Company&#8217;s balance sheets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_16" id="_SignificantAccountingPoliciesTextBlock-c0_cont_15"><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_17" id="_SignificantAccountingPoliciesTextBlock-c0_cont_16"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;Income Taxes.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_18" id="_SignificantAccountingPoliciesTextBlock-c0_cont_17"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_3" id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of
tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more
likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were&#160;no unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues under review that
could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_19" id="_SignificantAccountingPoliciesTextBlock-c0_cont_18"><ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates
and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including
among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;)
for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement
property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules
including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable
years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum
tax credits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_20" id="_SignificantAccountingPoliciesTextBlock-c0_cont_19"><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Income (Loss) Per Common Share</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_21" id="_SignificantAccountingPoliciesTextBlock-c0_cont_20"><ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_2" id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during
the period. The Company has not considered the effect of the warrants sold in the Public Offering and Private Placement to purchase
an aggregate of <ix:nonFraction contextRef="c37" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares">28,287,000</ix:nonFraction> shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent
upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_22" id="_SignificantAccountingPoliciesTextBlock-c0_cont_21"><ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_3" id="_EarningsPerSharePolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s statement of operations includes a presentation of income per share for common shares subject to possible redemption
in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for Common stock
subject to possible redemption is calculated by dividing the proportionate share of income on marketable securities held
by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to
possible redemption outstanding since original issuance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_23" id="_SignificantAccountingPoliciesTextBlock-c0_cont_22"><ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_4" id="_EarningsPerSharePolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Net
loss per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income, adjusted for income on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of
non-redeemable common stock outstanding for the period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_24" id="_SignificantAccountingPoliciesTextBlock-c0_cont_23"><ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_5" id="_EarningsPerSharePolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-redeemable
common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features.
Non-redeemable common stock participates in the income on marketable securities based on non-redeemable common stock shares&#8217;
proportionate interest.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_25" id="_SignificantAccountingPoliciesTextBlock-c0_cont_24"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="6" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 3.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0">2020</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0">2019</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; font-style: italic; text-indent: 0">Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: center; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: center; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">Numerator: Earnings allocable to Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.125in; width: 76%; text-align: left">Interest earned on marketable securities held in Trust Account</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestAndDividendIncomeSecuritiesOther" scale="0" unitRef="usd">2,605,038</ix:nonFraction></td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestAndDividendIncomeSecuritiesOther" scale="0" unitRef="usd">4,827,854</ix:nonFraction></td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Unrealized gain on marketable securities held in Trust Account</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="0" unitRef="usd">9,570</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="0" unitRef="usd">126,682</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0">Less: Income and franchise taxes</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:IncomeAndFranchiseTaxes" scale="0" unitRef="usd">564,980</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:IncomeAndFranchiseTaxes" scale="0" unitRef="usd">1,042,603</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Net income allocable to shares subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="0" unitRef="usd">2,049,628</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="0" unitRef="usd">3,911,933</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: left; text-indent: 0">Denominator: Weighted average Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0">Basic and diluted weighted average shares outstanding</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:numdotdecimal" name="thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" scale="0" unitRef="shares">27,104,439</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:numdotdecimal" name="thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" scale="0" unitRef="shares">27,123,666</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: left; text-indent: 0">Basic and diluted net income per common share</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:numdotdecimal" name="thcb:BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:numdotdecimal" name="thcb:BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; font-style: italic; text-align: left; text-indent: 0">Non-Redeemable Common Stock</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Numerator Net Income minus Net Earnings</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Net income</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">$</td><td style="padding: 0; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">1,375,461</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">$</td><td style="padding: 0; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">3,367,179</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Less: Income attributable to common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:IncomeAttributableToCommonStockSubjectToRedemption" scale="0" sign="-" unitRef="usd">2,049,628</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:IncomeAttributableToCommonStockSubjectToRedemption" scale="0" sign="-" unitRef="usd">3,911,933</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0">Non-Redeemable Net Loss</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:IncomeAdjustedNetLoss" scale="0" unitRef="usd">674,167</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:IncomeAdjustedNetLoss" scale="0" unitRef="usd">544,754</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Denominator: Weighted Average Non-Redeemable Common Stock</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0">Basic and diluted weighted average shares outstanding</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" unitRef="shares">8,382,317</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" unitRef="shares">7,927,608</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Basic and diluted net loss per common share</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" sign="-" unitRef="usdPershares">0.08</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" sign="-" unitRef="usdPershares">0.07</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_26" id="_SignificantAccountingPoliciesTextBlock-c0_cont_25"><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_27" id="_SignificantAccountingPoliciesTextBlock-c0_cont_26"><ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FederalDepositInsuranceCorporationPremiumExpense" scale="0" unitRef="usd">250,000</ix:nonFraction>. The Company has not experienced losses on this
account and management believes the Company is not exposed to significant risks on such account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_28" id="_SignificantAccountingPoliciesTextBlock-c0_cont_27"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value of Financial Instruments</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_29" id="_SignificantAccountingPoliciesTextBlock-c0_cont_28"><ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;Fair Value
Measurement,&#8221; approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term
nature.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_30" id="_SignificantAccountingPoliciesTextBlock-c0_cont_29"><ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently
Issued Accounting Standards</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_30"><ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#8217;s financial statements.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_InitialPublicOfferingDisclosureTextBlock-c0_cont_1" escape="true" name="thcb:InitialPublicOfferingDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3. INITIAL PUBLIC OFFERING</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_InitialPublicOfferingDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 7, 2019, the Company consummated the Initial Public Offering and sold <ix:nonFraction contextRef="c22" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">24,000,000</ix:nonFraction> units at a price of $<ix:nonFraction contextRef="c38" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Unit. <ix:nonNumeric contextRef="c0" name="us-gaap:BusinessCombinationReasonForBusinessCombination">Each
Unit consists of one share of common stock and one warrant (&#8220;Public Warrant&#8221;). On March 12, 2019, in connection with
the underwriters&#8217; exercise of the over-allotment option in full, the Company sold an additional <ix:nonFraction contextRef="c29" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">3,600,000</ix:nonFraction> Units at a price
of $<ix:nonFraction contextRef="c32" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Unit. Each Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share,
subject to adjustment (see Note 7).</ix:nonNumeric></span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_PrivatePlacementDisclosureTextBlock-c0_cont_1" escape="true" name="thcb:PrivatePlacementDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
4. PRIVATE PLACEMENT</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_PrivatePlacementDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Simultaneously
with the closing of the Initial Public Offering, the Sponsor and EarlyBirdCapital and its designee purchased an aggregate of <ix:nonFraction contextRef="c39" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">615,000</ix:nonFraction>
Private Units at a price of&#8201;$<ix:nonFraction contextRef="c40" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Private Unit, for an aggregate purchase price of $<ix:nonFraction contextRef="c39" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">6,150,000</ix:nonFraction>. <ix:nonNumeric contextRef="c39" name="us-gaap:SaleOfStockDescriptionOfTransaction">The Sponsor purchased
500,047 Private Units and EarlyBirdCapital and its designee purchased an aggregate of 114,953 Private Units. On March 12, 2019,
in connection with the underwriters&#8217; exercise of the over-allotment option in full, the purchasers purchased an aggregate
of an additional 72,000 additional Private Units, of which 58,542 Private Units were purchased by the Sponsor and 13,458 Private
Units were purchased by EarlyBirdCapital and its designee, for an aggregate purchase price of $720,000. Each Private Unit consists
of one share of common stock (&#8220;Private Share&#8221;) and one warrant (&#8220;Private Warrant&#8221;). Each Private Warrant
is exercisable to purchase one share of common stock at an exercise price of&#8201;$11.50 per share, subject to adjustment (see
Note 7).</ix:nonNumeric> The proceeds from the Private Units were added to the proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private
Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private
Units and all underlying securities will be worthless.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5. RELATED PARTY TRANSACTIONS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2018, the Sponsor purchased <ix:nonFraction contextRef="c41" decimals="INF" format="ixt:numdotdecimal" name="thcb:SponsorPurchased" scale="0" unitRef="shares">5,750,000</ix:nonFraction> shares (the &#8220;Founder Shares&#8221;) of the Company&#8217;s common stock for
an aggregate price of $<ix:nonFraction contextRef="c41" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" scale="0" unitRef="usd">25,000</ix:nonFraction>. On March 5, 2019, <ix:nonNumeric contextRef="c42" name="thcb:CommonStockDividendDescription">the Company effected a stock dividend of <ix:nonFraction contextRef="c42" decimals="1" format="ixt:numdotdecimal" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" unitRef="usdPershares">0.2</ix:nonFraction> shares of common stock for each
outstanding share (the &#8220;Stock Dividend&#8221;), resulting in <ix:nonFraction contextRef="c42" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockDividendsShares" scale="0" unitRef="shares">6,900,000</ix:nonFraction> Founder Shares being issued and outstanding. The
<ix:nonFraction contextRef="c42" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">6,900,000</ix:nonFraction> Founder Shares included an aggregate of up to <ix:nonFraction contextRef="c43" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" unitRef="shares">900,000</ix:nonFraction> shares subject to forfeiture by the Sponsor to the extent that
the underwriters&#8217; over-allotment was not exercised in full or in part, so that the holders of the Founder Shares would collectively
own <ix:nonFraction contextRef="c44" decimals="2" format="ixt:numdotdecimal" name="thcb:IssuedAndOutstandingSharesPercentage" scale="-2" unitRef="pure">20</ix:nonFraction>% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering (assuming the holders did not purchase
any Public Shares in the Initial Public Offering and excluding the Private Units and Representative Shares (see Note 7). In connection
with the underwriters&#8217; exercise of the over-allotment option in full on March 12, 2019, <ix:nonFraction contextRef="c29" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" unitRef="shares">900,000</ix:nonFraction> Founder Shares are no longer
subject to forfeiture.</ix:nonNumeric></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:nonNumeric contextRef="c45" name="us-gaap:BusinessCombinationControlObtainedDescription"><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder
Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination
and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing
after a Business Combination and, with respect to the remaining 50% of the Founder Shares, until the one year after the consummation
of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation,
merger, stock exchange or other similar transaction which results in all of the Company&#8217;s stockholders having the right
to exchange their shares of common stock for cash, securities or other property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement Units</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the initial public offering, the Company consummated the private placement of <ix:nonFraction contextRef="c37" decimals="INF" format="ixt:numdotdecimal" name="thcb:SaleOfStockNumberOfSharesIssuedInTransactions" scale="0" unitRef="shares">687,000</ix:nonFraction> Private Units at
a price of $<ix:nonFraction contextRef="c46" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Private Unit, generating total proceeds of $<ix:nonFraction contextRef="c37" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">6,870,000</ix:nonFraction>. The Private Units were sold to the Sponsor and EarlyBirdCapital
and its designees. The Private Units are identical to the units sold in the initial public offering, except that the warrants
underlying the Private Units are non-redeemable&#160;and may be exercised on a cashless basis, in each case so long as they continue
to be held by the initial purchasers or their permitted transferees. The initial purchasers have agreed not to transfer, assign
or sell any of the Private Units and underlying securities until after the completion of an initial business combination.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Service Fee</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_8" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vogel
Partners, LLP, an affiliate of Mr.&#160;Vogel, has agreed that, until the earlier of the consummation of an initial business combination
or Tuscan&#8217;s liquidation, it will make available to Tuscan certain general and administrative services, including office
space, utilities and administrative support, as Tuscan may require from time to time. Tuscan has agreed to pay Vogel Partners,
LLP $<ix:nonFraction contextRef="c47" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" scale="0" unitRef="usd">10,000</ix:nonFraction> per month for these services. Tuscan believes, based on rents and fees for similar services in the New&#160;York City
metropolitan area, that the fee charged by Vogel Partners, LLP is at least as favorable as it could have obtained from an unaffiliated
person.. For the year ended December 31, 2020 and 2019, the Company incurred $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:RelatedPartyServicesFeesAmount" scale="0" unitRef="usd">120,000</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="thcb:RelatedPartyServicesFeesAmount" scale="0" unitRef="usd">100,000</ix:nonFraction>, respectively, in fees for
these services. At December 31, 2020 and 2019, fees amounting to $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" scale="0" unitRef="usd">10,000</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" scale="0" unitRef="usd">0</ix:nonFraction> is included in accounts payable and accrued expenses
in the accompanying balance sheets.&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_9" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advance
from Related Party</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_10" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Chief Executive Officer advanced the Company an aggregate of $<ix:nonFraction contextRef="c48" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" scale="0" unitRef="usd">86,748</ix:nonFraction> to be used for the payment of costs related
to the Initial Public Offering. The advances were non-interest bearing, unsecured and due on demand. The advances were repaid
upon the consummation of the Initial Public Offering on March 7, 2019.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_11" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
to Affiliate</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_12" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, an affiliate of the Company paid expenses on behalf of the Company that were mainly settled
during the same period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_13" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Promissory
Note &#8211; Related Party</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_14" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
November 2018, the Company issued an unsecured promissory note to the Company&#8217;s Chief Executive Officer (the &#8220;Promissory
Note&#8221;), pursuant to which the Company borrowed an aggregate principal amount of $<ix:nonFraction contextRef="c49" decimals="0" format="ixt:numdotdecimal" name="us-gaap:UnsecuredDebt" scale="0" unitRef="usd">90,342</ix:nonFraction>. The Promissory Note was non-interest
bearing and payable on the earlier of (i) November 1, 2019, (ii) the consummation of the Initial Public Offering or (iii) the
date on which the Company determines not to proceed with the Initial Public Offering. The Promissory Note was repaid upon the
consummation of the Initial Public Offering on March 7, 2019.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_15" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Party Loans</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_16" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in order
to finance transaction costs in connection with a Business Combination, the Sponsor or certain of the Company&#8217;s officers
and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital
Loans&#8221;). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds
of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside
the Trust Account to the extent such funds are available. In the event that a Business Combination does not close, the Company
may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust
Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of
a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="thcb:WorkingCapitalLoans" scale="0" unitRef="usd">1,500,000</ix:nonFraction> of such Working Capital Loans
may be convertible into units of the post Business Combination entity at a price of $<ix:nonFraction contextRef="c3" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per unit. The units would be identical
to the Private Units.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_17" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 20, 2020, the Sponsor committed to provide an aggregate of $<ix:nonFraction contextRef="c50" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd">500,000</ix:nonFraction> in loans to the Company. The loans shall be non-interest
bearing, unsecured and due upon the consummation of a Business Combination. In the event that a Business Combination does not
close, the loans would be repaid only out of funds held outside the Trust Account to the extent such funds are available. Otherwise,
all amounts loaned to the Company would be forgiven.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 21, 2020,
the Company issued an unsecured promissory note to the Sponsor in the aggregate amount of $<ix:nonFraction contextRef="c51" decimals="0" format="ixt:numdotdecimal" name="us-gaap:UnsecuredDebt" scale="0" unitRef="usd">300,000</ix:nonFraction> (the &#8220;Note&#8221;), of
which $<ix:nonFraction contextRef="c51" decimals="0" format="ixt:numdotdecimal" name="thcb:AmountDrawn" scale="0" unitRef="usd">200,000</ix:nonFraction> was drawn upon on such date. The Note is non-interest bearing and payable upon the consummation of a Business Combination.
The Note is convertible, at the lender&#8217;s option, into units of the post Business Combination entity at a price of $<ix:nonFraction contextRef="c52" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" unitRef="usdPershares">10.00</ix:nonFraction>
per unit. The units would be identical to the Private Units. If a Business Combination is not consummated, the notes will not be
repaid by the Company and all amounts owed thereunder by the Company will be forgiven except to the extent that the Company has
funds available to it outside of its Trust Account. As of December 31, 2020, there was $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="0" unitRef="usd">200,000</ix:nonFraction> outstanding under the Note.</p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 8pt">&#160;&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6. COMMITMENTS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsDisclosureTextBlock-c0_cont_2" id="_CommitmentsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsDisclosureTextBlock-c0_cont_3" id="_CommitmentsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on March 7, 2019, the holders of the Founder Shares, Representative Shares, Private
Units, and any units that may be issued upon conversion of Working Capital Loans (and all underlying securities) are entitled
to registration rights. The holders of the majority of these securities are entitled to make up to two demands that the Company
register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at
any time commencing three months prior to the date on which the Founder Shares are to be released from escrow. The holders of
a majority of the Representative Shares, Private Units or units issued in payment of working capital loans made to the Company
(or underlying securities) can elect to exercise these registration rights at any time commencing after the Company consummates
a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital and its designee may only make a demand on
one occasion and only during the five-year period beginning on the effective date of the Initial Public Offering. In addition,
the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent
to the consummation of a Business Combination; provided, however, that EarlyBirdCapital and its designee may participate in a
&#8220;piggy-back&#8221; registration only during the seven-year period beginning on the effective date of the Initial Public
Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsDisclosureTextBlock-c0_cont_4" id="_CommitmentsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Business
Combination Marketing Agreement</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsDisclosureTextBlock-c0_cont_5" id="_CommitmentsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has engaged EarlyBirdCapital as an advisor in connection with a Business Combination to assist the Company in holding
meetings with its shareholders to discuss the potential Business Combination and the target business&#8217; attributes, introduce
the Company to potential investors that are interested in purchasing the Company&#8217;s securities in connection with a Business
Combination, assist the Company in obtaining shareholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. <ix:nonNumeric contextRef="c0" name="us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity">The Company will pay EarlyBirdCapital a cash fee
for such services upon the consummation of a Business Combination in an amount equal to $9,660,000 (exclusive of any applicable
finders&#8217; fees which might become payable); provided that up to 30% of the fee may be allocated at the Company&#8217;s sole
discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.</ix:nonNumeric></span></p></ix:continuation><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CommitmentsDisclosureTextBlock-c0_cont_6" id="_CommitmentsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Engagement of Morgan Stanley</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_CommitmentsDisclosureTextBlock-c0_cont_6"><p style="margin: 0pt 0; font: 10pt/107% Times New Roman, Times, Serif">We engaged Morgan Stanley &amp; Co. LLC (&#8220;Morgan
Stanley&#8221;) to provide financial advisory services in connection with the Microvast business combination, and, upon consummation
of the transaction with Microvast, we must pay that firm a transaction fee of $<ix:nonFraction contextRef="c53" decimals="-5" format="ixt:numdotdecimal" name="thcb:TransactionFee" scale="6" unitRef="usd">5.5</ix:nonFraction> million, plus expenses. Morgan Stanley also
acted as placement agent in connection with the PIPE Financing, and we are obligated to pay Morgan Stanley a placement fee equal
to (i) <ix:nonFraction contextRef="c53" decimals="3" format="ixt:numdotdecimal" name="thcb:PercentageOfPlacementFee" scale="-2" unitRef="pure">3.5</ix:nonFraction>% of the sum of (x) the aggregate gross proceeds raised in the PIPE Financing up to $<ix:nonFraction contextRef="c54" decimals="-6" format="ixt:numdotdecimal" name="thcb:GrossProceedsFromFinancing" scale="6" unitRef="usd">300</ix:nonFraction> million (not including funds
from the sale of certain excluded securities) and (y) any borrowings pursuant to a bridge financing provided in connection with
the proposed business combination by investors introduced by Morgan Stanley, and (ii) <ix:nonFraction contextRef="c54" decimals="3" format="ixt:numdotdecimal" name="thcb:PercentageOfGrossProceedsRaisedInFinancing" scale="-2" unitRef="pure">2.5</ix:nonFraction>% of the aggregate gross proceeds raised
in the PIPE Financing above $300 million.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7. STOCKHOLDERS&#8217; EQUITY</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i> &#8212;</b> The Company is authorized to issue <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">1,000,000</ix:nonFraction></ix:nonFraction> shares of preferred stock with a par value of $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c4" decimals="4" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction></ix:nonFraction> per share
with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.
At December 31, 2020 and 2019, there were no shares of preferred stock issued or outstanding.&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock &#8212;</i></b> The Company is authorized to issue <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">65,000,000</ix:nonFraction></ix:nonFraction> shares of common stock with a par value of $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c4" decimals="4" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction></ix:nonFraction> per share.
Holders of the common stock are entitled to one vote for each share. At December 31, 2020 and 2019, there were <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">8,396,246</ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">8,360,523</ix:nonFraction></ix:nonFraction>
shares of common stock issued and outstanding, excluding <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:numdotdecimal" name="thcb:CommonSharesSubjectToPossibleRedemption" scale="0" unitRef="shares">27,087,556</ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:numdotdecimal" name="thcb:CommonSharesSubjectToPossibleRedemption" scale="0" unitRef="shares">27,126,477</ix:nonFraction> shares of common stock subject to possible
redemption, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
&#8212;</i></b> The Public Warrants will become exercisable 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement
covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of
common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise
of the public warrants is not effective within 90 days following the consummation of a Business Combination, warrant holders may,
until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain
an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9)
of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders
will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion
of a Business Combination or earlier upon redemption or liquidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b><i>&#160;&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the Public Warrants become exercisable, the Company may redeem the Public Warrants:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;&#160;&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top"> <td style="width: 0.5in; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 0.25in; padding-right: 0.8pt"><ix:nonNumeric contextRef="c55" continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_1" name="thcb:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></ix:nonNumeric></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_2" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in whole and not in part;</span></ix:continuation></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_3" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_2"><span style="font-size: 7pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_4" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_3"><span style="font-size: 7pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_5" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_4"><span style="font-size: 7pt">&#160;</span></ix:continuation></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><p style="margin-top: 0; margin-bottom: 0"></p><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_6" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_5"> <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></td> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_7" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_6"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></ix:continuation></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_8" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_7"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a price of $0.01 per warrant;</span></ix:continuation></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_9" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_8"><span style="font-size: 7pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_10" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_9"><span style="font-size: 7pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_11" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_10"><span style="font-size: 7pt">&#160;</span></ix:continuation></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_12" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_11"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_13" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_12"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></ix:continuation></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_14" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_13"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon not less than 30 days&#8217; prior written notice of redemption;</span></ix:continuation></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_15" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_14"><span style="font-size: 7pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_16" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_15"><span style="font-size: 7pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_17" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_16"><span style="font-size: 7pt">&#160;</span></ix:continuation></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_18" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_19" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_18"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></ix:continuation></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_20" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_19"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the reported last sale price of the Company&#8217;s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and</span></ix:continuation></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_21" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_20"><span style="font-size: 7pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_22" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_21"><span style="font-size: 7pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_23" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_22"><span style="font-size: 7pt">&#160;</span></ix:continuation></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_24" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_23"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></td> <td style="padding-right: 0.8pt"><ix:continuation continuedAt="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_25" id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_24"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></ix:continuation></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:continuation id="_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings-c55_cont_25"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.</span></ix:continuation></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise
the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the
Private Warrants will be exercisable for cash or on a cashless basis, at the holder&#8217;s option, and be non-redeemable so long
as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than
the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable
by such holders on the same basis as the Public Warrants. In addition, so long as the Private Warrants are held by EarlyBirdCapital
and its designee, the Private Warrants will expire five years from the effective date of the Initial Public Offering.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances
including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants
will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination
Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds
with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust
Account with the respect to such warrants. Accordingly, the warrants may expire worthless.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if <ix:nonNumeric contextRef="c0" name="thcb:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings">(x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes
in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.50
per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s
board of directors, and in the case of any such issuance to our Sponsor, initial stockholders or their affiliates, without taking
into account any founders&#8217; shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances
represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination
on the date of the consummation of an initial Business Combination (net of redemptions), and (z) the volume weighted average trading
price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummated
an initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.50 per share, the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at
which the Company issues the additional shares of common stock or equity-linked securities.</ix:nonNumeric></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Representative
Shares</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2018, the Company issued to the designees of EarlyBirdCapital, for a nominal consideration, <ix:nonFraction contextRef="c56" decimals="INF" format="ixt:numdotdecimal" name="thcb:SaleOfStockNumberOfSharesIssuedInTransactions" scale="0" unitRef="shares">300,000</ix:nonFraction> shares (after giving
effect to the Stock Dividend) of common stock (the &#8220;Representative Shares&#8221;). The Company accounted for the Representative
Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders&#8217; equity. The Company
estimated the fair value of Representative Shares to be $<ix:nonFraction contextRef="c56" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" scale="0" unitRef="usd">1,200</ix:nonFraction> based upon the price of the Founder Shares issued to the Sponsor.
The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a
Business Combination. In addition, the holders have agreed (i) to waive their redemption rights (or to sell any shares in a tender
offer) with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights
to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination
within the Combination Period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately
following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(g)(1)
of FINRA&#8217;s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities will not be the subject of any hedging,
short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person
for a period of 180 days immediately following March 5, 2019 (&#8220;FINRA Restricted Period&#8221;), nor may they be sold, transferred,
assigned, pledged or hypothecated during the FINRA Restricted Period except to any underwriter and selected dealer participating
in the Initial Public Offering and their bona fide officers or partners.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in"><b>NOTE 8. INCOME
TAX </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_2" id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax liability are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_3" id="_IncomeTaxDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Deferred tax liability</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Unrealized gain on marketable securities</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" scale="0" unitRef="usd">21,468</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" scale="0" unitRef="usd">27,069</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Total deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" unitRef="usd">21,468</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" unitRef="usd">27,069</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation Allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Deferred tax liability</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="0" unitRef="usd">21,468</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="0" unitRef="usd">27,069</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_4" id="_IncomeTaxDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision consists of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_5" id="_IncomeTaxDisclosureTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Federal</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 10pt">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="0" unitRef="usd">372,365</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="0" unitRef="usd">868,182</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" sign="-" unitRef="usd">5,601</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" unitRef="usd">27,069</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">366,764</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">895,251</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_6" id="_IncomeTaxDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and 2019, the Company did not have any of U.S. federal and state net operating loss carryovers available
to offset future taxable income.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_7" id="_IncomeTaxDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_8" id="_IncomeTaxDisclosureTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">State taxes, net of federal tax benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" unitRef="pure">0.0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" unitRef="pure">0.0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure">21.0</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure">21.0</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">%</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities.
The Company&#8217;s tax returns since inception remain open to examination by the taxing authorities. The Company considers New York
to be a significant state tax jurisdiction.</span></p></ix:continuation><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_FairValueDisclosuresTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9. FAIR VALUE MEASUREMENTS</b>&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_2" id="_FairValueDisclosuresTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value
at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_3" id="_FairValueDisclosuresTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company
would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an
orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets
and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and
to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).
The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable
inputs used in order to value the assets and liabilities:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_4" id="_FairValueDisclosuresTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0.5in; padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5in; padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;1:</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
    transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing
    basis.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;2:</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
    inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or
    liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;3:</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_5" id="_FairValueDisclosuresTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at December 31, 2020
and 2019 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>
</div><div>

</div><ix:continuation id="_FairValueDisclosuresTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Cash and marketable securities held in Trust Account</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c57" decimals="0" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="0" unitRef="usd">282,254,978</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c58" decimals="0" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="0" unitRef="usd">280,103,245</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10. SUBSEQUENT EVENTS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_2" id="_SubsequentEventsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial
statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events
that would have required adjustment or disclosure in the financial statements.&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TUSCAN HOLDINGS CORP.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_3" id="_SubsequentEventsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in"><i>Proposed Business
Combination</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_4" id="_SubsequentEventsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 1, 2021, Tuscan entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with Microvast, Inc.,
a Delaware corporation (&#8220;Microvast&#8221;) and Merger Sub. Pursuant to the Merger Agreement, Merger Sub will merge with
and into Microvast and Microvast will survive the merger and become a wholly owned subsidiary of Tuscan. Under the Merger Agreement,
all of the equity interests of Microvast will be converted into an aggregate of <ix:nonFraction contextRef="c59" decimals="INF" format="ixt:numdotdecimal" name="thcb:NumberOfCommonStockConvertedByEquityInterests" scale="0" unitRef="shares">210,000,000</ix:nonFraction> shares of common stock (&#8220;closing
shares&#8221;). <ix:nonNumeric contextRef="c60" name="us-gaap:CommonStockConversionBasis">The Microvast shareholders and the investors in Microvast&#8217;s majority-owned subsidiary, Microvast Power System
(Houzhou) Co. Ltd. (&#8220;MPS&#8221;), will also have the ability to earn an additional <ix:nonFraction contextRef="c59" decimals="INF" format="ixt:numdotdecimal" name="thcb:AdditionalSharesOfCommonStockEarn" scale="0" unitRef="shares">20,000,000</ix:nonFraction> shares of common stock (&#8220;earnout
shares&#8221;) if the daily volume weighted average price of the common stock is greater than or equal to $<ix:nonFraction contextRef="c61" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SubsequentEventEffectOfChangeInTaxStatus" scale="0" unitRef="usd">18.00</ix:nonFraction> for any 20 trading
days within a 30 trading day period (or a change of control occurs that results in the holders of common stock receiving a per
share price equal to or in excess of $18.00), during the period commencing on the closing date and ending on the third anniversary
of the closing date. Concurrently with the execution of the Merger Agreement, Tuscan and Microvast will jointly acquire <ix:nonFraction contextRef="c62" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" unitRef="pure">100</ix:nonFraction>% ownership
of MPS and will discharge certain convertible loans of MPS.</ix:nonNumeric></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_5" id="_SubsequentEventsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Merger will be accounted for as a reverse recapitalization
in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Under this
method of accounting, Tuscan will be treated as the &#8220;acquired&#8221; company for accounting purposes and the Business Combination
will be treated as the equivalent of Microvast issuing stock for the net assets of Tuscan, accompanied by a recapitalization. The
net assets of Tuscan will be stated at historical cost, with no goodwill or other intangible assets recorded.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_6" id="_SubsequentEventsTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
the Merger Agreement provides that Tuscan will issue an aggregate of <ix:nonFraction contextRef="c60" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockSharesIssued1" scale="0" unitRef="shares">6,736,111</ix:nonFraction>&#160;shares of common stock upon conversion (the
&#8220;Bridge Notes Conversion&#8221;) of an aggregate of $<ix:nonFraction contextRef="c63" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ConvertibleNotesPayable" scale="0" unitRef="usd">57,500,000</ix:nonFraction> outstanding promissory notes issued by Microvast.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_7" id="_SubsequentEventsTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Further,
on February&#160;1, 2021, Tuscan, the Sponsor, Microvast and certain stockholders of Tuscan entered into the Sponsor Support Agreement
(the &#8220;Sponsor Support Agreement&#8221;), pursuant to which the Sponsor and certain officers and directors of Tuscan (collectively,
the &#8220;Sponsor Group&#8221;) agreed, among other things, to vote all equity interests of Tuscan held by such member of the
Sponsor Group in favor of the approval and adoption of the proposed business combination with Microvast. Additionally, such members
of the Sponsor Group have agreed not to (a) transfer any of their equity interests in the Company (or enter into any arrangement
with respect thereto) other than as set forth therein or (b) exercise any conversion rights of any equity interests held by such
member of the Sponsor Group in connection with the approval of the proposed business combination.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_8" id="_SubsequentEventsTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor also agreed that, to the extent that certain expenses of Tuscan are in excess of $<ix:nonFraction contextRef="c64" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">46,000,000</ix:nonFraction> (unless such expenses shall
have been approved by Microvast), the Sponsor will either (i) pay any such excess amount in cash or (ii) forfeit to Tuscan such
number of shares of common stock held by the Sponsor that would have a value equal to such excess. The Sponsor also agreed to
amend the escrow agreement to make certain adjustments to the terms of the escrow of its shares of common stock as set forth in
the Sponsor Support Agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_9" id="_SubsequentEventsTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Contemporaneously with
the execution of the Merger Agreement, certain investors entered into subscription agreements (the &#8220;Subscription Agreements&#8221;),
pursuant to which such investors subscribed for an aggregate value of $<ix:nonFraction contextRef="c65" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">482,500,000</ix:nonFraction>, representing <ix:nonFraction contextRef="c65" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">48,250,000</ix:nonFraction> shares of Tuscan common
stock at a purchase price of $<ix:nonFraction contextRef="c65" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" scale="0" unitRef="usd">10.00</ix:nonFraction> per share in a private placement (the &#8220;PIPE Financing&#8221;) to be consummated immediately
prior to the consummation of the Transactions. Affiliates of InterPrivate, a co-sponsor of Tuscan, subscribed to purchase <ix:nonFraction contextRef="c66" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" unitRef="shares">6.5</ix:nonFraction> million
shares in the PIPE Financing for an aggregate purchase price of $<ix:nonFraction contextRef="c66" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" unitRef="usd">65</ix:nonFraction> million.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_10" id="_SubsequentEventsTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the Closing, the former equityholders of <ix:nonNumeric contextRef="c67" name="us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity">Microvast will hold approximately 69.9% of the issued and outstanding shares
of common stock and the current stockholders of Tuscan will hold approximately 9.2% of the issued and outstanding shares of common
stock, which pro forma ownership (1)&#160;assumes no holder of the common stock sold in Tuscan&#8217;s initial public offering
(such persons, the &#8220;Public Stockholders&#8221;) exercises its conversion rights in connection with the business combination,
and (2)&#160;reflects the issuance of an aggregate of 48,250,000&#160;shares of Common Stock in the PIPE Financing and 6,736,111&#160;shares
of common stock in the Bridge Notes Conversion, but does not include the effect of any other financing of Tuscan. If the maximum
number of Public Shares are converted into cash such that Microvast does not have the right to terminate the Merger Agreement
(i.e., Tuscan has at least $5,000,001 of net tangible assets immediately prior to or upon consummation of the business combination),
such percentages will be approximately 76.8% and 0.2%, respectively.</ix:nonNumeric></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_11" id="_SubsequentEventsTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Consummation
of the proposed business combination is subject to customary conditions and covenants of the respective parties, including approval
of Tuscan&#8217;s stockholders and Tuscan having available cash of at least $<ix:nonFraction contextRef="c68" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="0" unitRef="usd">250,000,000</ix:nonFraction>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_12" id="_SubsequentEventsTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Extension Amendment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_13" id="_SubsequentEventsTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 12, 2021,
Tuscan filed a preliminary proxy statement seeking approval from its stockholders to amend Tuscan&#8217;s charter to extend the
date by which Tuscan is required to complete its initial business combination from April 30, 2021 to July 31, 2021 and to hold
an annual meeting for the election of directors in accordance with Nasdaq listing rules.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_14" id="_SubsequentEventsTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Nasdaq Compliance</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_15" id="_SubsequentEventsTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;6,
2021, we received a notice from the Listing Qualifications Department of The Nasdaq Stock Market stating that we failed to hold
an Annual Meeting of stockholders within 12&#160;months after our fiscal year ended December&#160;31, 2019, as required by Nasdaq
Listing Rule&#160;5620(a). In accordance with Nasdaq Listing Rule&#160;5810(c)(2)(G), we submitted a plan to regain compliance
on February&#160;4, 2021. Nasdaq accepted our plan and granted us an extension through June 29, 2021 to hold an annual meeting.
Nasdaq&#8217;s decision is subject to certain conditions, including that we provide periodic updates with respect to our proposed
business combination with Microvast.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_16" id="_SubsequentEventsTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>Loan Commitment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SubsequentEventsTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;12,
2021, the <ix:nonNumeric contextRef="c69" name="us-gaap:DebtInstrumentDescription">Sponsor extended a loan to Tuscan in the aggregate principal amount totaling $<ix:nonFraction contextRef="c70" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" unitRef="usd">1.2</ix:nonFraction>&#160;million, of which $400,000 was
drawn upon on such date. This loan was in addition to the previous $200,000 drawn upon the $300,000 convertible note that was committed
by the Sponsor on April 21, 2020. As a result of the February&#160;12, 2021 commitment, the Sponsor had committed to Tuscan a total
of $1.5 million, of which a total of $600,000 has been drawn upon, with $400,000 of the drawn amount pursuant to the February&#160;12,
2021 note. The Sponsor intends to convert the $1.5 million total loan balance into 150,000 Units immediately prior to the closing
of the proposed business combination with Microvast. Such units will have terms identical to the terms of the Company&#8217;s Private
Units and will consist of (i) 150,000&#160;shares of common stock and (ii) warrants to purchase 150,000&#160;shares of common stock
at an exercise price of $11.50 per share, subject to adjustment.</ix:nonNumeric>&#160;</p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-17</span></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" id="hidden-fact-1" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" id="hidden-fact-2" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" id="hidden-fact-3" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
<ix:nonFraction contextRef="c3" id="hidden-fact-4" name="us-gaap:PrepaidExpenseCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-5" name="us-gaap:TaxesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-6" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-7" name="us-gaap:NotesPayableRelatedPartiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-8" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-9" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-10" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-11" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-12" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-13" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-14" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-15" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-16" name="thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-17" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-18" name="thcb:CommonStockSubjectToPossibleRedemption" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-19" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-20" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-21" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-22" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-23" name="us-gaap:PaymentsToAcquireInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-24" name="thcb:ProceedsFromSalesOfUnitsUnderwritingDiscount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-25" name="thcb:ProceedsFromSaleOfPrivateUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-26" name="thcb:ProceedsFromConvertiblePromissoryNoteRelatedParty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-27" name="thcb:ProceedsFromPromissoryNotesRelatedparty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-28" name="thcb:RepaymentOfPromissoryNoteRelatedParty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-29" name="us-gaap:IncomeTaxesPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-30" name="thcb:InitialClassificationOfCommonStockSubjectToRedemption" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-31" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-32" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-33" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-34" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-35" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-36" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-37" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-38" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentTransitionReport">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001760689</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="thcb-20201231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-03-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-01-01</xbrli:startDate>
    <xbrli:endDate>2019-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-01-01</xbrli:startDate>
    <xbrli:endDate>2019-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-01-01</xbrli:startDate>
    <xbrli:endDate>2019-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-01-01</xbrli:startDate>
    <xbrli:endDate>2019-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-03-01</xbrli:startDate>
    <xbrli:endDate>2019-03-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-03-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-03-01</xbrli:startDate>
    <xbrli:endDate>2019-03-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">thcb:EarlyBirdCapitalMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-03-01</xbrli:startDate>
    <xbrli:endDate>2019-03-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">thcb:EarlyBirdCapitalMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-03-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">thcb:EarlyBirdCapitalMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-03-01</xbrli:startDate>
    <xbrli:endDate>2019-03-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:PrivateUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-03-01</xbrli:startDate>
    <xbrli:endDate>2019-03-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:PrivateUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-03-12</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-03-12</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-07</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYmd/eP2vefFYjlZ03F3sybkMF39kCdGz5Rojbdz8tM/wssVRLP7kcbIoHDqSY1cEXAJSJwSlCjxb8MtUGFs1NlaLqPlLHEPFbI1W6vdfoArFxb7wyCH52a39w5qvqHIArkIlF8GySb/8mu1Fz70KdjoFja/90wbDeoJk4769F9URCy4v82yBrB3FHEjyCZTNCfEOSIojhSodZLnleCtGnx] CSR-->
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-04-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-04-21</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-03-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:FoundeSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-11-01</xbrli:startDate>
    <xbrli:endDate>2018-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:FoundeSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-03-01</xbrli:startDate>
    <xbrli:endDate>2019-03-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-03-01</xbrli:startDate>
    <xbrli:endDate>2019-03-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-03-05</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:FoundeSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">thcb:VogelPartnersLlpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-04-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-04-21</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:PrivateUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-04-21</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:MorganStanleyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">thcb:PrivateInvestmentInPublicEquityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:MorganStanleyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">thcb:EarlyBirdCapitalMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-11-01</xbrli:startDate>
    <xbrli:endDate>2018-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-26</xbrli:startDate>
    <xbrli:endDate>2021-02-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:MicrovastPowerSystemMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-26</xbrli:startDate>
    <xbrli:endDate>2021-02-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-26</xbrli:startDate>
    <xbrli:endDate>2021-02-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:MicrovastPowerSystemMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-02-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">thcb:BridgeNotesConversionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-02-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-26</xbrli:startDate>
    <xbrli:endDate>2021-02-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="thcb:AgreementAxis">thcb:SubscriptionAgreementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-26</xbrli:startDate>
    <xbrli:endDate>2021-02-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="thcb:AgreementAxis">thcb:SubscriptionAgreementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:CosponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-26</xbrli:startDate>
    <xbrli:endDate>2021-02-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="thcb:AgreementAxis">thcb:MergerAgreementMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-26</xbrli:startDate>
    <xbrli:endDate>2021-02-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-02-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-02-02</xbrli:startDate>
    <xbrli:endDate>2021-02-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760689</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-02-12</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>f10k2020ex4-5_tuscanhold.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>DESCRIPTION OF REGISTRANT&rsquo;S
SECURITIES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The following summary of Tuscan Holdings
Corp.&rsquo;s securities is based on and qualified by the Company&rsquo;s Amended and Restated Articles of Incorporation (the &ldquo;Charter&rdquo;).
References to the &ldquo;Company&rdquo; and to &ldquo;we,&rdquo; &ldquo;us,&rdquo; and &ldquo;our&rdquo; refer to Tuscan Holdings
Corp.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is authorized to issue 65,000,000
shares of common stock, par value $0.0001, and 1,000,000 shares of preferred stock, par value $0.0001. There are no shares of preferred
stock currently outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Composition. </I>Each unit consists
of one share of common stock and one warrant. Each warrant entitles the holder to purchase one share of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Listing.</I> The units are listed on
the Nasdaq Capital Market under the symbol &ldquo;THCBU.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Authorization.&nbsp;</I>The outstanding
shares of the Company&rsquo;s common stock are duly authorized, validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Listing.&nbsp;</I>The Company&rsquo;s
common stock is listed on the Nasdaq Capital Market under the symbol &ldquo;THCB.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Voting Rights.&nbsp;</I>Common stockholders
of record are entitled to one vote for each share held on all matters to be voted on by stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tuscan Holdings Acquisition LLC, our sponsor
(&ldquo;Sponsor&rdquo;), as well as all of our officers and directors, have agreed to vote their respective shares of common stock
owned by them immediately prior to our initial public offering (the &ldquo;founder&rsquo;s common stock&rdquo;) and any shares
purchased following the initial public offering in the open market in favor of any proposed business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conversion Rights</I>.&nbsp;Holders
of common stock issued in the Company&rsquo;s initial public offering (which we refer to as &ldquo;public shares&rdquo;) have the
right to demand that the Company convert such shares into a pro rata portion of the Company&rsquo;s trust account upon the consummation
of our initial business combination, either in connection with a stockholder meeting called to approve the business combination
or by means of a tender offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The decision as to whether we will seek
stockholder approval of a proposed business combination or conduct a tender offer will be made by us, solely in our discretion,
and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would
require us to seek stockholder approval under the law or stock exchange listing requirement. We intend to conduct redemptions without
a stockholder vote pursuant to the tender offer rules of the Securities and Exchange Commission (&ldquo;SEC&rdquo;) unless stockholder
approval is required by law or stock exchange listing requirement or we choose to seek stockholder approval for business or other
legal reasons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a stockholder vote is not required and
we do not decide to hold a stockholder vote for business or other legal reasons, we will, pursuant to our Charter, conduct the
redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to consummating our
initial business combination. Our Charter requires these tender offer documents to contain substantially the same financial and
other information about the initial business combination and the redemption rights as is required under the SEC&rsquo;s proxy rules.
If, however, stockholder approval of the transaction is required by law or Nasdaq, or we decide to obtain stockholder approval
for business or other reasons, we will, like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation
pursuant to the proxy rules and not pursuant to the tender offer rules. If we seek stockholder approval, we will consummate our
initial business combination only if a majority of the outstanding shares of common stock voted are voted in favor of the business
combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Outside Date</I>. Pursuant to our Charter,
if we do not consummate an initial business combination by April 30, 2021 (unless such date is extended by our stockholders pursuant
to an amendment to our Charter), our corporate existence will cease except for the purposes of winding up our affairs and liquidating
and we will redeem 100% of our outstanding public shares for a pro rata portion of the funds held in the trust account, equal to
the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and
not previously released to us, divided by the number of then outstanding public shares, subject to applicable law and as further
described herein. Our Sponsor, officers and directors have agreed to waive their rights to participate in any liquidation distribution
from the trust account occurring upon our failure to consummate an initial business combination with respect to the founder&rsquo;s
common stock. Our Sponsor, officers and directors will therefore not participate in any liquidation distribution from the trust
account with respect to such shares. They will, however, participate in any liquidation distribution from the trust account with
respect to any shares of common stock acquired after our IPO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we seek to amend any provisions of our
Charter that would affect our public stockholders&rsquo; ability to convert their shares in connection with a business combination
or affect the substance or timing of our obligation to redeem 100% of our public shares if we do not complete a business combination
by the required date set forth in our Charter, we will provide public stockholders with the opportunity to convert their public
shares in connection with any such vote. This conversion right shall apply in the event of the approval of any such amendment,
whether proposed by our Sponsor, any executive officer, director or director nominee, or any other person.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Preemptive Rights.</I> Our stockholders
have no conversion, preemptive or other subscription rights and there are no sinking fund or redemption provisions applicable to
the shares of common stock, except that public stockholders have the right to sell their shares to us in a tender offer or have
their shares of common stock converted to cash equal to their pro rata share of the trust account if they vote on the proposed
business combination in connection with such business combination and the business combination is completed. Public stockholders
who sell or convert their stock into their share of the trust account still have the right to exercise the warrants that they received
as part of the units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dividends.</I>&nbsp;We have not paid
any cash dividends on our shares of common stock to date and do not intend to pay cash dividends prior to the completion of a business
combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements
and general financial condition subsequent to completion of a business combination. The payment of any dividends subsequent to
a business combination will be within the discretion of our then board of directors. It is the present intention of our board of
directors to retain all earnings, if any, for use in our business operations and, accordingly, our board does not anticipate declaring
any dividends in the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no shares of preferred stock
outstanding. Our Charter authorizes the issuance of 1,000,000&nbsp;shares of preferred stock with such designation, rights and
preferences as may be determined from time to time by our board of directors. Our board of directors is empowered, without stockholder
approval, to issue preferred stock with dividend, liquidation, conversion, voting or other rights which could adversely affect
the voting power or other rights of the holders of common stock. However, the underwriting agreement prohibits us, prior to a business
combination, from issuing preferred stock which participates in any manner in the proceeds of the trust account, or which votes
as a class with the common stock on a business combination. We may issue some or all of the preferred stock to effect a business
combination. In addition, the preferred stock could be utilized as a method of discouraging, delaying or preventing a change in
control of us. Although we do not currently intend to issue any shares of preferred stock, we cannot assure you that we will not
do so in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Listing</I>. The Company&rsquo;s warrants
are listed on the Nasdaq Capital Market under the symbol &ldquo;THCBW.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exercisability</I>. Each warrant entitles
the registered holder to purchase one share of common stock during the exercise period. No fractional shares will be issued upon
exercise of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exercise Price.</I>&nbsp;$11.50 per
share, subject to adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price and number of shares
of common stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a stock
dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However, except as described
below, the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if (x) we issue additional
shares of common stock or equity-linked&nbsp;securities for capital raising purposes in connection with the closing of our initial
business combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such issue price
or effective issue price to be determined in good faith by our board of directors, and in the case of any such issuance to our
Sponsor, initial stockholders or their affiliates, without taking into account any founders&rsquo; shares held by them prior to
such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and
interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial
business combination (net of redemptions), and (z) the Market Value is below $9.50 per share, the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which we
issue the additional shares of common stock or equity-linked&nbsp;securities. The &ldquo;Market Value&rdquo; for this purpose means
the volume weighted average trading price of our common stock during the 20 trading day period starting on the trading day prior
to the day on which we consummate our initial business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exercise Period.</I> The warrants will
become exercisable commencing 30 days after the completion of an initial business combination. &nbsp;The warrants will expire five
years after the consummation of our initial business combination, at 5:00 p.m., New York time, or earlier upon our liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No warrants will be exercisable for cash
unless we have an effective and current registration statement covering the shares of common stock issuable upon exercise of the
warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement
covering the shares of common stock issuable upon exercise of the public warrants is not effective within a specified period following
the consummation of our initial business combination, warrant holders may, until such time as there is an effective registration
statement and during any period when we shall have failed to maintain an effective registration statement, exercise warrants on
a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available.
If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.
In the event of such a cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number
of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying
the warrants, multiplied by the difference between the exercise price of the warrants and the &ldquo;fair market value&rdquo; (defined
below) by (y) the fair market value. The &ldquo;fair market value&rdquo; for this purpose will mean the average reported last sale
price of the shares of common stock for the 5 trading days ending on the trading day prior to the date of exercise. The warrants
will expire on the fifth anniversary of our completion of an initial business combination, at 5:00 p.m., New York City time, or
earlier upon redemption or liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants included in the units issued
privately concurrently with our IPO (the &ldquo;private warrants&rdquo;), as well as any warrants underlying additional units we
issue to our Sponsor, officers, directors or their affiliates in payment of working capital loans made to us, will be identical
to the warrants underlying the units offered in our IPO except that such warrants will be exercisable for cash or on a cashless
basis, at the holder&rsquo;s option, and will not be redeemable by us, in each case so long as they are still held by our Sponsor
or its permitted transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Redemption. </I>We may call the warrants
for redemption (excluding the private warrants and any warrants underlying additional units issued to our Sponsor, initial stockholders,
officers, directors or their affiliates in payment of working capital loans made to us), in whole and not in part, at a price of
$0.01 per warrant, (i) at any time after the warrants become exercisable, (ii) upon not less than 30 days&rsquo; prior written
notice of redemption to each warrant holder after the warrants become exercisable, (iii) &nbsp;if, and only if, the reported last
sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations
and recapitalizations), for any 20 trading days within a 30 trading day period commencing after the warrants become exercisable
and ending on the third business day prior to the notice of redemption to warrant holders, and (iv) if, and only if, there is a
current registration statement in effect with respect to the shares of common stock underlying such warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The right to exercise will be forfeited
unless the warrants are exercised prior to the date specified in the notice of redemption. On and after the redemption date, a
record holder of a warrant will have no further rights except to receive the redemption price for such holder&rsquo;s warrant upon
surrender of such warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we call the warrants for redemption
as described above, our management will have the option to require all holders that wish to exercise warrants to do so on a &ldquo;cashless
basis.&rdquo; In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of
common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the
warrants, multiplied by the difference between the exercise price of the warrants and the &ldquo;fair market value&rdquo; (defined
below) by (y) the fair market value. The &ldquo;fair market value&rdquo; for this purpose shall mean the average reported last
sale price of the shares of common stock for the 5 trading days ending on the third trading day prior to the date on which the
notice of redemption is sent to the holders of warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Fractional Shares. </I>No fractional
shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a
fractional interest in a share, we will, upon exercise, round up to the nearest whole number the number of shares of common stock
to be issued to the warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Certain Provisions of the Charter and
Bylaws</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Staggered Board of Directors</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors is divided into
three classes, each of which will generally serve for a term of three years with only one class of directors being elected in each
year. There is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50%
of the shares eligible to vote for the election of directors can elect all of the directors. As a result, in most circumstances,
a person can gain control of our board only by successfully engaging in a proxy contest at two or more annual meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Special Meeting of Stockholders</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our bylaws provide that special meetings
of our stockholders may be called only by a majority vote of our board of directors, by our president or by our chairman or by
our secretary at the request in writing of stockholders owning a majority of our issued and outstanding capital stock entitled
to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Advance Notice Requirements for Stockholder
Proposals and Director Nominations</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our bylaws provide that stockholders seeking
to bring business before our annual meeting of stockholders, or to nominate candidates for election as directors at our annual
meeting of stockholders must provide timely notice of their intent in writing. To be timely, a stockholder&rsquo;s notice will
need to be delivered to our principal executive offices not later than the close of business on the 60<SUP>th</SUP>&nbsp;day nor
earlier than the close of business on the 90<SUP>th</SUP>&nbsp;day prior to the scheduled date of the annual meeting of stockholders.
In the event that less than 70 days&rsquo; notice or prior public disclosure of the date of the annual meeting of stockholders
is given, a stockholder&rsquo;s notice shall be timely if delivered to our principal executive offices not later than the 10<SUP>th</SUP>&nbsp;day
following the day on which public announcement of the date of our annual meeting of stockholders is first made or sent by us. Our
bylaws also specify certain requirements as to the form and content of a stockholders&rsquo; meeting. These provisions may preclude
our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our
annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Authorized but Unissued Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our authorized but unissued common stock
and preferred stock are available for future issuances without stockholder approval and could be utilized for a variety of corporate
purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized
but unissued and unreserved common stock and preferred stock could render more difficult or discourage an attempt to obtain control
of us by means of a proxy contest, tender offer, merger or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exclusive Forum Selection</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Charter requires, to the fullest extent
permitted by law, that derivative actions brought in our name, actions against directors, officers and employees for breach of
fiduciary duty and other similar actions may be brought only in the Court of Chancery in the State of Delaware, except any action
(A) as to which the Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to the
jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of
Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other
than the Court of Chancery, (C) for which the Court of Chancery does not have subject matter jurisdiction or (D) any action arising
under the Securities Act, as to which the Court of Chancery and the federal district court for the District of Delaware shall have
concurrent jurisdiction. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have
consented to service of process on such stockholder&rsquo;s counsel. Although we believe this provision benefits us by providing
increased consistency in the application of Delaware law in the types of lawsuits to which it applies, a court may determine that
this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits
against our directors and officers, although our stockholders will not be deemed to have waived our compliance with federal securities
laws and the rules and regulations thereunder and therefore bring a claim in another appropriate forum. Additionally, we cannot
be certain that a court will decide that this provision is either applicable or enforceable, and if a court were to find the choice
of forum provision contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an
action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business,
operating results and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Charter provides that the exclusive
forum provision will be applicable to the fullest extent permitted by applicable law. Section 27 of the Exchange Act creates exclusive
federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations
thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created
by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Certain Anti-Takeover Provisions of
Delaware Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will be subject to the provisions of
Section 203 of the Delaware General Corporation Law regulating corporate takeovers upon completion of this offering. This statute
prevents certain Delaware corporations, under certain circumstances, from engaging in a &ldquo;business combination&rdquo; with:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">a stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an &ldquo;interested stockholder&rdquo;);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an affiliate of an interested stockholder; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an associate of an interested stockholder, for three years following the date that the stockholder became an interested stockholder.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A &ldquo;business combination&rdquo; includes
a merger or sale of more than 10% of our assets. However, the above provisions of Section 203 do not apply if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">our board of directors approves the transaction that made the stockholder an &ldquo;interested stockholder,&rdquo; prior to the date of the transaction;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">after the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">on or subsequent to the date of the transaction, the business combination is approved by our board of directors and authorized at a meeting of our stockholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">5</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0in; margin-bottom: 0in; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>3
<FILENAME>f10k2020ex10-9_tuscanhold.htm
<DESCRIPTION>CONVERTIBLE PROMISSORY NOTE, DATED AS OF FEBRUARY 12, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 10.9</B></P>

<P STYLE="margin: 0pt; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>PROMISSORY NOTE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,200,000</FONT></TD>
    <TD STYLE="width: 40%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of February 12, 2021</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tuscan Holdings Corp.
(&ldquo;Maker&rdquo;) promises to pay to the order of Tuscan Holdings Acquisition LLC or its successors or assigns (&ldquo;Payee&rdquo;)
the principal sum of One Million Two Hundred Thousand Dollars and No Cents ($1,200,000) in lawful money of the United States of
America, on the terms and conditions described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Principal</U>.
The principal balance of this Note shall be repayable on the consummation of the Maker&rsquo;s initial merger, stock exchange,
asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses
or entities (a &ldquo;Business Combination&rdquo;). Payee understands that if a Business Combination is not consummated, this Note
will not be repaid and all amounts owed hereunder will be forgiven except to the extent that the Maker has funds available to it
outside of its trust account established in connection with its initial public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Interest</U>.
No interest shall accrue on the unpaid principal balance of this Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Application
of Payments</U>. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due
under this Note, including (without limitation) reasonable attorneys&rsquo; fees, then to the payment in full of any late charges
and finally to the reduction of the unpaid principal balance of this Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Events
of Default</U>. The following shall constitute Events of Default:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">(a) <U>Failure
to Make Required Payments</U>. Failure by Maker to pay the principal of this Note within five (5) business days following the date
when due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">(b) <U>Voluntary
Bankruptcy, Etc.</U>&nbsp;The commencement by Maker of a voluntary case under the Federal Bankruptcy Code, as now constituted or
hereafter amended, or any other applicable federal or state bankruptcy, insolvency, reorganization, rehabilitation or other similar
law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator
(or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the
benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action
by Maker in furtherance of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">(c) <U>Involuntary
Bankruptcy, Etc.</U>&nbsp;The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of
maker in an involuntary case under the Federal Bankruptcy Code, as now or hereafter constituted, or any other applicable federal
or state bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator
(or similar official) of Maker or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs,
and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Remedies</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">(a) Upon
the occurrence of an Event of Default specified in Section 4(a), Payee may, by written notice to Maker, declare this Note to be
due and payable, whereupon the principal amount of this Note, and all other amounts payable thereunder, shall become immediately
due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything
contained herein or in the documents evidencing the same to the contrary notwithstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">(b) Upon
the occurrence of an Event of Default specified in Sections 4(b) and 4(c), the unpaid principal balance of, and all other sums
payable with regard to, this Note shall automatically and immediately become due and payable, in all cases without any action on
the part of Payee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.55pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Conversion</U>.
Upon consummation of a Business Combination, the Payee shall have the option, but not the obligation, to convert the principal
balance of this Note, in whole or in part at the option of the Payee, into units (&ldquo;Units&rdquo;) of the Maker at a price
of $10.00 per Unit, each Unit being identical to the &ldquo;private units&rdquo; (as defined in Maker&rsquo;s final prospectus
dated March 5, 2019). As promptly after notice by Payee to Maker to convert the principal balance of this Note, which must be made
at least 24 hours prior to the consummation of the Business Combination, as reasonably practicable and after Payee&rsquo;s surrender
of this Note, Maker shall have issued and delivered to Payee, without any charge to Payee, a certificate or certificates (issued
in the name(s) requested by Payee) for the number of Units of Maker issuable upon the conversion of this Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>Waivers</U>.
Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor,
protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by
Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting
any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or
sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and
Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution
issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Unconditional
Liability</U>. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement
of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other
party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or
consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted
by Payee with respect to the payment or other provisions of this Note, and agree that additional makers, endorsers, guarantors,
or sureties may become parties hereto without notice to them or affecting their liability hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9. <U>Notices</U>.
Any notice called for hereunder shall be deemed properly given if (i) sent by certified mail, return receipt requested, (ii) personally
delivered, (iii) dispatched by any form of private or governmental express mail or delivery service providing receipted delivery,
(iv) sent by telefacsimile or (v) sent by e-mail, to the following addresses or to such other address as either party may designate
by notice in accordance with this Section:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If to Maker:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Tuscan Holdings Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">135 E. 57th St., 18th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">New York, NY 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If to Payee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Stephen Vogel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">135 E. 57th St., 18th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">New York, NY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notice shall be deemed given on the earlier
of (i) actual receipt by the receiving party, (ii) the date shown on a telefacsimile transmission confirmation, (iii) the date
on which an e-mail transmission was received by the receiving party&rsquo;s on-line access provider (iv) the date reflected on
a signed delivery receipt, or (vi) two (2) Business Days following tender of delivery or dispatch by express mail or delivery service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10. <U>Construction</U>.
This Note shall be construed and enforced in accordance with the domestic, internal law, but not the law of conflict of laws,
of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11. <U>Severability</U>.
Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof,
and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision
in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
Maker, intending to be legally bound hereby, has caused this Note to be duly executed by its Chief Executive Officer the day and
year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TUSCAN HOLDINGS CORP.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="text-decoration: none">/s/ Stephen Vogel</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Vogel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>f10k2020ex21_tuscanhold.htm
<DESCRIPTION>LIST OF SUBSIDIARIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>Exhibit 21</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>List of Subsidiaries</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">TSCN Merger Sub Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">MVST SPV Inc.</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>f10k2020ex31-1_tuscanhold.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Stephen A. Vogel, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Annual
Report on Form 10-K of Tuscan Holdings Corp.;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by
this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge,
the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s
other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure
controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that
material information relating to the registrant, is made known to us by others within those entities, particularly during the
period in which this report is being prepared; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such internal
control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report
any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most
recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal
control over financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s
other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or
not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control
over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Date: March 24, 2021</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Stephen A. Vogel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Stephen A. Vogel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer<BR>
(Principal Executive Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>f10k2020ex31-2_tuscanhold.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF CHIEF FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Ruth Epstein, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Annual
Report on Form 10-K of Tuscan Holdings Corp.;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by
this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge,
the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s
other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure
controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that
material information relating to the registrant, is made known to us by others within those entities, particularly during the
period in which this report is being prepared; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such internal
control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report
any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most
recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal
control over financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s
other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or
not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control
over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Date: March 24, 2021</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Ruth Epstein</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Ruth Epstein</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer<BR>
(Principal Financial Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>f10k2020ex32_tuscanhold.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>18 U.S.C. SECTION 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Annual Report of
Tuscan Holdings Corp. (the &ldquo;Company&rdquo;) on Form 10-K for the year ended December 31, 2020 as filed with the Securities
and Exchange Commission (the &ldquo;Report&rdquo;), each of the undersigned, in the capacities and on the dates indicated below,
hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Report fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained
in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Date: March 24, 2021</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Stephen A. Vogel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Stephen A. Vogel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer<BR>
(Principal Executive Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ Ruth Epstein</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Ruth Epstein</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer<BR>
(Principal Financial Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>thcb-20201231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Mar 24 20:36:19 EDT 2021 -->
<xs:schema xmlns:thcb="http://thcb.com/20201231" elementFormDefault="qualified" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" targetNamespace="http://thcb.com/20201231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="thcb-20201231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="thcb-20201231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="thcb-20201231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="thcb-20201231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://thcb.com/role/ConsolidatedBalanceSheet" id="thcb_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals" id="thcb_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ConsolidatedIncomeStatement" id="thcb_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ShareholdersEquityType2or3" id="thcb_r_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - Statements of Changes in Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ShareholdersEquityType2or3_Parentheticals" id="thcb_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>005 - Statement - Statements of Changes in Stockholders&#8217; Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ConsolidatedCashFlow" id="thcb_r_ConsolidatedCashFlow">
        <link:definition>006 - Statement - Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/DescriptionofOrganizationandBusinessOperations" id="thcb_r_DescriptionofOrganizationandBusinessOperations">
        <link:definition>007 - Disclosure - Description of Organization and Business Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/SummaryofSignificantAccountingPolicies" id="thcb_r_SummaryofSignificantAccountingPolicies">
        <link:definition>008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/InitialPublicOffering" id="thcb_r_InitialPublicOffering">
        <link:definition>009 - Disclosure - Initial Public Offering</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/PrivatePlacement" id="thcb_r_PrivatePlacement">
        <link:definition>010 - Disclosure - Private Placement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/RelatedPartyTransactions" id="thcb_r_RelatedPartyTransactions">
        <link:definition>011 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/Commitments" id="thcb_r_Commitments">
        <link:definition>012 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/StockholdersEquity" id="thcb_r_StockholdersEquity">
        <link:definition>013 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/IncomeTax" id="thcb_r_IncomeTax">
        <link:definition>014 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/FairValueMeasurements" id="thcb_r_FairValueMeasurements">
        <link:definition>015 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/SubsequentEvents" id="thcb_r_SubsequentEvents">
        <link:definition>016 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/AccountingPoliciesByPolicy" id="thcb_r_AccountingPoliciesByPolicy">
        <link:definition>017 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables" id="thcb_r_SummaryofSignificantAccountingPoliciesTables">
        <link:definition>018 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/IncomeTaxTables" id="thcb_r_IncomeTaxTables">
        <link:definition>019 - Disclosure - Income Tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/FairValueMeasurementsTables" id="thcb_r_FairValueMeasurementsTables">
        <link:definition>020 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails" id="thcb_r_DescriptionofOrganizationandBusinessOperationsDetails">
        <link:definition>021 - Disclosure - Description of Organization and Business Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails" id="thcb_r_SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>022 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable" id="thcb_r_ScheduleofbasicanddilutedlosspershareTable">
        <link:definition>023 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/InitialPublicOfferingDetails" id="thcb_r_InitialPublicOfferingDetails">
        <link:definition>024 - Disclosure - Initial Public Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/PrivatePlacementDetails" id="thcb_r_PrivatePlacementDetails">
        <link:definition>025 - Disclosure - Private Placement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYmd/eP2vefFYjlZ03F3sybkMF39kCdGz5Rojbdz8tM/wssVRLP7kcbIoHDqSY1cEXAJSJwSlCjxb8MtUGFs1NlaLqPlLHEPFbI1W6vdfoArFxb7wyCH52a39w5qvqHIArkIlF8GySb/8mu1Fz70KdjoFja/90wbDeoJk4769F9URCy4v82yBrB3FHEjyCZTNCq9TgdigPCC5iH+dFOkFJb] CSR-->
      <link:roleType roleURI="http://thcb.com/role/RelatedPartyTransactionsDetails" id="thcb_r_RelatedPartyTransactionsDetails">
        <link:definition>026 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/CommitmentsDetails" id="thcb_r_CommitmentsDetails">
        <link:definition>027 - Disclosure - Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/StockholdersEquityDetails" id="thcb_r_StockholdersEquityDetails">
        <link:definition>028 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable" id="thcb_r_ScheduleofnetdeferredtaxliabilityTable">
        <link:definition>029 - Disclosure - Income Tax (Details) - Schedule of net deferred tax liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ScheduleofincometaxprovisionTable" id="thcb_r_ScheduleofincometaxprovisionTable">
        <link:definition>030 - Disclosure - Income Tax (Details) - Schedule of income tax provision</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable" id="thcb_r_ScheduleoffederalincometaxratetoeffectivetaxrateTable">
        <link:definition>031 - Disclosure - Income Tax (Details) - Schedule of federal income tax rate to effective tax rate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable" id="thcb_r_ScheduleoffairvaluehierarchyofthevaluationinputsTable">
        <link:definition>032 - Disclosure - Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/SubsequentEventsDetails" id="thcb_r_SubsequentEventsDetails">
        <link:definition>033 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://thcb.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd"/>
  <xs:element name="ScheduleOfBasicAndDilutedLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract"/>
  <xs:element name="InitialPublicOfferingDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_InitialPublicOfferingDisclosureAbstract"/>
  <xs:element name="PrivatePlacementDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_PrivatePlacementDisclosureAbstract"/>
  <xs:element name="ScheduleOfNetDeferredTaxLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract"/>
  <xs:element name="ScheduleOfIncomeTaxProvisionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_ScheduleOfIncomeTaxProvisionAbstract"/>
  <xs:element name="ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract"/>
  <xs:element name="ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract"/>
  <xs:element name="CommonStockSubjectToPossibleRedemptionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_CommonStockSubjectToPossibleRedemptionAbstract"/>
  <xs:element name="NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract"/>
  <xs:element name="DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract"/>
  <xs:element name="NonRedeemableCommonStockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_NonRedeemableCommonStockAbstract"/>
  <xs:element name="NumeratorNetIncomeMinusNetEarningsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_NumeratorNetIncomeMinusNetEarningsAbstract"/>
  <xs:element name="DenominatorWeightedAverageNonRedeemableCommonStockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract"/>
  <xs:element name="DeferredTaxLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_DeferredTaxLiabilityAbstract"/>
  <xs:element name="FederalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_FederalAbstract"/>
  <xs:element name="StateAndLocalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_StateAndLocalAbstract"/>
  <xs:element name="AssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_AssetsAbstract0"/>
  <xs:element name="CommonSharesSubjectToPossibleRedemption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="thcb_CommonSharesSubjectToPossibleRedemption"/>
  <xs:element name="BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede"/>
  <xs:element name="BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe"/>
  <xs:element name="StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts"/>
  <xs:element name="StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares"/>
  <xs:element name="CommonStockSubjectToPossibleRedemption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_CommonStockSubjectToPossibleRedemption"/>
  <xs:element name="CommonStockSubjectToPossibleRedemptionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_CommonStockSubjectToPossibleRedemptionShares"/>
  <xs:element name="ChangeInValueOfCommonStockSubjectToPossibleRedemption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption"/>
  <xs:element name="ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares"/>
  <xs:element name="SaleOfPrivateUnitAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_SaleOfPrivateUnitAmount"/>
  <xs:element name="IncreaseDecreaseInMarketableSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_IncreaseDecreaseInMarketableSecurities"/>
  <xs:element name="IncreaseDecreaseUnrealizedGainMarketableSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities"/>
  <xs:element name="CashWithdrawnAccountForRedemptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_CashWithdrawnAccountForRedemptions"/>
  <xs:element name="CashWithdrawnFromTrustAccountToPayIncomeTaxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes"/>
  <xs:element name="ProceedsFromSalesOfUnitsUnderwritingDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount"/>
  <xs:element name="ProceedsFromSaleOfPrivateUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_ProceedsFromSaleOfPrivateUnits"/>
  <xs:element name="ProceedsFromConvertiblePromissoryNoteRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty"/>
  <xs:element name="ProceedsFromPromissoryNotesRelatedparty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_ProceedsFromPromissoryNotesRelatedparty"/>
  <xs:element name="RepaymentOfPromissoryNoteRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_RepaymentOfPromissoryNoteRelatedParty"/>
  <xs:element name="PaymentOfOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_PaymentOfOfferingCosts"/>
  <xs:element name="InitialClassificationOfCommonStockSubjectToRedemption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_InitialClassificationOfCommonStockSubjectToRedemption"/>
  <xs:element name="ChangeInValueOfCommonStockSubjectToRedemption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_ChangeInValueOfCommonStockSubjectToRedemption"/>
  <xs:element name="InitialPublicOfferingDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_InitialPublicOfferingDisclosureTextBlock"/>
  <xs:element name="PrivatePlacementDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_PrivatePlacementDisclosureTextBlock"/>
  <xs:element name="EmergingGrowthPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_EmergingGrowthPolicyTextBlock"/>
  <xs:element name="CommonStockSubjectToPossibleRedemptionPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock"/>
  <xs:element name="IncomeAndFranchiseTaxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_IncomeAndFranchiseTaxes"/>
  <xs:element name="BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption"/>
  <xs:element name="BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption"/>
  <xs:element name="IncomeAttributableToCommonStockSubjectToRedemption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_IncomeAttributableToCommonStockSubjectToRedemption"/>
  <xs:element name="IncomeAdjustedNetLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_IncomeAdjustedNetLoss"/>
  <xs:element name="FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable"/>
  <xs:element name="FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems"/>
  <xs:element name="DescriptionofOrganizationandBusinessOperationsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
  <xs:element name="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems"/>
  <xs:element name="IssuanceOfUnitsDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_IssuanceOfUnitsDescription"/>
  <xs:element name="UnderwritersDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_UnderwritersDiscount"/>
  <xs:element name="AmountDepositInTrustAccount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_AmountDepositInTrustAccount"/>
  <xs:element name="OtherOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_OtherOfferingCosts"/>
  <xs:element name="PercentageOfTrustAccountRequiredForBusinessCombination" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_PercentageOfTrustAccountRequiredForBusinessCombination"/>
  <xs:element name="PublicSharePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_PublicSharePrice"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="thcb_SummaryofSignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="CashWithdrawnFromTrustAccountToPayFranchise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_CashWithdrawnFromTrustAccountToPayFranchise"/>
  <xs:element name="InitialPublicOfferingDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="thcb_InitialPublicOfferingDetailsTable"/>
  <xs:element name="InitialPublicOfferingDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_InitialPublicOfferingDetailsLineItems"/>
  <xs:element name="PrivatePlacementDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="thcb_PrivatePlacementDetailsTable"/>
  <xs:element name="PrivatePlacementDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_PrivatePlacementDetailsLineItems"/>
  <xs:element name="RelatedPartyTransactionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="thcb_RelatedPartyTransactionsDetailsTable"/>
  <xs:element name="RelatedPartyTransactionsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_RelatedPartyTransactionsDetailsLineItems"/>
  <xs:element name="SponsorPurchased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_SponsorPurchased"/>
  <xs:element name="CommonStockDividendDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_CommonStockDividendDescription"/>
  <xs:element name="IssuedAndOutstandingSharesPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="thcb_IssuedAndOutstandingSharesPercentage"/>
  <xs:element name="SaleOfStockNumberOfSharesIssuedInTransactions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_SaleOfStockNumberOfSharesIssuedInTransactions"/>
  <xs:element name="RelatedPartyServicesFeesAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_RelatedPartyServicesFeesAmount"/>
  <xs:element name="WorkingCapitalLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_WorkingCapitalLoans"/>
  <xs:element name="AmountDrawn" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_AmountDrawn"/>
  <xs:element name="CommitmentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="thcb_CommitmentsDetailsTable"/>
  <xs:element name="CommitmentsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_CommitmentsDetailsLineItems"/>
  <xs:element name="TransactionFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="thcb_TransactionFee"/>
  <xs:element name="PercentageOfPlacementFee" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_PercentageOfPlacementFee"/>
  <xs:element name="GrossProceedsFromFinancing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="thcb_GrossProceedsFromFinancing"/>
  <xs:element name="PercentageOfGrossProceedsRaisedInFinancing" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_PercentageOfGrossProceedsRaisedInFinancing"/>
  <xs:element name="StockholdersEquityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="thcb_StockholdersEquityDetailsTable"/>
  <xs:element name="StockholdersEquityDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_StockholdersEquityDetailsLineItems"/>
  <xs:element name="ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings"/>
  <xs:element name="AgreementDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_AgreementDomain"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="thcb_SubsequentEventsDetailsTable"/>
  <xs:element name="SubsequentEventsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_SubsequentEventsDetailsLineItems"/>
  <xs:element name="NumberOfCommonStockConvertedByEquityInterests" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_NumberOfCommonStockConvertedByEquityInterests"/>
  <xs:element name="AdditionalSharesOfCommonStockEarn" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_AdditionalSharesOfCommonStockEarn"/>
  <xs:element name="AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="thcb_AgreementAxis"/>
  <xs:element name="BridgeNotesConversionMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_BridgeNotesConversionMember"/>
  <xs:element name="CosponsorMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_CosponsorMember"/>
  <xs:element name="EarlyBirdCapitalMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_EarlyBirdCapitalMember"/>
  <xs:element name="FoundeSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_FoundeSharesMember"/>
  <xs:element name="MergerAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_MergerAgreementMember"/>
  <xs:element name="MicrovastPowerSystemMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_MicrovastPowerSystemMember"/>
  <xs:element name="MorganStanleyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_MorganStanleyMember"/>
  <xs:element name="PrivateInvestmentInPublicEquityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_PrivateInvestmentInPublicEquityMember"/>
  <xs:element name="PrivateUnitsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_PrivateUnitsMember"/>
  <xs:element name="SponsorMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_SponsorMember"/>
  <xs:element name="SubscriptionAgreementsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_SubscriptionAgreementsMember"/>
  <xs:element name="VogelPartnersLlpMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_VogelPartnersLlpMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="thcb_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>thcb-20201231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Mar 24 20:36:19 EDT 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedBalanceSheet" roleURI="http://thcb.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedIncomeStatement" roleURI="http://thcb.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedCashFlow" roleURI="http://thcb.com/role/ConsolidatedCashFlow"/>
  <calculationLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_TaxesPayableCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingCostsAndExpenses" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_InterestIncomeOther" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYmd/eP2vefFYjlZ03F3sybkMF39kCdGz5Rojbdz8tM/wssVRLP7kcbIoHDqSY1cEXAJSJwSlCjxb8MtUGFs1NlaLqPlLHEPFbI1W6vdfoArFxb7wyCH52a39w5qvqHIArkIlF8GySb/8mu1Fz70KdjoFja/90wbDeoJk4769F9URCy4v82yBrB3FHEjyCZTNAelYfSadaJ7ZSaOMTR90Ds] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="thcb_IncreaseDecreaseInMarketableSecurities" xlink:href="thcb-20201231.xsd#thcb_IncreaseDecreaseInMarketableSecurities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="thcb_IncreaseDecreaseInMarketableSecurities" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities" xlink:href="thcb-20201231.xsd#thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="thcb_CashWithdrawnAccountForRedemptions" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnAccountForRedemptions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="thcb_CashWithdrawnAccountForRedemptions" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromSaleOfPrivateUnits" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromSaleOfPrivateUnits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="thcb_ProceedsFromSaleOfPrivateUnits" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromPromissoryNotesRelatedparty" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromPromissoryNotesRelatedparty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="thcb_ProceedsFromPromissoryNotesRelatedparty" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="thcb_RepaymentOfPromissoryNoteRelatedParty" xlink:href="thcb-20201231.xsd#thcb_RepaymentOfPromissoryNoteRelatedParty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="thcb_RepaymentOfPromissoryNoteRelatedParty" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="thcb_PaymentOfOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_PaymentOfOfferingCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="thcb_PaymentOfOfferingCosts" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>thcb-20201231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Mar 24 20:36:19 EDT 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedBalanceSheet" roleURI="http://thcb.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedIncomeStatement" roleURI="http://thcb.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ShareholdersEquityType2or3" roleURI="http://thcb.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://thcb.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedCashFlow" roleURI="http://thcb.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_DescriptionofOrganizationandBusinessOperations" roleURI="http://thcb.com/role/DescriptionofOrganizationandBusinessOperations"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SummaryofSignificantAccountingPolicies" roleURI="http://thcb.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_InitialPublicOffering" roleURI="http://thcb.com/role/InitialPublicOffering"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_PrivatePlacement" roleURI="http://thcb.com/role/PrivatePlacement"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_RelatedPartyTransactions" roleURI="http://thcb.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_Commitments" roleURI="http://thcb.com/role/Commitments"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_StockholdersEquity" roleURI="http://thcb.com/role/StockholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_IncomeTax" roleURI="http://thcb.com/role/IncomeTax"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_FairValueMeasurements" roleURI="http://thcb.com/role/FairValueMeasurements"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SubsequentEvents" roleURI="http://thcb.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_AccountingPoliciesByPolicy" roleURI="http://thcb.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_IncomeTaxTables" roleURI="http://thcb.com/role/IncomeTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_FairValueMeasurementsTables" roleURI="http://thcb.com/role/FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleofbasicanddilutedlosspershareTable" roleURI="http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleofnetdeferredtaxliabilityTable" roleURI="http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleofincometaxprovisionTable" roleURI="http://thcb.com/role/ScheduleofincometaxprovisionTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleoffederalincometaxratetoeffectivetaxrateTable" roleURI="http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleoffairvaluehierarchyofthevaluationinputsTable" roleURI="http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_DescriptionofOrganizationandBusinessOperationsDetails" roleURI="http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_InitialPublicOfferingDetails" roleURI="http://thcb.com/role/InitialPublicOfferingDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_PrivatePlacementDetails" roleURI="http://thcb.com/role/PrivatePlacementDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_RelatedPartyTransactionsDetails" roleURI="http://thcb.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_CommitmentsDetails" roleURI="http://thcb.com/role/CommitmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_StockholdersEquityDetails" roleURI="http://thcb.com/role/StockholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SubsequentEventsDetails" roleURI="http://thcb.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#DocumentAndEntityInformation" roleURI="http://thcb.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_TaxesPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonSharesSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_CommonSharesSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="thcb_CommonSharesSubjectToPossibleRedemption" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherIncomeAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_InterestIncomeOther" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" xlink:href="thcb-20201231.xsd#thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" xlink:href="thcb-20201231.xsd#thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="thcb_CommonStockSubjectToPossibleRedemption" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionShares" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemptionShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionShares" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_SaleOfPrivateUnitAmount" xlink:href="thcb-20201231.xsd#thcb_SaleOfPrivateUnitAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="thcb_SaleOfPrivateUnitAmount" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_IncreaseDecreaseInMarketableSecurities" xlink:href="thcb-20201231.xsd#thcb_IncreaseDecreaseInMarketableSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="thcb_IncreaseDecreaseInMarketableSecurities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities" xlink:href="thcb-20201231.xsd#thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_CashWithdrawnAccountForRedemptions" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnAccountForRedemptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="thcb_CashWithdrawnAccountForRedemptions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromSaleOfPrivateUnits" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromSaleOfPrivateUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="thcb_ProceedsFromSaleOfPrivateUnits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromPromissoryNotesRelatedparty" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromPromissoryNotesRelatedparty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="thcb_ProceedsFromPromissoryNotesRelatedparty" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_RepaymentOfPromissoryNoteRelatedParty" xlink:href="thcb-20201231.xsd#thcb_RepaymentOfPromissoryNoteRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="thcb_RepaymentOfPromissoryNoteRelatedParty" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_PaymentOfOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_PaymentOfOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="thcb_PaymentOfOfferingCosts" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_InitialClassificationOfCommonStockSubjectToRedemption" xlink:href="thcb-20201231.xsd#thcb_InitialClassificationOfCommonStockSubjectToRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="thcb_InitialClassificationOfCommonStockSubjectToRedemption" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToRedemption" xlink:href="thcb-20201231.xsd#thcb_ChangeInValueOfCommonStockSubjectToRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToRedemption" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/DescriptionofOrganizationandBusinessOperations">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/InitialPublicOffering">
    <loc xlink:type="locator" xlink:label="thcb_InitialPublicOfferingDisclosureAbstract" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="thcb_InitialPublicOfferingDisclosureTextBlock" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_InitialPublicOfferingDisclosureAbstract" xlink:to="thcb_InitialPublicOfferingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/PrivatePlacement">
    <loc xlink:type="locator" xlink:label="thcb_PrivatePlacementDisclosureAbstract" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivatePlacementDisclosureTextBlock" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_PrivatePlacementDisclosureAbstract" xlink:to="thcb_PrivatePlacementDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/Commitments">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/StockholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/IncomeTax">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/FairValueMeasurements">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_EmergingGrowthPolicyTextBlock" xlink:href="thcb-20201231.xsd#thcb_EmergingGrowthPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="thcb_EmergingGrowthPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/IncomeTaxTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable">
    <loc xlink:type="locator" xlink:label="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" xlink:href="thcb-20201231.xsd#thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDividendIncomeSecuritiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeSecuritiesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" xlink:to="us-gaap_InterestAndDividendIncomeSecuritiesOther" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_IncomeAndFranchiseTaxes" xlink:href="thcb-20201231.xsd#thcb_IncomeAndFranchiseTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="thcb_IncomeAndFranchiseTaxes" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_NumeratorNetIncomeMinusNetEarningsAbstract" xlink:href="thcb-20201231.xsd#thcb_NumeratorNetIncomeMinusNetEarningsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="thcb_NumeratorNetIncomeMinusNetEarningsAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_NumeratorNetIncomeMinusNetEarningsAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_IncomeAttributableToCommonStockSubjectToRedemption" xlink:href="thcb-20201231.xsd#thcb_IncomeAttributableToCommonStockSubjectToRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_NumeratorNetIncomeMinusNetEarningsAbstract" xlink:to="thcb_IncomeAttributableToCommonStockSubjectToRedemption" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_IncomeAdjustedNetLoss" xlink:href="thcb-20201231.xsd#thcb_IncomeAdjustedNetLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_IncomeAttributableToCommonStockSubjectToRedemption" xlink:to="thcb_IncomeAdjustedNetLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract" xlink:href="thcb-20201231.xsd#thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable">
    <loc xlink:type="locator" xlink:label="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfNetDeferredTaxLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="thcb_DeferredTaxLiabilityAbstract" xlink:href="thcb-20201231.xsd#thcb_DeferredTaxLiabilityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:to="thcb_DeferredTaxLiabilityAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DeferredTaxLiabilityAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleofincometaxprovisionTable">
    <loc xlink:type="locator" xlink:label="thcb_ScheduleOfIncomeTaxProvisionAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfIncomeTaxProvisionAbstract"/>
    <loc xlink:type="locator" xlink:label="thcb_FederalAbstract" xlink:href="thcb-20201231.xsd#thcb_FederalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfIncomeTaxProvisionAbstract" xlink:to="thcb_FederalAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_FederalAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_FederalAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_StateAndLocalAbstract" xlink:href="thcb-20201231.xsd#thcb_StateAndLocalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfIncomeTaxProvisionAbstract" xlink:to="thcb_StateAndLocalAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StateAndLocalAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StateAndLocalAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfIncomeTaxProvisionAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfIncomeTaxProvisionAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable">
    <loc xlink:type="locator" xlink:label="thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable">
    <loc xlink:type="locator" xlink:label="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems" xlink:href="thcb-20201231.xsd#thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems"/>
    <loc xlink:type="locator" xlink:label="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" xlink:href="thcb-20201231.xsd#thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems" xlink:to="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails">
    <loc xlink:type="locator" xlink:label="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYmd/eP2vefFYjlZ03F3sybkMF39kCdGz5Rojbdz8tM/wssVRLP7kcbIoHDqSY1cEXAJSJwSlCjxb8MtUGFs1NlaLqPlLHEPFbI1W6vdfoArFxb7wyCH52a39w5qvqHIArkIlF8GySb/8mu1Fz70KdjoFja/90wbDeoJk4769F9URCy4v82yBrBvrDrYJtYKl+ROoozRe+C+HIsFFs0sMwi] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_EarlyBirdCapitalMember" xlink:href="thcb-20201231.xsd#thcb_EarlyBirdCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="thcb_EarlyBirdCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_SponsorMember" xlink:href="thcb-20201231.xsd#thcb_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="thcb_SponsorMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivateUnitsMember" xlink:href="thcb-20201231.xsd#thcb_PrivateUnitsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="thcb_PrivateUnitsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_IssuanceOfUnitsDescription" xlink:href="thcb-20201231.xsd#thcb_IssuanceOfUnitsDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="thcb_IssuanceOfUnitsDescription" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_UnderwritersDiscount" xlink:href="thcb-20201231.xsd#thcb_UnderwritersDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="thcb_UnderwritersDiscount" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_AmountDepositInTrustAccount" xlink:href="thcb-20201231.xsd#thcb_AmountDepositInTrustAccount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="thcb_AmountDepositInTrustAccount" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_OtherOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_OtherOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="thcb_OtherOfferingCosts" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_PercentageOfTrustAccountRequiredForBusinessCombination" xlink:href="thcb-20201231.xsd#thcb_PercentageOfTrustAccountRequiredForBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="thcb_PercentageOfTrustAccountRequiredForBusinessCombination" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_PublicSharePrice" xlink:href="thcb-20201231.xsd#thcb_PublicSharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="thcb_PublicSharePrice" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredOther1" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SharePrice" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_AssetsHeldInTrustCurrent" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_ShortTermBorrowings" order="19" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="thcb_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="thcb-20201231.xsd#thcb_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="thcb_SummaryofSignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayFranchise" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnFromTrustAccountToPayFranchise"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="thcb_CashWithdrawnFromTrustAccountToPayFranchise" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FederalDepositInsuranceCorporationPremiumExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalDepositInsuranceCorporationPremiumExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_FederalDepositInsuranceCorporationPremiumExpense" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/InitialPublicOfferingDetails">
    <loc xlink:type="locator" xlink:label="thcb_InitialPublicOfferingDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="thcb_InitialPublicOfferingDetailsTable" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="thcb_InitialPublicOfferingDetailsLineItems" xlink:to="thcb_InitialPublicOfferingDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationReasonForBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationReasonForBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_BusinessCombinationReasonForBusinessCombination" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/PrivatePlacementDetails">
    <loc xlink:type="locator" xlink:label="thcb_PrivatePlacementDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivatePlacementDetailsTable" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="thcb_PrivatePlacementDetailsLineItems" xlink:to="thcb_PrivatePlacementDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_PrivatePlacementDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_SponsorMember" xlink:href="thcb-20201231.xsd#thcb_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="thcb_SponsorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_PrivatePlacementDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_PrivatePlacementDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_PrivatePlacementDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockDescriptionOfTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_PrivatePlacementDetailsLineItems" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/RelatedPartyTransactionsDetails">
    <loc xlink:type="locator" xlink:label="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_RelatedPartyTransactionsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="thcb_RelatedPartyTransactionsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_RelatedPartyTransactionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="thcb_RelatedPartyTransactionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_RelatedPartyTransactionsDetailsTable" xlink:to="dei_LegalEntityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_RelatedPartyTransactionsDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_VogelPartnersLlpMember" xlink:href="thcb-20201231.xsd#thcb_VogelPartnersLlpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="thcb_VogelPartnersLlpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_FoundeSharesMember" xlink:href="thcb-20201231.xsd#thcb_FoundeSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="thcb_FoundeSharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_SponsorMember" xlink:href="thcb-20201231.xsd#thcb_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="thcb_SponsorMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivateUnitsMember" xlink:href="thcb-20201231.xsd#thcb_PrivateUnitsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="thcb_PrivateUnitsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_SponsorPurchased" xlink:href="thcb-20201231.xsd#thcb_SponsorPurchased"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="thcb_SponsorPurchased" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonStockDividendDescription" xlink:href="thcb-20201231.xsd#thcb_CommonStockDividendDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="thcb_CommonStockDividendDescription" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_CommonStockDividendsShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_IssuedAndOutstandingSharesPercentage" xlink:href="thcb-20201231.xsd#thcb_IssuedAndOutstandingSharesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="thcb_IssuedAndOutstandingSharesPercentage" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationControlObtainedDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationControlObtainedDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_BusinessCombinationControlObtainedDescription" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_SaleOfStockNumberOfSharesIssuedInTransactions" xlink:href="thcb-20201231.xsd#thcb_SaleOfStockNumberOfSharesIssuedInTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="thcb_SaleOfStockNumberOfSharesIssuedInTransactions" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_RelatedPartyServicesFeesAmount" xlink:href="thcb-20201231.xsd#thcb_RelatedPartyServicesFeesAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="thcb_RelatedPartyServicesFeesAmount" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnsecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_UnsecuredDebt" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_WorkingCapitalLoans" xlink:href="thcb-20201231.xsd#thcb_WorkingCapitalLoans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="thcb_WorkingCapitalLoans" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_AmountDrawn" xlink:href="thcb-20201231.xsd#thcb_AmountDrawn"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="thcb_AmountDrawn" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ShortTermBorrowings" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/CommitmentsDetails">
    <loc xlink:type="locator" xlink:label="thcb_CommitmentsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_CommitmentsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="thcb_CommitmentsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_CommitmentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="thcb_CommitmentsDetailsLineItems" xlink:to="thcb_CommitmentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_CommitmentsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_CommitmentsDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_MorganStanleyMember" xlink:href="thcb-20201231.xsd#thcb_MorganStanleyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="thcb_MorganStanleyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivateInvestmentInPublicEquityMember" xlink:href="thcb-20201231.xsd#thcb_PrivateInvestmentInPublicEquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="thcb_PrivateInvestmentInPublicEquityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_CommitmentsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_TransactionFee" xlink:href="thcb-20201231.xsd#thcb_TransactionFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_CommitmentsDetailsLineItems" xlink:to="thcb_TransactionFee" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_PercentageOfPlacementFee" xlink:href="thcb-20201231.xsd#thcb_PercentageOfPlacementFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_CommitmentsDetailsLineItems" xlink:to="thcb_PercentageOfPlacementFee" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_GrossProceedsFromFinancing" xlink:href="thcb-20201231.xsd#thcb_GrossProceedsFromFinancing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_CommitmentsDetailsLineItems" xlink:to="thcb_GrossProceedsFromFinancing" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_PercentageOfGrossProceedsRaisedInFinancing" xlink:href="thcb-20201231.xsd#thcb_PercentageOfGrossProceedsRaisedInFinancing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_CommitmentsDetailsLineItems" xlink:to="thcb_PercentageOfGrossProceedsRaisedInFinancing" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/StockholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="thcb_StockholdersEquityDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_StockholdersEquityDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="thcb_StockholdersEquityDetailsTable" xlink:href="thcb-20201231.xsd#thcb_StockholdersEquityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="thcb_StockholdersEquityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_StockholdersEquityDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_StockholdersEquityDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_EarlyBirdCapitalMember" xlink:href="thcb-20201231.xsd#thcb_EarlyBirdCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="thcb_EarlyBirdCapitalMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonSharesSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_CommonSharesSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="thcb_CommonSharesSubjectToPossibleRedemption" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings" xlink:href="thcb-20201231.xsd#thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_SaleOfStockNumberOfSharesIssuedInTransactions" xlink:href="thcb-20201231.xsd#thcb_SaleOfStockNumberOfSharesIssuedInTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="thcb_SaleOfStockNumberOfSharesIssuedInTransactions" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="thcb_SubsequentEventsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_SubsequentEventsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="thcb_SubsequentEventsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="thcb_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_AgreementAxis" xlink:href="thcb-20201231.xsd#thcb_AgreementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_SubsequentEventsDetailsTable" xlink:to="thcb_AgreementAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_AgreementDomain" xlink:href="thcb-20201231.xsd#thcb_AgreementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="thcb_AgreementAxis" xlink:to="thcb_AgreementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_AgreementDomain_0" xlink:href="thcb-20201231.xsd#thcb_AgreementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="thcb_AgreementAxis" xlink:to="thcb_AgreementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_SubsequentEventsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="thcb_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_MicrovastPowerSystemMember" xlink:href="thcb-20201231.xsd#thcb_MicrovastPowerSystemMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="thcb_MicrovastPowerSystemMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_SponsorMember" xlink:href="thcb-20201231.xsd#thcb_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="thcb_SponsorMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_CosponsorMember" xlink:href="thcb-20201231.xsd#thcb_CosponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="thcb_CosponsorMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_SubscriptionAgreementsMember" xlink:href="thcb-20201231.xsd#thcb_SubscriptionAgreementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_AgreementDomain" xlink:to="thcb_SubscriptionAgreementsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_MergerAgreementMember" xlink:href="thcb-20201231.xsd#thcb_MergerAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_AgreementDomain" xlink:to="thcb_MergerAgreementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_BridgeNotesConversionMember" xlink:href="thcb-20201231.xsd#thcb_BridgeNotesConversionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="thcb_BridgeNotesConversionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_NumberOfCommonStockConvertedByEquityInterests" xlink:href="thcb-20201231.xsd#thcb_NumberOfCommonStockConvertedByEquityInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="thcb_NumberOfCommonStockConvertedByEquityInterests" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockConversionBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockConversionBasis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CommonStockConversionBasis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="thcb_AdditionalSharesOfCommonStockEarn" xlink:href="thcb-20201231.xsd#thcb_AdditionalSharesOfCommonStockEarn"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="thcb_AdditionalSharesOfCommonStockEarn" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventEffectOfChangeInTaxStatus" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventEffectOfChangeInTaxStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SubsequentEventEffectOfChangeInTaxStatus" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CostsAndExpenses" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_Cash" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentDescription" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="15" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://thcb.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="34" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>thcb-20201231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Mar 24 20:36:19 EDT 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net Change in Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash &#8211; Beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash &#8211; End of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract_lbl" xml:lang="en-US">Schedule of basic and diluted loss per share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_InitialPublicOfferingDisclosureAbstract" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_InitialPublicOfferingDisclosureAbstract_lbl" xml:lang="en-US">Initial Public Offering Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_InitialPublicOfferingDisclosureAbstract" xlink:to="thcb_InitialPublicOfferingDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivatePlacementDisclosureAbstract" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PrivatePlacementDisclosureAbstract_lbl" xml:lang="en-US">Private Placement Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PrivatePlacementDisclosureAbstract" xlink:to="thcb_PrivatePlacementDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract_lbl" xml:lang="en-US">Disclosure Text Block Supplement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_DisclosureTextBlockSupplementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfNetDeferredTaxLiabilityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract_lbl" xml:lang="en-US">Schedule of net deferred tax liability [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:to="thcb_ScheduleOfNetDeferredTaxLiabilityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ScheduleOfIncomeTaxProvisionAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfIncomeTaxProvisionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ScheduleOfIncomeTaxProvisionAbstract_lbl" xml:lang="en-US">Schedule of income tax provision [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ScheduleOfIncomeTaxProvisionAbstract" xlink:to="thcb_ScheduleOfIncomeTaxProvisionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract_lbl" xml:lang="en-US">Schedule of federal income tax rate to effective tax rate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:to="thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract_lbl" xml:lang="en-US">Schedule of fair value hierarchy of the valuation inputs [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract" xlink:to="thcb_ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xml:lang="en-US">Cash and marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US">Income taxes payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Advances from related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Convertible promissory note &#8211; related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl" xml:lang="en-US">Common stock subject to possible redemption 27,087,556 and 27,126,477 at December 31, 2020 and 2019, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonSharesSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_CommonSharesSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CommonSharesSubjectToPossibleRedemption_lbl" xml:lang="en-US">Common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonSharesSubjectToPossibleRedemption" xlink:to="thcb_CommonSharesSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.0001 par value; 65,000,000 shares authorized; 8,396,246 and 8,360,523 shares issued and outstanding (excluding 27,087,556 and 27,126,477 shares subject to possible redemption) at December 31, 2020 and 2019, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common stock issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common stock outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Operating and formation costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncomeAbstract_lbl" xml:lang="en-US">Other income:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestIncomeOther_lbl" xml:lang="en-US">Interest earned on marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax_lbl" xml:lang="en-US">Unrealized gain on marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Income before provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" xlink:to="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe_lbl" xml:lang="en-US">Basic and diluted net income per share, Common stock subject to possible redemption (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" xlink:to="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding, Common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0" xml:lang="en-US">Basic and diluted weighted average shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted net loss per common share, Common stock (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl0" xml:lang="en-US">Basic and diluted net loss per common share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts_lbl" xml:lang="en-US">Sale of 27,600,000 Units, net of underwriting discount and offering expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" xlink:to="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" xlink:href="thcb-20201231.xsd#thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares_lbl" xml:lang="en-US">Sale of 27,600,000 Units, net of underwriting discount and offering expenses (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" xlink:to="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Sale of Units, net of underwriting discounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Sale of 687,000 Private Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0" xml:lang="en-US">Number of shares in amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl1" xml:lang="en-US">Sale of stock, consideration received on transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl2" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl3" xml:lang="en-US">Aggregate value of common stock subscribed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of 687,000 Private Units (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Number of shares in units (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xml:lang="en-US">Sale of stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl2" xml:lang="en-US">Sale of stock, number of shares issued in transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl3" xml:lang="en-US">Number of shares of common stock subscribed (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl3"/>
    <loc xlink:type="locator" xlink:label="thcb_SaleOfPrivateUnitAmount" xlink:href="thcb-20201231.xsd#thcb_SaleOfPrivateUnitAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_SaleOfPrivateUnitAmount_lbl" xml:lang="en-US">Sale of Private Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SaleOfPrivateUnitAmount" xlink:to="thcb_SaleOfPrivateUnitAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">Common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemption" xlink:to="thcb_CommonStockSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionShares" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemptionShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionShares_lbl" xml:lang="en-US">Common stock subject to possible redemption (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemptionShares" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionShares_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">Change in value of common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" xlink:href="thcb-20201231.xsd#thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares_lbl" xml:lang="en-US">Change in value of common stock subject to possible redemption (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income taxes payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CashWithdrawnAccountForRedemptions" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnAccountForRedemptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CashWithdrawnAccountForRedemptions_lbl" xml:lang="en-US">Cash withdrawn from Trust Account for redemptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CashWithdrawnAccountForRedemptions" xlink:to="thcb_CashWithdrawnAccountForRedemptions_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes_lbl" xml:lang="en-US">Cash withdrawn from Trust Account to pay income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes" xlink:to="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount_lbl" xml:lang="en-US">Proceeds from sale of Units, net of underwriting discounts paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount" xlink:to="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromSaleOfPrivateUnits" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromSaleOfPrivateUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_ProceedsFromSaleOfPrivateUnits_lbl" xml:lang="en-US">Proceeds from sale of Private Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromSaleOfPrivateUnits" xlink:to="thcb_ProceedsFromSaleOfPrivateUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Advances from related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty_lbl" xml:lang="en-US">Proceeds from convertible promissory note &#8211; related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty" xlink:to="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ProceedsFromPromissoryNotesRelatedparty" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromPromissoryNotesRelatedparty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_ProceedsFromPromissoryNotesRelatedparty_lbl" xml:lang="en-US">Proceeds from promissory note &#8211; related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromPromissoryNotesRelatedparty" xlink:to="thcb_ProceedsFromPromissoryNotesRelatedparty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Cash paid for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-Cash investing and financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_InitialClassificationOfCommonStockSubjectToRedemption" xlink:href="thcb-20201231.xsd#thcb_InitialClassificationOfCommonStockSubjectToRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_InitialClassificationOfCommonStockSubjectToRedemption_lbl" xml:lang="en-US">Initial classification of common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_InitialClassificationOfCommonStockSubjectToRedemption" xlink:to="thcb_InitialClassificationOfCommonStockSubjectToRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToRedemption" xlink:href="thcb-20201231.xsd#thcb_ChangeInValueOfCommonStockSubjectToRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToRedemption_lbl" xml:lang="en-US">Change in value of common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ChangeInValueOfCommonStockSubjectToRedemption" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="thcb_IncreaseDecreaseInMarketableSecurities" xlink:href="thcb-20201231.xsd#thcb_IncreaseDecreaseInMarketableSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="thcb_IncreaseDecreaseInMarketableSecurities_lbl" xml:lang="en-US">Interest earned on marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncreaseDecreaseInMarketableSecurities" xlink:to="thcb_IncreaseDecreaseInMarketableSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities" xlink:href="thcb-20201231.xsd#thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities_lbl" xml:lang="en-US">Unrealized gain on marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities" xlink:to="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl" xml:lang="en-US">Prepaid income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Investment of cash in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayment of advances from related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_RepaymentOfPromissoryNoteRelatedParty" xlink:href="thcb-20201231.xsd#thcb_RepaymentOfPromissoryNoteRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="thcb_RepaymentOfPromissoryNoteRelatedParty_lbl" xml:lang="en-US">Repayment of promissory note &#8211; related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_RepaymentOfPromissoryNoteRelatedParty" xlink:to="thcb_RepaymentOfPromissoryNoteRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PaymentOfOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_PaymentOfOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="thcb_PaymentOfOfferingCosts_lbl" xml:lang="en-US">Payment of offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PaymentOfOfferingCosts" xlink:to="thcb_PaymentOfOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings/ (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of basic and diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionAbstract" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemptionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionAbstract_lbl" xml:lang="en-US">Common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemptionAbstract" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" xlink:href="thcb-20201231.xsd#thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract_lbl" xml:lang="en-US">Numerator: Earnings allocable to Common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" xlink:to="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDividendIncomeSecuritiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeSecuritiesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestAndDividendIncomeSecuritiesOther_lbl" xml:lang="en-US">Interest earned on marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDividendIncomeSecuritiesOther" xlink:to="us-gaap_InterestAndDividendIncomeSecuritiesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized gain on marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US">Net income allocable to shares subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract" xlink:href="thcb-20201231.xsd#thcb_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract_lbl" xml:lang="en-US">Denominator: Weighted average Common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract" xlink:to="thcb_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" xlink:to="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">Basic and diluted net income per common share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" xlink:to="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_NonRedeemableCommonStockAbstract" xlink:href="thcb-20201231.xsd#thcb_NonRedeemableCommonStockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_NonRedeemableCommonStockAbstract_lbl" xml:lang="en-US">Non-Redeemable Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_NonRedeemableCommonStockAbstract" xlink:to="thcb_NonRedeemableCommonStockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_NumeratorNetIncomeMinusNetEarningsAbstract" xlink:href="thcb-20201231.xsd#thcb_NumeratorNetIncomeMinusNetEarningsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_NumeratorNetIncomeMinusNetEarningsAbstract_lbl" xml:lang="en-US">Numerator Net Income minus Net Earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_NumeratorNetIncomeMinusNetEarningsAbstract" xlink:to="thcb_NumeratorNetIncomeMinusNetEarningsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_IncomeAttributableToCommonStockSubjectToRedemption" xlink:href="thcb-20201231.xsd#thcb_IncomeAttributableToCommonStockSubjectToRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_IncomeAttributableToCommonStockSubjectToRedemption_lbl" xml:lang="en-US">Less: Income attributable to common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncomeAttributableToCommonStockSubjectToRedemption" xlink:to="thcb_IncomeAttributableToCommonStockSubjectToRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract" xlink:href="thcb-20201231.xsd#thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract_lbl" xml:lang="en-US">Denominator: Weighted Average Non-Redeemable Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract" xlink:to="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_InitialPublicOfferingDisclosureTextBlock" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_InitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US">INITIAL PUBLIC OFFERING</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_InitialPublicOfferingDisclosureTextBlock" xlink:to="thcb_InitialPublicOfferingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivatePlacementDisclosureTextBlock" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_PrivatePlacementDisclosureTextBlock_lbl" xml:lang="en-US">PRIVATE PLACEMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PrivatePlacementDisclosureTextBlock" xlink:to="thcb_PrivatePlacementDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS&apos; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAX</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of net deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_DeferredTaxLiabilityAbstract" xlink:href="thcb-20201231.xsd#thcb_DeferredTaxLiabilityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_DeferredTaxLiabilityAbstract_lbl" xml:lang="en-US">Deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_DeferredTaxLiabilityAbstract" xlink:to="thcb_DeferredTaxLiabilityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_FederalAbstract" xlink:href="thcb-20201231.xsd#thcb_FederalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_FederalAbstract_lbl" xml:lang="en-US">Federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_FederalAbstract" xlink:to="thcb_FederalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_StateAndLocalAbstract" xlink:href="thcb-20201231.xsd#thcb_StateAndLocalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_StateAndLocalAbstract_lbl" xml:lang="en-US">State and Local</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StateAndLocalAbstract" xlink:to="thcb_StateAndLocalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of federal income tax rate to effective tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory federal income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes, net of federal tax benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of fair value hierarchy of the valuation inputs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_AssetsAbstract0" xlink:href="thcb-20201231.xsd#thcb_AssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_AssetsAbstract0_lbl" xml:lang="en-US">Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AssetsAbstract0" xlink:to="thcb_AssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xml:lang="en-US">Cash and marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_IncomeAndFranchiseTaxes" xlink:href="thcb-20201231.xsd#thcb_IncomeAndFranchiseTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="thcb_IncomeAndFranchiseTaxes_lbl" xml:lang="en-US">Less: Income and franchise taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncomeAndFranchiseTaxes" xlink:to="thcb_IncomeAndFranchiseTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_IncomeAdjustedNetLoss" xlink:href="thcb-20201231.xsd#thcb_IncomeAdjustedNetLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="thcb_IncomeAdjustedNetLoss_lbl" xml:lang="en-US">Non-Redeemable Net Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncomeAdjustedNetLoss" xlink:to="thcb_IncomeAdjustedNetLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_lbl" xml:lang="en-US">Unrealized gain on marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_AgreementAxis" xlink:href="thcb-20201231.xsd#thcb_AgreementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_AgreementAxis_lbl" xml:lang="en-US">Agreement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AgreementAxis" xlink:to="thcb_AgreementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Price per unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl1" xml:lang="en-US">Price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl2" xml:lang="en-US">Per unit price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl2"/>
    <loc xlink:type="locator" xlink:label="thcb_IssuanceOfUnitsDescription" xlink:href="thcb-20201231.xsd#thcb_IssuanceOfUnitsDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_IssuanceOfUnitsDescription_lbl" xml:lang="en-US">Issuance of units, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IssuanceOfUnitsDescription" xlink:to="thcb_IssuanceOfUnitsDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_UnderwritersDiscount" xlink:href="thcb-20201231.xsd#thcb_UnderwritersDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_UnderwritersDiscount_lbl" xml:lang="en-US">Underwriters discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_UnderwritersDiscount" xlink:to="thcb_UnderwritersDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_AmountDepositInTrustAccount" xlink:href="thcb-20201231.xsd#thcb_AmountDepositInTrustAccount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_AmountDepositInTrustAccount_lbl" xml:lang="en-US">Deposit amount in trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AmountDepositInTrustAccount" xlink:to="thcb_AmountDepositInTrustAccount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Proceeds held in Trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl0" xml:lang="en-US">Common stock aggregate price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl1" xml:lang="en-US">Common stock aggregate price (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl2" xml:lang="en-US">Purchase price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Transaction costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl" xml:lang="en-US">Underwriting fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_OtherOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_OtherOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_OtherOfferingCosts_lbl" xml:lang="en-US">Other offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_OtherOfferingCosts" xlink:to="thcb_OtherOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PercentageOfTrustAccountRequiredForBusinessCombination" xlink:href="thcb-20201231.xsd#thcb_PercentageOfTrustAccountRequiredForBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_PercentageOfTrustAccountRequiredForBusinessCombination_lbl" xml:lang="en-US">Minimum percentage of trust account required for business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PercentageOfTrustAccountRequiredForBusinessCombination" xlink:to="thcb_PercentageOfTrustAccountRequiredForBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of outstanding voting securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PublicSharePrice" xlink:href="thcb-20201231.xsd#thcb_PublicSharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_PublicSharePrice_lbl" xml:lang="en-US">Public per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PublicSharePrice" xlink:to="thcb_PublicSharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl" xml:lang="en-US">Net tangible assets of business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xml:lang="en-US">Obligation to redeem percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Aggregate shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrustCurrent_lbl" xml:lang="en-US">Amount held of trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustCurrent" xlink:to="us-gaap_AssetsHeldInTrustCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Loan amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShortTermBorrowings_lbl0" xml:lang="en-US">Outstanding amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl0"/>
    <loc xlink:type="locator" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayFranchise" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnFromTrustAccountToPayFranchise"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayFranchise_lbl" xml:lang="en-US">Cash withdrawn from trust account to pay franchise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CashWithdrawnFromTrustAccountToPayFranchise" xlink:to="thcb_CashWithdrawnFromTrustAccountToPayFranchise_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Diluted loss per share (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FederalDepositInsuranceCorporationPremiumExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalDepositInsuranceCorporationPremiumExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FederalDepositInsuranceCorporationPremiumExpense_lbl" xml:lang="en-US">Federal depository insurance coverage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalDepositInsuranceCorporationPremiumExpense" xlink:to="us-gaap_FederalDepositInsuranceCorporationPremiumExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Number of Founder shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationReasonForBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationReasonForBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationReasonForBusinessCombination_lbl" xml:lang="en-US">Business combination, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationReasonForBusinessCombination" xlink:to="us-gaap_BusinessCombinationReasonForBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockDescriptionOfTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xml:lang="en-US">Private placement, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_SponsorPurchased" xlink:href="thcb-20201231.xsd#thcb_SponsorPurchased"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_SponsorPurchased_lbl" xml:lang="en-US">Sponsor purchased (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SponsorPurchased" xlink:to="thcb_SponsorPurchased_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonStockDividendDescription" xlink:href="thcb-20201231.xsd#thcb_CommonStockDividendDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CommonStockDividendDescription_lbl" xml:lang="en-US">Common stock dividend description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockDividendDescription" xlink:to="thcb_CommonStockDividendDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Dividend share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockDividendsShares_lbl" xml:lang="en-US">Common stock dividend shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsShares" xlink:to="us-gaap_CommonStockDividendsShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Forfeiture shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_IssuedAndOutstandingSharesPercentage" xlink:href="thcb-20201231.xsd#thcb_IssuedAndOutstandingSharesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_IssuedAndOutstandingSharesPercentage_lbl" xml:lang="en-US">Percentage of issued and outstanding shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IssuedAndOutstandingSharesPercentage" xlink:to="thcb_IssuedAndOutstandingSharesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationControlObtainedDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationControlObtainedDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationControlObtainedDescription_lbl" xml:lang="en-US">Description of business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationControlObtainedDescription" xlink:to="us-gaap_BusinessCombinationControlObtainedDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_SaleOfStockNumberOfSharesIssuedInTransactions" xlink:href="thcb-20201231.xsd#thcb_SaleOfStockNumberOfSharesIssuedInTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_SaleOfStockNumberOfSharesIssuedInTransactions_lbl" xml:lang="en-US">Shares in units (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SaleOfStockNumberOfSharesIssuedInTransactions" xlink:to="thcb_SaleOfStockNumberOfSharesIssuedInTransactions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="thcb_SaleOfStockNumberOfSharesIssuedInTransactions_lbl0" xml:lang="en-US">Common stock shares purchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SaleOfStockNumberOfSharesIssuedInTransactions" xlink:to="thcb_SaleOfStockNumberOfSharesIssuedInTransactions_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US">Per month service fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_RelatedPartyServicesFeesAmount" xlink:href="thcb-20201231.xsd#thcb_RelatedPartyServicesFeesAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_RelatedPartyServicesFeesAmount_lbl" xml:lang="en-US">Service fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_RelatedPartyServicesFeesAmount" xlink:to="thcb_RelatedPartyServicesFeesAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl" xml:lang="en-US">Aggregate amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnsecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnsecuredDebt_lbl" xml:lang="en-US">Aggregate note amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebt" xlink:to="us-gaap_UnsecuredDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_WorkingCapitalLoans" xlink:href="thcb-20201231.xsd#thcb_WorkingCapitalLoans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_WorkingCapitalLoans_lbl" xml:lang="en-US">Working capital loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_WorkingCapitalLoans" xlink:to="thcb_WorkingCapitalLoans_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US">Entity price per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Aggregate amount of loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl0" xml:lang="en-US">Aggregate principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="thcb_AmountDrawn" xlink:href="thcb-20201231.xsd#thcb_AmountDrawn"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_AmountDrawn_lbl" xml:lang="en-US">Amount drawn</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AmountDrawn" xlink:to="thcb_AmountDrawn_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xml:lang="en-US">Description of business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl0" xml:lang="en-US">Equityholders, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl0"/>
    <loc xlink:type="locator" xlink:label="thcb_TransactionFee" xlink:href="thcb-20201231.xsd#thcb_TransactionFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_TransactionFee_lbl" xml:lang="en-US">Transaction fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_TransactionFee" xlink:to="thcb_TransactionFee_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PercentageOfPlacementFee" xlink:href="thcb-20201231.xsd#thcb_PercentageOfPlacementFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_PercentageOfPlacementFee_lbl" xml:lang="en-US">Percentage of placement fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PercentageOfPlacementFee" xlink:to="thcb_PercentageOfPlacementFee_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_GrossProceedsFromFinancing" xlink:href="thcb-20201231.xsd#thcb_GrossProceedsFromFinancing"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_GrossProceedsFromFinancing_lbl" xml:lang="en-US">Gross proceeds from financing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_GrossProceedsFromFinancing" xlink:to="thcb_GrossProceedsFromFinancing_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PercentageOfGrossProceedsRaisedInFinancing" xlink:href="thcb-20201231.xsd#thcb_PercentageOfGrossProceedsRaisedInFinancing"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_PercentageOfGrossProceedsRaisedInFinancing_lbl" xml:lang="en-US">Percentage of gross proceeds raised in financing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PercentageOfGrossProceedsRaisedInFinancing" xlink:to="thcb_PercentageOfGrossProceedsRaisedInFinancing_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings" xlink:href="thcb-20201231.xsd#thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings_lbl" xml:lang="en-US">Warrants description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings" xlink:to="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_NumberOfCommonStockConvertedByEquityInterests" xlink:href="thcb-20201231.xsd#thcb_NumberOfCommonStockConvertedByEquityInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_NumberOfCommonStockConvertedByEquityInterests_lbl" xml:lang="en-US">Number of common stock converted by equity interests (in Shares)</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYmd/eP2vefFYjlZ03F3sybkMF39kCdGz5Rojbdz8tM/wssVRLP7kcbIoHDqSY1cEXAJSJwSlCjxb8MtUGFs1NlaLqPlLHEPFbI1W6vdfoArFxb7wyCH52a39w5qvqHIArkIlF8GySb/8mu1Fz70KdjoFja/90wbDeoJk4769F9URCy4v82yBrBMdpwF/dUW4WN9tntDmPSu88am1qbyZcQ] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_NumberOfCommonStockConvertedByEquityInterests" xlink:to="thcb_NumberOfCommonStockConvertedByEquityInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockConversionBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockConversionBasis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockConversionBasis_lbl" xml:lang="en-US">Merger agreement, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockConversionBasis" xlink:to="us-gaap_CommonStockConversionBasis_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_AdditionalSharesOfCommonStockEarn" xlink:href="thcb-20201231.xsd#thcb_AdditionalSharesOfCommonStockEarn"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_AdditionalSharesOfCommonStockEarn_lbl" xml:lang="en-US">Additional shares of common stock will earn (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AdditionalSharesOfCommonStockEarn" xlink:to="thcb_AdditionalSharesOfCommonStockEarn_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventEffectOfChangeInTaxStatus" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventEffectOfChangeInTaxStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventEffectOfChangeInTaxStatus_lbl" xml:lang="en-US">Subsequent Event, Effect of Change in Tax Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventEffectOfChangeInTaxStatus" xlink:to="us-gaap_SubsequentEventEffectOfChangeInTaxStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Percentage of ownership</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Number of shares of common stock issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Aggregate of outstanding promissory notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Expenses pay by sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Available cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Loan commitment, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_EmergingGrowthPolicyTextBlock" xlink:href="thcb-20201231.xsd#thcb_EmergingGrowthPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_EmergingGrowthPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_EmergingGrowthPolicyTextBlock" xlink:to="thcb_EmergingGrowthPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Cash and Marketable Securities Held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_lbl" xml:lang="en-US">Common Stock Subject to Possible Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Income (Loss) Per Common Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Standards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">Initial Public Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="thcb_EarlyBirdCapitalMember" xlink:href="thcb-20201231.xsd#thcb_EarlyBirdCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_EarlyBirdCapitalMember_lbl" xml:lang="en-US">Early Bird Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_EarlyBirdCapitalMember" xlink:to="thcb_EarlyBirdCapitalMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="thcb_EarlyBirdCapitalMember_lbl0" xml:lang="en-US">EarlyBirdCapital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_EarlyBirdCapitalMember" xlink:to="thcb_EarlyBirdCapitalMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="thcb_SponsorMember" xlink:href="thcb-20201231.xsd#thcb_SponsorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_SponsorMember_lbl" xml:lang="en-US">Sponsor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SponsorMember" xlink:to="thcb_SponsorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-allotment option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl0" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivateUnitsMember" xlink:href="thcb-20201231.xsd#thcb_PrivateUnitsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_PrivateUnitsMember_lbl" xml:lang="en-US">Private Units [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PrivateUnitsMember" xlink:to="thcb_PrivateUnitsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_FoundeSharesMember" xlink:href="thcb-20201231.xsd#thcb_FoundeSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_FoundeSharesMember_lbl" xml:lang="en-US">Founder Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_FoundeSharesMember" xlink:to="thcb_FoundeSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_VogelPartnersLlpMember" xlink:href="thcb-20201231.xsd#thcb_VogelPartnersLlpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_VogelPartnersLlpMember_lbl" xml:lang="en-US">Vogel Partners, LLP [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_VogelPartnersLlpMember" xlink:to="thcb_VogelPartnersLlpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_MorganStanleyMember" xlink:href="thcb-20201231.xsd#thcb_MorganStanleyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_MorganStanleyMember_lbl" xml:lang="en-US">Morgan Stanley [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_MorganStanleyMember" xlink:to="thcb_MorganStanleyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivateInvestmentInPublicEquityMember" xlink:href="thcb-20201231.xsd#thcb_PrivateInvestmentInPublicEquityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_PrivateInvestmentInPublicEquityMember_lbl" xml:lang="en-US">PIPE [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PrivateInvestmentInPublicEquityMember" xlink:to="thcb_PrivateInvestmentInPublicEquityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_MicrovastPowerSystemMember" xlink:href="thcb-20201231.xsd#thcb_MicrovastPowerSystemMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_MicrovastPowerSystemMember_lbl" xml:lang="en-US">Microvast Power System [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_MicrovastPowerSystemMember" xlink:to="thcb_MicrovastPowerSystemMember_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_BridgeNotesConversionMember" xlink:href="thcb-20201231.xsd#thcb_BridgeNotesConversionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_BridgeNotesConversionMember_lbl" xml:lang="en-US">Bridge Notes Conversion [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BridgeNotesConversionMember" xlink:to="thcb_BridgeNotesConversionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_SubscriptionAgreementsMember" xlink:href="thcb-20201231.xsd#thcb_SubscriptionAgreementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_SubscriptionAgreementsMember_lbl" xml:lang="en-US">Subscription Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SubscriptionAgreementsMember" xlink:to="thcb_SubscriptionAgreementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CosponsorMember" xlink:href="thcb-20201231.xsd#thcb_CosponsorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_CosponsorMember_lbl" xml:lang="en-US">Co-sponsor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CosponsorMember" xlink:to="thcb_CosponsorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_MergerAgreementMember" xlink:href="thcb-20201231.xsd#thcb_MergerAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="thcb_MergerAgreementMember_lbl" xml:lang="en-US">Merger Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_MergerAgreementMember" xlink:to="thcb_MergerAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" xlink:href="thcb-20201231.xsd#thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable_lbl" xml:lang="en-US">Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" xlink:to="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems" xlink:href="thcb-20201231.xsd#thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems_lbl" xml:lang="en-US">Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems" xlink:to="thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable_lbl" xml:lang="en-US">Description of Organization and Business Operations (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_lbl" xml:lang="en-US">Description of Organization and Business Operations (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="thcb-20201231.xsd#thcb_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_SummaryofSignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="thcb_SummaryofSignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_InitialPublicOfferingDetailsTable" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_InitialPublicOfferingDetailsTable_lbl" xml:lang="en-US">Initial Public Offering (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_InitialPublicOfferingDetailsTable" xlink:to="thcb_InitialPublicOfferingDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_InitialPublicOfferingDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_InitialPublicOfferingDetailsLineItems_lbl" xml:lang="en-US">Initial Public Offering (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_InitialPublicOfferingDetailsLineItems" xlink:to="thcb_InitialPublicOfferingDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivatePlacementDetailsTable" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PrivatePlacementDetailsTable_lbl" xml:lang="en-US">Private Placement (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PrivatePlacementDetailsTable" xlink:to="thcb_PrivatePlacementDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_PrivatePlacementDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PrivatePlacementDetailsLineItems_lbl" xml:lang="en-US">Private Placement (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PrivatePlacementDetailsLineItems" xlink:to="thcb_PrivatePlacementDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US">Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_RelatedPartyTransactionsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_RelatedPartyTransactionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_RelatedPartyTransactionsDetailsTable_lbl" xml:lang="en-US">Related Party Transactions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_RelatedPartyTransactionsDetailsTable" xlink:to="thcb_RelatedPartyTransactionsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_RelatedPartyTransactionsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_RelatedPartyTransactionsDetailsLineItems_lbl" xml:lang="en-US">Related Party Transactions (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_RelatedPartyTransactionsDetailsLineItems" xlink:to="thcb_RelatedPartyTransactionsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CommitmentsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_CommitmentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CommitmentsDetailsTable_lbl" xml:lang="en-US">Commitments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommitmentsDetailsTable" xlink:to="thcb_CommitmentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_CommitmentsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_CommitmentsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CommitmentsDetailsLineItems_lbl" xml:lang="en-US">Commitments (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommitmentsDetailsLineItems" xlink:to="thcb_CommitmentsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_StockholdersEquityDetailsTable" xlink:href="thcb-20201231.xsd#thcb_StockholdersEquityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_StockholdersEquityDetailsTable_lbl" xml:lang="en-US">Stockholders&apos; Equity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StockholdersEquityDetailsTable" xlink:to="thcb_StockholdersEquityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_StockholdersEquityDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_StockholdersEquityDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_StockholdersEquityDetailsLineItems_lbl" xml:lang="en-US">Stockholders&apos; Equity (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StockholdersEquityDetailsLineItems" xlink:to="thcb_StockholdersEquityDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_AgreementDomain" xlink:href="thcb-20201231.xsd#thcb_AgreementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_AgreementDomain_lbl" xml:lang="en-US">Agreement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AgreementDomain" xlink:to="thcb_AgreementDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_SubsequentEventsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SubsequentEventsDetailsTable" xlink:to="thcb_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="thcb_SubsequentEventsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_SubsequentEventsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_SubsequentEventsDetailsLineItems_lbl" xml:lang="en-US">Subsequent Events (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SubsequentEventsDetailsLineItems" xlink:to="thcb_SubsequentEventsDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_AdditionalSharesOfCommonStockEarn_lbl0" xml:lang="en-US">Additional shares of common stock earn.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AdditionalSharesOfCommonStockEarn" xlink:to="thcb_AdditionalSharesOfCommonStockEarn_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_AmountDepositInTrustAccount_lbl0" xml:lang="en-US">Amount deposit in trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AmountDepositInTrustAccount" xlink:to="thcb_AmountDepositInTrustAccount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_AmountDrawn_lbl0" xml:lang="en-US">Amount drawn.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AmountDrawn" xlink:to="thcb_AmountDrawn_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption_lbl0" xml:lang="en-US">Basic and diluted net income per common share (in Dollars per share).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" xlink:to="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption_lbl0" xml:lang="en-US">Basic and diluted weighted average shares outstanding (in Shares).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" xlink:to="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_CashWithdrawnAccountForRedemptions_lbl0" xml:lang="en-US">Cash withdrawn account for redemptions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CashWithdrawnAccountForRedemptions" xlink:to="thcb_CashWithdrawnAccountForRedemptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayFranchise_lbl0" xml:lang="en-US">Cash withdrawn from Trust Account to pay franchise.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CashWithdrawnFromTrustAccountToPayFranchise" xlink:to="thcb_CashWithdrawnFromTrustAccountToPayFranchise_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl0" xml:lang="en-US">Change in value of common stock subject to possible redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares_lbl0" xml:lang="en-US">Change in value of common stock subject to possible redemption shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToRedemption_lbl0" xml:lang="en-US">Change in value of common stock subject to redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ChangeInValueOfCommonStockSubjectToRedemption" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings_lbl0" xml:lang="en-US">Warrants description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings" xlink:to="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_CommonStockSubjectToPossibleRedemption_lbl0" xml:lang="en-US">Common stock subject to possible redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemption" xlink:to="thcb_CommonStockSubjectToPossibleRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of Common stock subject to possible redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionShares_lbl0" xml:lang="en-US">Common stock subject to possible redemption shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemptionShares" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_EmergingGrowthPolicyTextBlock_lbl0" xml:lang="en-US">It reperents emerging growth company policy text block.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_EmergingGrowthPolicyTextBlock" xlink:to="thcb_EmergingGrowthPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_GrossProceedsFromFinancing_lbl0" xml:lang="en-US">Gross proceeds from financing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_GrossProceedsFromFinancing" xlink:to="thcb_GrossProceedsFromFinancing_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_IncomeAdjustedNetLoss_lbl0" xml:lang="en-US">Adjusted net loss.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncomeAdjustedNetLoss" xlink:to="thcb_IncomeAdjustedNetLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_IncomeAndFranchiseTaxes_lbl0" xml:lang="en-US">Less: Income and franchise taxes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncomeAndFranchiseTaxes" xlink:to="thcb_IncomeAndFranchiseTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_IncreaseDecreaseInMarketableSecurities_lbl0" xml:lang="en-US">Interest earned on marketable securities held in Trust Account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncreaseDecreaseInMarketableSecurities" xlink:to="thcb_IncreaseDecreaseInMarketableSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities_lbl0" xml:lang="en-US">Unrealized gain on marketable securities held in Trust Account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities" xlink:to="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_InitialClassificationOfCommonStockSubjectToRedemption_lbl0" xml:lang="en-US">Initial classification of common stock subject to redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_InitialClassificationOfCommonStockSubjectToRedemption" xlink:to="thcb_InitialClassificationOfCommonStockSubjectToRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_IssuanceOfUnitsDescription_lbl0" xml:lang="en-US">Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary&apos;s or equity investee&apos;s stock sold, a description of the investors and whether the stock was issued in a business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IssuanceOfUnitsDescription" xlink:to="thcb_IssuanceOfUnitsDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_IssuedAndOutstandingSharesPercentage_lbl0" xml:lang="en-US">Percentage of issued and outstanding shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IssuedAndOutstandingSharesPercentage" xlink:to="thcb_IssuedAndOutstandingSharesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_NumberOfCommonStockConvertedByEquityInterests_lbl0" xml:lang="en-US">Number of common stock converted by equity interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_NumberOfCommonStockConvertedByEquityInterests" xlink:to="thcb_NumberOfCommonStockConvertedByEquityInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_OtherOfferingCosts_lbl0" xml:lang="en-US">Other offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_OtherOfferingCosts" xlink:to="thcb_OtherOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_PaymentOfOfferingCosts_lbl0" xml:lang="en-US">Payment of offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PaymentOfOfferingCosts" xlink:to="thcb_PaymentOfOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_PercentageOfGrossProceedsRaisedInFinancing_lbl0" xml:lang="en-US">Percentage of gross proceeds raised in financing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PercentageOfGrossProceedsRaisedInFinancing" xlink:to="thcb_PercentageOfGrossProceedsRaisedInFinancing_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_PercentageOfPlacementFee_lbl0" xml:lang="en-US">Percentage of  placement fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PercentageOfPlacementFee" xlink:to="thcb_PercentageOfPlacementFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_PercentageOfTrustAccountRequiredForBusinessCombination_lbl0" xml:lang="en-US">Minimum percentage of trust account required for business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PercentageOfTrustAccountRequiredForBusinessCombination" xlink:to="thcb_PercentageOfTrustAccountRequiredForBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty_lbl0" xml:lang="en-US">Proceeds from convertible promissory note &#8211; related party.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty" xlink:to="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_ProceedsFromPromissoryNotesRelatedparty_lbl0" xml:lang="en-US">Proceeds from promissory note - related party.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromPromissoryNotesRelatedparty" xlink:to="thcb_ProceedsFromPromissoryNotesRelatedparty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_ProceedsFromSaleOfPrivateUnits_lbl0" xml:lang="en-US">Proceeds from sale of Private Units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromSaleOfPrivateUnits" xlink:to="thcb_ProceedsFromSaleOfPrivateUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount_lbl0" xml:lang="en-US">Proceeds from sale of Units, net of underwriting discounts.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount" xlink:to="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_PublicSharePrice_lbl0" xml:lang="en-US">Public share price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PublicSharePrice" xlink:to="thcb_PublicSharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_RelatedPartyServicesFeesAmount_lbl0" xml:lang="en-US">Related party services fees amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_RelatedPartyServicesFeesAmount" xlink:to="thcb_RelatedPartyServicesFeesAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_RepaymentOfPromissoryNoteRelatedParty_lbl0" xml:lang="en-US">Repayment of promissory note &#8211; related party.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_RepaymentOfPromissoryNoteRelatedParty" xlink:to="thcb_RepaymentOfPromissoryNoteRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_SaleOfPrivateUnitAmount_lbl0" xml:lang="en-US">Sale of Private Units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SaleOfPrivateUnitAmount" xlink:to="thcb_SaleOfPrivateUnitAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_SaleOfStockNumberOfSharesIssuedInTransactions_lbl1" xml:lang="en-US">The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SaleOfStockNumberOfSharesIssuedInTransactions" xlink:to="thcb_SaleOfStockNumberOfSharesIssuedInTransactions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_SponsorPurchased_lbl0" xml:lang="en-US">The share purchase of  Sponsor purchased.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SponsorPurchased" xlink:to="thcb_SponsorPurchased_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts_lbl0" xml:lang="en-US">Sale of underwriting discounts and offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" xlink:to="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares_lbl0" xml:lang="en-US">Sale of underwriting shares discounts and offering cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" xlink:to="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_TransactionFee_lbl0" xml:lang="en-US">Amount of transaction fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_TransactionFee" xlink:to="thcb_TransactionFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_UnderwritersDiscount_lbl0" xml:lang="en-US">Underwriters discount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_UnderwritersDiscount" xlink:to="thcb_UnderwritersDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="thcb_WorkingCapitalLoans_lbl0" xml:lang="en-US">Amount of working capital loans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_WorkingCapitalLoans" xlink:to="thcb_WorkingCapitalLoans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_lbl1" xml:lang="en-US">CommonStockSubjectToPossibleRedemptionPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty_lbl1" xml:lang="en-US">ProceedsFromConvertiblePromissoryNoteRelatedParty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty" xlink:to="thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_IssuanceOfUnitsDescription_lbl1" xml:lang="en-US">IssuanceOfUnitsDescription</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IssuanceOfUnitsDescription" xlink:to="thcb_IssuanceOfUnitsDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_AmountDepositInTrustAccount_lbl1" xml:lang="en-US">AmountDepositInTrustAccount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AmountDepositInTrustAccount" xlink:to="thcb_AmountDepositInTrustAccount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede_lbl0" xml:lang="en-US">BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" xlink:to="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_SponsorPurchased_lbl1" xml:lang="en-US">SponsorPurchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SponsorPurchased" xlink:to="thcb_SponsorPurchased_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_UnderwritersDiscount_lbl1" xml:lang="en-US">UnderwritersDiscount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_UnderwritersDiscount" xlink:to="thcb_UnderwritersDiscount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_WorkingCapitalLoans_lbl1" xml:lang="en-US">WorkingCapitalLoans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_WorkingCapitalLoans" xlink:to="thcb_WorkingCapitalLoans_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_EmergingGrowthPolicyTextBlock_lbl1" xml:lang="en-US">EmergingGrowthPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_EmergingGrowthPolicyTextBlock" xlink:to="thcb_EmergingGrowthPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CosponsorMember_lbl0" xml:lang="en-US">CosponsorMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CosponsorMember" xlink:to="thcb_CosponsorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PaymentOfOfferingCosts_lbl1" xml:lang="en-US">PaymentOfOfferingCosts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PaymentOfOfferingCosts" xlink:to="thcb_PaymentOfOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_RepaymentOfPromissoryNoteRelatedParty_lbl1" xml:lang="en-US">RepaymentOfPromissoryNoteRelatedParty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_RepaymentOfPromissoryNoteRelatedParty" xlink:to="thcb_RepaymentOfPromissoryNoteRelatedParty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_AssetsAbstract0_lbl0" xml:lang="en-US">AssetsAbstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AssetsAbstract0" xlink:to="thcb_AssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_EarlyBirdCapitalMember_lbl1" xml:lang="en-US">EarlyBirdCapitalMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_EarlyBirdCapitalMember" xlink:to="thcb_EarlyBirdCapitalMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes_lbl0" xml:lang="en-US">CashWithdrawnFromTrustAccountToPayIncomeTaxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes" xlink:to="thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_InitialPublicOfferingDisclosureTextBlock_lbl0" xml:lang="en-US">InitialPublicOfferingDisclosureTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_InitialPublicOfferingDisclosureTextBlock" xlink:to="thcb_InitialPublicOfferingDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_AmountDrawn_lbl1" xml:lang="en-US">AmountDrawn</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AmountDrawn" xlink:to="thcb_AmountDrawn_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_SaleOfStockNumberOfSharesIssuedInTransactions_lbl2" xml:lang="en-US">SaleOfStockNumberOfSharesIssuedInTransactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SaleOfStockNumberOfSharesIssuedInTransactions" xlink:to="thcb_SaleOfStockNumberOfSharesIssuedInTransactions_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CommonStockSubjectToPossibleRedemption_lbl1" xml:lang="en-US">CommonStockSubjectToPossibleRedemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemption" xlink:to="thcb_CommonStockSubjectToPossibleRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_IncomeAndFranchiseTaxes_lbl1" xml:lang="en-US">IncomeAndFranchiseTaxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncomeAndFranchiseTaxes" xlink:to="thcb_IncomeAndFranchiseTaxes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CommonStockDividendDescription_lbl0" xml:lang="en-US">CommonStockDividendDescription</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockDividendDescription" xlink:to="thcb_CommonStockDividendDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption_lbl1" xml:lang="en-US">BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" xlink:to="thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_OtherOfferingCosts_lbl1" xml:lang="en-US">OtherOfferingCosts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_OtherOfferingCosts" xlink:to="thcb_OtherOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares_lbl1" xml:lang="en-US">ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_FoundeSharesMember_lbl0" xml:lang="en-US">FoundeSharesMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_FoundeSharesMember" xlink:to="thcb_FoundeSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PrivateInvestmentInPublicEquityMember_lbl0" xml:lang="en-US">PrivateInvestmentInPublicEquityMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PrivateInvestmentInPublicEquityMember" xlink:to="thcb_PrivateInvestmentInPublicEquityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_RelatedPartyServicesFeesAmount_lbl1" xml:lang="en-US">RelatedPartyServicesFeesAmount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_RelatedPartyServicesFeesAmount" xlink:to="thcb_RelatedPartyServicesFeesAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionShares_lbl1" xml:lang="en-US">CommonStockSubjectToPossibleRedemptionShares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemptionShares" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_IncreaseDecreaseInMarketableSecurities_lbl1" xml:lang="en-US">IncreaseDecreaseInMarketableSecurities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncreaseDecreaseInMarketableSecurities" xlink:to="thcb_IncreaseDecreaseInMarketableSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CommonSharesSubjectToPossibleRedemption_lbl0" xml:lang="en-US">CommonSharesSubjectToPossibleRedemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonSharesSubjectToPossibleRedemption" xlink:to="thcb_CommonSharesSubjectToPossibleRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract_lbl0" xml:lang="en-US">NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" xlink:to="thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings_lbl1" xml:lang="en-US">ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings" xlink:to="thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_MergerAgreementMember_lbl0" xml:lang="en-US">MergerAgreementMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_MergerAgreementMember" xlink:to="thcb_MergerAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_DeferredTaxLiabilityAbstract_lbl0" xml:lang="en-US">DeferredTaxLiabilityAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_DeferredTaxLiabilityAbstract" xlink:to="thcb_DeferredTaxLiabilityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_MicrovastPowerSystemMember_lbl0" xml:lang="en-US">MicrovastPowerSystemMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_MicrovastPowerSystemMember" xlink:to="thcb_MicrovastPowerSystemMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_AdditionalSharesOfCommonStockEarn_lbl1" xml:lang="en-US">AdditionalSharesOfCommonStockEarn</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AdditionalSharesOfCommonStockEarn" xlink:to="thcb_AdditionalSharesOfCommonStockEarn_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_SaleOfPrivateUnitAmount_lbl1" xml:lang="en-US">SaleOfPrivateUnitAmount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SaleOfPrivateUnitAmount" xlink:to="thcb_SaleOfPrivateUnitAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ProceedsFromSaleOfPrivateUnits_lbl1" xml:lang="en-US">ProceedsFromSaleOfPrivateUnits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromSaleOfPrivateUnits" xlink:to="thcb_ProceedsFromSaleOfPrivateUnits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_VogelPartnersLlpMember_lbl0" xml:lang="en-US">VogelPartnersLlpMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_VogelPartnersLlpMember" xlink:to="thcb_VogelPartnersLlpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares_lbl1" xml:lang="en-US">StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" xlink:to="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_IncomeAdjustedNetLoss_lbl1" xml:lang="en-US">IncomeAdjustedNetLoss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncomeAdjustedNetLoss" xlink:to="thcb_IncomeAdjustedNetLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CommonStockSubjectToPossibleRedemptionAbstract_lbl0" xml:lang="en-US">CommonStockSubjectToPossibleRedemptionAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CommonStockSubjectToPossibleRedemptionAbstract" xlink:to="thcb_CommonStockSubjectToPossibleRedemptionAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CashWithdrawnFromTrustAccountToPayFranchise_lbl1" xml:lang="en-US">CashWithdrawnFromTrustAccountToPayFranchise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CashWithdrawnFromTrustAccountToPayFranchise" xlink:to="thcb_CashWithdrawnFromTrustAccountToPayFranchise_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe_lbl0" xml:lang="en-US">BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" xlink:to="thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_IncomeAttributableToCommonStockSubjectToRedemption_lbl0" xml:lang="en-US">IncomeAttributableToCommonStockSubjectToRedemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncomeAttributableToCommonStockSubjectToRedemption" xlink:to="thcb_IncomeAttributableToCommonStockSubjectToRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_StateAndLocalAbstract_lbl0" xml:lang="en-US">StateAndLocalAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StateAndLocalAbstract" xlink:to="thcb_StateAndLocalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PercentageOfGrossProceedsRaisedInFinancing_lbl1" xml:lang="en-US">PercentageOfGrossProceedsRaisedInFinancing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PercentageOfGrossProceedsRaisedInFinancing" xlink:to="thcb_PercentageOfGrossProceedsRaisedInFinancing_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_InitialClassificationOfCommonStockSubjectToRedemption_lbl1" xml:lang="en-US">InitialClassificationOfCommonStockSubjectToRedemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_InitialClassificationOfCommonStockSubjectToRedemption" xlink:to="thcb_InitialClassificationOfCommonStockSubjectToRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount_lbl1" xml:lang="en-US">ProceedsFromSalesOfUnitsUnderwritingDiscount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount" xlink:to="thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ProceedsFromPromissoryNotesRelatedparty_lbl1" xml:lang="en-US">ProceedsFromPromissoryNotesRelatedparty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ProceedsFromPromissoryNotesRelatedparty" xlink:to="thcb_ProceedsFromPromissoryNotesRelatedparty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_NumberOfCommonStockConvertedByEquityInterests_lbl1" xml:lang="en-US">NumberOfCommonStockConvertedByEquityInterests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_NumberOfCommonStockConvertedByEquityInterests" xlink:to="thcb_NumberOfCommonStockConvertedByEquityInterests_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PercentageOfTrustAccountRequiredForBusinessCombination_lbl1" xml:lang="en-US">PercentageOfTrustAccountRequiredForBusinessCombination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PercentageOfTrustAccountRequiredForBusinessCombination" xlink:to="thcb_PercentageOfTrustAccountRequiredForBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_MorganStanleyMember_lbl0" xml:lang="en-US">MorganStanleyMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_MorganStanleyMember" xlink:to="thcb_MorganStanleyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_NumeratorNetIncomeMinusNetEarningsAbstract_lbl0" xml:lang="en-US">NumeratorNetIncomeMinusNetEarningsAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_NumeratorNetIncomeMinusNetEarningsAbstract" xlink:to="thcb_NumeratorNetIncomeMinusNetEarningsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities_lbl1" xml:lang="en-US">IncreaseDecreaseUnrealizedGainMarketableSecurities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities" xlink:to="thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_TransactionFee_lbl1" xml:lang="en-US">TransactionFee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_TransactionFee" xlink:to="thcb_TransactionFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_CashWithdrawnAccountForRedemptions_lbl1" xml:lang="en-US">CashWithdrawnAccountForRedemptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_CashWithdrawnAccountForRedemptions" xlink:to="thcb_CashWithdrawnAccountForRedemptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PublicSharePrice_lbl1" xml:lang="en-US">PublicSharePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PublicSharePrice" xlink:to="thcb_PublicSharePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_BridgeNotesConversionMember_lbl0" xml:lang="en-US">BridgeNotesConversionMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BridgeNotesConversionMember" xlink:to="thcb_BridgeNotesConversionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_AgreementAxis_lbl0" xml:lang="en-US">AgreementAxis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_AgreementAxis" xlink:to="thcb_AgreementAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_SubscriptionAgreementsMember_lbl0" xml:lang="en-US">SubscriptionAgreementsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SubscriptionAgreementsMember" xlink:to="thcb_SubscriptionAgreementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl1" xml:lang="en-US">ChangeInValueOfCommonStockSubjectToPossibleRedemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract_lbl0" xml:lang="en-US">DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract" xlink:to="thcb_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption_lbl1" xml:lang="en-US">BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" xlink:to="thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts_lbl1" xml:lang="en-US">StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" xlink:to="thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_ChangeInValueOfCommonStockSubjectToRedemption_lbl1" xml:lang="en-US">ChangeInValueOfCommonStockSubjectToRedemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_ChangeInValueOfCommonStockSubjectToRedemption" xlink:to="thcb_ChangeInValueOfCommonStockSubjectToRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PrivateUnitsMember_lbl0" xml:lang="en-US">PrivateUnitsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PrivateUnitsMember" xlink:to="thcb_PrivateUnitsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_GrossProceedsFromFinancing_lbl1" xml:lang="en-US">GrossProceedsFromFinancing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_GrossProceedsFromFinancing" xlink:to="thcb_GrossProceedsFromFinancing_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PercentageOfPlacementFee_lbl1" xml:lang="en-US">PercentageOfPlacementFee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PercentageOfPlacementFee" xlink:to="thcb_PercentageOfPlacementFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_PrivatePlacementDisclosureTextBlock_lbl0" xml:lang="en-US">PrivatePlacementDisclosureTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_PrivatePlacementDisclosureTextBlock" xlink:to="thcb_PrivatePlacementDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_IssuedAndOutstandingSharesPercentage_lbl1" xml:lang="en-US">IssuedAndOutstandingSharesPercentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_IssuedAndOutstandingSharesPercentage" xlink:to="thcb_IssuedAndOutstandingSharesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract_lbl0" xml:lang="en-US">DenominatorWeightedAverageNonRedeemableCommonStockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract" xlink:to="thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_SponsorMember_lbl0" xml:lang="en-US">SponsorMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_SponsorMember" xlink:to="thcb_SponsorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_FederalAbstract_lbl0" xml:lang="en-US">FederalAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_FederalAbstract" xlink:to="thcb_FederalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="thcb_NonRedeemableCommonStockAbstract_lbl0" xml:lang="en-US">NonRedeemableCommonStockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="thcb_NonRedeemableCommonStockAbstract" xlink:to="thcb_NonRedeemableCommonStockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl0" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Income Tax Liabilities, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsShares_lbl0" xml:lang="en-US">Common Stock Dividends, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsShares" xlink:to="us-gaap_CommonStockDividendsShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl0" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl1" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax_lbl0" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Transfer from Held-to-Maturity, Gain (Loss), before Adjustment and Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl0" xml:lang="en-US">Proceeds from Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl0" xml:lang="en-US">Operating Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl0" xml:lang="en-US">Business Acquisition, Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebt_lbl0" xml:lang="en-US">Unsecured Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebt" xlink:to="us-gaap_UnsecuredDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl0" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl0" xml:lang="en-US">Debt Instrument, Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Unrealized Gains on Trading Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationControlObtainedDescription_lbl0" xml:lang="en-US">Business Combination, Control Obtained Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationControlObtainedDescription" xlink:to="us-gaap_BusinessCombinationControlObtainedDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustCurrent_lbl0" xml:lang="en-US">Assets Held-in-trust, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustCurrent" xlink:to="us-gaap_AssetsHeldInTrustCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl0" xml:lang="en-US">Due to Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl0" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_lbl0" xml:lang="en-US">Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl0" xml:lang="en-US">Marketable Securities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl0" xml:lang="en-US">Payments to Acquire Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOther_lbl0" xml:lang="en-US">Interest Income, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl0" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndDividendIncomeSecuritiesOther_lbl0" xml:lang="en-US">Interest and Dividend Income, Securities, Operating, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDividendIncomeSecuritiesOther" xlink:to="us-gaap_InterestAndDividendIncomeSecuritiesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl1" xml:lang="en-US">Short-term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl0" xml:lang="en-US">Sale of Stock, Description of Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl0" xml:lang="en-US">Income Taxes Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl0" xml:lang="en-US">Conversion of Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl0" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockConversionBasis_lbl0" xml:lang="en-US">Common Stock, Conversion Basis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockConversionBasis" xlink:to="us-gaap_CommonStockConversionBasis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalDepositInsuranceCorporationPremiumExpense_lbl0" xml:lang="en-US">Federal Deposit Insurance Corporation Premium Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalDepositInsuranceCorporationPremiumExpense" xlink:to="us-gaap_FederalDepositInsuranceCorporationPremiumExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl0" xml:lang="en-US">Convertible Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl0" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Federal Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl0" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl0" xml:lang="en-US">Business Combination, Consideration Transferred, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl0" xml:lang="en-US">Marketable Securities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl0" xml:lang="en-US">Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl0" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value, Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl0" xml:lang="en-US">Expense Related to Distribution or Servicing and Underwriting Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl1" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl0" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl0" xml:lang="en-US">Notes Payable, Related Parties, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl0" xml:lang="en-US">Debt Instrument, Unamortized Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl0" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl0" xml:lang="en-US">Related Party Transaction, Due from (to) Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl0" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl0" xml:lang="en-US">Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl1" xml:lang="en-US">Business Acquisition, Description of Acquired Entity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationReasonForBusinessCombination_lbl0" xml:lang="en-US">Business Combination, Reason for Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationReasonForBusinessCombination" xlink:to="us-gaap_BusinessCombinationReasonForBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventEffectOfChangeInTaxStatus_lbl0" xml:lang="en-US">Subsequent Event, Effect of Change in Tax Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventEffectOfChangeInTaxStatus" xlink:to="us-gaap_SubsequentEventEffectOfChangeInTaxStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAbstract_lbl0" xml:lang="en-US">Component of Operating Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherIncomeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrent_lbl0" xml:lang="en-US">Taxes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl0" xml:lang="en-US">Chief Executive Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0" xml:lang="en-US">Repayments of Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl0" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl1" xml:lang="en-US">Earnings Per Share, Basic and Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>thcb-20201231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Mar 24 20:36:19 EDT 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedBalanceSheet" roleURI="http://thcb.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedIncomeStatement" roleURI="http://thcb.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ShareholdersEquityType2or3" roleURI="http://thcb.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://thcb.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ConsolidatedCashFlow" roleURI="http://thcb.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_DescriptionofOrganizationandBusinessOperations" roleURI="http://thcb.com/role/DescriptionofOrganizationandBusinessOperations"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SummaryofSignificantAccountingPolicies" roleURI="http://thcb.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_InitialPublicOffering" roleURI="http://thcb.com/role/InitialPublicOffering"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_PrivatePlacement" roleURI="http://thcb.com/role/PrivatePlacement"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_RelatedPartyTransactions" roleURI="http://thcb.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_Commitments" roleURI="http://thcb.com/role/Commitments"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_StockholdersEquity" roleURI="http://thcb.com/role/StockholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_IncomeTax" roleURI="http://thcb.com/role/IncomeTax"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_FairValueMeasurements" roleURI="http://thcb.com/role/FairValueMeasurements"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SubsequentEvents" roleURI="http://thcb.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_AccountingPoliciesByPolicy" roleURI="http://thcb.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_IncomeTaxTables" roleURI="http://thcb.com/role/IncomeTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_FairValueMeasurementsTables" roleURI="http://thcb.com/role/FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleofbasicanddilutedlosspershareTable" roleURI="http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleofnetdeferredtaxliabilityTable" roleURI="http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleofincometaxprovisionTable" roleURI="http://thcb.com/role/ScheduleofincometaxprovisionTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleoffederalincometaxratetoeffectivetaxrateTable" roleURI="http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_ScheduleoffairvaluehierarchyofthevaluationinputsTable" roleURI="http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_DescriptionofOrganizationandBusinessOperationsDetails" roleURI="http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_InitialPublicOfferingDetails" roleURI="http://thcb.com/role/InitialPublicOfferingDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_PrivatePlacementDetails" roleURI="http://thcb.com/role/PrivatePlacementDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_RelatedPartyTransactionsDetails" roleURI="http://thcb.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_CommitmentsDetails" roleURI="http://thcb.com/role/CommitmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_StockholdersEquityDetails" roleURI="http://thcb.com/role/StockholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#thcb_r_SubsequentEventsDetails" roleURI="http://thcb.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="thcb-20201231.xsd#DocumentAndEntityInformation" roleURI="http://thcb.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_TaxesPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="CommonSharesSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_CommonSharesSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="CommonSharesSubjectToPossibleRedemption" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherIncomeAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_InterestIncomeOther" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInValueOfCommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ChangeInValueOfCommonStockSubjectToPossibleRedemption" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" xlink:href="thcb-20201231.xsd#thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" xlink:href="thcb-20201231.xsd#thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CommonStockSubjectToPossibleRedemption" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockSubjectToPossibleRedemptionShares" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemptionShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CommonStockSubjectToPossibleRedemptionShares" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfPrivateUnitAmount" xlink:href="thcb-20201231.xsd#thcb_SaleOfPrivateUnitAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="SaleOfPrivateUnitAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInMarketableSecurities" xlink:href="thcb-20201231.xsd#thcb_IncreaseDecreaseInMarketableSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInMarketableSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseUnrealizedGainMarketableSecurities" xlink:href="thcb-20201231.xsd#thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseUnrealizedGainMarketableSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="CashWithdrawnAccountForRedemptions" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnAccountForRedemptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="CashWithdrawnAccountForRedemptions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashWithdrawnFromTrustAccountToPayIncomeTaxes" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="CashWithdrawnFromTrustAccountToPayIncomeTaxes" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromSalesOfUnitsUnderwritingDiscount" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromSalesOfUnitsUnderwritingDiscount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromSaleOfPrivateUnits" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromSaleOfPrivateUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromSaleOfPrivateUnits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromConvertiblePromissoryNoteRelatedParty" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromConvertiblePromissoryNoteRelatedParty" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromPromissoryNotesRelatedparty" xlink:href="thcb-20201231.xsd#thcb_ProceedsFromPromissoryNotesRelatedparty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromPromissoryNotesRelatedparty" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RepaymentOfPromissoryNoteRelatedParty" xlink:href="thcb-20201231.xsd#thcb_RepaymentOfPromissoryNoteRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentOfPromissoryNoteRelatedParty" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_PaymentOfOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentOfOfferingCosts" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialClassificationOfCommonStockSubjectToRedemption" xlink:href="thcb-20201231.xsd#thcb_InitialClassificationOfCommonStockSubjectToRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="InitialClassificationOfCommonStockSubjectToRedemption" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInValueOfCommonStockSubjectToRedemption" xlink:href="thcb-20201231.xsd#thcb_ChangeInValueOfCommonStockSubjectToRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ChangeInValueOfCommonStockSubjectToRedemption" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/DescriptionofOrganizationandBusinessOperations">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/InitialPublicOffering">
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingDisclosureAbstract" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingDisclosureTextBlock" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDisclosureAbstract" xlink:to="InitialPublicOfferingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/PrivatePlacement">
    <loc xlink:type="locator" xlink:label="PrivatePlacementDisclosureAbstract" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementDisclosureTextBlock" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDisclosureAbstract" xlink:to="PrivatePlacementDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/Commitments">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/StockholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/IncomeTax">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/FairValueMeasurements">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmergingGrowthPolicyTextBlock" xlink:href="thcb-20201231.xsd#thcb_EmergingGrowthPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="EmergingGrowthPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockSubjectToPossibleRedemptionPolicyTextBlock" xlink:href="thcb-20201231.xsd#thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="CommonStockSubjectToPossibleRedemptionPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/IncomeTaxTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" xlink:href="thcb-20201231.xsd#thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDividendIncomeSecuritiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeSecuritiesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" xlink:to="us-gaap_InterestAndDividendIncomeSecuritiesOther" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeAndFranchiseTaxes" xlink:href="thcb-20201231.xsd#thcb_IncomeAndFranchiseTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="IncomeAndFranchiseTaxes" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumeratorNetIncomeMinusNetEarningsAbstract" xlink:href="thcb-20201231.xsd#thcb_NumeratorNetIncomeMinusNetEarningsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="NumeratorNetIncomeMinusNetEarningsAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumeratorNetIncomeMinusNetEarningsAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeAttributableToCommonStockSubjectToRedemption" xlink:href="thcb-20201231.xsd#thcb_IncomeAttributableToCommonStockSubjectToRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumeratorNetIncomeMinusNetEarningsAbstract" xlink:to="IncomeAttributableToCommonStockSubjectToRedemption" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeAdjustedNetLoss" xlink:href="thcb-20201231.xsd#thcb_IncomeAdjustedNetLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAttributableToCommonStockSubjectToRedemption" xlink:to="IncomeAdjustedNetLoss" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="DenominatorWeightedAverageNonRedeemableCommonStockAbstract" xlink:href="thcb-20201231.xsd#thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="DenominatorWeightedAverageNonRedeemableCommonStockAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DenominatorWeightedAverageNonRedeemableCommonStockAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DenominatorWeightedAverageNonRedeemableCommonStockAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfNetDeferredTaxLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxLiabilityAbstract" xlink:href="thcb-20201231.xsd#thcb_DeferredTaxLiabilityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:to="DeferredTaxLiabilityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilityAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetDeferredTaxLiabilityAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleofincometaxprovisionTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIncomeTaxProvisionAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfIncomeTaxProvisionAbstract"/>
    <loc xlink:type="locator" xlink:label="FederalAbstract" xlink:href="thcb-20201231.xsd#thcb_FederalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxProvisionAbstract" xlink:to="FederalAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FederalAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FederalAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StateAndLocalAbstract" xlink:href="thcb-20201231.xsd#thcb_StateAndLocalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxProvisionAbstract" xlink:to="StateAndLocalAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StateAndLocalAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StateAndLocalAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxProvisionAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxProvisionAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract" xlink:href="thcb-20201231.xsd#thcb_ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" xlink:href="thcb-20201231.xsd#thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems" xlink:href="thcb-20201231.xsd#thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract" xlink:to="FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYmd/eP2vefFYjlZ03F3sybkMF39kCdGz5Rojbdz8tM/wssVRLP7kcbIoHDqSY1cEXAJSJwSlCjxb8MtUGFs1NlaLqPlLHEPFbI1W6vdfoArFxb7wyCH52a39w5qvqHIArkIlF8GySb/8mu1Fz70KdjoFja/90wbDeoJk4769F9URCy4v82yBrBENXpVWiLHr4SeYylqPf1A+ZusCBtKhC4] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable" xlink:to="FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionofOrganizationandBusinessOperationsDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="thcb-20201231.xsd#thcb_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="SponsorMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivateUnitsMember" xlink:href="thcb-20201231.xsd#thcb_PrivateUnitsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PrivateUnitsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EarlyBirdCapitalMember" xlink:href="thcb-20201231.xsd#thcb_EarlyBirdCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="EarlyBirdCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfUnitsDescription" xlink:href="thcb-20201231.xsd#thcb_IssuanceOfUnitsDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="IssuanceOfUnitsDescription" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritersDiscount" xlink:href="thcb-20201231.xsd#thcb_UnderwritersDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="UnderwritersDiscount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmountDepositInTrustAccount" xlink:href="thcb-20201231.xsd#thcb_AmountDepositInTrustAccount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="AmountDepositInTrustAccount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherOfferingCosts" xlink:href="thcb-20201231.xsd#thcb_OtherOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="OtherOfferingCosts" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfTrustAccountRequiredForBusinessCombination" xlink:href="thcb-20201231.xsd#thcb_PercentageOfTrustAccountRequiredForBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="PercentageOfTrustAccountRequiredForBusinessCombination" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicSharePrice" xlink:href="thcb-20201231.xsd#thcb_PublicSharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="PublicSharePrice" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredOther1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SharePrice" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_AssetsHeldInTrustCurrent" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_ShortTermBorrowings" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="thcb-20201231.xsd#thcb_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="CashWithdrawnFromTrustAccountToPayFranchise" xlink:href="thcb-20201231.xsd#thcb_CashWithdrawnFromTrustAccountToPayFranchise"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="CashWithdrawnFromTrustAccountToPayFranchise" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FederalDepositInsuranceCorporationPremiumExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalDepositInsuranceCorporationPremiumExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_FederalDepositInsuranceCorporationPremiumExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/InitialPublicOfferingDetails">
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingDisclosureAbstract" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingDetailsTable" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_InitialPublicOfferingDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDisclosureAbstract" xlink:to="InitialPublicOfferingDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="InitialPublicOfferingDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationReasonForBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationReasonForBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_BusinessCombinationReasonForBusinessCombination" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/PrivatePlacementDetails">
    <loc xlink:type="locator" xlink:label="PrivatePlacementDisclosureAbstract" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementDetailsTable" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDetailsTable"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_PrivatePlacementDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDisclosureAbstract" xlink:to="PrivatePlacementDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="thcb-20201231.xsd#thcb_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="SponsorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="PrivatePlacementDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockDescriptionOfTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsLineItems" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/RelatedPartyTransactionsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_RelatedPartyTransactionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_RelatedPartyTransactionsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="dei_LegalEntityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="VogelPartnersLlpMember" xlink:href="thcb-20201231.xsd#thcb_VogelPartnersLlpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="VogelPartnersLlpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_ChiefExecutiveOfficerMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FoundeSharesMember" xlink:href="thcb-20201231.xsd#thcb_FoundeSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="FoundeSharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="thcb-20201231.xsd#thcb_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="SponsorMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivateUnitsMember" xlink:href="thcb-20201231.xsd#thcb_PrivateUnitsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PrivateUnitsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="RelatedPartyTransactionsDetailsLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="SponsorPurchased" xlink:href="thcb-20201231.xsd#thcb_SponsorPurchased"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="SponsorPurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockDividendDescription" xlink:href="thcb-20201231.xsd#thcb_CommonStockDividendDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="CommonStockDividendDescription" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_CommonStockDividendsShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedAndOutstandingSharesPercentage" xlink:href="thcb-20201231.xsd#thcb_IssuedAndOutstandingSharesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="IssuedAndOutstandingSharesPercentage" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationControlObtainedDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationControlObtainedDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_BusinessCombinationControlObtainedDescription" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfStockNumberOfSharesIssuedInTransactions" xlink:href="thcb-20201231.xsd#thcb_SaleOfStockNumberOfSharesIssuedInTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="SaleOfStockNumberOfSharesIssuedInTransactions" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyServicesFeesAmount" xlink:href="thcb-20201231.xsd#thcb_RelatedPartyServicesFeesAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="RelatedPartyServicesFeesAmount" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnsecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_UnsecuredDebt" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapitalLoans" xlink:href="thcb-20201231.xsd#thcb_WorkingCapitalLoans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="WorkingCapitalLoans" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmountDrawn" xlink:href="thcb-20201231.xsd#thcb_AmountDrawn"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="AmountDrawn" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ShortTermBorrowings" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/CommitmentsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_CommitmentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CommitmentsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_CommitmentsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MorganStanleyMember" xlink:href="thcb-20201231.xsd#thcb_MorganStanleyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="MorganStanleyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PrivateInvestmentInPublicEquityMember" xlink:href="thcb-20201231.xsd#thcb_PrivateInvestmentInPublicEquityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="PrivateInvestmentInPublicEquityMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsTable" xlink:to="CommitmentsDetailsLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransactionFee" xlink:href="thcb-20201231.xsd#thcb_TransactionFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsLineItems" xlink:to="TransactionFee" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfPlacementFee" xlink:href="thcb-20201231.xsd#thcb_PercentageOfPlacementFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsLineItems" xlink:to="PercentageOfPlacementFee" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossProceedsFromFinancing" xlink:href="thcb-20201231.xsd#thcb_GrossProceedsFromFinancing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsLineItems" xlink:to="GrossProceedsFromFinancing" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfGrossProceedsRaisedInFinancing" xlink:href="thcb-20201231.xsd#thcb_PercentageOfGrossProceedsRaisedInFinancing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsLineItems" xlink:to="PercentageOfGrossProceedsRaisedInFinancing" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/StockholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="StockholdersEquityDetailsTable" xlink:href="thcb-20201231.xsd#thcb_StockholdersEquityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="StockholdersEquityDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_StockholdersEquityDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="StockholdersEquityDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EarlyBirdCapitalMember" xlink:href="thcb-20201231.xsd#thcb_EarlyBirdCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="EarlyBirdCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_WarrantMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="StockholdersEquityDetailsLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonSharesSubjectToPossibleRedemption" xlink:href="thcb-20201231.xsd#thcb_CommonSharesSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="CommonSharesSubjectToPossibleRedemption" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings" xlink:href="thcb-20201231.xsd#thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfStockNumberOfSharesIssuedInTransactions" xlink:href="thcb-20201231.xsd#thcb_SaleOfStockNumberOfSharesIssuedInTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="SaleOfStockNumberOfSharesIssuedInTransactions" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="thcb-20201231.xsd#thcb_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsLineItems" xlink:href="thcb-20201231.xsd#thcb_SubsequentEventsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MicrovastPowerSystemMember" xlink:href="thcb-20201231.xsd#thcb_MicrovastPowerSystemMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="MicrovastPowerSystemMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="thcb-20201231.xsd#thcb_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SponsorMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CosponsorMember" xlink:href="thcb-20201231.xsd#thcb_CosponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="CosponsorMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgreementAxis" xlink:href="thcb-20201231.xsd#thcb_AgreementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="AgreementAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgreementDomain" xlink:href="thcb-20201231.xsd#thcb_AgreementDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementAxis" xlink:to="AgreementDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SubscriptionAgreementsMember" xlink:href="thcb-20201231.xsd#thcb_SubscriptionAgreementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementAxis" xlink:to="SubscriptionAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MergerAgreementMember" xlink:href="thcb-20201231.xsd#thcb_MergerAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementAxis" xlink:to="MergerAgreementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BridgeNotesConversionMember" xlink:href="thcb-20201231.xsd#thcb_BridgeNotesConversionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="BridgeNotesConversionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="SubsequentEventsDetailsLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="NumberOfCommonStockConvertedByEquityInterests" xlink:href="thcb-20201231.xsd#thcb_NumberOfCommonStockConvertedByEquityInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="NumberOfCommonStockConvertedByEquityInterests" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockConversionBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockConversionBasis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CommonStockConversionBasis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalSharesOfCommonStockEarn" xlink:href="thcb-20201231.xsd#thcb_AdditionalSharesOfCommonStockEarn"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="AdditionalSharesOfCommonStockEarn" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventEffectOfChangeInTaxStatus" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventEffectOfChangeInTaxStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SubsequentEventEffectOfChangeInTaxStatus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CostsAndExpenses" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_Cash" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentDescription" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://thcb.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="thcb-20201231.xsd#thcb_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>f10k2020_tuscanhold_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:thcb="http://thcb.com/20201231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="thcb-20201231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <instant>2021-03-23</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-07</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-07</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-07</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">thcb:EarlyBirdCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-07</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">thcb:EarlyBirdCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-07</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">thcb:EarlyBirdCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-12</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:PrivateUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-12</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:PrivateUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-12</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-12</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-07</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <instant>2020-04-20</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-07</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:FoundeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:FoundeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-05</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-05</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <instant>2019-03-05</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:FoundeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">thcb:VogelPartnersLlpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-20</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thcb:PrivateUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:MorganStanleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">thcb:PrivateInvestmentInPublicEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:MorganStanleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">thcb:EarlyBirdCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-26</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:MicrovastPowerSystemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-26</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
        </entity>
        <period>
            <startDate>2021-01-26</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:MicrovastPowerSystemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">thcb:BridgeNotesConversionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-26</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="thcb:AgreementAxis">thcb:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-26</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:CosponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="thcb:AgreementAxis">thcb:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-26</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="thcb:AgreementAxis">thcb:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-26</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thcb:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-02</startDate>
            <endDate>2021-02-12</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760689</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-12</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0">2020</dei:DocumentFiscalYearFocus>
    <dei:EntityFileNumber contextRef="c0">001-38826</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">TUSCAN HOLDINGS CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0">83-2530757</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0">135 E. 57th St.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0">18th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">10022</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">(646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">948-7100</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">THCB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="c0">true</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c2" decimals="0" unitRef="usd">282348000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c1" decimals="INF" unitRef="shares">35483802</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="0" unitRef="usd">135961</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="0" unitRef="usd">140303</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent contextRef="c4" decimals="0" unitRef="usd">69818</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c3" decimals="0" unitRef="usd">22499</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c4" decimals="0" unitRef="usd">186247</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="0" unitRef="usd">158460</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c4" decimals="0" unitRef="usd">396368</us-gaap:AssetsCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c3" decimals="0" unitRef="usd">282254978</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c4" decimals="0" unitRef="usd">280103245</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:Assets contextRef="c3" decimals="0" unitRef="usd">282413438</us-gaap:Assets>
    <us-gaap:Assets contextRef="c4" decimals="0" unitRef="usd">280499613</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c3" decimals="0" unitRef="usd">320978</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c4" decimals="0" unitRef="usd">269055</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c3" decimals="0" unitRef="usd">302547</us-gaap:TaxesPayableCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="c3" decimals="0" unitRef="usd">22179</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="0" unitRef="usd">645704</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c4" decimals="0" unitRef="usd">269055</us-gaap:LiabilitiesCurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="c3" decimals="0" unitRef="usd">200000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c3" decimals="0" unitRef="usd">21468</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c4" decimals="0" unitRef="usd">27069</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities contextRef="c3" decimals="0" unitRef="usd">867172</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c4" decimals="0" unitRef="usd">296124</us-gaap:Liabilities>
    <thcb:CommonSharesSubjectToPossibleRedemption contextRef="c3" decimals="INF" unitRef="shares">27087556</thcb:CommonSharesSubjectToPossibleRedemption>
    <thcb:CommonSharesSubjectToPossibleRedemption contextRef="c4" decimals="INF" unitRef="shares">27126477</thcb:CommonSharesSubjectToPossibleRedemption>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount contextRef="c3" decimals="0" unitRef="usd">276546264</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount contextRef="c4" decimals="0" unitRef="usd">275203480</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c4" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c4" decimals="INF" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c4" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">65000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c4" decimals="INF" unitRef="shares">65000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="INF" unitRef="shares">8396246</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">8396246</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c4" decimals="INF" unitRef="shares">8360523</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c4" decimals="INF" unitRef="shares">8360523</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c3" decimals="0" unitRef="usd">840</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c4" decimals="0" unitRef="usd">836</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c3" decimals="0" unitRef="usd">257314</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c4" decimals="0" unitRef="usd">1632786</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="0" unitRef="usd">4741848</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="0" unitRef="usd">3366387</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="0" unitRef="usd">5000002</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="0" unitRef="usd">5000009</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="0" unitRef="usd">282413438</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c4" decimals="0" unitRef="usd">280499613</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses contextRef="c0" decimals="0" unitRef="usd">921665</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c5" decimals="0" unitRef="usd">778815</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="0" unitRef="usd">-921665</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c5" decimals="0" unitRef="usd">-778815</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther contextRef="c0" decimals="0" unitRef="usd">2654140</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther contextRef="c5" decimals="0" unitRef="usd">4912346</us-gaap:InterestIncomeOther>
    <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax contextRef="c0" decimals="0" unitRef="usd">9750</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax contextRef="c5" decimals="0" unitRef="usd">128899</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c0" decimals="0" unitRef="usd">2663890</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c5" decimals="0" unitRef="usd">5041245</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c0" decimals="0" unitRef="usd">1742225</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c5" decimals="0" unitRef="usd">4262430</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="0" unitRef="usd">366764</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c5" decimals="0" unitRef="usd">895251</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd">1375461</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="0" unitRef="usd">3367179</us-gaap:NetIncomeLoss>
    <thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede contextRef="c0" decimals="INF" unitRef="shares">27104439</thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede>
    <thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede contextRef="c5" decimals="INF" unitRef="shares">27123666</thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede>
    <thcb:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe contextRef="c0" decimals="2" unitRef="usdPershares">0.08</thcb:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe>
    <thcb:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe contextRef="c5" decimals="2" unitRef="usdPershares">0.14</thcb:BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="c0" decimals="INF" unitRef="shares">8382317</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="c5" decimals="INF" unitRef="shares">7927608</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="c0" decimals="2" unitRef="usdPershares">-0.08</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="c5" decimals="2" unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:SharesOutstanding contextRef="c6" decimals="INF" unitRef="shares">7200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c6" decimals="0" unitRef="usd">720</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c7" decimals="0" unitRef="usd">25480</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c8" decimals="0" unitRef="usd">-792</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="0" unitRef="usd">25408</us-gaap:StockholdersEquity>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c4" decimals="0" unitRef="usd">27600000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares contextRef="c10" decimals="INF" unitRef="shares">27600000</thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares>
    <thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts contextRef="c10" decimals="0" unitRef="usd">2760</thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts>
    <thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts contextRef="c11" decimals="0" unitRef="usd">269938142</thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts>
    <thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts contextRef="c5" decimals="0" unitRef="usd">269940902</thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts>
    <thcb:SaleOfPrivateUnitAmount contextRef="c5" decimals="0" unitRef="usd">687000</thcb:SaleOfPrivateUnitAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c10" decimals="INF" unitRef="shares">687000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c10" decimals="0" unitRef="usd">68</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c11" decimals="0" unitRef="usd">6869932</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c5" decimals="0" unitRef="usd">6870000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <thcb:CommonStockSubjectToPossibleRedemptionShares contextRef="c10" decimals="INF" unitRef="shares">-27126477</thcb:CommonStockSubjectToPossibleRedemptionShares>
    <thcb:CommonStockSubjectToPossibleRedemption contextRef="c10" decimals="0" unitRef="usd">-2712</thcb:CommonStockSubjectToPossibleRedemption>
    <thcb:CommonStockSubjectToPossibleRedemption contextRef="c11" decimals="0" unitRef="usd">-275200768</thcb:CommonStockSubjectToPossibleRedemption>
    <thcb:CommonStockSubjectToPossibleRedemption contextRef="c5" decimals="0" unitRef="usd">-275203480</thcb:CommonStockSubjectToPossibleRedemption>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="0" unitRef="usd">3367179</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="0" unitRef="usd">3367179</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c13" decimals="INF" unitRef="shares">8360523</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c13" decimals="0" unitRef="usd">836</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c14" decimals="0" unitRef="usd">1632786</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c15" decimals="0" unitRef="usd">3366387</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="0" unitRef="usd">5000009</us-gaap:StockholdersEquity>
    <thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares contextRef="c16" decimals="INF" unitRef="shares">35723</thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares>
    <thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemption contextRef="c16" decimals="0" unitRef="usd">4</thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemption contextRef="c17" decimals="0" unitRef="usd">-1375472</thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemption contextRef="c0" decimals="0" unitRef="usd">-1375468</thcb:ChangeInValueOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:NetIncomeLoss contextRef="c18" decimals="0" unitRef="usd">1375461</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd">1375461</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c19" decimals="INF" unitRef="shares">8396246</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c19" decimals="0" unitRef="usd">840</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c20" decimals="0" unitRef="usd">257314</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c21" decimals="0" unitRef="usd">4741848</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="0" unitRef="usd">5000002</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd">1375461</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="0" unitRef="usd">3367179</us-gaap:NetIncomeLoss>
    <thcb:IncreaseDecreaseInMarketableSecurities contextRef="c0" decimals="0" unitRef="usd">2654140</thcb:IncreaseDecreaseInMarketableSecurities>
    <thcb:IncreaseDecreaseInMarketableSecurities contextRef="c5" decimals="0" unitRef="usd">4912346</thcb:IncreaseDecreaseInMarketableSecurities>
    <thcb:IncreaseDecreaseUnrealizedGainMarketableSecurities contextRef="c0" decimals="0" unitRef="usd">9750</thcb:IncreaseDecreaseUnrealizedGainMarketableSecurities>
    <thcb:IncreaseDecreaseUnrealizedGainMarketableSecurities contextRef="c5" decimals="0" unitRef="usd">128899</thcb:IncreaseDecreaseUnrealizedGainMarketableSecurities>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c0" decimals="0" unitRef="usd">-5601</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c5" decimals="0" unitRef="usd">27069</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="0" unitRef="usd">-163748</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c5" decimals="0" unitRef="usd">186222</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="c0" decimals="0" unitRef="usd">-69818</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="c5" decimals="0" unitRef="usd">69818</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c0" decimals="0" unitRef="usd">51923</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c5" decimals="0" unitRef="usd">268605</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c0" decimals="0" unitRef="usd">302547</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="0" unitRef="usd">-705994</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c5" decimals="0" unitRef="usd">-1634432</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c5" decimals="0" unitRef="usd">276000000</us-gaap:PaymentsToAcquireInvestments>
    <thcb:CashWithdrawnAccountForRedemptions contextRef="c0" decimals="0" unitRef="usd">32684</thcb:CashWithdrawnAccountForRedemptions>
    <thcb:CashWithdrawnFromTrustAccountToPayIncomeTaxes contextRef="c0" decimals="0" unitRef="usd">479473</thcb:CashWithdrawnFromTrustAccountToPayIncomeTaxes>
    <thcb:CashWithdrawnFromTrustAccountToPayIncomeTaxes contextRef="c5" decimals="0" unitRef="usd">938000</thcb:CashWithdrawnFromTrustAccountToPayIncomeTaxes>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="0" unitRef="usd">512157</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c5" decimals="0" unitRef="usd">-275062000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <thcb:ProceedsFromSalesOfUnitsUnderwritingDiscount contextRef="c5" decimals="0" unitRef="usd">270480000</thcb:ProceedsFromSalesOfUnitsUnderwritingDiscount>
    <thcb:ProceedsFromSaleOfPrivateUnits contextRef="c5" decimals="0" unitRef="usd">6870000</thcb:ProceedsFromSaleOfPrivateUnits>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="c0" decimals="0" unitRef="usd">25012</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="c5" decimals="0" unitRef="usd">86748</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c0" decimals="0" unitRef="usd">2833</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c5" decimals="0" unitRef="usd">86748</us-gaap:RepaymentsOfRelatedPartyDebt>
    <thcb:ProceedsFromConvertiblePromissoryNoteRelatedParty contextRef="c0" decimals="0" unitRef="usd">200000</thcb:ProceedsFromConvertiblePromissoryNoteRelatedParty>
    <thcb:ProceedsFromPromissoryNotesRelatedparty contextRef="c5" decimals="0" unitRef="usd">15000</thcb:ProceedsFromPromissoryNotesRelatedparty>
    <thcb:RepaymentOfPromissoryNoteRelatedParty contextRef="c5" decimals="0" unitRef="usd">90342</thcb:RepaymentOfPromissoryNoteRelatedParty>
    <thcb:PaymentOfOfferingCosts contextRef="c0" decimals="0" unitRef="usd">32684</thcb:PaymentOfOfferingCosts>
    <thcb:PaymentOfOfferingCosts contextRef="c5" decimals="0" unitRef="usd">455423</thcb:PaymentOfOfferingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="0" unitRef="usd">189495</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c5" decimals="0" unitRef="usd">276819235</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c0" decimals="0" unitRef="usd">-4342</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c5" decimals="0" unitRef="usd">122803</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="0" unitRef="usd">140303</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c9" decimals="0" unitRef="usd">17500</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="0" unitRef="usd">135961</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="0" unitRef="usd">140303</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IncomeTaxesPaid contextRef="c5" decimals="0" unitRef="usd">938000</us-gaap:IncomeTaxesPaid>
    <thcb:InitialClassificationOfCommonStockSubjectToRedemption contextRef="c5" decimals="0" unitRef="usd">271835860</thcb:InitialClassificationOfCommonStockSubjectToRedemption>
    <thcb:ChangeInValueOfCommonStockSubjectToRedemption contextRef="c0" decimals="0" unitRef="usd">1342784</thcb:ChangeInValueOfCommonStockSubjectToRedemption>
    <thcb:ChangeInValueOfCommonStockSubjectToRedemption contextRef="c5" decimals="0" unitRef="usd">3367620</thcb:ChangeInValueOfCommonStockSubjectToRedemption>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tuscan
Holdings Corp. (the &#x201c;Company&#x201d;) was incorporated in Delaware on November 5, 2018. The Company was formed for the purpose
of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business
combination with one or more businesses or entities (the &#x201c;Business Combination&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Although
the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company
is focusing its search on companies in the cannabis industry.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has one subsidiary, TSCN Merger Sub Inc., a wholly-owned subsidiary of the Company incorporated in Delaware on January
21, 2021 (&#x201c;Merger Sub&#x201d;) (see Note 10).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
activity through December 31, 2020 relates to the Company&#x2019;s formation, the initial public offering (&#x201c;Initial Public
Offering&#x201d;), which is described below, identifying a target company for a Business Combination, activities in connection
with the proposed acquisition of Microvast, Inc., a Delaware corporation (&#x201c;Microvast&#x201d;) (see Note 10). The Company
will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates
non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s Initial Public Offering was declared effective on March 5, 2019. On March 7, 2019,
the Company consummated the Initial Public Offering of 24,000,000 units (the &#x201c;Units&#x201d; and, with respect to the shares
of common stock included in the Units sold, the &#x201c;Public Shares&#x201d;) at $10.00 per Unit, generating gross proceeds of
$240,000,000, which is described in Note 3.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 615,000 units (the &#x201c;Private Units&#x201d;)
at a price of $10.00 per Private Unit in a private placement to Tuscan Holdings Acquisition LLC (the &#x201c;Sponsor&#x201d;) and
EarlyBirdCapital, Inc. (&#x201c;EarlyBirdCapital&#x201d;) and its designee, generating gross proceeds of $6,150,000, which is described
in Note 4.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on March 7, 2019, an amount of $240,000,000 ($10.00 per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (&#x201c;Trust
Account&#x201d;) which are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment
Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;), with a maturity of 180 days or less or in any open-ended
investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company
Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;), as determined by the Company, until the earlier of: (i) the
completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 12, 2019, the underwriters exercised their over-allotment option in full, resulting in the sale of an additional 3,600,000
Units for $36,000,000, less the underwriters&#x2019; discount of $720,000. In connection with the underwriters&#x2019; exercise
of their over-allotment option, the Company also consummated the sale of an additional 72,000 Private Units at $10.00 per Private
Unit, generating total gross proceeds of $720,000. A total of $36,000,000 was deposited into the Trust Account from the sale of
the additional Units pursuant to the over-allotment option and the additional sale of Private Units, bringing the aggregate proceeds
held in the Trust Account to $276,000,000.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
costs amounted to $6,059,098, consisting of $5,520,000 of underwriting fees and $539,098 of other offering costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public
Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally
toward consummating a Business Combination. The Company&#x2019;s Business Combination must be with one or more target businesses
that together have a fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income
earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete
a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the
target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination
successfully.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will provide its holders of the outstanding Public Shares (the &#x201c;public stockholders&#x201d;) with the opportunity
to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with
a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether
the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely
in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro&#160;rata portion of the amount
then in the Trust Account ($10.00 per Public Share, plus any pro&#160;rata interest earned on the funds held in the Trust Account
and not previously released to the Company to pay its franchise and income tax obligations). There will be no redemption rights
upon the completion of a Business Combination with respect to the Company&#x2019;s warrants. &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such
consummation of a Business Combination and, solely if the Company seeks stockholder approval, a majority of the shares voted are
voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold
a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of
Incorporation (the &#x201c;Amended and Restated Certificate of Incorporation&#x201d;), conduct the redemptions pursuant to the tender
offer rules of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and file tender offer documents with the SEC prior
to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company
decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with
a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder
approval in connection with a Business Combination, the Company&#x2019;s Sponsor and EarlyBirdCapital have agreed to vote their
Founder Shares (as defined in Note 5), Private Shares (as defined in Note 4) and any Public Shares purchased after the Initial
Public Offering in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote
to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination.
Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against
the proposed transaction or do not vote at all.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor and EarlyBirdCapital have agreed (a) to waive their rights to liquidating distributions from the Trust Account with respect
to the Founder Shares and Private Shares if the Company fails to consummate a Business Combination and (b) not to propose an amendment
to the Amended and Restated Certificate of Incorporation that would affect a public stockholders&#x2019; ability to convert or
sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company&#x2019;s
obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides
the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had until December 7, 2020 to complete a Business Combination (the &#x201c;Combination Period&#x201d;). On December 3,
2020, the Company held a special meeting pursuant to which the Company&#x2019;s stockholders approved extending the
Combination Period from December 7, 2020 to April 30, 2021 (the &#x201c;Extension Date&#x201d;). In connection with the
approval of the extension, stockholders elected to redeem an aggregate of 3,198 shares of the Company&#x2019;s common stock.
As a result, an aggregate of approximately $32,700 (or approximately $10.22 per share) was released from the Company&#x2019;s
Trust Account to pay such stockholders. Additionally, the Company has filed a preliminary proxy statement on March 12, 2021 seeking approval to
further extend date for which the Company is required to complete a business combination to July 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account
including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and
income taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders&#x2019;
rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law,
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining
stockholders and the Company&#x2019;s board of directors, dissolve and liquidate, subject in each case to the Company&#x2019;s obligations
under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company&#x2019;s warrants, which will expire worthless if the Company fails
to complete a Business Combination within the Combination Period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent
any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which
the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00
per Public Share, except as to any claims by a third party who executed an agreement with the Company waiving any right, title,
interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the
Company&#x2019;s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under
the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). Moreover, in the event that an executed waiver is deemed
to be unenforceable against a third party, the Insiders will not be responsible to the extent of any liability for such third-party
claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account by endeavoring
to have all vendors, service providers, prospective target businesses or other entities with which the Company does business,
execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust
Account.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Risks
and Uncertainties &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus
could have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for a target company,
the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidity and Going Concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account
outside of the Trust Account for working capital purposes. As of December 31, 2020, the Company had $135,961 held outside of the
Trust Account. As of April 20, 2020, the Sponsor committed to provide an aggregate of $500,000 in loans to the Company. The loans
shall be non-interest bearing, unsecured and due upon the consummation of a Business Combination. In the event that a Business
Combination does not close, the loans would be repaid only out of funds held outside the Trust Account to the extent such funds
are available. Otherwise, all amounts loaned to the Company would be forgiven. On April 21, 2020, the Sponsor loaned the Company
an aggregate of $200,000 (see Note 5).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Until the consummation
of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective
acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the
target business to acquire, and structuring, negotiating and consummating the Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company will need
to raise further additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors,
or third parties. In addition to the loan commitment described herein (see Note 10), the Company&#x2019;s officers, directors and
Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable
in their sole discretion, to meet the Company&#x2019;s working capital needs. Accordingly, the Company may not be able to obtain
additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve
liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential
transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it
on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company&#x2019;s ability to continue
as a going concern through April 30, 2021 (or July 31, 2021, if our stockholders approve an amendment to our amended and restated
certificate of incorporation), the current date that the Company will be required to cease all operations, except for the purpose
of winding up, if a Business Combination is not consummated. These financial statements do not include any adjustments relating
to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable
to continue as a going concern.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c22" decimals="INF" unitRef="shares">24000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c23" decimals="2" unitRef="usdPershares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c24" decimals="0" unitRef="usd">240000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c25" decimals="INF" unitRef="shares">615000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c26" decimals="2" unitRef="usdPershares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c27" decimals="0" unitRef="usd">6150000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <thcb:IssuanceOfUnitsDescription contextRef="c0">Following
the closing of the Initial Public Offering on March 7, 2019, an amount of $240,000,000 ($10.00 per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (&#x201c;Trust
Account&#x201d;) which are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment
Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;), with a maturity of 180 days or less or in any open-ended
investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company
Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;), as determined by the Company, until the earlier of: (i) the
completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.&#160;</thcb:IssuanceOfUnitsDescription>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c28" decimals="INF" unitRef="shares">240000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c3" decimals="2" unitRef="usdPershares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c29" decimals="INF" unitRef="shares">3600000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c29" decimals="0" unitRef="usd">36000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <thcb:UnderwritersDiscount contextRef="c29" decimals="0" unitRef="usd">720000</thcb:UnderwritersDiscount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c30" decimals="INF" unitRef="shares">72000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c31" decimals="2" unitRef="usdPershares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c30" decimals="0" unitRef="usd">720000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <thcb:AmountDepositInTrustAccount contextRef="c32" decimals="0" unitRef="usd">36000000</thcb:AmountDepositInTrustAccount>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="c30" decimals="0" unitRef="usd">276000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c0" decimals="0" unitRef="usd">6059098</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees contextRef="c0" decimals="0" unitRef="usd">5520000</us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees>
    <thcb:OtherOfferingCosts contextRef="c0" decimals="0" unitRef="usd">539098</thcb:OtherOfferingCosts>
    <thcb:PercentageOfTrustAccountRequiredForBusinessCombination contextRef="c0" decimals="2" unitRef="pure">0.80</thcb:PercentageOfTrustAccountRequiredForBusinessCombination>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c3" decimals="2" unitRef="pure">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <thcb:PublicSharePrice contextRef="c0" decimals="2" unitRef="usdPershares">10.00</thcb:PublicSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1 contextRef="c0" decimals="0" unitRef="usd">5000001</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c3" decimals="2" unitRef="pure">1</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c33" decimals="INF" unitRef="shares">3198</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c33" decimals="0" unitRef="usd">32700</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockPricePerShare contextRef="c34" decimals="2" unitRef="usdPershares">10.22</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SharePrice contextRef="c3" decimals="2" unitRef="usdPershares">10.00</us-gaap:SharePrice>
    <us-gaap:AssetsHeldInTrustCurrent contextRef="c3" decimals="0" unitRef="usd">135961</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:ShortTermBorrowings contextRef="c35" decimals="0" unitRef="usd">500000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c36" decimals="0" unitRef="usd">200000</us-gaap:ShortTermBorrowings>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States
of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Emerging
Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended (the
&#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered
public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could
differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of December 31, 2020 and 2019.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash
and Marketable Securities Held in Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;At
December 31, 2020 and 2019, the assets held in the Trust Account were substantially held in U.S. Treasury Bills. During the year
ended December 31, 2020 and 2019, the Company withdrew $479,473 and $938,000 of interest income from the Trust Account, respectively,
to pay its franchise and income tax obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock Subject to Possible Redemption&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Common stock subject to mandatory redemption
is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common
stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#x2019; equity. The Company&#x2019;s common stock features certain redemption rights that are
considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, common
stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders&#x2019;
equity section of the Company&#x2019;s balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;Income Taxes.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of
tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more
likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were&#160;no unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues under review that
could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates
and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including
among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#x201c;IRC&#x201d;)
for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement
property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules
including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable
years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum
tax credits.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Net
Income (Loss) Per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during
the period. The Company has not considered the effect of the warrants sold in the Public Offering and Private Placement to purchase
an aggregate of 28,287,000 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent
upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s statement of operations includes a presentation of income per share for common shares subject to possible redemption
in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for Common stock
subject to possible redemption is calculated by dividing the proportionate share of income on marketable securities held
by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to
possible redemption outstanding since original issuance.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
loss per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income, adjusted for income on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of
non-redeemable common stock outstanding for the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-redeemable
common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features.
Non-redeemable common stock participates in the income on marketable securities based on non-redeemable common stock shares&#x2019;
proportionate interest.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 3.9pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"&gt;2020&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"&gt;2019&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; font-style: italic; text-indent: 0"&gt;Common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: center; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: center; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;Numerator: Earnings allocable to Common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.125in; width: 76%; text-align: left"&gt;Interest earned on marketable securities held in Trust Account&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;2,605,038&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;4,827,854&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0"&gt;Unrealized gain on marketable securities held in Trust Account&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;9,570&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;126,682&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0"&gt;Less: Income and franchise taxes&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(564,980&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(1,042,603&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Net income allocable to shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;2,049,628&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;3,911,933&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Denominator: Weighted average Common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;27,104,439&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;27,123,666&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Basic and diluted net income per common share&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;0.08&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;0.14&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; font-style: italic; text-align: left; text-indent: 0"&gt;Non-Redeemable Common Stock&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Numerator Net Income minus Net Earnings&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0"&gt;Net income&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;1,375,461&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;3,367,179&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0"&gt;Less: Income attributable to common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(2,049,628&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(3,911,933&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0"&gt;Non-Redeemable Net Loss&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(674,167&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(544,754&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Denominator: Weighted Average Non-Redeemable Common Stock&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;8,382,317&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;7,927,608&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Basic and diluted net loss per common share&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(0.08&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(0.07&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Concentration
of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this
account and management believes the Company is not exposed to significant risks on such account.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;Fair Value
Measurement,&#x201d; approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term
nature.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recently
Issued Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States
of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <thcb:EmergingGrowthPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Emerging
Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended (the
&#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered
public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</thcb:EmergingGrowthPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could
differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 7pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of December 31, 2020 and 2019.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash
and Marketable Securities Held in Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;At
December 31, 2020 and 2019, the assets held in the Trust Account were substantially held in U.S. Treasury Bills. During the year
ended December 31, 2020 and 2019, the Company withdrew $479,473 and $938,000 of interest income from the Trust Account, respectively,
to pay its franchise and income tax obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <thcb:CashWithdrawnFromTrustAccountToPayFranchise contextRef="c0" decimals="0" unitRef="usd">479473</thcb:CashWithdrawnFromTrustAccountToPayFranchise>
    <thcb:CashWithdrawnFromTrustAccountToPayFranchise contextRef="c5" decimals="-3" unitRef="usd">938000</thcb:CashWithdrawnFromTrustAccountToPayFranchise>
    <thcb:CommonStockSubjectToPossibleRedemptionPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock Subject to Possible Redemption&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Common stock subject to mandatory redemption
is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common
stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#x2019; equity. The Company&#x2019;s common stock features certain redemption rights that are
considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, common
stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders&#x2019;
equity section of the Company&#x2019;s balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</thcb:CommonStockSubjectToPossibleRedemptionPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;Income Taxes.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of
tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more
likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were&#160;no unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues under review that
could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates
and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including
among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#x201c;IRC&#x201d;)
for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement
property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules
including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable
years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum
tax credits.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Net
Income (Loss) Per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during
the period. The Company has not considered the effect of the warrants sold in the Public Offering and Private Placement to purchase
an aggregate of 28,287,000 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent
upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s statement of operations includes a presentation of income per share for common shares subject to possible redemption
in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for Common stock
subject to possible redemption is calculated by dividing the proportionate share of income on marketable securities held
by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to
possible redemption outstanding since original issuance.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
loss per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income, adjusted for income on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of
non-redeemable common stock outstanding for the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-redeemable
common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features.
Non-redeemable common stock participates in the income on marketable securities based on non-redeemable common stock shares&#x2019;
proportionate interest.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 3.9pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"&gt;2020&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"&gt;2019&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; font-style: italic; text-indent: 0"&gt;Common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: center; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: center; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;Numerator: Earnings allocable to Common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.125in; width: 76%; text-align: left"&gt;Interest earned on marketable securities held in Trust Account&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;2,605,038&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;4,827,854&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0"&gt;Unrealized gain on marketable securities held in Trust Account&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;9,570&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;126,682&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0"&gt;Less: Income and franchise taxes&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(564,980&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(1,042,603&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Net income allocable to shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;2,049,628&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;3,911,933&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Denominator: Weighted average Common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;27,104,439&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;27,123,666&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Basic and diluted net income per common share&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;0.08&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;0.14&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; font-style: italic; text-align: left; text-indent: 0"&gt;Non-Redeemable Common Stock&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Numerator Net Income minus Net Earnings&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0"&gt;Net income&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;1,375,461&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;3,367,179&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0"&gt;Less: Income attributable to common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(2,049,628&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(3,911,933&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0"&gt;Non-Redeemable Net Loss&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(674,167&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(544,754&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Denominator: Weighted Average Non-Redeemable Common Stock&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;8,382,317&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;7,927,608&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Basic and diluted net loss per common share&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(0.08&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(0.07&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c37" decimals="INF" unitRef="shares">28287000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 3.9pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"&gt;2020&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"&gt;2019&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; font-style: italic; text-indent: 0"&gt;Common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: center; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: center; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;Numerator: Earnings allocable to Common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.125in; width: 76%; text-align: left"&gt;Interest earned on marketable securities held in Trust Account&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;2,605,038&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;4,827,854&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0"&gt;Unrealized gain on marketable securities held in Trust Account&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;9,570&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;126,682&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0"&gt;Less: Income and franchise taxes&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(564,980&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(1,042,603&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Net income allocable to shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;2,049,628&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;3,911,933&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Denominator: Weighted average Common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;27,104,439&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;27,123,666&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Basic and diluted net income per common share&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;0.08&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;0.14&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; font-style: italic; text-align: left; text-indent: 0"&gt;Non-Redeemable Common Stock&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Numerator Net Income minus Net Earnings&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0"&gt;Net income&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;1,375,461&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;3,367,179&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0"&gt;Less: Income attributable to common stock subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(2,049,628&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0"&gt;(3,911,933&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0"&gt;Non-Redeemable Net Loss&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(674,167&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(544,754&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Denominator: Weighted Average Non-Redeemable Common Stock&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;8,382,317&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;7,927,608&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;Basic and diluted net loss per common share&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(0.08&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0"&gt;(0.07&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:InterestAndDividendIncomeSecuritiesOther contextRef="c0" decimals="0" unitRef="usd">2605038</us-gaap:InterestAndDividendIncomeSecuritiesOther>
    <us-gaap:InterestAndDividendIncomeSecuritiesOther contextRef="c5" decimals="0" unitRef="usd">4827854</us-gaap:InterestAndDividendIncomeSecuritiesOther>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c0" decimals="0" unitRef="usd">9570</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c5" decimals="0" unitRef="usd">126682</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <thcb:IncomeAndFranchiseTaxes contextRef="c0" decimals="0" unitRef="usd">564980</thcb:IncomeAndFranchiseTaxes>
    <thcb:IncomeAndFranchiseTaxes contextRef="c5" decimals="0" unitRef="usd">1042603</thcb:IncomeAndFranchiseTaxes>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="c0" decimals="0" unitRef="usd">2049628</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="c5" decimals="0" unitRef="usd">3911933</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption contextRef="c0" decimals="INF" unitRef="shares">27104439</thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption>
    <thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption contextRef="c5" decimals="INF" unitRef="shares">27123666</thcb:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption>
    <thcb:BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption contextRef="c0" decimals="2" unitRef="usdPershares">0.08</thcb:BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption>
    <thcb:BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption contextRef="c5" decimals="2" unitRef="usdPershares">0.14</thcb:BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd">1375461</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="0" unitRef="usd">3367179</us-gaap:NetIncomeLoss>
    <thcb:IncomeAttributableToCommonStockSubjectToRedemption contextRef="c0" decimals="0" unitRef="usd">-2049628</thcb:IncomeAttributableToCommonStockSubjectToRedemption>
    <thcb:IncomeAttributableToCommonStockSubjectToRedemption contextRef="c5" decimals="0" unitRef="usd">-3911933</thcb:IncomeAttributableToCommonStockSubjectToRedemption>
    <thcb:IncomeAdjustedNetLoss contextRef="c0" decimals="0" unitRef="usd">674167</thcb:IncomeAdjustedNetLoss>
    <thcb:IncomeAdjustedNetLoss contextRef="c5" decimals="0" unitRef="usd">544754</thcb:IncomeAdjustedNetLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="c0" decimals="INF" unitRef="shares">8382317</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="c5" decimals="INF" unitRef="shares">7927608</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="c0" decimals="2" unitRef="usdPershares">-0.08</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="c5" decimals="2" unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Concentration
of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this
account and management believes the Company is not exposed to significant risks on such account.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FederalDepositInsuranceCorporationPremiumExpense contextRef="c0" decimals="0" unitRef="usd">250000</us-gaap:FederalDepositInsuranceCorporationPremiumExpense>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;Fair Value
Measurement,&#x201d; approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term
nature.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recently
Issued Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <thcb:InitialPublicOfferingDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3. INITIAL PUBLIC OFFERING&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 7, 2019, the Company consummated the Initial Public Offering and sold 24,000,000 units at a price of $10.00 per Unit. Each
Unit consists of one share of common stock and one warrant (&#x201c;Public Warrant&#x201d;). On March 12, 2019, in connection with
the underwriters&#x2019; exercise of the over-allotment option in full, the Company sold an additional 3,600,000 Units at a price
of $10.00 per Unit. Each Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share,
subject to adjustment (see Note 7).&lt;/span&gt;&lt;/p&gt;</thcb:InitialPublicOfferingDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c22" decimals="INF" unitRef="shares">24000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare contextRef="c38" decimals="2" unitRef="usdPershares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:BusinessCombinationReasonForBusinessCombination contextRef="c0">Each
Unit consists of one share of common stock and one warrant (&#x201c;Public Warrant&#x201d;). On March 12, 2019, in connection with
the underwriters&#x2019; exercise of the over-allotment option in full, the Company sold an additional 3,600,000 Units at a price
of $10.00 per Unit. Each Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share,
subject to adjustment (see Note 7).</us-gaap:BusinessCombinationReasonForBusinessCombination>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c29" decimals="INF" unitRef="shares">3600000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c32" decimals="2" unitRef="usdPershares">10.00</us-gaap:SaleOfStockPricePerShare>
    <thcb:PrivatePlacementDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
4. PRIVATE PLACEMENT&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Simultaneously
with the closing of the Initial Public Offering, the Sponsor and EarlyBirdCapital and its designee purchased an aggregate of 615,000
Private Units at a price of&#x2009;$10.00 per Private Unit, for an aggregate purchase price of $6,150,000. The Sponsor purchased
500,047 Private Units and EarlyBirdCapital and its designee purchased an aggregate of 114,953 Private Units. On March 12, 2019,
in connection with the underwriters&#x2019; exercise of the over-allotment option in full, the purchasers purchased an aggregate
of an additional 72,000 additional Private Units, of which 58,542 Private Units were purchased by the Sponsor and 13,458 Private
Units were purchased by EarlyBirdCapital and its designee, for an aggregate purchase price of $720,000. Each Private Unit consists
of one share of common stock (&#x201c;Private Share&#x201d;) and one warrant (&#x201c;Private Warrant&#x201d;). Each Private Warrant
is exercisable to purchase one share of common stock at an exercise price of&#x2009;$11.50 per share, subject to adjustment (see
Note 7). The proceeds from the Private Units were added to the proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private
Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private
Units and all underlying securities will be worthless.&lt;/span&gt;&lt;/p&gt;</thcb:PrivatePlacementDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c39" decimals="INF" unitRef="shares">615000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c40" decimals="2" unitRef="usdPershares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c39" decimals="0" unitRef="usd">6150000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockDescriptionOfTransaction contextRef="c39">The Sponsor purchased
500,047 Private Units and EarlyBirdCapital and its designee purchased an aggregate of 114,953 Private Units. On March 12, 2019,
in connection with the underwriters&#x2019; exercise of the over-allotment option in full, the purchasers purchased an aggregate
of an additional 72,000 additional Private Units, of which 58,542 Private Units were purchased by the Sponsor and 13,458 Private
Units were purchased by EarlyBirdCapital and its designee, for an aggregate purchase price of $720,000. Each Private Unit consists
of one share of common stock (&#x201c;Private Share&#x201d;) and one warrant (&#x201c;Private Warrant&#x201d;). Each Private Warrant
is exercisable to purchase one share of common stock at an exercise price of&#x2009;$11.50 per share, subject to adjustment (see
Note 7).</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5. RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Founder
Shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2018, the Sponsor purchased 5,750,000 shares (the &#x201c;Founder Shares&#x201d;) of the Company&#x2019;s common stock for
an aggregate price of $25,000. On March 5, 2019, the Company effected a stock dividend of 0.2 shares of common stock for each
outstanding share (the &#x201c;Stock Dividend&#x201d;), resulting in 6,900,000 Founder Shares being issued and outstanding. The
6,900,000 Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture by the Sponsor to the extent that
the underwriters&#x2019; over-allotment was not exercised in full or in part, so that the holders of the Founder Shares would collectively
own 20% of the Company&#x2019;s issued and outstanding shares after the Initial Public Offering (assuming the holders did not purchase
any Public Shares in the Initial Public Offering and excluding the Private Units and Representative Shares (see Note 7). In connection
with the underwriters&#x2019; exercise of the over-allotment option in full on March 12, 2019, 900,000 Founder Shares are no longer
subject to forfeiture.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder
Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination
and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing
after a Business Combination and, with respect to the remaining 50% of the Founder Shares, until the one year after the consummation
of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation,
merger, stock exchange or other similar transaction which results in all of the Company&#x2019;s stockholders having the right
to exchange their shares of common stock for cash, securities or other property.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Private
Placement Units&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the consummation of the initial public offering, the Company consummated the private placement of 687,000 Private Units at
a price of $10.00 per Private Unit, generating total proceeds of $6,870,000. The Private Units were sold to the Sponsor and EarlyBirdCapital
and its designees. The Private Units are identical to the units sold in the initial public offering, except that the warrants
underlying the Private Units are non-redeemable&#160;and may be exercised on a cashless basis, in each case so long as they continue
to be held by the initial purchasers or their permitted transferees. The initial purchasers have agreed not to transfer, assign
or sell any of the Private Units and underlying securities until after the completion of an initial business combination.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Administrative
Service Fee&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vogel
Partners, LLP, an affiliate of Mr.&#160;Vogel, has agreed that, until the earlier of the consummation of an initial business combination
or Tuscan&#x2019;s liquidation, it will make available to Tuscan certain general and administrative services, including office
space, utilities and administrative support, as Tuscan may require from time to time. Tuscan has agreed to pay Vogel Partners,
LLP $10,000 per month for these services. Tuscan believes, based on rents and fees for similar services in the New&#160;York City
metropolitan area, that the fee charged by Vogel Partners, LLP is at least as favorable as it could have obtained from an unaffiliated
person.. For the year ended December 31, 2020 and 2019, the Company incurred $120,000 and $100,000, respectively, in fees for
these services. At December 31, 2020 and 2019, fees amounting to $10,000 and $0 is included in accounts payable and accrued expenses
in the accompanying balance sheets.&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Advance
from Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s Chief Executive Officer advanced the Company an aggregate of $86,748 to be used for the payment of costs related
to the Initial Public Offering. The advances were non-interest bearing, unsecured and due on demand. The advances were repaid
upon the consummation of the Initial Public Offering on March 7, 2019.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Due
to Affiliate&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2020, an affiliate of the Company paid expenses on behalf of the Company that were mainly settled
during the same period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Promissory
Note &#x2013; Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
November 2018, the Company issued an unsecured promissory note to the Company&#x2019;s Chief Executive Officer (the &#x201c;Promissory
Note&#x201d;), pursuant to which the Company borrowed an aggregate principal amount of $90,342. The Promissory Note was non-interest
bearing and payable on the earlier of (i) November 1, 2019, (ii) the consummation of the Initial Public Offering or (iii) the
date on which the Company determines not to proceed with the Initial Public Offering. The Promissory Note was repaid upon the
consummation of the Initial Public Offering on March 7, 2019.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Related
Party Loans&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In addition, in order
to finance transaction costs in connection with a Business Combination, the Sponsor or certain of the Company&#x2019;s officers
and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital
Loans&#x201d;). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds
of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside
the Trust Account to the extent such funds are available. In the event that a Business Combination does not close, the Company
may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust
Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of
a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $1,500,000 of such Working Capital Loans
may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical
to the Private Units.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 20, 2020, the Sponsor committed to provide an aggregate of $500,000 in loans to the Company. The loans shall be non-interest
bearing, unsecured and due upon the consummation of a Business Combination. In the event that a Business Combination does not
close, the loans would be repaid only out of funds held outside the Trust Account to the extent such funds are available. Otherwise,
all amounts loaned to the Company would be forgiven.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On April 21, 2020,
the Company issued an unsecured promissory note to the Sponsor in the aggregate amount of $300,000 (the &#x201c;Note&#x201d;), of
which $200,000 was drawn upon on such date. The Note is non-interest bearing and payable upon the consummation of a Business Combination.
The Note is convertible, at the lender&#x2019;s option, into units of the post Business Combination entity at a price of $10.00
per unit. The units would be identical to the Private Units. If a Business Combination is not consummated, the notes will not be
repaid by the Company and all amounts owed thereunder by the Company will be forgiven except to the extent that the Company has
funds available to it outside of its Trust Account. As of December 31, 2020, there was $200,000 outstanding under the Note.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <thcb:SponsorPurchased contextRef="c41" decimals="INF" unitRef="shares">5750000</thcb:SponsorPurchased>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="c41" decimals="0" unitRef="usd">25000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <thcb:CommonStockDividendDescription contextRef="c42">the Company effected a stock dividend of 0.2 shares of common stock for each
outstanding share (the &#x201c;Stock Dividend&#x201d;), resulting in 6,900,000 Founder Shares being issued and outstanding. The
6,900,000 Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture by the Sponsor to the extent that
the underwriters&#x2019; over-allotment was not exercised in full or in part, so that the holders of the Founder Shares would collectively
own 20% of the Company&#x2019;s issued and outstanding shares after the Initial Public Offering (assuming the holders did not purchase
any Public Shares in the Initial Public Offering and excluding the Private Units and Representative Shares (see Note 7). In connection
with the underwriters&#x2019; exercise of the over-allotment option in full on March 12, 2019, 900,000 Founder Shares are no longer
subject to forfeiture.</thcb:CommonStockDividendDescription>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="c42" decimals="1" unitRef="usdPershares">0.2</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsShares contextRef="c42" decimals="INF" unitRef="shares">6900000</us-gaap:CommonStockDividendsShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c42" decimals="INF" unitRef="shares">6900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited contextRef="c43" decimals="INF" unitRef="shares">900000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <thcb:IssuedAndOutstandingSharesPercentage contextRef="c44" decimals="2" unitRef="pure">0.20</thcb:IssuedAndOutstandingSharesPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited contextRef="c29" decimals="INF" unitRef="shares">900000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:BusinessCombinationControlObtainedDescription contextRef="c45">The
holders of the Founder Shares have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder
Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination
and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing
after a Business Combination and, with respect to the remaining 50% of the Founder Shares, until the one year after the consummation
of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation,
merger, stock exchange or other similar transaction which results in all of the Company&#x2019;s stockholders having the right
to exchange their shares of common stock for cash, securities or other property.&#160;</us-gaap:BusinessCombinationControlObtainedDescription>
    <thcb:SaleOfStockNumberOfSharesIssuedInTransactions contextRef="c37" decimals="INF" unitRef="shares">687000</thcb:SaleOfStockNumberOfSharesIssuedInTransactions>
    <us-gaap:SaleOfStockPricePerShare contextRef="c46" decimals="2" unitRef="usdPershares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c37" decimals="0" unitRef="usd">6870000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty contextRef="c47" decimals="0" unitRef="usd">10000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <thcb:RelatedPartyServicesFeesAmount contextRef="c0" decimals="0" unitRef="usd">120000</thcb:RelatedPartyServicesFeesAmount>
    <thcb:RelatedPartyServicesFeesAmount contextRef="c5" decimals="0" unitRef="usd">100000</thcb:RelatedPartyServicesFeesAmount>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c3" decimals="0" unitRef="usd">10000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c4" decimals="0" unitRef="usd">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:RelatedPartyTransactionDueFromToRelatedParty contextRef="c48" decimals="0" unitRef="usd">86748</us-gaap:RelatedPartyTransactionDueFromToRelatedParty>
    <us-gaap:UnsecuredDebt contextRef="c49" decimals="0" unitRef="usd">90342</us-gaap:UnsecuredDebt>
    <thcb:WorkingCapitalLoans contextRef="c0" decimals="0" unitRef="usd">1500000</thcb:WorkingCapitalLoans>
    <us-gaap:BusinessAcquisitionSharePrice contextRef="c3" decimals="2" unitRef="usdPershares">10.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c50" decimals="0" unitRef="usd">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:UnsecuredDebt contextRef="c51" decimals="0" unitRef="usd">300000</us-gaap:UnsecuredDebt>
    <thcb:AmountDrawn contextRef="c51" decimals="0" unitRef="usd">200000</thcb:AmountDrawn>
    <us-gaap:BusinessAcquisitionSharePrice contextRef="c52" decimals="2" unitRef="usdPershares">10.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:ShortTermBorrowings contextRef="c3" decimals="0" unitRef="usd">200000</us-gaap:ShortTermBorrowings>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6. COMMITMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Registration
Rights&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to a registration rights agreement entered into on March 7, 2019, the holders of the Founder Shares, Representative Shares, Private
Units, and any units that may be issued upon conversion of Working Capital Loans (and all underlying securities) are entitled
to registration rights. The holders of the majority of these securities are entitled to make up to two demands that the Company
register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at
any time commencing three months prior to the date on which the Founder Shares are to be released from escrow. The holders of
a majority of the Representative Shares, Private Units or units issued in payment of working capital loans made to the Company
(or underlying securities) can elect to exercise these registration rights at any time commencing after the Company consummates
a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital and its designee may only make a demand on
one occasion and only during the five-year period beginning on the effective date of the Initial Public Offering. In addition,
the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent
to the consummation of a Business Combination; provided, however, that EarlyBirdCapital and its designee may participate in a
&#x201c;piggy-back&#x201d; registration only during the seven-year period beginning on the effective date of the Initial Public
Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Business
Combination Marketing Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has engaged EarlyBirdCapital as an advisor in connection with a Business Combination to assist the Company in holding
meetings with its shareholders to discuss the potential Business Combination and the target business&#x2019; attributes, introduce
the Company to potential investors that are interested in purchasing the Company&#x2019;s securities in connection with a Business
Combination, assist the Company in obtaining shareholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. The Company will pay EarlyBirdCapital a cash fee
for such services upon the consummation of a Business Combination in an amount equal to $9,660,000 (exclusive of any applicable
finders&#x2019; fees which might become payable); provided that up to 30% of the fee may be allocated at the Company&#x2019;s sole
discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Engagement of Morgan Stanley&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="margin: 0pt 0; font: 10pt/107% Times New Roman, Times, Serif"&gt;We engaged Morgan Stanley &amp;amp; Co. LLC (&#x201c;Morgan
Stanley&#x201d;) to provide financial advisory services in connection with the Microvast business combination, and, upon consummation
of the transaction with Microvast, we must pay that firm a transaction fee of $5.5 million, plus expenses. Morgan Stanley also
acted as placement agent in connection with the PIPE Financing, and we are obligated to pay Morgan Stanley a placement fee equal
to (i) 3.5% of the sum of (x) the aggregate gross proceeds raised in the PIPE Financing up to $300 million (not including funds
from the sale of certain excluded securities) and (y) any borrowings pursuant to a bridge financing provided in connection with
the proposed business combination by investors introduced by Morgan Stanley, and (ii) 2.5% of the aggregate gross proceeds raised
in the PIPE Financing above $300 million.&lt;/p&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="c0">The Company will pay EarlyBirdCapital a cash fee
for such services upon the consummation of a Business Combination in an amount equal to $9,660,000 (exclusive of any applicable
finders&#x2019; fees which might become payable); provided that up to 30% of the fee may be allocated at the Company&#x2019;s sole
discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
    <thcb:TransactionFee contextRef="c53" decimals="-5" unitRef="usd">5500000</thcb:TransactionFee>
    <thcb:PercentageOfPlacementFee contextRef="c53" decimals="3" unitRef="pure">0.035</thcb:PercentageOfPlacementFee>
    <thcb:GrossProceedsFromFinancing contextRef="c54" decimals="-6" unitRef="usd">300000000</thcb:GrossProceedsFromFinancing>
    <thcb:PercentageOfGrossProceedsRaisedInFinancing contextRef="c54" decimals="3" unitRef="pure">0.025</thcb:PercentageOfGrossProceedsRaisedInFinancing>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7. STOCKHOLDERS&#x2019; EQUITY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt; &#x2014;&lt;/b&gt; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share
with such designation, rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors.
At December 31, 2020 and 2019, there were no shares of preferred stock issued or outstanding.&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock &#x2014;&lt;/i&gt;&lt;/b&gt; The Company is authorized to issue 65,000,000 shares of common stock with a par value of $0.0001 per share.
Holders of the common stock are entitled to one vote for each share. At December 31, 2020 and 2019, there were 8,396,246 and 8,360,523
shares of common stock issued and outstanding, excluding 27,087,556 and 27,126,477 shares of common stock subject to possible
redemption, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants
&#x2014;&lt;/i&gt;&lt;/b&gt; The Public Warrants will become exercisable 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement
covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of
common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise
of the public warrants is not effective within 90 days following the consummation of a Business Combination, warrant holders may,
until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain
an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9)
of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders
will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion
of a Business Combination or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Once
the Public Warrants become exercisable, the Company may redeem the Public Warrants:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in; padding-right: 0.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 0.25in; padding-right: 0.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"/&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at a price of $0.01 per warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon not less than 30 days&#x2019; prior written notice of redemption;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if, and only if, the reported last sale price of the Company&#x2019;s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise
the Public Warrants to do so on a &#x201c;cashless basis,&#x201d; as described in the warrant agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the
Private Warrants will be exercisable for cash or on a cashless basis, at the holder&#x2019;s option, and be non-redeemable so long
as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than
the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable
by such holders on the same basis as the Public Warrants. In addition, so long as the Private Warrants are held by EarlyBirdCapital
and its designee, the Private Warrants will expire five years from the effective date of the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances
including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants
will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination
Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds
with respect to their warrants, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust
Account with the respect to such warrants. Accordingly, the warrants may expire worthless.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes
in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.50
per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company&#x2019;s
board of directors, and in the case of any such issuance to our Sponsor, initial stockholders or their affiliates, without taking
into account any founders&#x2019; shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances
represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination
on the date of the consummation of an initial Business Combination (net of redemptions), and (z) the volume weighted average trading
price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummated
an initial Business Combination (such price, the &#x201c;Market Value&#x201d;) is below $9.50 per share, the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at
which the Company issues the additional shares of common stock or equity-linked securities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Representative
Shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2018, the Company issued to the designees of EarlyBirdCapital, for a nominal consideration, 300,000 shares (after giving
effect to the Stock Dividend) of common stock (the &#x201c;Representative Shares&#x201d;). The Company accounted for the Representative
Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders&#x2019; equity. The Company
estimated the fair value of Representative Shares to be $1,200 based upon the price of the Founder Shares issued to the Sponsor.
The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a
Business Combination. In addition, the holders have agreed (i) to waive their redemption rights (or to sell any shares in a tender
offer) with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights
to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination
within the Combination Period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately
following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(g)(1)
of FINRA&#x2019;s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities will not be the subject of any hedging,
short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person
for a period of 180 days immediately following March 5, 2019 (&#x201c;FINRA Restricted Period&#x201d;), nor may they be sold, transferred,
assigned, pledged or hypothecated during the FINRA Restricted Period except to any underwriter and selected dealer participating
in the Initial Public Offering and their bona fide officers or partners.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c4" decimals="INF" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c4" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">65000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c4" decimals="INF" unitRef="shares">65000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c4" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="INF" unitRef="shares">8396246</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">8396246</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c4" decimals="INF" unitRef="shares">8360523</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c4" decimals="INF" unitRef="shares">8360523</us-gaap:CommonStockSharesOutstanding>
    <thcb:CommonSharesSubjectToPossibleRedemption contextRef="c3" decimals="INF" unitRef="shares">27087556</thcb:CommonSharesSubjectToPossibleRedemption>
    <thcb:CommonSharesSubjectToPossibleRedemption contextRef="c4" decimals="INF" unitRef="shares">27126477</thcb:CommonSharesSubjectToPossibleRedemption>
    <thcb:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings contextRef="c55">&#x25cf;in whole and not in part;&#160;&#160;&#160; &#160;&#160;&#x25cf;at a price of $0.01 per warrant;&#160;&#160;&#160;&#160;&#x25cf;upon not less than 30 days&#x2019; prior written notice of redemption;&#160;&#160;&#160;&#160;&#x25cf;if, and only if, the reported last sale price of the Company&#x2019;s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and&#160;&#160;&#160;&#160;&#x25cf;if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.</thcb:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings>
    <thcb:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings contextRef="c0">(x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes
in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.50
per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company&#x2019;s
board of directors, and in the case of any such issuance to our Sponsor, initial stockholders or their affiliates, without taking
into account any founders&#x2019; shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances
represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination
on the date of the consummation of an initial Business Combination (net of redemptions), and (z) the volume weighted average trading
price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummated
an initial Business Combination (such price, the &#x201c;Market Value&#x201d;) is below $9.50 per share, the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at
which the Company issues the additional shares of common stock or equity-linked securities.</thcb:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings>
    <thcb:SaleOfStockNumberOfSharesIssuedInTransactions contextRef="c56" decimals="INF" unitRef="shares">300000</thcb:SaleOfStockNumberOfSharesIssuedInTransactions>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="c56" decimals="0" unitRef="usd">1200</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;NOTE 8. INCOME
TAX &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s net deferred tax liability are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Deferred tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"&gt;Unrealized gain on marketable securities&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(21,468&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(27,069&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Total deferred tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,468&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(27,069&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation Allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-31"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-32"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Deferred tax liability&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(21,468&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(27,069&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax provision consists of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;372,365&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;868,182&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,601&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,069&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;State and Local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-33"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-34"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-35"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-36"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-37"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-38"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;366,764&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;895,251&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2020 and 2019, the Company did not have any of U.S. federal and state net operating loss carryovers available
to offset future taxable income.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the federal income tax rate to the Company&#x2019;s effective tax rate is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Statutory federal income tax rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities.
The Company&#x2019;s tax returns since inception remain open to examination by the taxing authorities. The Company considers New York
to be a significant state tax jurisdiction.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Deferred tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"&gt;Unrealized gain on marketable securities&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(21,468&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(27,069&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Total deferred tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,468&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(27,069&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation Allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-31"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-32"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Deferred tax liability&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(21,468&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(27,069&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities contextRef="c3" decimals="0" unitRef="usd">21468</us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities contextRef="c4" decimals="0" unitRef="usd">27069</us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c3" decimals="0" unitRef="usd">21468</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c4" decimals="0" unitRef="usd">27069</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c3" decimals="0" unitRef="usd">21468</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c4" decimals="0" unitRef="usd">27069</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;372,365&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;868,182&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,601&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,069&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;State and Local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-33"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-34"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-35"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-36"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-37"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-38"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;366,764&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;895,251&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c0" decimals="0" unitRef="usd">372365</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c5" decimals="0" unitRef="usd">868182</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c0" decimals="0" unitRef="usd">-5601</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c5" decimals="0" unitRef="usd">27069</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="0" unitRef="usd">366764</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c5" decimals="0" unitRef="usd">895251</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Statutory federal income tax rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="3" unitRef="pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c5" decimals="3" unitRef="pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c0" decimals="3" unitRef="pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c5" decimals="3" unitRef="pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c0" decimals="3" unitRef="pure">0.210</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c5" decimals="3" unitRef="pure">0.210</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9. FAIR VALUE MEASUREMENTS&lt;/b&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value
at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company
would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an
orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets
and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and
to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).
The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable
inputs used in order to value the assets and liabilities:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in; padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5in; padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;1:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted
    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
    transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing
    basis.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;2:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Observable
    inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or
    liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;3:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unobservable
    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table
presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at December 31, 2020
and 2019 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Cash and marketable securities held in Trust Account&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;282,254,978&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;280,103,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Cash and marketable securities held in Trust Account&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;282,254,978&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;280,103,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c57" decimals="0" unitRef="usd">282254978</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c58" decimals="0" unitRef="usd">280103245</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10. SUBSEQUENT EVENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial
statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events
that would have required adjustment or disclosure in the financial statements.&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;Proposed Business
Combination&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 1, 2021, Tuscan entered into an agreement and plan of merger (the &#x201c;Merger Agreement&#x201d;) with Microvast, Inc.,
a Delaware corporation (&#x201c;Microvast&#x201d;) and Merger Sub. Pursuant to the Merger Agreement, Merger Sub will merge with
and into Microvast and Microvast will survive the merger and become a wholly owned subsidiary of Tuscan. Under the Merger Agreement,
all of the equity interests of Microvast will be converted into an aggregate of 210,000,000 shares of common stock (&#x201c;closing
shares&#x201d;). The Microvast shareholders and the investors in Microvast&#x2019;s majority-owned subsidiary, Microvast Power System
(Houzhou) Co. Ltd. (&#x201c;MPS&#x201d;), will also have the ability to earn an additional 20,000,000 shares of common stock (&#x201c;earnout
shares&#x201d;) if the daily volume weighted average price of the common stock is greater than or equal to $18.00 for any 20 trading
days within a 30 trading day period (or a change of control occurs that results in the holders of common stock receiving a per
share price equal to or in excess of $18.00), during the period commencing on the closing date and ending on the third anniversary
of the closing date. Concurrently with the execution of the Merger Agreement, Tuscan and Microvast will jointly acquire 100% ownership
of MPS and will discharge certain convertible loans of MPS.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Merger will be accounted for as a reverse recapitalization
in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). Under this
method of accounting, Tuscan will be treated as the &#x201c;acquired&#x201d; company for accounting purposes and the Business Combination
will be treated as the equivalent of Microvast issuing stock for the net assets of Tuscan, accompanied by a recapitalization. The
net assets of Tuscan will be stated at historical cost, with no goodwill or other intangible assets recorded.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Additionally,
the Merger Agreement provides that Tuscan will issue an aggregate of 6,736,111&#160;shares of common stock upon conversion (the
&#x201c;Bridge Notes Conversion&#x201d;) of an aggregate of $57,500,000 outstanding promissory notes issued by Microvast.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Further,
on February&#160;1, 2021, Tuscan, the Sponsor, Microvast and certain stockholders of Tuscan entered into the Sponsor Support Agreement
(the &#x201c;Sponsor Support Agreement&#x201d;), pursuant to which the Sponsor and certain officers and directors of Tuscan (collectively,
the &#x201c;Sponsor Group&#x201d;) agreed, among other things, to vote all equity interests of Tuscan held by such member of the
Sponsor Group in favor of the approval and adoption of the proposed business combination with Microvast. Additionally, such members
of the Sponsor Group have agreed not to (a) transfer any of their equity interests in the Company (or enter into any arrangement
with respect thereto) other than as set forth therein or (b) exercise any conversion rights of any equity interests held by such
member of the Sponsor Group in connection with the approval of the proposed business combination.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor also agreed that, to the extent that certain expenses of Tuscan are in excess of $46,000,000 (unless such expenses shall
have been approved by Microvast), the Sponsor will either (i) pay any such excess amount in cash or (ii) forfeit to Tuscan such
number of shares of common stock held by the Sponsor that would have a value equal to such excess. The Sponsor also agreed to
amend the escrow agreement to make certain adjustments to the terms of the escrow of its shares of common stock as set forth in
the Sponsor Support Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Contemporaneously with
the execution of the Merger Agreement, certain investors entered into subscription agreements (the &#x201c;Subscription Agreements&#x201d;),
pursuant to which such investors subscribed for an aggregate value of $482,500,000, representing 48,250,000 shares of Tuscan common
stock at a purchase price of $10.00 per share in a private placement (the &#x201c;PIPE Financing&#x201d;) to be consummated immediately
prior to the consummation of the Transactions. Affiliates of InterPrivate, a co-sponsor of Tuscan, subscribed to purchase 6.5 million
shares in the PIPE Financing for an aggregate purchase price of $65 million.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Immediately
following the Closing, the former equityholders of Microvast will hold approximately 69.9% of the issued and outstanding shares
of common stock and the current stockholders of Tuscan will hold approximately 9.2% of the issued and outstanding shares of common
stock, which pro forma ownership (1)&#160;assumes no holder of the common stock sold in Tuscan&#x2019;s initial public offering
(such persons, the &#x201c;Public Stockholders&#x201d;) exercises its conversion rights in connection with the business combination,
and (2)&#160;reflects the issuance of an aggregate of 48,250,000&#160;shares of Common Stock in the PIPE Financing and 6,736,111&#160;shares
of common stock in the Bridge Notes Conversion, but does not include the effect of any other financing of Tuscan. If the maximum
number of Public Shares are converted into cash such that Microvast does not have the right to terminate the Merger Agreement
(i.e., Tuscan has at least $5,000,001 of net tangible assets immediately prior to or upon consummation of the business combination),
such percentages will be approximately 76.8% and 0.2%, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Consummation
of the proposed business combination is subject to customary conditions and covenants of the respective parties, including approval
of Tuscan&#x2019;s stockholders and Tuscan having available cash of at least $250,000,000.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;Extension Amendment&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March 12, 2021,
Tuscan filed a preliminary proxy statement seeking approval from its stockholders to amend Tuscan&#x2019;s charter to extend the
date by which Tuscan is required to complete its initial business combination from April 30, 2021 to July 31, 2021 and to hold
an annual meeting for the election of directors in accordance with Nasdaq listing rules.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;Nasdaq Compliance&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On January&#160;6,
2021, we received a notice from the Listing Qualifications Department of The Nasdaq Stock Market stating that we failed to hold
an Annual Meeting of stockholders within 12&#160;months after our fiscal year ended December&#160;31, 2019, as required by Nasdaq
Listing Rule&#160;5620(a). In accordance with Nasdaq Listing Rule&#160;5810(c)(2)(G), we submitted a plan to regain compliance
on February&#160;4, 2021. Nasdaq accepted our plan and granted us an extension through June 29, 2021 to hold an annual meeting.
Nasdaq&#x2019;s decision is subject to certain conditions, including that we provide periodic updates with respect to our proposed
business combination with Microvast.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;Loan Commitment&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On February&#160;12,
2021, the Sponsor extended a loan to Tuscan in the aggregate principal amount totaling $1.2&#160;million, of which $400,000 was
drawn upon on such date. This loan was in addition to the previous $200,000 drawn upon the $300,000 convertible note that was committed
by the Sponsor on April 21, 2020. As a result of the February&#160;12, 2021 commitment, the Sponsor had committed to Tuscan a total
of $1.5 million, of which a total of $600,000 has been drawn upon, with $400,000 of the drawn amount pursuant to the February&#160;12,
2021 note. The Sponsor intends to convert the $1.5 million total loan balance into 150,000 Units immediately prior to the closing
of the proposed business combination with Microvast. Such units will have terms identical to the terms of the Company&#x2019;s Private
Units and will consist of (i) 150,000&#160;shares of common stock and (ii) warrants to purchase 150,000&#160;shares of common stock
at an exercise price of $11.50 per share, subject to adjustment.&#160;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <thcb:NumberOfCommonStockConvertedByEquityInterests contextRef="c59" decimals="INF" unitRef="shares">210000000</thcb:NumberOfCommonStockConvertedByEquityInterests>
    <us-gaap:CommonStockConversionBasis contextRef="c60">The Microvast shareholders and the investors in Microvast&#x2019;s majority-owned subsidiary, Microvast Power System
(Houzhou) Co. Ltd. (&#x201c;MPS&#x201d;), will also have the ability to earn an additional 20,000,000 shares of common stock (&#x201c;earnout
shares&#x201d;) if the daily volume weighted average price of the common stock is greater than or equal to $18.00 for any 20 trading
days within a 30 trading day period (or a change of control occurs that results in the holders of common stock receiving a per
share price equal to or in excess of $18.00), during the period commencing on the closing date and ending on the third anniversary
of the closing date. Concurrently with the execution of the Merger Agreement, Tuscan and Microvast will jointly acquire 100% ownership
of MPS and will discharge certain convertible loans of MPS.</us-gaap:CommonStockConversionBasis>
    <thcb:AdditionalSharesOfCommonStockEarn contextRef="c59" decimals="INF" unitRef="shares">20000000</thcb:AdditionalSharesOfCommonStockEarn>
    <us-gaap:SubsequentEventEffectOfChangeInTaxStatus contextRef="c61" decimals="2" unitRef="usd">18.00</us-gaap:SubsequentEventEffectOfChangeInTaxStatus>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c62" decimals="2" unitRef="pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ConversionOfStockSharesIssued1 contextRef="c60" decimals="INF" unitRef="shares">6736111</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConvertibleNotesPayable contextRef="c63" decimals="0" unitRef="usd">57500000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:CostsAndExpenses contextRef="c64" decimals="0" unitRef="usd">46000000</us-gaap:CostsAndExpenses>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c65" decimals="0" unitRef="usd">482500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c65" decimals="INF" unitRef="shares">48250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="c65" decimals="2" unitRef="usd">10.00</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c66" decimals="-5" unitRef="shares">6500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c66" decimals="-6" unitRef="usd">65000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="c67">Microvast will hold approximately 69.9% of the issued and outstanding shares
of common stock and the current stockholders of Tuscan will hold approximately 9.2% of the issued and outstanding shares of common
stock, which pro forma ownership (1)&#160;assumes no holder of the common stock sold in Tuscan&#x2019;s initial public offering
(such persons, the &#x201c;Public Stockholders&#x201d;) exercises its conversion rights in connection with the business combination,
and (2)&#160;reflects the issuance of an aggregate of 48,250,000&#160;shares of Common Stock in the PIPE Financing and 6,736,111&#160;shares
of common stock in the Bridge Notes Conversion, but does not include the effect of any other financing of Tuscan. If the maximum
number of Public Shares are converted into cash such that Microvast does not have the right to terminate the Merger Agreement
(i.e., Tuscan has at least $5,000,001 of net tangible assets immediately prior to or upon consummation of the business combination),
such percentages will be approximately 76.8% and 0.2%, respectively.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
    <us-gaap:Cash contextRef="c68" decimals="0" unitRef="usd">250000000</us-gaap:Cash>
    <us-gaap:DebtInstrumentDescription contextRef="c69">Sponsor extended a loan to Tuscan in the aggregate principal amount totaling $1.2&#160;million, of which $400,000 was
drawn upon on such date. This loan was in addition to the previous $200,000 drawn upon the $300,000 convertible note that was committed
by the Sponsor on April 21, 2020. As a result of the February&#160;12, 2021 commitment, the Sponsor had committed to Tuscan a total
of $1.5 million, of which a total of $600,000 has been drawn upon, with $400,000 of the drawn amount pursuant to the February&#160;12,
2021 note. The Sponsor intends to convert the $1.5 million total loan balance into 150,000 Units immediately prior to the closing
of the proposed business combination with Microvast. Such units will have terms identical to the terms of the Company&#x2019;s Private
Units and will consist of (i) 150,000&#160;shares of common stock and (ii) warrants to purchase 150,000&#160;shares of common stock
at an exercise price of $11.50 per share, subject to adjustment.</us-gaap:DebtInstrumentDescription>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c70" decimals="-5" unitRef="usd">1200000</us-gaap:DebtInstrumentFaceAmount>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="hidden-fact-0">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="hidden-fact-1">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="hidden-fact-2">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="hidden-fact-3">Yes</dei:EntityInteractiveDataCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="c3"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TaxesPayableCurrent
      contextRef="c4"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="c4"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="c4"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c3"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c4"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c3"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c4"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c3"
      id="hidden-fact-12"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c4"
      id="hidden-fact-13"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c3"
      id="hidden-fact-14"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c4"
      id="hidden-fact-15"
      unitRef="shares"
      xsi:nil="true"/>
    <thcb:StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts
      contextRef="c12"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="c12"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <thcb:CommonStockSubjectToPossibleRedemption
      contextRef="c12"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c10"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c11"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c16"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c17"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="c0"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <thcb:ProceedsFromSalesOfUnitsUnderwritingDiscount
      contextRef="c0"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <thcb:ProceedsFromSaleOfPrivateUnits
      contextRef="c0"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <thcb:ProceedsFromConvertiblePromissoryNoteRelatedParty
      contextRef="c5"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <thcb:ProceedsFromPromissoryNotesRelatedparty
      contextRef="c0"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <thcb:RepaymentOfPromissoryNoteRelatedParty
      contextRef="c0"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaid
      contextRef="c0"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <thcb:InitialClassificationOfCommonStockSubjectToRedemption
      contextRef="c0"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="c3"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="c4"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c0"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c5"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c0"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c5"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c0"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c5"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:EntityCentralIndexKey contextRef="c0">0001760689</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991829934504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 23, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TUSCAN HOLDINGS CORP.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">THCB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,483,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282,348,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001760689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-2530757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">135 E. 57th St.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">18th Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(646)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">948-7100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 20-F, 40-F<br> -Number 240<br> -Section 15<br> -Subsection d-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991829177848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 135,961<span></span>
</td>
<td class="nump">$ 140,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">69,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">22,499<span></span>
</td>
<td class="nump">186,247<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">158,460<span></span>
</td>
<td class="nump">396,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in Trust Account</a></td>
<td class="nump">282,254,978<span></span>
</td>
<td class="nump">280,103,245<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">282,413,438<span></span>
</td>
<td class="nump">280,499,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">320,978<span></span>
</td>
<td class="nump">269,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">302,547<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Advances from related party</a></td>
<td class="nump">22,179<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">645,704<span></span>
</td>
<td class="nump">269,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Convertible promissory note &#8211; related party</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">21,468<span></span>
</td>
<td class="nump">27,069<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">867,172<span></span>
</td>
<td class="nump">296,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Common stock subject to possible redemption 27,087,556 and 27,126,477 at December 31, 2020 and 2019, respectively</a></td>
<td class="nump">276,546,264<span></span>
</td>
<td class="nump">275,203,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 65,000,000 shares authorized; 8,396,246 and 8,360,523 shares issued and outstanding (excluding 27,087,556 and 27,126,477 shares subject to possible redemption) at December 31, 2020 and 2019, respectively</a></td>
<td class="nump">840<span></span>
</td>
<td class="nump">836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">257,314<span></span>
</td>
<td class="nump">1,632,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">4,741,848<span></span>
</td>
<td class="nump">3,366,387<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">5,000,002<span></span>
</td>
<td class="nump">5,000,009<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 282,413,438<span></span>
</td>
<td class="nump">$ 280,499,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991829898248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CommonSharesSubjectToPossibleRedemption', window );">Common stock subject to possible redemption</a></td>
<td class="nump">27,087,556<span></span>
</td>
<td class="nump">27,126,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">65,000,000<span></span>
</td>
<td class="nump">65,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">8,396,246<span></span>
</td>
<td class="nump">8,360,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">8,396,246<span></span>
</td>
<td class="nump">8,360,523<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CommonSharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CommonSharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991929819896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating and formation costs</a></td>
<td class="nump">$ 921,665<span></span>
</td>
<td class="nump">$ 778,815<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(921,665)<span></span>
</td>
<td class="num">(778,815)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest earned on marketable securities held in Trust Account</a></td>
<td class="nump">2,654,140<span></span>
</td>
<td class="nump">4,912,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax', window );">Unrealized gain on marketable securities held in Trust Account</a></td>
<td class="nump">9,750<span></span>
</td>
<td class="nump">128,899<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">2,663,890<span></span>
</td>
<td class="nump">5,041,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before provision for income taxes</a></td>
<td class="nump">1,742,225<span></span>
</td>
<td class="nump">4,262,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(366,764)<span></span>
</td>
<td class="num">(895,251)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,375,461<span></span>
</td>
<td class="nump">$ 3,367,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede', window );">Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption (in Shares)</a></td>
<td class="nump">27,104,439<span></span>
</td>
<td class="nump">27,123,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe', window );">Basic and diluted net income per share, Common stock subject to possible redemption (in Dollars per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding, Common stock (in Shares)</a></td>
<td class="nump">8,382,317<span></span>
</td>
<td class="nump">7,927,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per common share, Common stock (in Dollars per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991829047096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Changes in Stockholders&#8217; Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings/ (Accumulated Deficit)</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 720<span></span>
</td>
<td class="nump">$ 25,480<span></span>
</td>
<td class="num">$ (792)<span></span>
</td>
<td class="nump">$ 25,408<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2018</a></td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts', window );">Sale of 27,600,000 Units, net of underwriting discount and offering expenses</a></td>
<td class="nump">$ 2,760<span></span>
</td>
<td class="nump">269,938,142<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">269,940,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares', window );">Sale of 27,600,000 Units, net of underwriting discount and offering expenses (in Shares)</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of 687,000 Private Units</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">6,869,932<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,870,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of 687,000 Private Units (in Shares)</a></td>
<td class="nump">687,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CommonStockSubjectToPossibleRedemption', window );">Common stock subject to possible redemption</a></td>
<td class="num">$ (2,712)<span></span>
</td>
<td class="num">(275,200,768)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(275,203,480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CommonStockSubjectToPossibleRedemptionShares', window );">Common stock subject to possible redemption (in Shares)</a></td>
<td class="num">(27,126,477)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,367,179<span></span>
</td>
<td class="nump">3,367,179<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 836<span></span>
</td>
<td class="nump">1,632,786<span></span>
</td>
<td class="nump">3,366,387<span></span>
</td>
<td class="nump">5,000,009<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2019</a></td>
<td class="nump">8,360,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption', window );">Change in value of common stock subject to possible redemption</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="num">(1,375,472)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,375,468)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares', window );">Change in value of common stock subject to possible redemption (in Shares)</a></td>
<td class="nump">35,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,375,461<span></span>
</td>
<td class="nump">1,375,461<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 840<span></span>
</td>
<td class="nump">$ 257,314<span></span>
</td>
<td class="nump">$ 4,741,848<span></span>
</td>
<td class="nump">$ 5,000,002<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2020</a></td>
<td class="nump">8,396,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in value of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in value of common stock subject to possible redemption shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CommonStockSubjectToPossibleRedemptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock subject to possible redemption shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CommonStockSubjectToPossibleRedemptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of underwriting discounts and offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of underwriting shares discounts and offering cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824254840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Changes in Stockholders&#8217; Equity (Parentheticals)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Sale of Units, net of underwriting discounts</a></td>
<td class="nump">$ 27,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SaleOfPrivateUnitAmount', window );">Sale of Private Units</a></td>
<td class="nump">$ 687,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_SaleOfPrivateUnitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Private Units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_SaleOfPrivateUnitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991828996776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,375,461<span></span>
</td>
<td class="nump">$ 3,367,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_IncreaseDecreaseInMarketableSecurities', window );">Interest earned on marketable securities held in Trust Account</a></td>
<td class="num">(2,654,140)<span></span>
</td>
<td class="num">(4,912,346)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities', window );">Unrealized gain on marketable securities held in Trust Account</a></td>
<td class="num">(9,750)<span></span>
</td>
<td class="num">(128,899)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax provision</a></td>
<td class="num">(5,601)<span></span>
</td>
<td class="nump">27,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">163,748<span></span>
</td>
<td class="num">(186,222)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">69,818<span></span>
</td>
<td class="num">(69,818)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">51,923<span></span>
</td>
<td class="nump">268,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">302,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(705,994)<span></span>
</td>
<td class="num">(1,634,432)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Investment of cash in Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(276,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CashWithdrawnAccountForRedemptions', window );">Cash withdrawn from Trust Account for redemptions</a></td>
<td class="nump">32,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes', window );">Cash withdrawn from Trust Account to pay income taxes</a></td>
<td class="nump">479,473<span></span>
</td>
<td class="nump">938,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">512,157<span></span>
</td>
<td class="num">(275,062,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount', window );">Proceeds from sale of Units, net of underwriting discounts paid</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">270,480,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ProceedsFromSaleOfPrivateUnits', window );">Proceeds from sale of Private Units</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,870,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Advances from related party</a></td>
<td class="nump">25,012<span></span>
</td>
<td class="nump">86,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of advances from related party</a></td>
<td class="num">(2,833)<span></span>
</td>
<td class="num">(86,748)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty', window );">Proceeds from convertible promissory note &#8211; related party</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ProceedsFromPromissoryNotesRelatedparty', window );">Proceeds from promissory note &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RepaymentOfPromissoryNoteRelatedParty', window );">Repayment of promissory note &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(90,342)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_PaymentOfOfferingCosts', window );">Payment of offering costs</a></td>
<td class="num">(32,684)<span></span>
</td>
<td class="num">(455,423)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">189,495<span></span>
</td>
<td class="nump">276,819,235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="num">(4,342)<span></span>
</td>
<td class="nump">122,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &#8211; Beginning of period</a></td>
<td class="nump">140,303<span></span>
</td>
<td class="nump">17,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &#8211; End of period</a></td>
<td class="nump">135,961<span></span>
</td>
<td class="nump">140,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">938,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-Cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_InitialClassificationOfCommonStockSubjectToRedemption', window );">Initial classification of common stock subject to possible redemption</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">271,835,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ChangeInValueOfCommonStockSubjectToRedemption', window );">Change in value of common stock subject to possible redemption</a></td>
<td class="nump">$ 1,342,784<span></span>
</td>
<td class="nump">$ 3,367,620<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CashWithdrawnAccountForRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash withdrawn account for redemptions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CashWithdrawnAccountForRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_ChangeInValueOfCommonStockSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in value of common stock subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_ChangeInValueOfCommonStockSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_IncreaseDecreaseInMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest earned on marketable securities held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_IncreaseDecreaseInMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrealized gain on marketable securities held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_InitialClassificationOfCommonStockSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial classification of common stock subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_InitialClassificationOfCommonStockSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_PaymentOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_PaymentOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from convertible promissory note &#8211; related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_ProceedsFromPromissoryNotesRelatedparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from promissory note - related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_ProceedsFromPromissoryNotesRelatedparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_ProceedsFromSaleOfPrivateUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of Private Units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_ProceedsFromSaleOfPrivateUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of Units, net of underwriting discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_RepaymentOfPromissoryNoteRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of promissory note &#8211; related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_RepaymentOfPromissoryNoteRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824027432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tuscan
Holdings Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on November 5, 2018. The Company was formed for the purpose
of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business
combination with one or more businesses or entities (the &#8220;Business Combination&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company
is focusing its search on companies in the cannabis industry.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one subsidiary, TSCN Merger Sub Inc., a wholly-owned subsidiary of the Company incorporated in Delaware on January
21, 2021 (&#8220;Merger Sub&#8221;) (see Note 10).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
activity through December 31, 2020 relates to the Company&#8217;s formation, the initial public offering (&#8220;Initial Public
Offering&#8221;), which is described below, identifying a target company for a Business Combination, activities in connection
with the proposed acquisition of Microvast, Inc., a Delaware corporation (&#8220;Microvast&#8221;) (see Note 10). The Company
will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates
non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering was declared effective on March 5, 2019. On March 7, 2019,
the Company consummated the Initial Public Offering of 24,000,000 units (the &#8220;Units&#8221; and, with respect to the shares
of common stock included in the Units sold, the &#8220;Public Shares&#8221;) at $10.00 per Unit, generating gross proceeds of
$240,000,000, which is described in Note 3.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 615,000 units (the &#8220;Private Units&#8221;)
at a price of $10.00 per Private Unit in a private placement to Tuscan Holdings Acquisition LLC (the &#8220;Sponsor&#8221;) and
EarlyBirdCapital, Inc. (&#8220;EarlyBirdCapital&#8221;) and its designee, generating gross proceeds of $6,150,000, which is described
in Note 4.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on March 7, 2019, an amount of $240,000,000 ($10.00 per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (&#8220;Trust
Account&#8221;) which are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment
Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 180 days or less or in any open-ended
investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company
Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), as determined by the Company, until the earlier of: (i) the
completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 12, 2019, the underwriters exercised their over-allotment option in full, resulting in the sale of an additional 3,600,000
Units for $36,000,000, less the underwriters&#8217; discount of $720,000. In connection with the underwriters&#8217; exercise
of their over-allotment option, the Company also consummated the sale of an additional 72,000 Private Units at $10.00 per Private
Unit, generating total gross proceeds of $720,000. A total of $36,000,000 was deposited into the Trust Account from the sale of
the additional Units pursuant to the over-allotment option and the additional sale of Private Units, bringing the aggregate proceeds
held in the Trust Account to $276,000,000.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs amounted to $6,059,098, consisting of $5,520,000 of underwriting fees and $539,098 of other offering costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public
Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally
toward consummating a Business Combination. The Company&#8217;s Business Combination must be with one or more target businesses
that together have a fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income
earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete
a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the
target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination
successfully.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide its holders of the outstanding Public Shares (the &#8220;public stockholders&#8221;) with the opportunity
to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with
a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether
the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely
in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro&#160;rata portion of the amount
then in the Trust Account ($10.00 per Public Share, plus any pro&#160;rata interest earned on the funds held in the Trust Account
and not previously released to the Company to pay its franchise and income tax obligations). There will be no redemption rights
upon the completion of a Business Combination with respect to the Company&#8217;s warrants. &#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such
consummation of a Business Combination and, solely if the Company seeks stockholder approval, a majority of the shares voted are
voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold
a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of
Incorporation (the &#8220;Amended and Restated Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender
offer rules of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC prior
to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company
decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with
a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder
approval in connection with a Business Combination, the Company&#8217;s Sponsor and EarlyBirdCapital have agreed to vote their
Founder Shares (as defined in Note 5), Private Shares (as defined in Note 4) and any Public Shares purchased after the Initial
Public Offering in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote
to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination.
Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against
the proposed transaction or do not vote at all.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor and EarlyBirdCapital have agreed (a) to waive their rights to liquidating distributions from the Trust Account with respect
to the Founder Shares and Private Shares if the Company fails to consummate a Business Combination and (b) not to propose an amendment
to the Amended and Restated Certificate of Incorporation that would affect a public stockholders&#8217; ability to convert or
sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company&#8217;s
obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides
the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had until December 7, 2020 to complete a Business Combination (the &#8220;Combination Period&#8221;). On December 3,
2020, the Company held a special meeting pursuant to which the Company&#8217;s stockholders approved extending the
Combination Period from December 7, 2020 to April 30, 2021 (the &#8220;Extension Date&#8221;). In connection with the
approval of the extension, stockholders elected to redeem an aggregate of 3,198 shares of the Company&#8217;s common stock.
As a result, an aggregate of approximately $32,700 (or approximately $10.22 per share) was released from the Company&#8217;s
Trust Account to pay such stockholders. Additionally, the Company has filed a preliminary proxy statement on March 12, 2021 seeking approval to
further extend date for which the Company is required to complete a business combination to July 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account
including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and
income taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders&#8217;
rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law,
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining
stockholders and the Company&#8217;s board of directors, dissolve and liquidate, subject in each case to the Company&#8217;s obligations
under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails
to complete a Business Combination within the Combination Period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent
any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which
the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00
per Public Share, except as to any claims by a third party who executed an agreement with the Company waiving any right, title,
interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the
Company&#8217;s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under
the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Moreover, in the event that an executed waiver is deemed
to be unenforceable against a third party, the Insiders will not be responsible to the extent of any liability for such third-party
claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account by endeavoring
to have all vendors, service providers, prospective target businesses or other entities with which the Company does business,
execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust
Account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus
could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company,
the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity and Going Concern</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account
outside of the Trust Account for working capital purposes. As of December 31, 2020, the Company had $135,961 held outside of the
Trust Account. As of April 20, 2020, the Sponsor committed to provide an aggregate of $500,000 in loans to the Company. The loans
shall be non-interest bearing, unsecured and due upon the consummation of a Business Combination. In the event that a Business
Combination does not close, the loans would be repaid only out of funds held outside the Trust Account to the extent such funds
are available. Otherwise, all amounts loaned to the Company would be forgiven. On April 21, 2020, the Sponsor loaned the Company
an aggregate of $200,000 (see Note 5).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until the consummation
of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective
acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the
target business to acquire, and structuring, negotiating and consummating the Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will need
to raise further additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors,
or third parties. In addition to the loan commitment described herein (see Note 10), the Company&#8217;s officers, directors and
Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable
in their sole discretion, to meet the Company&#8217;s working capital needs. Accordingly, the Company may not be able to obtain
additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve
liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential
transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it
on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company&#8217;s ability to continue
as a going concern through April 30, 2021 (or July 31, 2021, if our stockholders approve an amendment to our amended and restated
certificate of incorporation), the current date that the Company will be required to cease all operations, except for the purpose
of winding up, if a Business Combination is not consummated. These financial statements do not include any adjustments relating
to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable
to continue as a going concern.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991825796504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the
&#8220;Securities Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered
public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could
differ significantly from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Cash Equivalents</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of December 31, 2020 and 2019.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Marketable Securities Held in Trust Account</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">At
December 31, 2020 and 2019, the assets held in the Trust Account were substantially held in U.S. Treasury Bills. During the year
ended December 31, 2020 and 2019, the Company withdrew $479,473 and $938,000 of interest income from the Trust Account, respectively,
to pay its franchise and income tax obligations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Subject to Possible Redemption</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption
is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common
stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#8217; equity. The Company&#8217;s common stock features certain redemption rights that are
considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, common
stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders&#8217;
equity section of the Company&#8217;s balance sheets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;Income Taxes.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of
tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more
likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were&#160;no unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues under review that
could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates
and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including
among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;)
for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement
property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules
including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable
years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum
tax credits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Income (Loss) Per Common Share</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during
the period. The Company has not considered the effect of the warrants sold in the Public Offering and Private Placement to purchase
an aggregate of 28,287,000 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent
upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s statement of operations includes a presentation of income per share for common shares subject to possible redemption
in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for Common stock
subject to possible redemption is calculated by dividing the proportionate share of income on marketable securities held
by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to
possible redemption outstanding since original issuance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Net
loss per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income, adjusted for income on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of
non-redeemable common stock outstanding for the period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-redeemable
common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features.
Non-redeemable common stock participates in the income on marketable securities based on non-redeemable common stock shares&#8217;
proportionate interest.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="6" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 3.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0">2020</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0">2019</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; font-style: italic; text-indent: 0">Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: center; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: center; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">Numerator: Earnings allocable to Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.125in; width: 76%; text-align: left">Interest earned on marketable securities held in Trust Account</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">2,605,038</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">4,827,854</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Unrealized gain on marketable securities held in Trust Account</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">9,570</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">126,682</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0">Less: Income and franchise taxes</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(564,980</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(1,042,603</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Net income allocable to shares subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">2,049,628</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">3,911,933</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: left; text-indent: 0">Denominator: Weighted average Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0">Basic and diluted weighted average shares outstanding</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">27,104,439</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">27,123,666</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: left; text-indent: 0">Basic and diluted net income per common share</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">0.08</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">0.14</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; font-style: italic; text-align: left; text-indent: 0">Non-Redeemable Common Stock</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Numerator Net Income minus Net Earnings</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Net income</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">$</td><td style="padding: 0; text-align: right; text-indent: 0">1,375,461</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">$</td><td style="padding: 0; text-align: right; text-indent: 0">3,367,179</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Less: Income attributable to common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(2,049,628</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(3,911,933</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0">Non-Redeemable Net Loss</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(674,167</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(544,754</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Denominator: Weighted Average Non-Redeemable Common Stock</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0">Basic and diluted weighted average shares outstanding</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">8,382,317</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">7,927,608</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Basic and diluted net loss per common share</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(0.08</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(0.07</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this
account and management believes the Company is not exposed to significant risks on such account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value of Financial Instruments</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;Fair Value
Measurement,&#8221; approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term
nature.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently
Issued Accounting Standards</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#8217;s financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824280488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_InitialPublicOfferingDisclosureAbstract', window );"><strong>Initial Public Offering Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_InitialPublicOfferingDisclosureTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3. INITIAL PUBLIC OFFERING</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 7, 2019, the Company consummated the Initial Public Offering and sold 24,000,000 units at a price of $10.00 per Unit. Each
Unit consists of one share of common stock and one warrant (&#8220;Public Warrant&#8221;). On March 12, 2019, in connection with
the underwriters&#8217; exercise of the over-allotment option in full, the Company sold an additional 3,600,000 Units at a price
of $10.00 per Unit. Each Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share,
subject to adjustment (see Note 7).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_InitialPublicOfferingDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_InitialPublicOfferingDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_InitialPublicOfferingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_InitialPublicOfferingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824288072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_PrivatePlacementDisclosureAbstract', window );"><strong>Private Placement Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_PrivatePlacementDisclosureTextBlock', window );">PRIVATE PLACEMENT</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
4. PRIVATE PLACEMENT</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Simultaneously
with the closing of the Initial Public Offering, the Sponsor and EarlyBirdCapital and its designee purchased an aggregate of 615,000
Private Units at a price of&#8201;$10.00 per Private Unit, for an aggregate purchase price of $6,150,000. The Sponsor purchased
500,047 Private Units and EarlyBirdCapital and its designee purchased an aggregate of 114,953 Private Units. On March 12, 2019,
in connection with the underwriters&#8217; exercise of the over-allotment option in full, the purchasers purchased an aggregate
of an additional 72,000 additional Private Units, of which 58,542 Private Units were purchased by the Sponsor and 13,458 Private
Units were purchased by EarlyBirdCapital and its designee, for an aggregate purchase price of $720,000. Each Private Unit consists
of one share of common stock (&#8220;Private Share&#8221;) and one warrant (&#8220;Private Warrant&#8221;). Each Private Warrant
is exercisable to purchase one share of common stock at an exercise price of&#8201;$11.50 per share, subject to adjustment (see
Note 7). The proceeds from the Private Units were added to the proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private
Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private
Units and all underlying securities will be worthless.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_PrivatePlacementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_PrivatePlacementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_PrivatePlacementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_PrivatePlacementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824262792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5. RELATED PARTY TRANSACTIONS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2018, the Sponsor purchased 5,750,000 shares (the &#8220;Founder Shares&#8221;) of the Company&#8217;s common stock for
an aggregate price of $25,000. On March 5, 2019, the Company effected a stock dividend of 0.2 shares of common stock for each
outstanding share (the &#8220;Stock Dividend&#8221;), resulting in 6,900,000 Founder Shares being issued and outstanding. The
6,900,000 Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture by the Sponsor to the extent that
the underwriters&#8217; over-allotment was not exercised in full or in part, so that the holders of the Founder Shares would collectively
own 20% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering (assuming the holders did not purchase
any Public Shares in the Initial Public Offering and excluding the Private Units and Representative Shares (see Note 7). In connection
with the underwriters&#8217; exercise of the over-allotment option in full on March 12, 2019, 900,000 Founder Shares are no longer
subject to forfeiture.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder
Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination
and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing
after a Business Combination and, with respect to the remaining 50% of the Founder Shares, until the one year after the consummation
of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation,
merger, stock exchange or other similar transaction which results in all of the Company&#8217;s stockholders having the right
to exchange their shares of common stock for cash, securities or other property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement Units</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the initial public offering, the Company consummated the private placement of 687,000 Private Units at
a price of $10.00 per Private Unit, generating total proceeds of $6,870,000. The Private Units were sold to the Sponsor and EarlyBirdCapital
and its designees. The Private Units are identical to the units sold in the initial public offering, except that the warrants
underlying the Private Units are non-redeemable&#160;and may be exercised on a cashless basis, in each case so long as they continue
to be held by the initial purchasers or their permitted transferees. The initial purchasers have agreed not to transfer, assign
or sell any of the Private Units and underlying securities until after the completion of an initial business combination.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Service Fee</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vogel
Partners, LLP, an affiliate of Mr.&#160;Vogel, has agreed that, until the earlier of the consummation of an initial business combination
or Tuscan&#8217;s liquidation, it will make available to Tuscan certain general and administrative services, including office
space, utilities and administrative support, as Tuscan may require from time to time. Tuscan has agreed to pay Vogel Partners,
LLP $10,000 per month for these services. Tuscan believes, based on rents and fees for similar services in the New&#160;York City
metropolitan area, that the fee charged by Vogel Partners, LLP is at least as favorable as it could have obtained from an unaffiliated
person.. For the year ended December 31, 2020 and 2019, the Company incurred $120,000 and $100,000, respectively, in fees for
these services. At December 31, 2020 and 2019, fees amounting to $10,000 and $0 is included in accounts payable and accrued expenses
in the accompanying balance sheets.&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advance
from Related Party</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Chief Executive Officer advanced the Company an aggregate of $86,748 to be used for the payment of costs related
to the Initial Public Offering. The advances were non-interest bearing, unsecured and due on demand. The advances were repaid
upon the consummation of the Initial Public Offering on March 7, 2019.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
to Affiliate</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, an affiliate of the Company paid expenses on behalf of the Company that were mainly settled
during the same period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Promissory
Note &#8211; Related Party</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
November 2018, the Company issued an unsecured promissory note to the Company&#8217;s Chief Executive Officer (the &#8220;Promissory
Note&#8221;), pursuant to which the Company borrowed an aggregate principal amount of $90,342. The Promissory Note was non-interest
bearing and payable on the earlier of (i) November 1, 2019, (ii) the consummation of the Initial Public Offering or (iii) the
date on which the Company determines not to proceed with the Initial Public Offering. The Promissory Note was repaid upon the
consummation of the Initial Public Offering on March 7, 2019.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Party Loans</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in order
to finance transaction costs in connection with a Business Combination, the Sponsor or certain of the Company&#8217;s officers
and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital
Loans&#8221;). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds
of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside
the Trust Account to the extent such funds are available. In the event that a Business Combination does not close, the Company
may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust
Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of
a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $1,500,000 of such Working Capital Loans
may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical
to the Private Units.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 20, 2020, the Sponsor committed to provide an aggregate of $500,000 in loans to the Company. The loans shall be non-interest
bearing, unsecured and due upon the consummation of a Business Combination. In the event that a Business Combination does not
close, the loans would be repaid only out of funds held outside the Trust Account to the extent such funds are available. Otherwise,
all amounts loaned to the Company would be forgiven.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 21, 2020,
the Company issued an unsecured promissory note to the Sponsor in the aggregate amount of $300,000 (the &#8220;Note&#8221;), of
which $200,000 was drawn upon on such date. The Note is non-interest bearing and payable upon the consummation of a Business Combination.
The Note is convertible, at the lender&#8217;s option, into units of the post Business Combination entity at a price of $10.00
per unit. The units would be identical to the Private Units. If a Business Combination is not consummated, the notes will not be
repaid by the Company and all amounts owed thereunder by the Company will be forgiven except to the extent that the Company has
funds available to it outside of its Trust Account. As of December 31, 2020, there was $200,000 outstanding under the Note.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824171608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">COMMITMENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6. COMMITMENTS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on March 7, 2019, the holders of the Founder Shares, Representative Shares, Private
Units, and any units that may be issued upon conversion of Working Capital Loans (and all underlying securities) are entitled
to registration rights. The holders of the majority of these securities are entitled to make up to two demands that the Company
register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at
any time commencing three months prior to the date on which the Founder Shares are to be released from escrow. The holders of
a majority of the Representative Shares, Private Units or units issued in payment of working capital loans made to the Company
(or underlying securities) can elect to exercise these registration rights at any time commencing after the Company consummates
a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital and its designee may only make a demand on
one occasion and only during the five-year period beginning on the effective date of the Initial Public Offering. In addition,
the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent
to the consummation of a Business Combination; provided, however, that EarlyBirdCapital and its designee may participate in a
&#8220;piggy-back&#8221; registration only during the seven-year period beginning on the effective date of the Initial Public
Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Business
Combination Marketing Agreement</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 8pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has engaged EarlyBirdCapital as an advisor in connection with a Business Combination to assist the Company in holding
meetings with its shareholders to discuss the potential Business Combination and the target business&#8217; attributes, introduce
the Company to potential investors that are interested in purchasing the Company&#8217;s securities in connection with a Business
Combination, assist the Company in obtaining shareholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. The Company will pay EarlyBirdCapital a cash fee
for such services upon the consummation of a Business Combination in an amount equal to $9,660,000 (exclusive of any applicable
finders&#8217; fees which might become payable); provided that up to 30% of the fee may be allocated at the Company&#8217;s sole
discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Engagement of Morgan Stanley</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="margin: 0pt 0; font: 10pt/107% Times New Roman, Times, Serif">We engaged Morgan Stanley &amp; Co. LLC (&#8220;Morgan
Stanley&#8221;) to provide financial advisory services in connection with the Microvast business combination, and, upon consummation
of the transaction with Microvast, we must pay that firm a transaction fee of $5.5 million, plus expenses. Morgan Stanley also
acted as placement agent in connection with the PIPE Financing, and we are obligated to pay Morgan Stanley a placement fee equal
to (i) 3.5% of the sum of (x) the aggregate gross proceeds raised in the PIPE Financing up to $300 million (not including funds
from the sale of certain excluded securities) and (y) any borrowings pursuant to a bridge financing provided in connection with
the proposed business combination by investors introduced by Morgan Stanley, and (ii) 2.5% of the aggregate gross proceeds raised
in the PIPE Financing above $300 million.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824249016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7. STOCKHOLDERS&#8217; EQUITY</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i> &#8212;</b> The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share
with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.
At December 31, 2020 and 2019, there were no shares of preferred stock issued or outstanding.&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock &#8212;</i></b> The Company is authorized to issue 65,000,000 shares of common stock with a par value of $0.0001 per share.
Holders of the common stock are entitled to one vote for each share. At December 31, 2020 and 2019, there were 8,396,246 and 8,360,523
shares of common stock issued and outstanding, excluding 27,087,556 and 27,126,477 shares of common stock subject to possible
redemption, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
&#8212;</i></b> The Public Warrants will become exercisable 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement
covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of
common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise
of the public warrants is not effective within 90 days following the consummation of a Business Combination, warrant holders may,
until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain
an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9)
of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders
will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion
of a Business Combination or earlier upon redemption or liquidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b><i>&#160;&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the Public Warrants become exercisable, the Company may redeem the Public Warrants:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;&#160;&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top"> <td style="width: 0.5in; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 0.25in; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in whole and not in part;</span></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-size: 7pt">&#160;</span></td> <td style="padding-right: 0.8pt"><span style="font-size: 7pt">&#160;</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><p style="margin-top: 0; margin-bottom: 0"/> <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a price of $0.01 per warrant;</span></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-size: 7pt">&#160;</span></td> <td style="padding-right: 0.8pt"><span style="font-size: 7pt">&#160;</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon not less than 30 days&#8217; prior written notice of redemption;</span></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-size: 7pt">&#160;</span></td> <td style="padding-right: 0.8pt"><span style="font-size: 7pt">&#160;</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the reported last sale price of the Company&#8217;s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and</span></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-size: 7pt">&#160;</span></td> <td style="padding-right: 0.8pt"><span style="font-size: 7pt">&#160;</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise
the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the
Private Warrants will be exercisable for cash or on a cashless basis, at the holder&#8217;s option, and be non-redeemable so long
as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than
the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable
by such holders on the same basis as the Public Warrants. In addition, so long as the Private Warrants are held by EarlyBirdCapital
and its designee, the Private Warrants will expire five years from the effective date of the Initial Public Offering.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances
including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants
will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination
Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds
with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust
Account with the respect to such warrants. Accordingly, the warrants may expire worthless.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes
in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.50
per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s
board of directors, and in the case of any such issuance to our Sponsor, initial stockholders or their affiliates, without taking
into account any founders&#8217; shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances
represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination
on the date of the consummation of an initial Business Combination (net of redemptions), and (z) the volume weighted average trading
price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummated
an initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.50 per share, the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at
which the Company issues the additional shares of common stock or equity-linked securities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Representative
Shares</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2018, the Company issued to the designees of EarlyBirdCapital, for a nominal consideration, 300,000 shares (after giving
effect to the Stock Dividend) of common stock (the &#8220;Representative Shares&#8221;). The Company accounted for the Representative
Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders&#8217; equity. The Company
estimated the fair value of Representative Shares to be $1,200 based upon the price of the Founder Shares issued to the Sponsor.
The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a
Business Combination. In addition, the holders have agreed (i) to waive their redemption rights (or to sell any shares in a tender
offer) with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights
to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination
within the Combination Period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately
following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(g)(1)
of FINRA&#8217;s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities will not be the subject of any hedging,
short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person
for a period of 180 days immediately following March 5, 2019 (&#8220;FINRA Restricted Period&#8221;), nor may they be sold, transferred,
assigned, pledged or hypothecated during the FINRA Restricted Period except to any underwriter and selected dealer participating
in the Initial Public Offering and their bona fide officers or partners.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991929834424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAX</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in"><b>NOTE 8. INCOME
TAX </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax liability are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Deferred tax liability</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Unrealized gain on marketable securities</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(21,468</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(27,069</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Total deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,468</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,069</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation Allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Deferred tax liability</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(21,468</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(27,069</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision consists of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Federal</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 10pt">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">372,365</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">868,182</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,601</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,069</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">366,764</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">895,251</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and 2019, the Company did not have any of U.S. federal and state net operating loss carryovers available
to offset future taxable income.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">State taxes, net of federal tax benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">21.0</td><td style="padding-bottom: 4pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">21.0</td><td style="padding-bottom: 4pt; text-align: left">%</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities.
The Company&#8217;s tax returns since inception remain open to examination by the taxing authorities. The Company considers New York
to be a significant state tax jurisdiction.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824268376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9. FAIR VALUE MEASUREMENTS</b>&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value
at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company
would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an
orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets
and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and
to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).
The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable
inputs used in order to value the assets and liabilities:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0.5in; padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5in; padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;1:</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
    transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing
    basis.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;2:</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
    inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or
    liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;3:</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at December 31, 2020
and 2019 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Cash and marketable securities held in Trust Account</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">282,254,978</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">280,103,245</td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991825844616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10. SUBSEQUENT EVENTS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial
statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events
that would have required adjustment or disclosure in the financial statements.&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-align: justify; text-indent: 0in"><i>Proposed Business
Combination</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 1, 2021, Tuscan entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with Microvast, Inc.,
a Delaware corporation (&#8220;Microvast&#8221;) and Merger Sub. Pursuant to the Merger Agreement, Merger Sub will merge with
and into Microvast and Microvast will survive the merger and become a wholly owned subsidiary of Tuscan. Under the Merger Agreement,
all of the equity interests of Microvast will be converted into an aggregate of 210,000,000 shares of common stock (&#8220;closing
shares&#8221;). The Microvast shareholders and the investors in Microvast&#8217;s majority-owned subsidiary, Microvast Power System
(Houzhou) Co. Ltd. (&#8220;MPS&#8221;), will also have the ability to earn an additional 20,000,000 shares of common stock (&#8220;earnout
shares&#8221;) if the daily volume weighted average price of the common stock is greater than or equal to $18.00 for any 20 trading
days within a 30 trading day period (or a change of control occurs that results in the holders of common stock receiving a per
share price equal to or in excess of $18.00), during the period commencing on the closing date and ending on the third anniversary
of the closing date. Concurrently with the execution of the Merger Agreement, Tuscan and Microvast will jointly acquire 100% ownership
of MPS and will discharge certain convertible loans of MPS.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Merger will be accounted for as a reverse recapitalization
in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Under this
method of accounting, Tuscan will be treated as the &#8220;acquired&#8221; company for accounting purposes and the Business Combination
will be treated as the equivalent of Microvast issuing stock for the net assets of Tuscan, accompanied by a recapitalization. The
net assets of Tuscan will be stated at historical cost, with no goodwill or other intangible assets recorded.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
the Merger Agreement provides that Tuscan will issue an aggregate of 6,736,111&#160;shares of common stock upon conversion (the
&#8220;Bridge Notes Conversion&#8221;) of an aggregate of $57,500,000 outstanding promissory notes issued by Microvast.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Further,
on February&#160;1, 2021, Tuscan, the Sponsor, Microvast and certain stockholders of Tuscan entered into the Sponsor Support Agreement
(the &#8220;Sponsor Support Agreement&#8221;), pursuant to which the Sponsor and certain officers and directors of Tuscan (collectively,
the &#8220;Sponsor Group&#8221;) agreed, among other things, to vote all equity interests of Tuscan held by such member of the
Sponsor Group in favor of the approval and adoption of the proposed business combination with Microvast. Additionally, such members
of the Sponsor Group have agreed not to (a) transfer any of their equity interests in the Company (or enter into any arrangement
with respect thereto) other than as set forth therein or (b) exercise any conversion rights of any equity interests held by such
member of the Sponsor Group in connection with the approval of the proposed business combination.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor also agreed that, to the extent that certain expenses of Tuscan are in excess of $46,000,000 (unless such expenses shall
have been approved by Microvast), the Sponsor will either (i) pay any such excess amount in cash or (ii) forfeit to Tuscan such
number of shares of common stock held by the Sponsor that would have a value equal to such excess. The Sponsor also agreed to
amend the escrow agreement to make certain adjustments to the terms of the escrow of its shares of common stock as set forth in
the Sponsor Support Agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Contemporaneously with
the execution of the Merger Agreement, certain investors entered into subscription agreements (the &#8220;Subscription Agreements&#8221;),
pursuant to which such investors subscribed for an aggregate value of $482,500,000, representing 48,250,000 shares of Tuscan common
stock at a purchase price of $10.00 per share in a private placement (the &#8220;PIPE Financing&#8221;) to be consummated immediately
prior to the consummation of the Transactions. Affiliates of InterPrivate, a co-sponsor of Tuscan, subscribed to purchase 6.5 million
shares in the PIPE Financing for an aggregate purchase price of $65 million.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"/></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the Closing, the former equityholders of Microvast will hold approximately 69.9% of the issued and outstanding shares
of common stock and the current stockholders of Tuscan will hold approximately 9.2% of the issued and outstanding shares of common
stock, which pro forma ownership (1)&#160;assumes no holder of the common stock sold in Tuscan&#8217;s initial public offering
(such persons, the &#8220;Public Stockholders&#8221;) exercises its conversion rights in connection with the business combination,
and (2)&#160;reflects the issuance of an aggregate of 48,250,000&#160;shares of Common Stock in the PIPE Financing and 6,736,111&#160;shares
of common stock in the Bridge Notes Conversion, but does not include the effect of any other financing of Tuscan. If the maximum
number of Public Shares are converted into cash such that Microvast does not have the right to terminate the Merger Agreement
(i.e., Tuscan has at least $5,000,001 of net tangible assets immediately prior to or upon consummation of the business combination),
such percentages will be approximately 76.8% and 0.2%, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Consummation
of the proposed business combination is subject to customary conditions and covenants of the respective parties, including approval
of Tuscan&#8217;s stockholders and Tuscan having available cash of at least $250,000,000.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Extension Amendment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 12, 2021,
Tuscan filed a preliminary proxy statement seeking approval from its stockholders to amend Tuscan&#8217;s charter to extend the
date by which Tuscan is required to complete its initial business combination from April 30, 2021 to July 31, 2021 and to hold
an annual meeting for the election of directors in accordance with Nasdaq listing rules.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Nasdaq Compliance</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;6,
2021, we received a notice from the Listing Qualifications Department of The Nasdaq Stock Market stating that we failed to hold
an Annual Meeting of stockholders within 12&#160;months after our fiscal year ended December&#160;31, 2019, as required by Nasdaq
Listing Rule&#160;5620(a). In accordance with Nasdaq Listing Rule&#160;5810(c)(2)(G), we submitted a plan to regain compliance
on February&#160;4, 2021. Nasdaq accepted our plan and granted us an extension through June 29, 2021 to hold an annual meeting.
Nasdaq&#8217;s decision is subject to certain conditions, including that we provide periodic updates with respect to our proposed
business combination with Microvast.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>Loan Commitment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;12,
2021, the Sponsor extended a loan to Tuscan in the aggregate principal amount totaling $1.2&#160;million, of which $400,000 was
drawn upon on such date. This loan was in addition to the previous $200,000 drawn upon the $300,000 convertible note that was committed
by the Sponsor on April 21, 2020. As a result of the February&#160;12, 2021 commitment, the Sponsor had committed to Tuscan a total
of $1.5 million, of which a total of $600,000 has been drawn upon, with $400,000 of the drawn amount pursuant to the February&#160;12,
2021 note. The Sponsor intends to convert the $1.5 million total loan balance into 150,000 Units immediately prior to the closing
of the proposed business combination with Microvast. Such units will have terms identical to the terms of the Company&#8217;s Private
Units and will consist of (i) 150,000&#160;shares of common stock and (ii) warrants to purchase 150,000&#160;shares of common stock
at an exercise price of $11.50 per share, subject to adjustment.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824385304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_EmergingGrowthPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the
&#8220;Securities Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered
public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could
differ significantly from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 7pt Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Cash Equivalents</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of December 31, 2020 and 2019.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Cash and Marketable Securities Held in Trust Account</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Marketable Securities Held in Trust Account</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">At
December 31, 2020 and 2019, the assets held in the Trust Account were substantially held in U.S. Treasury Bills. During the year
ended December 31, 2020 and 2019, the Company withdrew $479,473 and $938,000 of interest income from the Trust Account, respectively,
to pay its franchise and income tax obligations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock', window );">Common Stock Subject to Possible Redemption</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Subject to Possible Redemption</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption
is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common
stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#8217; equity. The Company&#8217;s common stock features certain redemption rights that are
considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, common
stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders&#8217;
equity section of the Company&#8217;s balance sheets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;Income Taxes.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of
tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more
likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were&#160;no unrecognized tax benefits and no amounts accrued
for interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues under review that
could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates
and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including
among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;)
for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement
property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules
including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable
years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum
tax credits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Common Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Income (Loss) Per Common Share</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during
the period. The Company has not considered the effect of the warrants sold in the Public Offering and Private Placement to purchase
an aggregate of 28,287,000 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent
upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s statement of operations includes a presentation of income per share for common shares subject to possible redemption
in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for Common stock
subject to possible redemption is calculated by dividing the proportionate share of income on marketable securities held
by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to
possible redemption outstanding since original issuance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Net
loss per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income, adjusted for income on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of
non-redeemable common stock outstanding for the period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-redeemable
common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features.
Non-redeemable common stock participates in the income on marketable securities based on non-redeemable common stock shares&#8217;
proportionate interest.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="6" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 3.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0">2020</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0">2019</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; font-style: italic; text-indent: 0">Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: center; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: center; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">Numerator: Earnings allocable to Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.125in; width: 76%; text-align: left">Interest earned on marketable securities held in Trust Account</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">2,605,038</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">4,827,854</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Unrealized gain on marketable securities held in Trust Account</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">9,570</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">126,682</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0">Less: Income and franchise taxes</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(564,980</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(1,042,603</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Net income allocable to shares subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">2,049,628</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">3,911,933</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: left; text-indent: 0">Denominator: Weighted average Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0">Basic and diluted weighted average shares outstanding</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">27,104,439</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">27,123,666</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: left; text-indent: 0">Basic and diluted net income per common share</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">0.08</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">0.14</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; font-style: italic; text-align: left; text-indent: 0">Non-Redeemable Common Stock</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Numerator Net Income minus Net Earnings</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Net income</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">$</td><td style="padding: 0; text-align: right; text-indent: 0">1,375,461</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">$</td><td style="padding: 0; text-align: right; text-indent: 0">3,367,179</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Less: Income attributable to common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(2,049,628</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(3,911,933</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0">Non-Redeemable Net Loss</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(674,167</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(544,754</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Denominator: Weighted Average Non-Redeemable Common Stock</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0">Basic and diluted weighted average shares outstanding</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">8,382,317</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">7,927,608</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Basic and diluted net loss per common share</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(0.08</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(0.07</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this
account and management believes the Company is not exposed to significant risks on such account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value of Financial Instruments</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;Fair Value
Measurement,&#8221; approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term
nature.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently
Issued Accounting Standards</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#8217;s financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_EmergingGrowthPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It reperents emerging growth company policy text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_EmergingGrowthPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991824328520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted loss per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="6" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 3.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0">2020</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0">2019</td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; font-style: italic; text-indent: 0">Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: center; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: center; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0">Numerator: Earnings allocable to Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="2" style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.125in; width: 76%; text-align: left">Interest earned on marketable securities held in Trust Account</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">2,605,038</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">4,827,854</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Unrealized gain on marketable securities held in Trust Account</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">9,570</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">126,682</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0">Less: Income and franchise taxes</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(564,980</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(1,042,603</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Net income allocable to shares subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">2,049,628</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">3,911,933</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: left; text-indent: 0">Denominator: Weighted average Common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0">Basic and diluted weighted average shares outstanding</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">27,104,439</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">27,123,666</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-align: left; text-indent: 0">Basic and diluted net income per common share</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">0.08</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">0.14</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; font-style: italic; text-align: left; text-indent: 0">Non-Redeemable Common Stock</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Numerator Net Income minus Net Earnings</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Net income</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">$</td><td style="padding: 0; text-align: right; text-indent: 0">1,375,461</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">$</td><td style="padding: 0; text-align: right; text-indent: 0">3,367,179</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0 0 0 0.125in; text-align: left; text-indent: 0">Less: Income attributable to common stock subject to possible redemption</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(2,049,628</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0">(3,911,933</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 0.25in; text-align: left; text-indent: 0">Non-Redeemable Net Loss</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(674,167</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(544,754</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Denominator: Weighted Average Non-Redeemable Common Stock</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0">Basic and diluted weighted average shares outstanding</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">8,382,317</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">7,927,608</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-align: left; text-indent: 0">Basic and diluted net loss per common share</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(0.08</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 4pt double; text-align: left; text-indent: 0">$</td><td style="padding: 0; border-bottom: Black 4pt double; text-align: right; text-indent: 0">(0.07</td><td style="padding: 0; text-align: left; text-indent: 0">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991825680264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of net deferred tax liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Deferred tax liability</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Unrealized gain on marketable securities</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(21,468</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(27,069</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">Total deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,468</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,069</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation Allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Deferred tax liability</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(21,468</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(27,069</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of income tax provision</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Federal</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 10pt">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">372,365</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">868,182</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,601</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,069</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">366,764</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">895,251</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of federal income tax rate to effective tax rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-size: 7pt">&#160;</span></td><td><span style="font-size: 7pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">State taxes, net of federal tax benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">21.0</td><td style="padding-bottom: 4pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">21.0</td><td style="padding-bottom: 4pt; text-align: left">%</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991825810200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of fair value hierarchy of the valuation inputs</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Cash and marketable securities held in Trust Account</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">282,254,978</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">280,103,245</td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991817686280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 12, 2019</div></th>
<th class="th"><div>Mar. 07, 2019</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 21, 2020</div></th>
<th class="th"><div>Apr. 20, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Description of Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of shares in amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_IssuanceOfUnitsDescription', window );">Issuance of units, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Following
the closing of the Initial Public Offering on March 7, 2019, an amount of $240,000,000 ($10.00 per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (&#8220;Trust
Account&#8221;) which are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment
Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 180 days or less or in any open-ended
investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company
Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), as determined by the Company, until the earlier of: (i) the
completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,059,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees', window );">Underwriting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_OtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 539,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_PercentageOfTrustAccountRequiredForBusinessCombination', window );">Minimum percentage of trust account required for business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding voting securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_PublicSharePrice', window );">Public per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Net tangible assets of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Obligation to redeem percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Amount held of trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Description of Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares in units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Description of Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares in units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of shares in amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_SponsorMember', window );">Sponsor [Member] | Early Bird Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Description of Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares in units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of shares in amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-allotment option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Description of Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares in units (in Shares)</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of shares in amount</a></td>
<td class="nump">$ 36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_UnderwritersDiscount', window );">Underwriters discount</a></td>
<td class="nump">720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_AmountDepositInTrustAccount', window );">Deposit amount in trust account</a></td>
<td class="nump">$ 36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_PrivateUnitsMember', window );">Private Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Description of Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares in units (in Shares)</a></td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of shares in amount</a></td>
<td class="nump">$ 720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Proceeds held in Trust account</a></td>
<td class="nump">$ 276,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Description of Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares in units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">687,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of shares in amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Description of Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares in units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Aggregate shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Description of Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of shares in amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_AmountDepositInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount deposit in trust account</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_AmountDepositInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_IssuanceOfUnitsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_IssuanceOfUnitsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_OtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_OtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_PercentageOfTrustAccountRequiredForBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of trust account required for business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_PercentageOfTrustAccountRequiredForBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_PublicSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Public share price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_PublicSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_UnderwritersDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Underwriters discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_UnderwritersDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expense related to distribution, servicing and underwriting fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=thcb_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=thcb_EarlyBirdCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=thcb_EarlyBirdCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_PrivateUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=thcb_PrivateUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991901948952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CashWithdrawnFromTrustAccountToPayFranchise', window );">Cash withdrawn from trust account to pay franchise</a></td>
<td class="nump">$ 479,473<span></span>
</td>
<td class="nump">$ 938,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalDepositInsuranceCorporationPremiumExpense', window );">Federal depository insurance coverage</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Diluted loss per share (in Shares)</a></td>
<td class="nump">28,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CashWithdrawnFromTrustAccountToPayFranchise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash withdrawn from Trust Account to pay franchise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CashWithdrawnFromTrustAccountToPayFranchise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalDepositInsuranceCorporationPremiumExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalDepositInsuranceCorporationPremiumExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991908202776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract', window );"><strong>Numerator: Earnings allocable to Common stock subject to possible redemption</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeSecuritiesOther', window );">Interest earned on marketable securities held in Trust Account</a></td>
<td class="nump">$ 2,605,038<span></span>
</td>
<td class="nump">$ 4,827,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain on marketable securities held in Trust Account</a></td>
<td class="nump">9,570<span></span>
</td>
<td class="nump">126,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_IncomeAndFranchiseTaxes', window );">Less: Income and franchise taxes</a></td>
<td class="num">(564,980)<span></span>
</td>
<td class="num">(1,042,603)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Net income allocable to shares subject to possible redemption</a></td>
<td class="nump">$ 2,049,628<span></span>
</td>
<td class="nump">$ 3,911,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption', window );">Basic and diluted weighted average shares outstanding (in Shares)</a></td>
<td class="nump">27,104,439<span></span>
</td>
<td class="nump">27,123,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption', window );">Basic and diluted net income per common share (in Dollars per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_NumeratorNetIncomeMinusNetEarningsAbstract', window );"><strong>Numerator Net Income minus Net Earnings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,375,461<span></span>
</td>
<td class="nump">$ 3,367,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_IncomeAttributableToCommonStockSubjectToRedemption', window );">Less: Income attributable to common stock subject to possible redemption</a></td>
<td class="num">(2,049,628)<span></span>
</td>
<td class="num">(3,911,933)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_IncomeAdjustedNetLoss', window );">Non-Redeemable Net Loss</a></td>
<td class="num">$ (674,167)<span></span>
</td>
<td class="num">$ (544,754)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract', window );"><strong>Denominator: Weighted Average Non-Redeemable Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding (in Shares)</a></td>
<td class="nump">8,382,317<span></span>
</td>
<td class="nump">7,927,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic and diluted net income per common share (in Dollars per share).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic and diluted weighted average shares outstanding (in Shares).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_IncomeAdjustedNetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted net loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_IncomeAdjustedNetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_IncomeAndFranchiseTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Less: Income and franchise taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_IncomeAndFranchiseTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_IncomeAttributableToCommonStockSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_IncomeAttributableToCommonStockSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_NumeratorNetIncomeMinusNetEarningsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_NumeratorNetIncomeMinusNetEarningsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeSecuritiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other operating dividend and interest income, including amortization and accretion of premiums and discounts, on securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeSecuritiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991829146328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 12, 2019</div></th>
<th class="th"><div>Mar. 07, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_InitialPublicOfferingDetailsLineItems', window );"><strong>Initial Public Offering (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationReasonForBusinessCombination', window );">Business combination, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each
Unit consists of one share of common stock and one warrant (&#8220;Public Warrant&#8221;). On March 12, 2019, in connection with
the underwriters&#8217; exercise of the over-allotment option in full, the Company sold an additional 3,600,000 Units at a price
of $10.00 per Unit. Each Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share,
subject to adjustment (see Note 7).<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_InitialPublicOfferingDetailsLineItems', window );"><strong>Initial Public Offering (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_InitialPublicOfferingDetailsLineItems', window );"><strong>Initial Public Offering (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_InitialPublicOfferingDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_InitialPublicOfferingDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationReasonForBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents a description of the primary reason for the business combination which may consist of general categories such as top-line growth, synergistic benefits, market share, and diversification and the more detailed factors that might apply.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationReasonForBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991822474808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement (Details) - Sponsor [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_PrivatePlacementDetailsLineItems', window );"><strong>Private Placement (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction | shares</a></td>
<td class="nump">615,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction | $</a></td>
<td class="nump">$ 6,150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Private placement, description</a></td>
<td class="text">The Sponsor purchased
500,047 Private Units and EarlyBirdCapital and its designee purchased an aggregate of 114,953 Private Units. On March 12, 2019,
in connection with the underwriters&#8217; exercise of the over-allotment option in full, the purchasers purchased an aggregate
of an additional 72,000 additional Private Units, of which 58,542 Private Units were purchased by the Sponsor and 13,458 Private
Units were purchased by EarlyBirdCapital and its designee, for an aggregate purchase price of $720,000. Each Private Unit consists
of one share of common stock (&#8220;Private Share&#8221;) and one warrant (&#8220;Private Warrant&#8221;). Each Private Warrant
is exercisable to purchase one share of common stock at an exercise price of&#8201;$11.50 per share, subject to adjustment (see
Note 7).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_PrivatePlacementDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_PrivatePlacementDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=thcb_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991818017544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 12, 2019</div></th>
<th class="th"><div>Mar. 05, 2019</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 21, 2020</div></th>
<th class="th"><div>Apr. 20, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_IssuedAndOutstandingSharesPercentage', window );">Percentage of issued and outstanding shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Per unit price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RelatedPartyServicesFeesAmount', window );">Service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_WorkingCapitalLoans', window );">Working capital loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Entity price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_FoundeSharesMember', window );">Founder Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SponsorPurchased', window );">Sponsor purchased (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Common stock aggregate price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CommonStockDividendDescription', window );">Common stock dividend description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company effected a stock dividend of 0.2 shares of common stock for each
outstanding share (the &#8220;Stock Dividend&#8221;), resulting in 6,900,000 Founder Shares being issued and outstanding. The
6,900,000 Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture by the Sponsor to the extent that
the underwriters&#8217; over-allotment was not exercised in full or in part, so that the holders of the Founder Shares would collectively
own 20% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering (assuming the holders did not purchase
any Public Shares in the Initial Public Offering and excluding the Private Units and Representative Shares (see Note 7). In connection
with the underwriters&#8217; exercise of the over-allotment option in full on March 12, 2019, 900,000 Founder Shares are no longer
subject to forfeiture.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsShares', window );">Common stock dividend shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of Founder shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationControlObtainedDescription', window );">Description of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
holders of the Founder Shares have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder
Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination
and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing
after a Business Combination and, with respect to the remaining 50% of the Founder Shares, until the one year after the consummation
of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation,
merger, stock exchange or other similar transaction which results in all of the Company&#8217;s stockholders having the right
to exchange their shares of common stock for cash, securities or other property.&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture shares (in Shares)</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Per unit price (in Dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="nump">$ 36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SaleOfStockNumberOfSharesIssuedInTransactions', window );">Shares in units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">687,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Per unit price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Per unit price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Aggregate note amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount of loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_AmountDrawn', window );">Amount drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_PrivateUnitsMember', window );">Private Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Common stock aggregate price</a></td>
<td class="nump">$ 276,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Per unit price (in Dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="nump">$ 720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Entity price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Aggregate note amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=thcb_VogelPartnersLlpMember', window );">Vogel Partners, LLP [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">Per month service fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_AmountDrawn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount drawn.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_AmountDrawn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CommonStockDividendDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CommonStockDividendDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_IssuedAndOutstandingSharesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of issued and outstanding shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_IssuedAndOutstandingSharesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_RelatedPartyServicesFeesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party services fees amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_RelatedPartyServicesFeesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_RelatedPartyTransactionsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_RelatedPartyTransactionsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_SaleOfStockNumberOfSharesIssuedInTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_SaleOfStockNumberOfSharesIssuedInTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_SponsorPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The share purchase of  Sponsor purchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_SponsorPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_WorkingCapitalLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of working capital loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_WorkingCapitalLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationControlObtainedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents a description of how the entity obtained control of the acquired entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationControlObtainedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDueFromToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_FoundeSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=thcb_FoundeSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=thcb_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=thcb_PrivateUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=thcb_PrivateUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=thcb_VogelPartnersLlpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=thcb_VogelPartnersLlpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991908167368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CommitmentsDetailsLineItems', window );"><strong>Commitments (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Description of business combination</a></td>
<td class="text">The Company will pay EarlyBirdCapital a cash fee
for such services upon the consummation of a Business Combination in an amount equal to $9,660,000 (exclusive of any applicable
finders&#8217; fees which might become payable); provided that up to 30% of the fee may be allocated at the Company&#8217;s sole
discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_MorganStanleyMember', window );">Morgan Stanley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CommitmentsDetailsLineItems', window );"><strong>Commitments (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_TransactionFee', window );">Transaction fee</a></td>
<td class="nump">$ 5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_PercentageOfPlacementFee', window );">Percentage of placement fee</a></td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_MorganStanleyMember', window );">Morgan Stanley [Member] | PIPE [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CommitmentsDetailsLineItems', window );"><strong>Commitments (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_GrossProceedsFromFinancing', window );">Gross proceeds from financing</a></td>
<td class="nump">$ 300.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_PercentageOfGrossProceedsRaisedInFinancing', window );">Percentage of gross proceeds raised in financing</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CommitmentsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CommitmentsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_GrossProceedsFromFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds from financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_GrossProceedsFromFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_PercentageOfGrossProceedsRaisedInFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of gross proceeds raised in financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_PercentageOfGrossProceedsRaisedInFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_PercentageOfPlacementFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of  placement fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_PercentageOfPlacementFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_TransactionFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_TransactionFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_MorganStanleyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_MorganStanleyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=thcb_PrivateInvestmentInPublicEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=thcb_PrivateInvestmentInPublicEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991828860184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000,000<span></span>
</td>
<td class="nump">65,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,396,246<span></span>
</td>
<td class="nump">8,360,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,396,246<span></span>
</td>
<td class="nump">8,360,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_CommonSharesSubjectToPossibleRedemption', window );">Common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,087,556<span></span>
</td>
<td class="nump">27,126,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings', window );">Warrants description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes
in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.50
per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s
board of directors, and in the case of any such issuance to our Sponsor, initial stockholders or their affiliates, without taking
into account any founders&#8217; shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances
represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination
on the date of the consummation of an initial Business Combination (net of redemptions), and (z) the volume weighted average trading
price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummated
an initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.50 per share, the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at
which the Company issues the additional shares of common stock or equity-linked securities.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=thcb_EarlyBirdCapitalMember', window );">EarlyBirdCapital [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SaleOfStockNumberOfSharesIssuedInTransactions', window );">Common stock shares purchased</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Common stock aggregate price (in Dollars)</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings', window );">Warrants description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#9679;in whole and not in part;&#160;&#160;&#160; &#160;&#160;&#9679;at a price of $0.01 per warrant;&#160;&#160;&#160;&#160;&#9679;upon not less than 30 days&#8217; prior written notice of redemption;&#160;&#160;&#160;&#160;&#9679;if, and only if, the reported last sale price of the Company&#8217;s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and&#160;&#160;&#160;&#160;&#9679;if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_CommonSharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_CommonSharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_SaleOfStockNumberOfSharesIssuedInTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_SaleOfStockNumberOfSharesIssuedInTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_StockholdersEquityDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_StockholdersEquityDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=thcb_EarlyBirdCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=thcb_EarlyBirdCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991829855944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Tax (Details) - Schedule of net deferred tax liability - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_DeferredTaxLiabilityAbstract', window );"><strong>Deferred tax liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities', window );">Unrealized gain on marketable securities</a></td>
<td class="num">$ (21,468)<span></span>
</td>
<td class="num">$ (27,069)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liability</a></td>
<td class="num">(21,468)<span></span>
</td>
<td class="num">(27,069)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation Allowance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">$ (21,468)<span></span>
</td>
<td class="num">$ (27,069)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_DeferredTaxLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_DeferredTaxLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991828980488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details) - Schedule of income tax provision - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_FederalAbstract', window );"><strong>Federal</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">$ 372,365<span></span>
</td>
<td class="nump">$ 868,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(5,601)<span></span>
</td>
<td class="nump">27,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_StateAndLocalAbstract', window );"><strong>State and Local</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">$ 366,764<span></span>
</td>
<td class="nump">$ 895,251<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_FederalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_FederalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_StateAndLocalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_StateAndLocalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991822509096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details) - Schedule of federal income tax rate to effective tax rate<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract', window );"><strong>Schedule of federal income tax rate to effective tax rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal tax benefit</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991982575400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Cash and marketable securities held in Trust Account</a></td>
<td class="nump">$ 282,254,978<span></span>
</td>
<td class="nump">$ 280,103,245<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139991820805640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 12, 2021</div></th>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventEffectOfChangeInTaxStatus', window );">Subsequent Event, Effect of Change in Tax Status</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate value of common stock subscribed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,870,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Equityholders, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company will pay EarlyBirdCapital a cash fee
for such services upon the consummation of a Business Combination in an amount equal to $9,660,000 (exclusive of any applicable
finders&#8217; fees which might become payable); provided that up to 30% of the fee may be allocated at the Company&#8217;s sole
discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_NumberOfCommonStockConvertedByEquityInterests', window );">Number of common stock converted by equity interests (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_AdditionalSharesOfCommonStockEarn', window );">Additional shares of common stock will earn (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Available cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=thcb_BridgeNotesConversionMember', window );">Bridge Notes Conversion [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Aggregate of outstanding promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_AgreementAxis=thcb_SubscriptionAgreementsMember', window );">Subscription Agreements [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate value of common stock subscribed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 482,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares of common stock subscribed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Purchase price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_AgreementAxis=thcb_MergerAgreementMember', window );">Merger Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Equityholders, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Microvast will hold approximately 69.9% of the issued and outstanding shares
of common stock and the current stockholders of Tuscan will hold approximately 9.2% of the issued and outstanding shares of common
stock, which pro forma ownership (1)&#160;assumes no holder of the common stock sold in Tuscan&#8217;s initial public offering
(such persons, the &#8220;Public Stockholders&#8221;) exercises its conversion rights in connection with the business combination,
and (2)&#160;reflects the issuance of an aggregate of 48,250,000&#160;shares of Common Stock in the PIPE Financing and 6,736,111&#160;shares
of common stock in the Bridge Notes Conversion, but does not include the effect of any other financing of Tuscan. If the maximum
number of Public Shares are converted into cash such that Microvast does not have the right to terminate the Merger Agreement
(i.e., Tuscan has at least $5,000,001 of net tangible assets immediately prior to or upon consummation of the business combination),
such percentages will be approximately 76.8% and 0.2%, respectively.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_MicrovastPowerSystemMember', window );">Microvast Power System [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockConversionBasis', window );">Merger agreement, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Microvast shareholders and the investors in Microvast&#8217;s majority-owned subsidiary, Microvast Power System
(Houzhou) Co. Ltd. (&#8220;MPS&#8221;), will also have the ability to earn an additional 20,000,000 shares of common stock (&#8220;earnout
shares&#8221;) if the daily volume weighted average price of the common stock is greater than or equal to $18.00 for any 20 trading
days within a 30 trading day period (or a change of control occurs that results in the holders of common stock receiving a per
share price equal to or in excess of $18.00), during the period commencing on the closing date and ending on the third anniversary
of the closing date. Concurrently with the execution of the Merger Agreement, Tuscan and Microvast will jointly acquire 100% ownership
of MPS and will discharge certain convertible loans of MPS.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of shares of common stock issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,736,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_SponsorMember', window );">Sponsor [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Expenses pay by sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Loan commitment, description</a></td>
<td class="text">Sponsor extended a loan to Tuscan in the aggregate principal amount totaling $1.2&#160;million, of which $400,000 was
drawn upon on such date. This loan was in addition to the previous $200,000 drawn upon the $300,000 convertible note that was committed
by the Sponsor on April 21, 2020. As a result of the February&#160;12, 2021 commitment, the Sponsor had committed to Tuscan a total
of $1.5 million, of which a total of $600,000 has been drawn upon, with $400,000 of the drawn amount pursuant to the February&#160;12,
2021 note. The Sponsor intends to convert the $1.5 million total loan balance into 150,000 Units immediately prior to the closing
of the proposed business combination with Microvast. Such units will have terms identical to the terms of the Company&#8217;s Private
Units and will consist of (i) 150,000&#160;shares of common stock and (ii) warrants to purchase 150,000&#160;shares of common stock
at an exercise price of $11.50 per share, subject to adjustment.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_CosponsorMember', window );">Co-sponsor [Member] | Subscription Agreements [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_thcb_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate value of common stock subscribed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares of common stock subscribed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_AdditionalSharesOfCommonStockEarn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares of common stock earn.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_AdditionalSharesOfCommonStockEarn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_NumberOfCommonStockConvertedByEquityInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common stock converted by equity interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_NumberOfCommonStockConvertedByEquityInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_SubsequentEventsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_SubsequentEventsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>thcb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockConversionBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of basis for conversion of convertible common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockConversionBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventEffectOfChangeInTaxStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monetary effect of a change in the tax status effective after year-end but before the financial statements for the reporting period are issued or available to be issue by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32590-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventEffectOfChangeInTaxStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=thcb_BridgeNotesConversionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=thcb_BridgeNotesConversionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_AgreementAxis=thcb_SubscriptionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_AgreementAxis=thcb_SubscriptionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_thcb_AgreementAxis=thcb_MergerAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">thcb_AgreementAxis=thcb_MergerAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_MicrovastPowerSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_MicrovastPowerSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_CosponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=thcb_CosponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>48
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M3M1!"[:DZU3=\Z?/;$?( (QY*LU?]+2S=3HH7DO%LYTS(,B2?/N?/N\2L>>
MO08'LG,@ISJX.P?7$-TB,[2NJ*+#@>!/2&AKB*8O3&Z,-[!)<EW&J1+P:0)^
M:GA)4YK'#$UU!(D^HB_3*_3^W8=!3T%T;=.+=Y$NMY%(0Z0K%I\A%W<1<8AC
M<1^?[([[A^X]X%02(R4Q8N*Y#?'&:R%8KA"5$HBU!'3+@*X)Z#4%I')ER\K6
M*S!>>M-LAMCU^P$>]#;[["UFGN,Z;FEV ,HK07FMH.X$*VBR0$D>\XPA19^9
MM(%LC:);Q2=9T)A==* 72"8VK#-$MAINX_A[+()^A",[";\DX9]$@CU#<Y),
M(IHO$%<K)F '-%=QR\RO(2+$Z_>/LE^WPE% O- ./"B!!ZW 9US1%+VNM%$C
MQJ#^[7[D!<X1R+J9VP_<H"&[80DR?'/=FHQ"FWYDBLY3AB2#Q"8J@5RO6*J7
M#YH):#9H%,=\G2L;B;">Z(@0W^N'T1$/FZ6#'9=XOIU*5%*)VO-].QO=H-%T
M>CV;VB!&-H@>=CWW&*+-TH%E$^"&#=DO(?9/:CMI0N=):E+<TGNP4[5IIY7Z
MKC 2%?3%E%!7E,:Q6+-JXUB;ME-?5<2I%\UB1X*^XS>4#.\)#&Y%/MEK3:_H
MK4!Q':@#ZRL\!MKZ=2?ULD,FE:)@TEZ#Q49KI41+P3.885*J(/D%%>K%2HA8
M6A,.CUM3^Y?^#SZ5H.%V13ML7S=-*W;'QJVW?L\/'>^83MVN=1U52H?;I6[,
M\PT3*M&+OX ")%)R\8)RKACZ^:>(8'Q^0DWJ @8#+_P<L_A^P3RD66DA;A?#
M*[9D4)"%WC!E%[%SL4@?]H+:QK:8A4[0;ZA'I7WX#?$SS?AF,KJ<W$QFDVMK
M1\9U38N"$(?D&&3=CD S)EX#RDK\\!OJQ[,L47#NL"MSN_<W#$8_(- APTH3
M<;LH:H9P'H*30OP(I['Y/W! 0HJC@DMI-@LL)I85YM!$PJX3A5W?#XQ^P"TF
M0=<+0T05@@F<97,8NEZ'^*T-C.-=B"$+9DY<J7TM6@0U#'PO($&M0=A,?>*X
M7N0T5+L27]RNOE.=A!5/%TQ(TQ/"<W3]=5W;0(<GBDJ$2;L(PZ"ZVYPFVUWT
MSCF#WH%UOT$;FJ[9.<)=>*)_D5Q1H8?9M5IQD?S+%N?0K'*&H'%IT39#[EI)
M!1=)_F#+:CN<;UB=/R#08<HJ]2?MZK^_.JWY"ORVA$5=&(&[Q-NN5[@+G*Y/
MW%=3>RK1>_8<IVMSV;SB=R':=\R'[]T8I#[51-ZQVMB,W,"^&<C> ?BM<661
M: Z@\?IX]1&&_)@6"6B^%:AE6O%#%Q]O7XL=#EP21DUXJW&$M(\C]W X@4<P
MSE*10^VL#9O4QPLO]'#D'<N>Q=!U@\"-&LY\I!I$2/L@LAV;3FTU.]CUN<,W
M<\>Q$#8:-N@UJ08+TCY8U/0:C7Z_0M/9[?C7S[<W5]?WTY+&'U\FL[^M-/S:
M6XRF$Y;5U'[$ZNV]OM+O#G^CXB'))4K9$GR=LQ!"B>WKN.V-XH5YHS7G2O',
M7*X8A4IH _A\R6$HW-WHEV3E2]'A?U!+ P04    " !OJWA2X5H5/ T#  #
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M#E#WEXS)MQ/]6J%^437]#U!+ P04    " !OJWA2H9XM,4\"   ;!0  &
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;(U436_;, S]*X(W;"U0Q+'SU76.
M@:;ML!T*! VR'88=%)NQA<I2*M%Q^^]'R8F7H4DW'VQ1(M][I$DEC3:/M@1
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M3>6*=[ZW B<#1 %."#T$/A0C81QZP0CPCFLP/5+7.L?NP%MQT@$ ZI' CT8
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MF[=<S846R_I%T:/06I3UQP5G,#<9 ?A^)J!OV%Z8#=IWC5?_ 5!+ P04
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MV>$!M0O%-,(G5E)8G-0&<HG\*?EJ![\'E@TZM W*'8X[2-==SM1F[0G%@MK
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M['N;)((PX^#!*M"H:.M>Y.,28"S\)\MRDER'/+L R*%DMAY %N#)]X)F)GZ
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M5^>GUP_B]/S\YOOUP]7U;^+VYO>K\ZN+^TWFW;WV]<W#13 9BK^^ASB35ML
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M)&*%'L#]909D\'_0!LW_+_'E_P%02P,$%     @ ;ZMX4B;Y(\D2 P  J 8
M !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULE55;;],P%'[OKS@*"#&I
MY-;NPM966G>!2K!5@[$'Q(.;G#1FCAUL9]G^/<=.5C9$)_'0QCZ7[SO?B7TR
M:96^-26BA?M*2#,-2FOKPR@R68D5,Z&J49*G4+IBEK9Z'9E:(\M]4B6B-([W
MHHIQ&<PFWK;4LXEJK. 2EQI,4U5,/\Q1J'8:),&CX8JO2^L,T6Q2LS5^07M=
M+S7MH@U*SBN4ABL)&HMI<)P<SL<NW@=\X]B:)VMP2E9*W;K-(I\&L2L(!6;6
M(3!ZW.$)"N& J(Q?/6:PH72)3]>/Z.=>.VE9,8,G2MSPW);3X"" ' O6"'NE
MVH_8Z]EU>)D2QO]#V\6.]P+(&F-5U2=3!167W9/=]WUXDG 0;TE(^X34U]T1
M^2I/F66SB58M:!=-:&[AI?IL*HY+]U*^6$U>3GEVMI#<<B9@V:P$S^"R*%!S
MN9Y$EL!=2)3U0/,.*-T"E*3P64E;&CB3.>;/ 2*J:E-:^EC:/'T1\12S$$;)
M$-(XC5_ &VVDCCS>Z/^DPBDWF5"FT0C?CU?&:CHI/U[@&V_XQIYOO(WO8O%U
M<?P)EM?S3XL3N#P_/[M:7'SX5VM?!KJX_'HV&(6P!1 NY> STUD)^ZY7R?LA
MV!+A1%4UDP^0*>EOG,7<V[>U@<D<C!(YI.-A',?N!PW%&F 6&-2:9PBJ@-=)
M')*K1@W7Y [AC&7EP"T]%3>406%*(IB2:9^3J:JB*TBG.;OU1,[;,JV9M/#V
MS:N#-(V/^H)N.K,W)D<[(<F#3EZ2/NKCTG')_F:WW)8#)ZVADZ=;S2UJX_*3
M_2/ >]09-[X,%Z/N4+]C0BA+H\6"JCT$ 1:-$,\[Y[O!:'+D.7=1U+31<*]O
MS?5?K1EL:PT\UP7$RJU XZE*HJ!HJZ!N2")S=6YOW%_O(0EW.S(?/AR89O63
M6N+06/Z39H=7^-8@PH6R"/L[X;^.=?1D>E2HUWY&&J)NI.T&R<:Z&</'W?3Y
M$][-<'I/:RX-""PH-0[W=P/0W5SL-E;5?A:ME*7)YI<E?4I0NP#R%XH*[3>.
M8/-QFOT&4$L#!!0    ( &^K>%(]UR\34 0  #D*   9    >&PO=V]R:W-H
M965T<R]S:&5E=#$Q+GAM;*56VV[;.!!]]U<,O,6B ;2V)-MQVC@&G,3%!M@D
M1I*V#XM]H*6QQ88B59**XK_?(64ISL79 OMBB^2<,V<NO$PJI>]-AFCA,1?2
MG'0S:XO/_;Y),LR9Z:D"):VLE,Z9I:%>]TVAD:4>E(M^'(:'_9QQV9U._-Q"
M3R>JM()+7&@P99XSO3E%H:J3;M1M)F[X.K-NHC^=%&R-MVB_%@M-HW[+DO(<
MI>%*@L;527<6?3X=.GMO\(UC97:^P46R5.K>#2[2DV[H!*' Q#H&1G\/>(9"
M."*2\7/+V6U=.N#N=\/^Q<=.L2R9P3,EOO/49B?=HRZDN&*EL#>J^A.W\8P<
M7Z*$\;]0U;;#L M)::S*MV!2D'-9_[/';1YV $?[ /$6$'O=M2.O\IQ9-IUH
M58%VUL3F/GRH'DWBN'1%N;6:5CGA['2A^0.S" O!$J1DVTG?$JU;["=;BM.:
M(MY#$<5PJ:3-#,QEBNES@C[I:47%C:C3^%W&<TQZ,(@"B,,X?(=OT 8Y\'R#
M7PT2SKE)A#*E1OA[MC164W?\\XZG8>MIZ#T-]WFZN?@VNYO#XJ_9V?QR?G7W
M5CK?I[BZOIMWACUX106W/*=>8Q)5:<2F4W&;@<T07"1<KD&M_/!"<LN9@$6Y
M%#R!Z]4*-2T'?O&V4-(H#4RF,&=:;$ZY3L]8P2TAW"2WAKK:\+5$A*+4248]
MG](2L/5:X]KED1P=1J,@#,-.D]JOT@&9!0:%YHFS^?VWHSB,CC]$82\,H4 -
MN\8!K+R,'=K&6\L 'PZ#:!0Z1SVXVU'?ZNJ,0EH>CN&%CO\9710-@T^CP7/6
M'EQ+N&2$@2AVO1E]"CI<0J*DW)XQ;4E*V@FZTMRB-BX/T?@8\!%UP@TV=5(/
MJ/]@0BCK6U(5GH((5Z40=;4:A=KL$=LA+C=.4^[0%.4X=NG:G7D61."\5QFG
M($9'P6@8O\A<A7HW,<O-JZZ)!L%P=-3 .OM@_YG^7VN <;PM_YR1Y%VM+N^&
M&VM<#I1$,!G3'I2H/*=,TMF9W,-'E_XX/&Z@M\[*ST7'!UZ4PU9,:T9%>&G]
MO9YO[%_(V*YVN&F*RY8"P:JG2/8+<WM%/C7%JUT3]4;UKO'P@*[-Y0]J,\?.
MTA]T,_BN^6@0.U>*Q(P/ZCU2:)4@I@966N6^>F]4F-J#RD14]DW$GB,$,A2I
MZU!G<Z=) \R21)72]CH7=5.?J;Q@<@.I0@-2N2KEA4#RSN"TI&,*C7%&2RY9
MNV6VC+O3"W*HTF"//L-$NXU>-"(7 I:T 4T=WXIVHC?3F&)>;[$&6 ?G&\)0
M(I_R6]O_++GVMX5Q"%849.WK*UAU$/C6>>W?S=*>K@\ L7%),YB4=!)P?%)'
M+Q6;"4I%[ZT[I[]SG>>HU_[18L GNK[9V]GV732KGP-/YO6CBHZK-9<&!*X(
M&O;&HR[H^J%2#ZPJ_.-@J2P]-?QG1F\[U,Z UE>*>FL[< [:U^+T7U!+ P04
M    " !OJWA2K],*5N4+  "^(0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6RM6FUO&S<2_KZ_@O#E#@FPE24YCMWF!7"<%!<@38S8;5$<[@.U2TEL
M=I<;DFM%]^OOF2&Y6LF2TO;N2Z)=D<-Y>>:9&<HO5L9^=DNEO/A:5XU[>;+T
MOOWA]-052U5+-S*M:O#-W-A:>CS:Q:EKK9(E;ZJKT^EX_.RTEKHY>?6"W]W8
M5R],YRO=J!LK7%?7TJY?J\JL7IY,3M*+3WJQ]/3B]-6+5B[4K?(_MS<63Z>]
ME%+7JG':-,*J^<N3J\D/KY_2>E[PBU8K-_@LR)*9,9_IX5WY\F1,"JE*%9XD
M2/QWKZY559$@J/$ERCSICZ2-P\])^H]L.VR92:>N3?6K+OWRY<GEB2C57':5
M_V16_U31GG.25YC*\;]B%=:>87'1.6_JN!D:U+H)_\NOT0^##9?C QNF<<.4
M]0X'L99OI)>O7EBS$I960QI]8%-Y-Y33#07EUEM\J['/O_JD*NE5*6ZD]6MQ
M9V7C)/O+O3CUD$^K3HLHZW60-3T@:S(5/YG&+YUXVY2JW!9P"L5Z[:9)N]?3
MHQ+?J&(DSB:YF(ZGXR/RSGIKSUC>V9^V5OSK:N:\Q=._CYSSM#_G*9_S]- Y
M;]]?W;U](VZN/MW])NX^77VXO;J^>_?QP^T^KQZ7]>'CW=OL?"0.RQ0_F@X.
MM]GM4EKEQ+LF^V#N53U3%HZ;7.;"+Y6X;6&FL:+M;+$$CDMQGE^<C_/Q>"Q<
MV/B8UOWC;Y?3Z?AYE"F"3'XY>?Y$F#D+NS9U*YLUO9Y</'>B,'6-' -<B\\"
M5)%))-QB8=4"_A:MU86BK8^FYW3>2'QLQ$\2>D '4O'[?"A5J/D<20L-9918
MZGM=JJ8D&>/1-.F+I]V#A9+%,@/[."^;4C>+L';+M%M>_";*3*;EX!B'7*8]
MNA'/\N_'P3G;GA SQ2N<ZTA!TFESV$C<+55V<*MNBJHK>=O .["B:X4W(NV*
MUKEN]CO<0-_ L+G2OH,AL_56-/$E/:JO7C58NI0^HV<^=F6U5];%( E PGXG
MJ\KXFM:NI!.-\=BJ;*$)#[!ZWE65@%A\;)$CN7"&A?(A2U-!JDL8V#%N9;JJ
M1#PJ)MQ[5:TSLVH0W;\? LU^'R;SY1S*\[YWC?9:5N*FFU6Z$!^!#DL+'TL(
MJ.G34+M2EVQ7PGE&B(I;^S@<E4L*J:\4JB3[QNI["M7/V.'X^T\*-=#!CY)L
M38(?.Z7$!X.5%T]&D ]W-$VH/]E*^Z4X%)L4A.2JG5B9EDM8'Z"4/9-I2I\#
MB"/H-T94IEF '_8B*F#V>&R7$C9* %:5^1"7A;(>A5]4NM:4K_":8E5=SC$@
M=!+)PK&Y0+3THB%TH2A7@L*R?5KBKZ[QNLH%.PS/;3SL?(.D;?4">2AI*XUW
M6&(:)=9X'F (@>"^@_V()5*\[AR8UCF"Y4PW_$U&H:7E)2=F(U9+782H%95Q
M!(>>RX+4 ?NH+YVL'-E';E"E$X\FT]'Y6+30(;(0<DZ6OZ.LPUG$5F&G:RO@
M*L^VR<X1(Z'=DHW^CXQ.M:J0K?:R2J]$TKC2G]43EDF.G8[)\8S?4JX=^Q)Q
MDN)L_-W@"U)-FY+M4$V!MUEPV7[WT&$/XT*G6T4-($D]$B6.:X#W\0!E!P.4
MLWM#I'/*!V!X"0D%$AW/<T:G0R28#<U!*<-J ^/;2GG*%GCQ2Z?+L"BKE5W0
M,3&\7T$G2"/2P/"A#JBO8(3?]!$1,*&2,-%(RM?]_,=R4^(AQ1+;6.HD,VC?
M'XFWVAZK>K!_"455T8%7M'(;)5N+!A[=SBB16'93R4(QK00ZN]4UE)6-,IT#
M:?<\M9LR]$Y'RFP#99I(F;L.C1M5@&8;V;/M#X:T9Y<73%@[U.HS.6@7)N/1
M..3/<%DN%JI15G*I]L:3/M:$E*-=S_++BW'H,^X>D/=*(0\=G)Z@FRHI)=);
M(&O]6MOR.F09\P'M*A5QEU)NGTC*;,I8KPNH$L5V_!4?%,O-0=\%UMS4V96T
M0)1W&:=/M3Y0A9C:F^^L*A6R;U8I-J%&5L_4H*I3VC(^*LH"3##:A<Q!H\1Y
M0S6>"@0(FH[A^,&UG2((0M12P8;8=FQL",75,M("/!$F5 $.>N3\WE][M@U*
MRJ%2D>TI%0\K\<!) _P'KAG2"R=Y8O^F5VF6^*'8\,-(7)7H*S0-!%3>LUME
M[PF3/Z*\_V(6JLIH@@ &X<KW[V]R;NCF<UWIV-#]9$=A80Y#7;*3(CRDP4')
MVENCCFM)[KGK7"&;GE&&] 7<@JKAO5I^AJ?O);B*0 )'AUU]]0[95+$WY9;A
M\"@;SHA)#1& BU>9:Y'-L ;&!)?OV]ZUK:$V$CZ(AQ(^+0A: [YS:VKA,>-S
M]/'_**T:.LV@%5T';XK>[1G<3OS '$($4=/DR5P(5[J-YKW(F8*O[\F4F8QY
M89&S0>\YH!H*<N3TM#TE[P>U$K\9^UE<:[]&9?"@50/#*?!6R7R3O1 E '*4
M#LZ:';T)+FA\072B4M)Y\LQ<WAL;$MA1U KNI#E!S(PB1,T"N0J'=4V/LS*#
MW0YH':'2!I1S354T? N,SF$"3.,SV_EPUD)<.PL.H68E>)/6P;/\D*="SPT]
M\T9R5;;KYRM_]%#>)VM#\&?>[L/'!X[)*_V 1(6S*&BMH^CW[(:7MN-&LU6-
M4RZ+X:'%; ^)GLE*-LA6OA4AQ<I[>L[8ASM7 &A]=\OR]5*KN7C[%63"(/[(
M>$>!"&+*+??M3G*/+I_E%T\O1:#.SL4^C\N@7*?B5Q@'PVQ0)8L5X\ X$A@T
M'A[K%_&^;L!M"@B:(>A<1[J&"3".5&7''6R)VM"4^X18U4I=9AWJW\%Z?VA$
MZB>0BS" C,2;4"^N>A9\T]'*[%NP?,B=0_>2AGVPZ=296LIJOKN,DX^-HC:T
M6@.5WE=P;<E*\%HGP3.AWZ5>R-08/XU=9SRN<? GSW?0L?\BI<^<-+X.'-_V
M<JFHJ=0,_%&(#6\I=E3<7%.@B+I.AOYV,Y\DK6;&6K/:O6- 2X7VOB62YPQD
MJ'X_SL^>3E-'TRO.#@FW QN491%E#*V4D1$X@S+V6#\1O<LF:3A]K/'Z3T/,
MTKZP,7LXCR5[2W3NZ#M0'%,;$7M!T3>R1Q-KG^$A,T3*C.Q_RXR(J2Q@ZKU!
MDT-7 [(L=2S4-!33_$MS.8H[<==PI@ALH8>W"<&X8]--:FMI.(AU_L 8$NJY
M==SLEJC+A3?#OJY/3D?%&^6S\['Y!(Q@_"(T^B9'%RF;K>#,T9PYJFJQ*XV%
MOQ2/(\A_14DEKZ5^F[V3H#X2[[;3?#BI?7NNX^:'0AE:UYVC8B!,YY-?T@R1
MQ><[BSE=7(4R1&2MN&_83NF1^$ACUDK3_'GXF' Y-DND"Y2 I.+9P4G<9=,U
M&":)[.'QV_=\K@/ HG/MH+GC.R=>=Y^N P^-\J6)&4,7&VK+<QE%"Z4+6ZE[
MBZ#O1ZRAIGL<!4V_X?0 H<;LB(REG*5E25KON"[Z_ANR0U(?"T*\,=C$@M-\
M)\6S0P"CO*.X)5ZD"XE<Q-:OHAIG^\0JM2NL"OO"#>^C27X>+^K@48[B7E6S
MF"_0ZA[)JXEL<:*)4V4"+'AA?W!I%@77</3W3=,D)G@J".R]W(^QJ2G9FK?H
MWCZ[@L!*4.$.Y7M(-G0O$4= CBY=9#ULD9(+Z.*0 [.;4J18^,8MZ?YDIO;6
MHGT=S\%N9G] _T+"9(.$J?Y"<N]/F3^4W!NJR<@MH90[UN(!,6VT0O^Y0)/1
M\*\N,7JI^<K^8D.3 I[:[SZ^@_;B+(9YV-1L=S+(LU#0'TWC6JJ^I96K)@22
M[KC(&U3^ RRX1FNWMP/>ZDW^+!"RH?1!WAU*[G EG_^_TC+[8VDI]J?ENT-F
M!5?YX95<0"X%TX422=_/5!;!&R]Z-O--*898X]:28*C"W>[.<A8XP%Q_M_7@
M9ZJM;1CWLXCXX3T%9N&4-' 4>60K;S#9L=/WS!2L(:.IA];P)Z:@NX\1'^W[
MQ?=T\)LZ7P337PX0,G!P^'F]?]O_<<)5^$U^LSS\90/ZP84&3U1JCJWCT<7Y
M2;CC30_>M/P+_<QX;VK^N%02*M("?#\WT#(^T ']GVR\^B]02P,$%     @
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M;*59;7/;N!'^SE^!<=-6GE%D28X3Y^QXQGF;9-I+7-NYFTZG'R 2E' F"08
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M/SP]ZV(8Z1@??)^TC<-,B>Z$8@05*:[H+#9RD,/I=#S%"!HU'\F<G+,$D0$
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M'!4ZL&825N'S9-=5_T'O5Q0>YNFW(KKT1?Z''U2ZI]W/4>?A5YCM\O!;%B(
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M<TV9A(*8/-L=M!F-?LL=0L\":FA$>66*!E%?<WNDPD0HT.U%5>M,M7'<D [
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M3M+M";%1J G6U-;\3H;T3*_@RB)=&L<R^<]9@$(-L6A^9J7BRIR++U>VI?Y
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M6**Y0)0\M;;1@=)L/QW2-J58VB719HQM*M>:Y.FU"S4,U]HV'&VMJYKYXYY
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M2G=A7:8'$:\Q/X%A$D(:I_$!O&&;YM#C#?\[S6MN<J%,K1%^7"R,U?1A_'W
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MK)(:[PFXJ2I!KTM49C>+^M'!\2 WI?6.>#ZMQ097:+_7]^2LN$/)986:I=%
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MY^VV?M$.^]_P]LJX$[21FD%AX5*3RZM1!-2N86M84X?17QOK%BD<2W=S(?D
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MXJPS5\*@<>B#RM"CH'GDP[WUH=/Z9Y:Q-$\UVV(H0]@QF-0_XHN@WW,F(.-
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MH.G5-\#W"\[5[H-^R&?_)-OE_P!02P,$%     @ ;ZMX4N?GUW3# @  50<
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MNX?:.=!ZKI3=&2Y!^Y).?@-02P,$%     @ ;ZMX4M4R5&MF!   ;@X  !D
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MD+N*'#LMY.]ZD[<J?VTG/T]A[[A;^DT?<J>-? )!<H@4?(@4K/EY_R92_OX
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M>*CW09, G@X*D[6;1PEK^D5)%U3-3Q57BY>T7PL0M3MHT.F@D39OX>F10EU
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MSK'%$ ;P?#O@_<O?#Z[]_KCGUWY,M./>Y9;1-;JZAZ)<3Z(^K]>@7J\$XQN
M\Z<O=P@,J/D_!FIMH%ZRJ"/J8C;W%QUF-5#F/P-E/2%]Z3<Q[=CQ_(X)EF\@
MS;=#VI]\0R-M\ 0:MQ'Z\.&VET\-L/DO!VQ3 VQ3.[ I, %D@]Y>FA]76W]&
M;ONQK7F()[6/5=3G41^)V##80D370.>,YQ 9HOCBJ+C)>*J_7UGQ+..QOMQ2
M LVQ6@#OUQS\7=ZH3V(.WWV=_0]02P,$%     @ ;ZMX4A82VX*I P  Y D
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M6<;J;6.]\EHM_L-7IV3@G!#/<:=-@-K5Y^"CNJO5/:=!?7ZPNCMKB690[MS
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M1X\DD-*2X[W<?X7:S]#RQ9)K]TOV=6W@D;C4*/,:;!3D3%1/>JC[< ((1RV
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M#4[/)QZH_C+WAI&MNP\K:>AVN65%[Q\J&T#[I91F9]@K-KZHV5]02P,$%
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MP/MS!;KQ+^CK"=477J[^!U!+ P04    " !OJWA23]&:IQ@#  ",$0  #0
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M%     @ ;ZMX4I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M^8T**AF0-IXF8,H0IFR73&1O1K7[0P7MFV(^!I Y IG'A9S[Z_HQAJB27*U
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M 7H;U-N\4V_G'[5U<\]SC?N_DVH_OFOG[:?E\^;BZYUPUG":>?P%4$L#!!0
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M@2I'H2I'P2I'X2I' 2M'(:M (:M (:M (:M (:M (:M (:M (:M (:M (:M
M(6N*0M84A:PI"EE3%+*F_TG6#ZV7?_T/L%V36JKFX,^Z'ZVS+U!+ 0(4 Q0
M   ( &^K>%('04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ ;ZMX4KD^O\3O    *P(  !$
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M970R+GAM;%!+ 0(4 Q0    ( &^K>%+A6A4\#0,  , *   8
M  " @?,3  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !O
MJWA2QA 8Y#,$   @#@  &               @($V%P  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ ;ZMX4F<<6XF3!   M!(  !@
M         ("!GQL  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( &^K>%*AGBTQ3P(  !L%   8              " @6@@  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !OJWA2J6D0MM@&  !W'
M&               @('M(@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ ;ZMX4GLU=Z[]%0  4T(  !@              ("!^RD  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( &^K>%(5KNG*(1(
M #LQ   8              " @2Y   !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " !OJWA2)ODCR1(#  "H!@  &0              @(&%
M4@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( &^K>%(]
MUR\34 0  #D*   9              " @<Y5  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ ;ZMX4J_3"E;E"P  OB$  !D
M     ("!55H  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &^K>%(.U7=6L T  / C   9              "
M@:&"  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ ;ZMX
M4DG_]G+5$@  EC<  !D              ("!B)   'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " !OJWA20O[B7]8#  #T"   &0
M        @(&4HP  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( &^K>%*WZ^XY.@,  ($(   9              " @:&G  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ ;ZMX4H&?FGAO @  %P4
M !D              ("!$JL  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " !OJWA2PVKP0!0(  #5)@  &0              @(&XK0
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( &^K>%+GY]=T
MPP(  %4'   9              " @0.V  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ ;ZMX4M4R5&MF!   ;@X  !D
M ("!_;@  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !O
MJWA2N2JF.+L#   L"P  &0              @(&:O0  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( &^K>%+I@[==Y@,  'T)   9
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M970S,"YX;6Q02P$"% ,4    " !OJWA2,\W2P]<"   M"0  &0
M    @(%[W   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M &^K>%+S9YIJ:0(  !P'   9              " @8G?  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ ;ZMX4GN BW!* @  704  !D
M             ("!*>(  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " !OJWA2X0Z0CS\*  #\(@  &0              @(&JY   >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( &^K>%)/T9JG& ,
M (P1   -              "  2#O  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     J "H 70L  $CZ      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>71</ContextCount>
  <ElementCount>276</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>24</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Statements of Changes in Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Statements of Changes in Stockholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Statements of Changes in Stockholders??? Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ShareholdersEquityType2or3_Parentheticals</Role>
      <ShortName>Statements of Changes in Stockholders??? Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Description of Organization and Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/DescriptionofOrganizationandBusinessOperations</Role>
      <ShortName>Description of Organization and Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/InitialPublicOffering</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Private Placement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/PrivatePlacement</Role>
      <ShortName>Private Placement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://thcb.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thcb.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Income Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/IncomeTaxTables</Role>
      <ShortName>Income Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thcb.com/role/IncomeTax</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thcb.com/role/FairValueMeasurements</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Description of Organization and Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails</Role>
      <ShortName>Description of Organization and Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/DescriptionofOrganizationandBusinessOperations</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable</Role>
      <ShortName>Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Initial Public Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/InitialPublicOfferingDetails</Role>
      <ShortName>Initial Public Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/InitialPublicOffering</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Private Placement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/PrivatePlacementDetails</Role>
      <ShortName>Private Placement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/PrivatePlacement</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/RelatedPartyTransactions</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/CommitmentsDetails</Role>
      <ShortName>Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/Commitments</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/StockholdersEquity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Income Tax (Details) - Schedule of net deferred tax liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable</Role>
      <ShortName>Income Tax (Details) - Schedule of net deferred tax liability</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/IncomeTaxTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Income Tax (Details) - Schedule of income tax provision</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ScheduleofincometaxprovisionTable</Role>
      <ShortName>Income Tax (Details) - Schedule of income tax provision</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/IncomeTaxTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Income Tax (Details) - Schedule of federal income tax rate to effective tax rate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable</Role>
      <ShortName>Income Tax (Details) - Schedule of federal income tax rate to effective tax rate</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/IncomeTaxTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable</Role>
      <ShortName>Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="f10k2020_tuscanhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thcb.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thcb.com/role/SubsequentEvents</ParentRole>
      <Position>34</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="f10k2020_tuscanhold.htm">f10k2020_tuscanhold.htm</File>
    <File>f10k2020ex10-9_tuscanhold.htm</File>
    <File>f10k2020ex21_tuscanhold.htm</File>
    <File>f10k2020ex31-1_tuscanhold.htm</File>
    <File>f10k2020ex31-2_tuscanhold.htm</File>
    <File>f10k2020ex32_tuscanhold.htm</File>
    <File>f10k2020ex4-5_tuscanhold.htm</File>
    <File>thcb-20201231.xsd</File>
    <File>thcb-20201231_cal.xml</File>
    <File>thcb-20201231_def.xml</File>
    <File>thcb-20201231_lab.xml</File>
    <File>thcb-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>54
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f10k2020_tuscanhold.htm": {
   "axisCustom": 1,
   "axisStandard": 10,
   "contextCount": 71,
   "dts": {
    "calculationLink": {
     "local": [
      "thcb-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "thcb-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "f10k2020_tuscanhold.htm"
     ]
    },
    "labelLink": {
     "local": [
      "thcb-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "thcb-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "thcb-20201231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 317,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 27,
    "http://thcb.com/20201231": 8,
    "http://xbrl.sec.gov/dei/2019-01-31": 9,
    "total": 44
   },
   "keyCustom": 52,
   "keyStandard": 224,
   "memberCustom": 12,
   "memberStandard": 10,
   "nsprefix": "thcb",
   "nsuri": "http://thcb.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://thcb.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "thcb:InitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Initial Public Offering",
     "role": "http://thcb.com/role/InitialPublicOffering",
     "shortName": "Initial Public Offering",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "thcb:InitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "thcb:PrivatePlacementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Private Placement",
     "role": "http://thcb.com/role/PrivatePlacement",
     "shortName": "Private Placement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "thcb:PrivatePlacementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Related Party Transactions",
     "role": "http://thcb.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Commitments",
     "role": "http://thcb.com/role/Commitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Stockholders' Equity",
     "role": "http://thcb.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Income Tax",
     "role": "http://thcb.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Fair Value Measurements",
     "role": "http://thcb.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Subsequent Events",
     "role": "http://thcb.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Accounting Policies, by Policy (Policies)",
     "role": "http://thcb.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Balance Sheets",
     "role": "http://thcb.com/role/ConsolidatedBalanceSheet",
     "shortName": "Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c4",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Income Tax (Tables)",
     "role": "http://thcb.com/role/IncomeTaxTables",
     "shortName": "Income Tax (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://thcb.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "thcb:IssuanceOfUnitsDescription",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c3",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Description of Organization and Business Operations (Details)",
     "role": "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
     "shortName": "Description of Organization and Business Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "lang": "en-US",
      "name": "thcb:IssuanceOfUnitsDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "thcb:CashWithdrawnFromTrustAccountToPayFranchise",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "role": "http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "thcb:CashWithdrawnFromTrustAccountToPayFranchise",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestAndDividendIncomeSecuritiesOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share",
     "role": "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable",
     "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestAndDividendIncomeSecuritiesOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "thcb:IssuanceOfUnitsDescription",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c3",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Initial Public Offering (Details)",
     "role": "http://thcb.com/role/InitialPublicOfferingDetails",
     "shortName": "Initial Public Offering (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationReasonForBusinessCombination",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c39",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Private Placement (Details)",
     "role": "http://thcb.com/role/PrivatePlacementDetails",
     "shortName": "Private Placement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c39",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockDescriptionOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "thcb:CommonStockDividendDescription",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c43",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Related Party Transactions (Details)",
     "role": "http://thcb.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "thcb:CommonStockDividendDescription",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c43",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Commitments (Details)",
     "role": "http://thcb.com/role/CommitmentsDetails",
     "shortName": "Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c53",
      "decimals": "-5",
      "lang": null,
      "name": "thcb:TransactionFee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://thcb.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "lang": "en-US",
      "name": "thcb:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "thcb:CommonSharesSubjectToPossibleRedemption",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Balance Sheets (Parentheticals)",
     "role": "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "shortName": "Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Income Tax (Details) - Schedule of net deferred tax liability",
     "role": "http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable",
     "shortName": "Income Tax (Details) - Schedule of net deferred tax liability",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Income Tax (Details) - Schedule of income tax provision",
     "role": "http://thcb.com/role/ScheduleofincometaxprovisionTable",
     "shortName": "Income Tax (Details) - Schedule of income tax provision",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Income Tax (Details) - Schedule of federal income tax rate to effective tax rate",
     "role": "http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable",
     "shortName": "Income Tax (Details) - Schedule of federal income tax rate to effective tax rate",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c57",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs",
     "role": "http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable",
     "shortName": "Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c57",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockConversionBasis",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c61",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SubsequentEventEffectOfChangeInTaxStatus",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - Subsequent Events (Details)",
     "role": "http://thcb.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockConversionBasis",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c61",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SubsequentEventEffectOfChangeInTaxStatus",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Statements of Operations",
     "role": "http://thcb.com/role/ConsolidatedIncomeStatement",
     "shortName": "Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Statements of Changes in Stockholders\u2019 Equity",
     "role": "http://thcb.com/role/ShareholdersEquityType2or3",
     "shortName": "Statements of Changes in Stockholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Statements of Changes in Stockholders\u2019 Equity (Parentheticals)",
     "role": "http://thcb.com/role/ShareholdersEquityType2or3_Parentheticals",
     "shortName": "Statements of Changes in Stockholders\u2019 Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "006 - Statement - Statements of Cash Flows",
     "role": "http://thcb.com/role/ConsolidatedCashFlow",
     "shortName": "Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": "0",
      "lang": null,
      "name": "thcb:IncreaseDecreaseInMarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - Description of Organization and Business Operations",
     "role": "http://thcb.com/role/DescriptionofOrganizationandBusinessOperations",
     "shortName": "Description of Organization and Business Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://thcb.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2020_tuscanhold.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 24,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://thcb.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r104",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_AdditionalSharesOfCommonStockEarn": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares of common stock earn.",
        "label": "AdditionalSharesOfCommonStockEarn",
        "terseLabel": "Additional shares of common stock will earn (in Shares)"
       }
      }
     },
     "localname": "AdditionalSharesOfCommonStockEarn",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_AgreementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AgreementAxis",
        "terseLabel": "Agreement [Axis]"
       }
      }
     },
     "localname": "AgreementAxis",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_AgreementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreement [Domain]"
       }
      }
     },
     "localname": "AgreementDomain",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_AmountDepositInTrustAccount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount deposit in trust account",
        "label": "AmountDepositInTrustAccount",
        "terseLabel": "Deposit amount in trust account"
       }
      }
     },
     "localname": "AmountDepositInTrustAccount",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_AmountDrawn": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount drawn.",
        "label": "AmountDrawn",
        "terseLabel": "Amount drawn"
       }
      }
     },
     "localname": "AmountDrawn",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basic and diluted net income per common share (in Dollars per share).",
        "label": "BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption",
        "terseLabel": "Basic and diluted net income per common share (in Dollars per share)"
       }
      }
     },
     "localname": "BasicAndDilutedNetIncomelossPerShareCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "thcb_BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe",
        "terseLabel": "Basic and diluted net income per share, Common stock subject to possible redemption (in Dollars per share)"
       }
      }
     },
     "localname": "BasicAndDilutedNetLossPerShareCommonStockSubjectToPossibleRedemptioninDollarsPe",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede",
        "terseLabel": "Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption (in Shares)"
       }
      }
     },
     "localname": "BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRede",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basic and diluted weighted average shares outstanding (in Shares).",
        "label": "BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption",
        "terseLabel": "Basic and diluted weighted average shares outstanding (in Shares)"
       }
      }
     },
     "localname": "BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_BridgeNotesConversionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BridgeNotesConversionMember",
        "terseLabel": "Bridge Notes Conversion [Member]"
       }
      }
     },
     "localname": "BridgeNotesConversionMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_CashWithdrawnAccountForRedemptions": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash withdrawn account for redemptions.",
        "label": "CashWithdrawnAccountForRedemptions",
        "terseLabel": "Cash withdrawn from Trust Account for redemptions"
       }
      }
     },
     "localname": "CashWithdrawnAccountForRedemptions",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_CashWithdrawnFromTrustAccountToPayFranchise": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash withdrawn from Trust Account to pay franchise.",
        "label": "CashWithdrawnFromTrustAccountToPayFranchise",
        "terseLabel": "Cash withdrawn from trust account to pay franchise"
       }
      }
     },
     "localname": "CashWithdrawnFromTrustAccountToPayFranchise",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_CashWithdrawnFromTrustAccountToPayIncomeTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CashWithdrawnFromTrustAccountToPayIncomeTaxes",
        "terseLabel": "Cash withdrawn from Trust Account to pay income taxes"
       }
      }
     },
     "localname": "CashWithdrawnFromTrustAccountToPayIncomeTaxes",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in value of common stock subject to possible redemption.",
        "label": "ChangeInValueOfCommonStockSubjectToPossibleRedemption",
        "terseLabel": "Change in value of common stock subject to possible redemption"
       }
      }
     },
     "localname": "ChangeInValueOfCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in value of common stock subject to possible redemption shares.",
        "label": "ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares",
        "terseLabel": "Change in value of common stock subject to possible redemption (in Shares)"
       }
      }
     },
     "localname": "ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_ChangeInValueOfCommonStockSubjectToRedemption": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in value of common stock subject to redemption.",
        "label": "ChangeInValueOfCommonStockSubjectToRedemption",
        "terseLabel": "Change in value of common stock subject to possible redemption"
       }
      }
     },
     "localname": "ChangeInValueOfCommonStockSubjectToRedemption",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants description.",
        "label": "ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings",
        "terseLabel": "Warrants description"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstandings",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_CommitmentsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments (Details) [Line Items]"
       }
      }
     },
     "localname": "CommitmentsDetailsLineItems",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_CommitmentsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments (Details) [Table]"
       }
      }
     },
     "localname": "CommitmentsDetailsTable",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_CommonSharesSubjectToPossibleRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CommonSharesSubjectToPossibleRedemption",
        "terseLabel": "Common stock subject to possible redemption"
       }
      }
     },
     "localname": "CommonSharesSubjectToPossibleRedemption",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_CommonStockDividendDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CommonStockDividendDescription",
        "terseLabel": "Common stock dividend description"
       }
      }
     },
     "localname": "CommonStockDividendDescription",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_CommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock subject to possible redemption.",
        "label": "CommonStockSubjectToPossibleRedemption",
        "terseLabel": "Common stock subject to possible redemption"
       }
      }
     },
     "localname": "CommonStockSubjectToPossibleRedemption",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_CommonStockSubjectToPossibleRedemptionPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Common stock subject to possible redemption.",
        "label": "CommonStockSubjectToPossibleRedemptionPolicyTextBlock",
        "terseLabel": "Common Stock Subject to Possible Redemption"
       }
      }
     },
     "localname": "CommonStockSubjectToPossibleRedemptionPolicyTextBlock",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "thcb_CommonStockSubjectToPossibleRedemptionShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock subject to possible redemption shares.",
        "label": "CommonStockSubjectToPossibleRedemptionShares",
        "terseLabel": "Common stock subject to possible redemption (in Shares)"
       }
      }
     },
     "localname": "CommonStockSubjectToPossibleRedemptionShares",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_CosponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CosponsorMember",
        "terseLabel": "Co-sponsor [Member]"
       }
      }
     },
     "localname": "CosponsorMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_DeferredTaxLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DeferredTaxLiabilityAbstract",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilityAbstract",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_DenominatorWeightedAverageNonRedeemableCommonStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DenominatorWeightedAverageNonRedeemableCommonStockAbstract",
        "terseLabel": "Denominator: Weighted Average Non-Redeemable Common Stock"
       }
      }
     },
     "localname": "DenominatorWeightedAverageNonRedeemableCommonStockAbstract",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_DescriptionofOrganizationandBusinessOperationsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Organization and Business Operations (Details) [Line Items]"
       }
      }
     },
     "localname": "DescriptionofOrganizationandBusinessOperationsDetailsLineItems",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_DescriptionofOrganizationandBusinessOperationsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Organization and Business Operations (Details) [Table]"
       }
      }
     },
     "localname": "DescriptionofOrganizationandBusinessOperationsDetailsTable",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://thcb.com/20201231",
     "xbrltype": "stringItemType"
    },
    "thcb_EarlyBirdCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EarlyBirdCapitalMember",
        "terseLabel": "Early Bird Capital [Member]",
        "verboseLabel": "EarlyBirdCapital [Member]"
       }
      }
     },
     "localname": "EarlyBirdCapitalMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_EmergingGrowthPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It reperents emerging growth company policy text block.",
        "label": "EmergingGrowthPolicyTextBlock",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EmergingGrowthPolicyTextBlock",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs [Line Items]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsLineItems",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) - Schedule of fair value hierarchy of the valuation inputs [Table]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsScheduleoffairvaluehierarchyofthevaluationinputsTable",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_FederalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FederalAbstract",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "FederalAbstract",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofincometaxprovisionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_FoundeSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FoundeSharesMember",
        "terseLabel": "Founder Shares [Member]"
       }
      }
     },
     "localname": "FoundeSharesMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_GrossProceedsFromFinancing": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross proceeds from financing.",
        "label": "GrossProceedsFromFinancing",
        "terseLabel": "Gross proceeds from financing"
       }
      }
     },
     "localname": "GrossProceedsFromFinancing",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_IncomeAdjustedNetLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted net loss.",
        "label": "IncomeAdjustedNetLoss",
        "negatedLabel": "Non-Redeemable Net Loss"
       }
      }
     },
     "localname": "IncomeAdjustedNetLoss",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_IncomeAndFranchiseTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Less: Income and franchise taxes.",
        "label": "IncomeAndFranchiseTaxes",
        "negatedLabel": "Less: Income and franchise taxes"
       }
      }
     },
     "localname": "IncomeAndFranchiseTaxes",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_IncomeAttributableToCommonStockSubjectToRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncomeAttributableToCommonStockSubjectToRedemption",
        "terseLabel": "Less: Income attributable to common stock subject to possible redemption"
       }
      }
     },
     "localname": "IncomeAttributableToCommonStockSubjectToRedemption",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_IncreaseDecreaseInMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest earned on marketable securities held in Trust Account.",
        "label": "IncreaseDecreaseInMarketableSecurities",
        "negatedLabel": "Interest earned on marketable securities held in Trust Account"
       }
      }
     },
     "localname": "IncreaseDecreaseInMarketableSecurities",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_IncreaseDecreaseUnrealizedGainMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized gain on marketable securities held in Trust Account.",
        "label": "IncreaseDecreaseUnrealizedGainMarketableSecurities",
        "negatedLabel": "Unrealized gain on marketable securities held in Trust Account"
       }
      }
     },
     "localname": "IncreaseDecreaseUnrealizedGainMarketableSecurities",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_InitialClassificationOfCommonStockSubjectToRedemption": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial classification of common stock subject to redemption.",
        "label": "InitialClassificationOfCommonStockSubjectToRedemption",
        "terseLabel": "Initial classification of common stock subject to possible redemption"
       }
      }
     },
     "localname": "InitialClassificationOfCommonStockSubjectToRedemption",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_InitialPublicOfferingDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering (Details) [Line Items]"
       }
      }
     },
     "localname": "InitialPublicOfferingDetailsLineItems",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_InitialPublicOfferingDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering (Details) [Table]"
       }
      }
     },
     "localname": "InitialPublicOfferingDetailsTable",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_InitialPublicOfferingDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering Disclosure [Abstract]"
       }
      }
     },
     "localname": "InitialPublicOfferingDisclosureAbstract",
     "nsuri": "http://thcb.com/20201231",
     "xbrltype": "stringItemType"
    },
    "thcb_InitialPublicOfferingDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "InitialPublicOfferingDisclosureTextBlock",
        "terseLabel": "INITIAL PUBLIC OFFERING"
       }
      }
     },
     "localname": "InitialPublicOfferingDisclosureTextBlock",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/InitialPublicOffering"
     ],
     "xbrltype": "textBlockItemType"
    },
    "thcb_IssuanceOfUnitsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.",
        "label": "IssuanceOfUnitsDescription",
        "terseLabel": "Issuance of units, description"
       }
      }
     },
     "localname": "IssuanceOfUnitsDescription",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_IssuedAndOutstandingSharesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of issued and outstanding shares.",
        "label": "IssuedAndOutstandingSharesPercentage",
        "terseLabel": "Percentage of issued and outstanding shares"
       }
      }
     },
     "localname": "IssuedAndOutstandingSharesPercentage",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "thcb_MergerAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MergerAgreementMember",
        "terseLabel": "Merger Agreement [Member]"
       }
      }
     },
     "localname": "MergerAgreementMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_MicrovastPowerSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MicrovastPowerSystemMember",
        "terseLabel": "Microvast Power System [Member]"
       }
      }
     },
     "localname": "MicrovastPowerSystemMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_MorganStanleyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MorganStanleyMember",
        "terseLabel": "Morgan Stanley [Member]"
       }
      }
     },
     "localname": "MorganStanleyMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_NumberOfCommonStockConvertedByEquityInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common stock converted by equity interests",
        "label": "NumberOfCommonStockConvertedByEquityInterests",
        "terseLabel": "Number of common stock converted by equity interests (in Shares)"
       }
      }
     },
     "localname": "NumberOfCommonStockConvertedByEquityInterests",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract",
        "terseLabel": "Numerator: Earnings allocable to Common stock subject to possible redemption"
       }
      }
     },
     "localname": "NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_NumeratorNetIncomeMinusNetEarningsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NumeratorNetIncomeMinusNetEarningsAbstract",
        "terseLabel": "Numerator Net Income minus Net Earnings"
       }
      }
     },
     "localname": "NumeratorNetIncomeMinusNetEarningsAbstract",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_OtherOfferingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other offering costs.",
        "label": "OtherOfferingCosts",
        "terseLabel": "Other offering costs"
       }
      }
     },
     "localname": "OtherOfferingCosts",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_PaymentOfOfferingCosts": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of offering costs.",
        "label": "PaymentOfOfferingCosts",
        "negatedLabel": "Payment of offering costs"
       }
      }
     },
     "localname": "PaymentOfOfferingCosts",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_PercentageOfGrossProceedsRaisedInFinancing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of gross proceeds raised in financing.",
        "label": "PercentageOfGrossProceedsRaisedInFinancing",
        "terseLabel": "Percentage of gross proceeds raised in financing"
       }
      }
     },
     "localname": "PercentageOfGrossProceedsRaisedInFinancing",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "thcb_PercentageOfPlacementFee": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of  placement fee.",
        "label": "PercentageOfPlacementFee",
        "terseLabel": "Percentage of placement fee"
       }
      }
     },
     "localname": "PercentageOfPlacementFee",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "thcb_PercentageOfTrustAccountRequiredForBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of trust account required for business combination.",
        "label": "PercentageOfTrustAccountRequiredForBusinessCombination",
        "terseLabel": "Minimum percentage of trust account required for business combination"
       }
      }
     },
     "localname": "PercentageOfTrustAccountRequiredForBusinessCombination",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "thcb_PrivateInvestmentInPublicEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PrivateInvestmentInPublicEquityMember",
        "terseLabel": "PIPE [Member]"
       }
      }
     },
     "localname": "PrivateInvestmentInPublicEquityMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_PrivatePlacementDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement (Details) [Line Items]"
       }
      }
     },
     "localname": "PrivatePlacementDetailsLineItems",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_PrivatePlacementDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement (Details) [Table]"
       }
      }
     },
     "localname": "PrivatePlacementDetailsTable",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_PrivatePlacementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Disclosure [Abstract]"
       }
      }
     },
     "localname": "PrivatePlacementDisclosureAbstract",
     "nsuri": "http://thcb.com/20201231",
     "xbrltype": "stringItemType"
    },
    "thcb_PrivatePlacementDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PrivatePlacementDisclosureTextBlock",
        "terseLabel": "PRIVATE PLACEMENT"
       }
      }
     },
     "localname": "PrivatePlacementDisclosureTextBlock",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/PrivatePlacement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "thcb_PrivateUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PrivateUnitsMember",
        "terseLabel": "Private Units [Member]"
       }
      }
     },
     "localname": "PrivateUnitsMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_ProceedsFromConvertiblePromissoryNoteRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from convertible promissory note \u2013 related party.",
        "label": "ProceedsFromConvertiblePromissoryNoteRelatedParty",
        "terseLabel": "Proceeds from convertible promissory note \u2013 related party"
       }
      }
     },
     "localname": "ProceedsFromConvertiblePromissoryNoteRelatedParty",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_ProceedsFromPromissoryNotesRelatedparty": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from promissory note - related party.",
        "label": "ProceedsFromPromissoryNotesRelatedparty",
        "terseLabel": "Proceeds from promissory note \u2013 related party"
       }
      }
     },
     "localname": "ProceedsFromPromissoryNotesRelatedparty",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_ProceedsFromSaleOfPrivateUnits": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of Private Units.",
        "label": "ProceedsFromSaleOfPrivateUnits",
        "terseLabel": "Proceeds from sale of Private Units"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPrivateUnits",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_ProceedsFromSalesOfUnitsUnderwritingDiscount": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of Units, net of underwriting discounts.",
        "label": "ProceedsFromSalesOfUnitsUnderwritingDiscount",
        "terseLabel": "Proceeds from sale of Units, net of underwriting discounts paid"
       }
      }
     },
     "localname": "ProceedsFromSalesOfUnitsUnderwritingDiscount",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_PublicSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public share price.",
        "label": "PublicSharePrice",
        "terseLabel": "Public per share (in Dollars per share)"
       }
      }
     },
     "localname": "PublicSharePrice",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "thcb_RelatedPartyServicesFeesAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party services fees amount.",
        "label": "RelatedPartyServicesFeesAmount",
        "terseLabel": "Service fees"
       }
      }
     },
     "localname": "RelatedPartyServicesFeesAmount",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_RelatedPartyTransactionsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDetailsLineItems",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_RelatedPartyTransactionsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) [Table]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDetailsTable",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_RepaymentOfPromissoryNoteRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment of promissory note \u2013 related party.",
        "label": "RepaymentOfPromissoryNoteRelatedParty",
        "negatedLabel": "Repayment of promissory note \u2013 related party"
       }
      }
     },
     "localname": "RepaymentOfPromissoryNoteRelatedParty",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_SaleOfPrivateUnitAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Private Units.",
        "label": "SaleOfPrivateUnitAmount",
        "terseLabel": "Sale of Private Units"
       }
      }
     },
     "localname": "SaleOfPrivateUnitAmount",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_SaleOfStockNumberOfSharesIssuedInTransactions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "SaleOfStockNumberOfSharesIssuedInTransactions",
        "terseLabel": "Shares in units (in Shares)",
        "verboseLabel": "Common stock shares purchased"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransactions",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_ScheduleOfBasicAndDilutedLossPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of basic and diluted loss per share [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfBasicAndDilutedLossPerShareAbstract",
     "nsuri": "http://thcb.com/20201231",
     "xbrltype": "stringItemType"
    },
    "thcb_ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value hierarchy of the valuation inputs [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfFairValueHierarchyOfTheValuationInputsAbstract",
     "nsuri": "http://thcb.com/20201231",
     "xbrltype": "stringItemType"
    },
    "thcb_ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of federal income tax rate to effective tax rate [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfFederalIncomeTaxRateToEffectiveTaxRateAbstract",
     "nsuri": "http://thcb.com/20201231",
     "xbrltype": "stringItemType"
    },
    "thcb_ScheduleOfIncomeTaxProvisionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of income tax provision [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfIncomeTaxProvisionAbstract",
     "nsuri": "http://thcb.com/20201231",
     "xbrltype": "stringItemType"
    },
    "thcb_ScheduleOfNetDeferredTaxLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of net deferred tax liability [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfNetDeferredTaxLiabilityAbstract",
     "nsuri": "http://thcb.com/20201231",
     "xbrltype": "stringItemType"
    },
    "thcb_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SponsorMember",
        "terseLabel": "Sponsor [Member]"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/PrivatePlacementDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_SponsorPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The share purchase of  Sponsor purchased.",
        "label": "SponsorPurchased",
        "terseLabel": "Sponsor purchased (in Shares)"
       }
      }
     },
     "localname": "SponsorPurchased",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_StateAndLocalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "StateAndLocalAbstract",
        "terseLabel": "State and Local"
       }
      }
     },
     "localname": "StateAndLocalAbstract",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ScheduleofincometaxprovisionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of underwriting discounts and offering costs.",
        "label": "StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts",
        "terseLabel": "Sale of 27,600,000 Units, net of underwriting discount and offering expenses"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCosts",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of underwriting shares discounts and offering cost.",
        "label": "StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares",
        "terseLabel": "Sale of 27,600,000 Units, net of underwriting discount and offering expenses (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueSalesUnderwritingDiscountAndOfferingCostsShares",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "thcb_StockholdersEquityDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity (Details) [Line Items]"
       }
      }
     },
     "localname": "StockholdersEquityDetailsLineItems",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_StockholdersEquityDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity (Details) [Table]"
       }
      }
     },
     "localname": "StockholdersEquityDetailsTable",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_SubscriptionAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SubscriptionAgreementsMember",
        "terseLabel": "Subscription Agreements [Member]"
       }
      }
     },
     "localname": "SubscriptionAgreementsMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_SubsequentEventsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsLineItems",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_SubsequentEventsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsTable",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_SummaryofSignificantAccountingPoliciesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_SummaryofSignificantAccountingPoliciesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "localname": "SummaryofSignificantAccountingPoliciesDetailsTable",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "thcb_TransactionFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction fee.",
        "label": "TransactionFee",
        "terseLabel": "Transaction fee"
       }
      }
     },
     "localname": "TransactionFee",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_UnderwritersDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriters discount.",
        "label": "UnderwritersDiscount",
        "terseLabel": "Underwriters discount"
       }
      }
     },
     "localname": "UnderwritersDiscount",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "thcb_VogelPartnersLlpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "VogelPartnersLlpMember",
        "terseLabel": "Vogel Partners, LLP [Member]"
       }
      }
     },
     "localname": "VogelPartnersLlpMember",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "thcb_WorkingCapitalLoans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of working capital loans.",
        "label": "WorkingCapitalLoans",
        "terseLabel": "Working capital loans"
       }
      }
     },
     "localname": "WorkingCapitalLoans",
     "nsuri": "http://thcb.com/20201231",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r233",
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r17",
      "r138"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r135",
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r63",
      "r96",
      "r98",
      "r102",
      "r107",
      "r177",
      "r181",
      "r189",
      "r228",
      "r243"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r7",
      "r35",
      "r63",
      "r107",
      "r177",
      "r181",
      "r189"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrustCurrent": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Assets Held-in-trust, Current",
        "terseLabel": "Amount held of trust account"
       }
      }
     },
     "localname": "AssetsHeldInTrustCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r132",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.",
        "label": "Business Acquisition, Description of Acquired Entity",
        "terseLabel": "Description of business combination",
        "verboseLabel": "Equityholders, description"
       }
      }
     },
     "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of outstanding voting securities"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Entity price per unit (in Dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.",
        "label": "Business Combination, Consideration Transferred, Other",
        "terseLabel": "Net tangible assets of business combination"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationControlObtainedDescription": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a description of how the entity obtained control of the acquired entity.",
        "label": "Business Combination, Control Obtained Description",
        "terseLabel": "Description of business combination"
       }
      }
     },
     "localname": "BusinessCombinationControlObtainedDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationReasonForBusinessCombination": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a description of the primary reason for the business combination which may consist of general categories such as top-line growth, synergistic benefits, market share, and diversification and the more detailed factors that might apply.",
        "label": "Business Combination, Reason for Business Combination",
        "terseLabel": "Business combination, description"
       }
      }
     },
     "localname": "BusinessCombinationReasonForBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r24",
      "r258",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Available cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r24",
      "r55"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash \u2013 End of period",
        "periodStartLabel": "Cash \u2013 Beginning of period",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet",
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r8",
      "r56",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r49",
      "r190"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net Change in Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r33",
      "r112",
      "r234",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/Commitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockConversionBasis": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of basis for conversion of convertible common stock.",
        "label": "Common Stock, Conversion Basis",
        "terseLabel": "Merger agreement, description"
       }
      }
     },
     "localname": "CommonStockConversionBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividend share (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsShares": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits.",
        "label": "Common Stock Dividends, Shares",
        "terseLabel": "Common stock dividend shares (in Shares)"
       }
      }
     },
     "localname": "CommonStockDividendsShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r69",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "verboseLabel": "Common stock issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding",
        "verboseLabel": "Common stock outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 65,000,000 shares authorized; 8,396,246 and 8,360,523 shares issued and outstanding (excluding 27,087,556 and 27,126,477 shares subject to possible redemption) at December 31, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r89",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r58",
      "r59",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Number of shares of common stock issued (in Shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r12",
      "r231",
      "r245",
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "terseLabel": "Aggregate of outstanding promissory notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "terseLabel": "Expenses pay by sponsor"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r64",
      "r156",
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofincometaxprovisionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r64",
      "r156",
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofincometaxprovisionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r229",
      "r231",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentDescription": {
     "auth_ref": [
      "r10",
      "r12",
      "r118",
      "r229",
      "r231",
      "r239",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.",
        "label": "Debt Instrument, Description",
        "terseLabel": "Loan commitment, description"
       }
      }
     },
     "localname": "DebtInstrumentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r199",
      "r200"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate amount of loans",
        "verboseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r198",
      "r200"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Sale of Units, net of underwriting discounts"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r64",
      "r157",
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofincometaxprovisionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r53",
      "r64",
      "r157",
      "r163",
      "r164",
      "r165"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred tax provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r13",
      "r14",
      "r148",
      "r230",
      "r241"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedLabel": "Total deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r141",
      "r142"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r64",
      "r157",
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofincometaxprovisionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r142",
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities": {
     "auth_ref": [
      "r154",
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on trading securities.",
        "label": "Deferred Tax Liabilities, Unrealized Gains on Trading Securities",
        "negatedLabel": "Unrealized gain on marketable securities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofnetdeferredtaxliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r26",
      "r67",
      "r204"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Related Parties, Current",
        "terseLabel": "Advances from related party"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Basic and diluted net loss per common share, Common stock (in Dollars per share)",
        "verboseLabel": "Basic and diluted net loss per common share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement",
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r61",
      "r84",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income (Loss) Per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r144",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory federal income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r144",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleoffederalincometaxratetoeffectivetaxrateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r73",
      "r78",
      "r80",
      "r86",
      "r108",
      "r117",
      "r119",
      "r135",
      "r136",
      "r137",
      "r159",
      "r160",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r253",
      "r254",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/ShareholdersEquityType2or3",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Percentage of ownership"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense related to distribution, servicing and underwriting fees.",
        "label": "Expense Related to Distribution or Servicing and Underwriting Fees",
        "terseLabel": "Underwriting fees"
       }
      }
     },
     "localname": "ExpenseRelatedToDistributionOrServicingAndUnderwritingFees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r184",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of fair value hierarchy of the valuation inputs"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r130",
      "r185",
      "r212",
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r122",
      "r123",
      "r128",
      "r130",
      "r185",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r61",
      "r187",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FederalDepositInsuranceCorporationPremiumExpense": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance.",
        "label": "Federal Deposit Insurance Corporation Premium Expense",
        "terseLabel": "Federal depository insurance coverage"
       }
      }
     },
     "localname": "FederalDepositInsuranceCorporationPremiumExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "Initial Public Offering [Member]",
        "verboseLabel": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r66",
      "r96",
      "r97",
      "r100",
      "r101",
      "r103"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r145",
      "r146",
      "r152",
      "r161",
      "r167",
      "r169",
      "r170",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAX"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r64",
      "r79",
      "r80",
      "r95",
      "r143",
      "r162",
      "r168",
      "r252"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "terseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement",
      "http://thcb.com/role/ScheduleofincometaxprovisionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r39",
      "r61",
      "r139",
      "r140",
      "r146",
      "r147",
      "r151",
      "r158",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofincometaxprovisionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r50",
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeSecuritiesOther": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other operating dividend and interest income, including amortization and accretion of premiums and discounts, on securities.",
        "label": "Interest and Dividend Income, Securities, Operating, Other",
        "terseLabel": "Interest earned on marketable securities held in Trust Account"
       }
      }
     },
     "localname": "InterestAndDividendIncomeSecuritiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOther": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income earned from interest bearing assets classified as other.",
        "label": "Interest Income, Other",
        "terseLabel": "Interest earned on marketable securities held in Trust Account"
       }
      }
     },
     "localname": "InterestIncomeOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r28",
      "r63",
      "r99",
      "r107",
      "r178",
      "r181",
      "r182",
      "r189"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r21",
      "r63",
      "r107",
      "r189",
      "r232",
      "r248"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r30",
      "r63",
      "r107",
      "r178",
      "r181",
      "r182",
      "r189"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r3",
      "r29"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Cash and marketable securities held in Trust Account"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleoffairvaluehierarchyofthevaluationinputsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Cash and marketable securities held in Trust Account"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Cash and Marketable Securities Held in Trust Account"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Marketable Securities, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gain on marketable securities held in Trust Account"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r49",
      "r51",
      "r54"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r37",
      "r38",
      "r40",
      "r54",
      "r63",
      "r72",
      "r74",
      "r75",
      "r76",
      "r77",
      "r79",
      "r80",
      "r81",
      "r96",
      "r97",
      "r100",
      "r101",
      "r103",
      "r107",
      "r189",
      "r235",
      "r251"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thcb.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow",
      "http://thcb.com/role/ConsolidatedIncomeStatement",
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable",
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-Cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r32",
      "r67",
      "r204"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).",
        "label": "Notes Payable, Related Parties, Noncurrent",
        "terseLabel": "Convertible promissory note \u2013 related party"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://thcb.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "terseLabel": "Operating and formation costs"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r96",
      "r97",
      "r100",
      "r101",
      "r103"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r1",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "OCI, Debt Securities, Available-for-Sale, Transfer from Held-to-Maturity, Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Unrealized gain on marketable securities held in Trust Account"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Component of Operating Income [Abstract]",
        "terseLabel": "Other income:"
       }
      }
     },
     "localname": "OtherIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "totalLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-allotment option [Member]",
        "verboseLabel": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/InitialPublicOfferingDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Investment of cash in Trust Account"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock par value (in Dollars per share)",
        "verboseLabel": "Preferred stock, par value (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r22",
      "r23"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r4",
      "r6",
      "r109",
      "r110"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails",
      "http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Aggregate shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Advances from related party"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r116"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "terseLabel": "Common stock subject to possible redemption 27,087,556 and 27,126,477 at December 31, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r129",
      "r203",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails",
      "http://thcb.com/role/StockholdersEquityDetails",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r129",
      "r203",
      "r204",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionDueFromToRelatedParty": {
     "auth_ref": [
      "r67",
      "r204"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.",
        "label": "Related Party Transaction, Due from (to) Related Party",
        "terseLabel": "Aggregate amount"
       }
      }
     },
     "localname": "RelatedPartyTransactionDueFromToRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.",
        "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party",
        "terseLabel": "Per month service fee"
       }
      }
     },
     "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r129",
      "r203",
      "r206",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails",
      "http://thcb.com/role/StockholdersEquityDetails",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r201",
      "r202",
      "r204",
      "r207",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedLabel": "Repayment of advances from related party"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r119",
      "r138",
      "r247",
      "r256",
      "r257"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r73",
      "r78",
      "r80",
      "r108",
      "r135",
      "r136",
      "r137",
      "r159",
      "r160",
      "r253",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings/ (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Obligation to redeem percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Gross proceeds",
        "netLabel": "Sale of stock, consideration received on transaction",
        "terseLabel": "Sale of 687,000 Private Units",
        "totalLabel": "Aggregate value of common stock subscribed",
        "verboseLabel": "Number of shares in amount"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/PrivatePlacementDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails",
      "http://thcb.com/role/ShareholdersEquityType2or3",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.",
        "label": "Purchase price per share",
        "netLabel": "Common stock aggregate price (in Dollars)",
        "terseLabel": "Proceeds held in Trust account",
        "verboseLabel": "Common stock aggregate price"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails",
      "http://thcb.com/role/StockholdersEquityDetails",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockDescriptionOfTransaction": {
     "auth_ref": [
      "r176",
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.",
        "label": "Sale of Stock, Description of Transaction",
        "terseLabel": "Private placement, description"
       }
      }
     },
     "localname": "SaleOfStockDescriptionOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/InitialPublicOfferingDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails",
      "http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of stock, number of shares issued in transaction",
        "netLabel": "Sale of stock",
        "terseLabel": "Sale of 687,000 Private Units (in Shares)",
        "totalLabel": "Number of shares of common stock subscribed (in Shares)",
        "verboseLabel": "Number of shares in units (in Shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/InitialPublicOfferingDetails",
      "http://thcb.com/role/PrivatePlacementDetails",
      "http://thcb.com/role/ShareholdersEquityType2or3",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Per unit price (in Dollars per share)",
        "netLabel": "Price per share",
        "terseLabel": "Price per share (in Dollars per share)",
        "verboseLabel": "Price per unit"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/InitialPublicOfferingDetails",
      "http://thcb.com/role/PrivatePlacementDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of income tax provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of net deferred tax liability"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of basic and diluted loss per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of federal income tax rate to effective tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r131",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in Dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in Shares)",
        "periodStartLabel": "Balance (in Shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r9",
      "r229",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Loan amount",
        "verboseLabel": "Outstanding amount"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r34",
      "r69",
      "r70",
      "r71",
      "r73",
      "r78",
      "r80",
      "r86",
      "r108",
      "r117",
      "r119",
      "r135",
      "r136",
      "r137",
      "r159",
      "r160",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r253",
      "r254",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/ShareholdersEquityType2or3",
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r86",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r117",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Number of Founder shares (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/InitialPublicOfferingDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited",
        "terseLabel": "Forfeiture shares (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r19",
      "r20",
      "r63",
      "r105",
      "r107",
      "r189"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet",
      "http://thcb.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r62",
      "r119",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventEffectOfChangeInTaxStatus": {
     "auth_ref": [
      "r153"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monetary effect of a change in the tax status effective after year-end but before the financial statements for the reporting period are issued or available to be issue by the entity.",
        "label": "Subsequent Event, Effect of Change in Tax Status",
        "terseLabel": "Subsequent Event, Effect of Change in Tax Status"
       }
      }
     },
     "localname": "SubsequentEventEffectOfChangeInTaxStatus",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r197",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r197",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r197",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r209",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://thcb.com/role/InitialPublicOfferingDetails",
      "http://thcb.com/role/PrivatePlacementDetails",
      "http://thcb.com/role/RelatedPartyTransactionsDetails",
      "http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://thcb.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "terseLabel": "Net income allocable to shares subject to possible redemption"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebt": {
     "auth_ref": [
      "r12",
      "r231",
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Unsecured Debt",
        "terseLabel": "Aggregate note amount"
       }
      }
     },
     "localname": "UnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r87",
      "r88",
      "r90",
      "r91",
      "r92",
      "r93",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Diluted loss per share (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Basic and diluted weighted average shares outstanding, Common stock (in Shares)",
        "verboseLabel": "Basic and diluted weighted average shares outstanding (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thcb.com/role/ConsolidatedIncomeStatement",
      "http://thcb.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32590-109319"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.2)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r262": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r263": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r264": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r265": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r266": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r267": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r268": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(b))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>55
<FILENAME>0001213900-21-017601-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-21-017601-xbrl.zip
M4$L#!!0    ( &^K>%(%[2),3L0! .3*#0 7    9C$P:S(P,C!?='5S8V%N
M:&]L9"YH=&WL?6EWVTBRY??\%1AW]3O2.9 L4MY=[3DJV>[6:V]CN;I>SY<Y
M()$4T08!-A;1[%\_L>4"$" EES:7^,Y,M25A261&1L9RX\;/__O;+ W.=5$F
M>?:7!X/]@P>!SL9YG&1G?WGPZ^G>T>GQR<F#__U*_?R_]O:"O^I,%U&EXV"T
M#([SV?QTG 1?BB@K)WDQ"W:JV6ZP%TRK:O[BX</%8K$_AFO*<5+H,J^+L2[Q
M%\'>GCSNN-#XL!?!;_#$]U$1#!\%PX,7AT]>#)X';UY_@1^& [Y\6L$X8:Q9
M^2+Y5OWE@?>.;Z,BW<^+LX=)EB:9_I]?/K][6)DQ115\V,/AP>#QWL%P;_CD
M@7O(7JG'C0?!S_MG^?G&YSS;.QR8YU33\<@^!'_ +X3KX,JANRJK9]U#CJOB
M8;6<ZX=PA2Z2L;D!!O"U^X[AP<'A0_SS*"JUN3S6B;V:KC2? G_ 03_?.QAX
M@T[*_-%P\'3-"^0*<P/^,5EW>59643:VXY%EMW=TB8%;B;X'#PZ]I;!#*9L#
M61R:80P>_L_[=Z?CJ9Y%>^T!U>4>3G-I;YU$Y8AN-'^A-6M.4UE4J]?#+SLN
M_9:NF9W_>0?+Y4]EW%HMN?+)0_ZC-^BS*)IWCAG_T#6.\CLF)\NS"PAHGNVU
MA/3;BI3*^P;/GS]_2'^52_LOPGW]X-7/4QW%KU2 __=SE52I?A7\_)#_H=3/
M,UU%P3C/*IW!BE3Z6_60[B--LZ?_72?G?WEPS'_?^P*C?1 \!)WQD)_Z\RB/
MEZ]^CI/SH*R6J?[+@PE<^B(8',RKX$LRTV7P02^"S_DLRD+^11B<PH=.'M!=
M.(*'^+\_S\T#9E%QEF0O@@.XXN&\=15JMK>)3D&O?:Y3O?<I.M.HQ/P1\ /V
MJGP.#WD9R(^CO*KR&?UFD<35%,=X\.<'*V/?*Y/_:/CCO'H9C/(BU@4_Z9<T
M&G\-AO!999XFL?VC>2[_?6#^_N#5?_UI\.3@I8Q[9?0/5X:_?BK,T]H3,K_L
MO)L)@:?"I3 ;N.1[49J<P:_&L,BZ@$D9O?KUP\F7-Z^#TR]'7]Z<_OQPU+$8
MU_;NTS?'OWX^^7+RYC0X^O Z>/,_QW\[^O#7-\'QQ_?O3TY/3SY^N.$!_1:5
M4SBUJQSN?[U_O ^'Y^-'SV]T$.4\RCKD].F\<L*!U]SDM+S]^/E]\'/R#;7<
M!]9?K$J^59_UY"\/QF#Q9-$,W@QGY8O7^1BNR2I2(J\&!WM___EAX]Y7]WQ"
MUT\D6TI_>2#6U8M1GJ>C*$WS:I1_ZYKG(SAYHO2SGN=%U?6]DVB6I,L7F]3T
M?_WI^=-'3]QD-)=,9FKTBM^F^'7!I[HHZRBK@BJ'YXS1P L&AT%>!(/'._%N
MD$^":JKQ3W615 F\_\VW\33*0!T>C2O\\^#YX:/[+0]O8;9PDI8:K'>=Q6#'
M7UQ$7L1@_<_@[],X6N(3=-8E(Y_@.7G\)HM?P^4/7KW68ST;Z2(X'(27W]AO
MDW(<I?^$E[V%WY0/7J$-M;K'VS_?U_4%'V^6E.@<@E&0Z@!F!*?^PM/^)@,C
M;HFW\IT/7AV@O?KLV?#)=I(OJ%3;L_E9GR4E.J;5!_@+'7)??CT]/OH0_.WC
MN]<G'_YZ"D;(YT_[K)EN9Y)WWGR+0$?BT%%1%G;(050&Y5R/DTD"NB+)5%*5
M 6C5 F[;_1%$H(I&L _&.DWG4<QA$E@C_!EN&)N?+SUJS]ZW9OLX3]-H7L+
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M_>#QTVH:G%;[;;F_A.G8]Y(AO.09//UMFN=%GYMXYV;I&/[YL?B2+[('KW
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MMI=*HT6'\-!C5\7@ DMO5M[;S?K;-$+%=7Z#J-V-^K@3(__=ZO^7I0$)1;A
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MMRVTN47);^HR]"^5W^9U87Y+K\='M'LF8:QG'_L/_L&*+M:NJ*UL'*51]C4
MDVO\59DB(:ES=+5KQ!I@ZH16"K-!"#[DYWHV@JL?8Z^]P3-J3[_07/"/S^KH
MA4?[&%VJ),-*1^8J+T)N?.?1TA#7J\^A'@9,&S 7Y 2*EG0'2?XC!-J%SHNS
M*).?;9_ZH$QF28-WKTTX"R+-S.E8/F2NXOILPPBX'WP$L=>CHL8<WH"["U(A
M'WT2D:WB%V6!S3@QTRQ,-7XX?VACN[SG7QV9Z\VN492H>I^,D0NLK$+PYL?[
M,"5N\OWR^QWS-'.]>0R]_LOI\8= 7G1:C^RC&K6M7<^EIA:+:8Z4X=C9A#A]
MRB1F*D5B@RG=N^T+S,NI!6V3+*W]N<*(1]@!YJKEZBU=14FJJ WN?O#)T&=I
MCA<BQ43'L\)V*22)H=?BKB$8[CJFD9'R1ZG ]FH@E92&4<LK:AIBJ,ZE=E=N
M >DND]X>5V.D:\,VC-?1;/S':A<+9\I;DZ=B/)1,]">>Z(\RT3>HF>_L7)UX
M&A;5*RH;1;V28E8S9]CTD=7RX_#IXX/PX.# ]$XR.W.2DT*W7%[\9ZLB1-Q]
M8I80B0T"%&\=_(2\1@<#QVRDS'/].^S3J+F!/S*CK(4W!M[VT_ Q#I.8GXCM
M\)MI9D#O>N1>%1JF75./W&#*4# [[ZFC DS-<];#MOM<;+H3@GI!:I*,NJP<
M[ _]SE(^%PT.7$?P,)]=D8^DUJ6AD(IC=Q=AY>D:'[$],JB@N5!/PN<'O%#=
M*W-3&N+N2C@U^18Q!PG _H%GF1:D9%2DRU^2(C[FD]\<C=R]0GAS&=8DAP[-
M\:)("(#96K"6<K=[YN331VO JO8"'AXT]EE;DG:B";89/DNH@X^6IJVYM,=H
MB"39IE+Y'XU@'G;M")K?HEJ;EJ@CW8YJ[]%K$*$[(2T?S8Y_&MI-KUQ# 3Z7
M8>UP4H:/2,O@0B&[,EAO;W![X[^)S3LII0$XV'V=^YSI%3(M])Y4FRBDFR$#
MB5!?&!Y.MA)38YU(A@RYL(P"7/.BYFH.!ON/?2HYLJ/H&]BF*>'9=$]F!5=Y
M=ULB.KPE#,YT9FA*S@HP4AQC'NGB1P=FFLAVM]X222L+.&T@ZF8E^PE'0H.0
MW00SKJ*2_BG2*V?Y*2LT$=O[?IJ?)C,X-J(,J5U-FTNV/46 O0;?,*5ALUM&
M;-C7SNE83:,QF]!&87R2OWPR?_%/^"<#.G.I0T;9OD71;_MTBY,G\X9?VW)5
MY=B@L2%73\+!8Y$JE%[_5E^*K5NN+MC*&/=D^PA@RHJJ= =%UTN)2@S7 T/?
M1L*=+"MAQZ")ET;NEJW,<NVVML+J&[(\V_/TA2&G&+GNVJA3L(=D5!)I+Y,"
MA?AZ,C^HS7R)?;W0="#J,^KR!!-=:Z&<(5HJZ=CD3C)6,P6YK$PA-4<N^HI$
M!_/$&(;9.B#N$!D,Y111'1NMC%*2_ZC1._(P?.*?*:8M8+'2.\8W.HQYAXBB
M/6R6S&Q N5"-5LK;8RM[JT-G'SYQ*KM#I[ _F^:E1_)BO\9]"GU YP':_>E/
MA_3=+9&OOE=!/!W*%[S-L7TTGF$=X^Z9,J2Z6?VBQM#"IMTMA*YTY#VU\Q?
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M*7-<4W,<!L@?W4B78^1^BEWZ+#&<[$<*A*=YQ'3O<,_V<+P,5=F3^X$Q.2I
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MF2#1G8A:,!J*R(MR-5)M6,6+,:I5[=?0V$ILP=47N/A$]ZG!+@/3^K%99GM
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ML\@GI\91"3O-I5ZR?STEFGTJKEF:>;M*YDMCYW'ZU19=PE9:1$6\!\[?5^Z
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M<EX/KZA".J<5C,@\"BMJ(/>4@W;H@SJ945^@=]:6[M+.**U1VPP<A(1[,]:
M5(EG#<$NG,AC!@51T3(;+67*1(< UAIY.S7FW_BJ:R[?2)>(%F$@RDK VE))
MYI'R\)$?7,<BA[WRI/A-32ZT<?TD.V>WFYQ^+RI>8M.EL=^\5WHJRLSI"U20
M^0_U]5400\>Y-WH;"VAN CJ"F5% $<=-N)7HV1-G]V&5C'$NP+:M^@+ 5W4H
M!W)_N^.?-O@62IZ]T7ER!1M@_N?)W>I=5$9'S>'*.E7)NB@G:S($_>SO.Y[
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M@LE&@V(QMV(*=.HUQ[+.#&.$)2;%FK#BGNW3&=0O(@XO@!N@PX#I,?V[KB;
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MJP5].9;1:H'NZY1[HGA43E(Z,KPV!&@(QD]I7S.RY2@!G(*TS.]CFX9E<F[
MJAK<_B+GKNJA3X1J*9 4=1-)83&AR@,2ENAK"8MR"N]X>O-)#%L[E<8E#";
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MED$/V/@6;\%DV-YZ]O=-NI0@L<&!8X#T$8 VC"[;Z]R.O%=$)= BNG:LC;_
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MS<.GY7JZ^ *T\S]*.N()&0<="M##F+TD&B21W;H#BJ\0N_S;@>*O)>EA2Y)
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M 9.%YC@?-RYCK,_V2Y2_O ZXDXD;S>,2)J*Q&"$"H&IG04$^7N=3Z/@W@_P
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M6FY@0:CFPHX.P5P<(7X]DF_[[^1,KZP7YI?-!]?J\M[/"2KM0.@J+7BO2R/
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M*0>#-+:]SACR?:Y#8A [6H)[!WXDHC&@T6\:P[BI!$>=AP8/U\4$89"HOQZ
MX6C\7(2I":F?VQ?,1"L(XQ09P/*P&.-:>M\#S*7"00=8HX?[UATY>$?:%9_[
MGF/V[S+#IQ'KM ;H@)_P4%7U13;'H_#QE+HOD.LVJZF!WP>W%YZK*"^3HN;O
MW M+ZQXTAY^Y#6%5HI@.@EU6#HT1'E/;RT3N7:S$=(!X'HL1(T9 .1!7O^)6
M@OGN@H4AB4(Y50=&GV:3Q';'(&W SP<''Z5!AE4GA<!F>G%18I&I>[&]240[
M+IB3-*&"57XP"U4J,3:A)<)I>[,@A]UIP3ZK8^A5H+TOC2-+1;I.N@'HF2*=
M<,(E-E" FP_./CK$- FJ=25*)2P'33K;0+K;?=G=,G983+8,7%(9:'" ST3T
MC9AVK2BC\[),\>/"]ZX _*,XQ[/##Z:6B+N#)%R;5K>?4\!5UFM?M$B4?5%!
M!L".^; ?O]C=C[>WF0YCZ"[N>+WX]M=5EAJ-C''Q0U3'-9$>/:9%?XR")%7P
MRNRF&.LTSY;%3EPZI_.RJ 'L)S2<Y2;V&/E\!=4Q]ODQF)8JJX5O)\P]N]YQ
M1LL7?J[*9D[U\"DS2$4A@Y3Y&E('8NM!CUG-0Q("2B# ,_<+AGK-O=1]EYG5
M-+DL;5&7)1HDN""'!QT$?P9Z,7R/IDTXB.3T-!*;E R'0@B*.'=LGS%3W4@V
MP3 MZJEFVNTIPU!VYLY7L5"M;%# 5U?B3)A+!YK?SG$?*%3,O:>2@]RT2YT@
M=KI+DN$',C2M-\:;8 Y6$P0X@B8AJPZB"FSV6CI9.B/T]T39/>E9B('0F\\!
M>>UNK'73O9\3Y.]EX]&C9-DG^CA6)68$V &%-)2LAAARV3_OE#CW?:?G^];O
MW&@*I--"96"_;&[ /%>N)E280D%$[2G>#/0BW:\ZPV.RD6UB7QO(.C\97VZT
M5H.=5)0G@3.3F8^:DS0UWX1Y\9CQ'!2-G(.!&UE.C3\,(F_S85>)G==ZDMYX
MR+#L7>=2(1T=K7-M9GQ%?YIQSQG2+LFB)RF(!>7:>6_,P9Y97<8/ /:]13TT
MF4"KL,L\>%FLC_"WFM.M8)GVGDP=XN[68ZI#7)^5^S6G^S ;X[LM] Q*&PI-
M_-C6Q;L^QF>O A="#BS_TV9L[H",+&;[M3KJFOQX/=FG8*>S^>)8PE6^YVII
MYW]\_G(GWJ,;'2HCN&,9 C#/7\8[>^T0,U^RX?6S@/ K%US8D#) DXX(F93C
MLA@3EGJ%N=%/]DH<ZR#KG,UF.H7.$;.2K89V_I"WH&=@R"<3QF5WG4,0)SJ&
MA?Q(;XRQ .)9S?>B%T7R%@JRXS*1_=%>9&0RQS9T6@#V!CX>?SR2JD%@M6^O
MKCQ"V?#ZC_OV65Z Z!Z<NYN\[GX<LK4:7#6G8W=DO.I==%TI$Q%+2_],BYOK
MA1Q:R07X"UGNOV<S.H?[KT:O?I(SA[&PE)G %Y:^F$Z)ZIBG; P+!.] O&/H
MS:]&.S=[<3MQ)T4MYF%4 >/E1S:V-TD,$O-$6.JBC#XVXSR;1*=N>-8G1U[M
M'J>\WZ=6_0 ',.J-'7YOI:>Y^5H=D!N2DQ]&&)T:;H<8#VF13R7$**I).=4$
MK[QQB+(5DJR]F&0<C9L%8D@P! F6)Y.'PDP4%)Z@\/C4#L#+ZA[3%LX2L[/-
M+'(NFJP[#8P*!8.<+7I\>+NAB^:$U0[(9DUQ7R!G"EX4K+SNSY-O9",]LMF0
MBP2!NG,-#_UQCUW<;1@<Y [:L?[>^PG@.>94\VWO*"G>ZY.'30I>P?T()G@"
MV-J2DP@/P(O]T<N?<"NWS%'XKN!F#UPUX[_/<-3?QUC-_GH$D1<X4I#-*U(0
MQG5=SD.8TTFA7",R]2%;_4%U"%#8X=T=-K *%1R_+R0DA)4$XZ7PP2^BF1F_
M1[5=K*P55E@@; ?R@@8"KS@PFBB/=K<H 8$,1>VKB>-7+("Q7U:Q&V^_>MG2
MQ'+Y"4>3U:VLGOG7UC8638W^@'=76BLX5&O@'^SL./\@[AK2WD,H_J>Z3]G=
MB?=?/E_KP6\TIQ.I -[>$;1!%GKC:($I!N7$ ,E40/4+$B^Z)J6HUAI[>^Q9
M0/'%4*9O!$(J!6.F]&A;-@4E*Y!L,7^?4LJ-3Y+JGB0>559W.=+@7&5HK:TH
MPL>1A8<('O"WQ@@9 P]LDRE;XL%16)=30&AXIO5"'$$TB7(^=0' 5T]%"*.?
M B0J?!]I)M<%! _E*G]7)H4"(SQ;K*_Q;ZZ%6GGVG5A1HMU/=I!R0*T$)6U>
M5HC=&R]&8SE[.+.T**%LR)S"'[='._02CMC$<(Y)R?SXG)-?5TFMTBJY*AC_
MD/).7.YW!N57.("KA,X]YZPECF54YF56-G7TXPX_SWL6?.#'7?Z]7Z4'+:Z<
MI,(V#1 \XR.I5AH+PH2HQG8$+B4Z"+LXX=.=Y20%-['B'*[L19*Z-\HT."NN
M$EH\*JYT43-OW?Q/[//4P.G"%*&;.Y=<V57FL=('>)_FK1+F?KG Q0J3=-2;
M54>A 1.,F$>)6S=.\H2::LP7MCD0"B5Y _Z?5_4I;M_M"AM.08#H!10*09\6
MDX$ @(B\SKTYPG83-@<\%3W+EH B$U.- @!)UNW^H$(G<H-I5HO@[0=(;_ $
M!;9@X4H;7$!TVRS[EF_\>22J+BFZO@P?RF5(IHSZ4"Z W'W=;_)@YF3\VK\E
MA=.@^U+!=J6=7YN /H6C:_M3W['-^@]C -L=KXUG"J3% KU[YA#^*4I)^/[H
M(%!\.EDH\QZ@S]76L@:-<4"6]7NVK*&0PW<8N,5@6RYJ,ZD+H^JF"R::\T#$
MHA!$C+Y !OWVJU@EGK]@+E(>K<SND['(Z1M[^SM;&\DF,?_VF_$]7WJYO;4Q
MV=S8V=SX>1-7U&@YOD,32($5"F%_SZD@WQ(S=\H*GXM7SZ^RI>)(/YASB\ Y
MZ&CSRZ8FI<N./F#"E\WYA?%E"AWMO'+.3;\?(V^Q%TJJC?+&HO;:5]->)P&9
M-RU("#!4M%34<HM%-C$7?8H%[7ZQG.)&U=O=F+]>&+&!=T#UT<0A1"^]<$<(
M-TU ^6 0CL&>@H!N4\&2*QFN#<$2P2" ;M?E-X\N/'"-]8<J8?:?3B7,]KH2
MYI&>@&_<:HW=<.!6G%CTI#5\RD.8$X UE 4V=UD,!+2A.E I&Q:]8=->V!WD
M4^)X\>%+((!A'QTS$%.AH485 K*+4KG*&@$2 4P0J7A!O*F8J0/0?K(?LE /
M%)B/%M _N+#@+\/X#PB%0FP5REW-U.BVH/IV1@&#H*?01D!36>Z-(21["#@/
MVN^RCR[*XIE[-,#3S+1R= 8S+*3ETGG^,QA;,S1+\<KW@6VA1IB_O*@@2\.]
M;PSU,D'N8:Y[;@%EC35WI6)&1<F:;<"BY<;>RV,/SJS24**+11I>=QVV2@#T
M&8+#6.-P$U!OC!Q PS!1,:<- (L9L<;+1$:TSHC<^SF]+:G+O<=-L2<>O0:(
MOD$A@D@LQ$_BW1=[\?/];:ERX?".3F\CX\J7\3.4\0.20'S)3KR_]SS>?K[%
M:'7FC!H+)$=2!_19;G1VNL]]%;_8@^C>M-8+"%^Z(PN-E]1I\,KXH/O[>_1F
M\B+0!YEB* ]GM4A^IY#3C[O[^_&+_?N1!;RV=[GW25_5>GK+B:C5@L7J$= %
M'"$?U8^B S^H_\ A-'( ?IH1D9V]E_'.UGX,%3#/]T=;/R%$@!,=O.Y^?!Z_
MVMZ)=Y_OVRR9&YQJ#6[[U8@6L2]P?0CNY+/M5\;\-=^=91,*5 NB ;NR2[!9
M;S,GE1K7<TY!B*W1MID%?\H(M?%O?91RO(C3\HISAN _\\O-'[='+W9_PCG"
M/&SMVS2KS+M:#UE'-^_OG*[7S8"&U:^;=^/=_1?Q]HM77T\WA^</"[?M@?HC
MNKG[W.V=E_'+5Z]B1>HY&E#/+UZ8CVW?4#V_?+5GU,3VO5#/#UOLO[)G^2[[
M3Y.E #,#^R@LK,;?-.;VY!NS;WR?3,6=<*=\KT!^"ZOO*FRK8*P_O'V>VS9.
M!HZD)@Z7GK.]&_#W6#PLT 'G55G7%I^2[,3G%HYHI$ZSF;FN@U:8 !+' 5IV
M1NB#6^YO8QUN"' I@(:V\=)([5%2Y<O7696R^*(HPV>-DVO67^OK1K\?<R9S
M%+6JG6 1!]JF$>'XRFA435#$VR_^8M.<RO:3&R>_,F*0EYP2F0LVS+3)\Y73
M#^&>=N-]?[NNV2WES9<RVCVSWK6=O)33X)?AH+"?]68C>['3W25U@UV*VKL$
M<_(FXC\PV,#!";W880%\&_0_H)QQ*Q8EH5D ^_?F!ABK?C'#S@O7$ U5&=C6
ME*K540/(-1FIV]I[%6^]>@GB ,=2L,OQCO4S*3_NQ7L[MB#""AX&9C1H!!CS
MCWN[]+1RJ@AP )^SOG*_T9R(B-DW"57@KG^)6[SS$KPI8]B]H' @[W^KX'7?
M?&9/I*%E3*+N:QF"=903)R=_$E085M1LBEW*6AGAI "EJ6ZJ933.\IR3= F
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M1Z/:9D_TP7#@8%%F([&F/E_-UMA/I)[*4=@G?)Z*F2^J;V/->PX,6/G6ICA
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MME9E)'+(T\MD3/')!>SJFBG!CMBM8EK$0]%FY "A"OVI8!31_OV=FE+&L9
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M&KG2N'LD4R??2W-_ SL(I78>&3,X)!B$&[!_VR>[F^<8^.27P5F/VD (]:L
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M[,Z(C\@..:"/>9E,%&E$9>JT])Y0/6TH*<'K1?[X:8L?%7H4]'AD] BTB U
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M/+0K[$P14O.S3&+WADL<#@K\.ZEF> 0+,5NF0(5(6+$)_PEIO63-I?@)AF
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M -N'R/])H]3/3_]A9 ?\;:%7WG8]@3MC,NL\4QL3+8C%4%IPU+62:O&0,)Y
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MGORF5*5YP,F54!M;J[CJO$_I#?E:[0;2+=(5$5<_^W;'7BJ>A3H8J3EI+><
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M"6T&]E,_E#Q2[_G>@ X'AP28">:"<*LCW'QHVFXX+AV@FK.+V.QFCO')#.Q
M0RDE==/#/M%;U#^)EVBY3!SI6*HD0^ RMF09:=4F8@N#B%.4]#M0LC*_LLFY
M*7ZB9H6ZC%+"@/%J><OE[@A;I5-S&M3B2&,&;OB'8(ZC#SD>&ZLTL(@_D/T?
M*6(;==R1H5OY4BU9V_1,/1Z!R[#M>Y+2>-ZGU.S[R];=IUC)!L:/&Y&=+"W9
M4=).!(_I_5)W5-)+[0%5S)S>0-]+[9+>$Q;J8WH0-PIRS)<@$D3F< C'H80
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M&^>5S=_CA@LH\IH->X'LE.<Q6#QW@C<LYQ%[A3]N,:?6R8;)FQMD(&"2"!'
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M.=^T_#D[5/ES[3F.]P*DK"TN=6+#1)DAF"QF#FBVVGP6<+X' F>6"JF?S#[
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M!/7)% PXJ2@ +>7P9O#PN3Z$<@-CVQUP 3>VF%%YL]2.%V;0M#P"'3[ZGH%
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M+12((H:-N7&ZLZG>+$SER[0^:@*1% Z(&$!!\NZQ*1;^!OZ>;!#BVP5BZ8P
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M:6=!VW3;N9B%:^84\BG)F8"!H/7'%3E.3,V,M0X*LLO/R-&,V*%HE8J6)]M
ML]%>!N548( ^L6Z /6"KCKGQ4W# ;(])BC]M,S5@@K$^"/W5%F:XD3&7.(;(
MY+)H?#ILTI@/1I/66\8L)_LY#(@F*/#1@.452%8%DSU))91&5XE5)(:PY3.%
M!CXSK6BDQ&45!KB9&7_ S/L#)1!1HVBNNI/ MJ@JD,04"J:O5VH2;NYFW:7
MTK+-,XIJMI;3:(<+:K1MYRRJ[3JZUEF/JD0!(&-J&7)Y]H%/?'%+]  3X)]Y
M1SX+^RF#;A><RPK'W)@U(_U8JY9IJR<U6\1@V*7SN&0M4KNSLO/87? \'M8V
M^I624B-][J21<1&(M!F;#PP=2$EW28S+)HA@I/Z>HHWV]5H(A9IO&%]F'!QJ
M<-IWQXP)\V409>8YOR-^@,"?J6-X@!*6GC8B9(;N+9>SNB.^9$55^W!N+F=F
M@\#^@S.8>$A8F#G8V.^J?^H/1 #R%B5$3]444]]7UB;O_\YBV7<\;XR98/^>
M(ICX,VQ07_XL@S8<D.H'GF>/(]A2^:^_F4_N('[ /6[^S)M>[2HV_AZ'\NF/
MV!84;E0I?!SV>2>"./% ?DX,]%<EK$H+)=(5#]XO_@WU(I@6BN=_O>N]*WK$
MO+A<D3^>?_%+CVJK<5Q\C:H P"KS;7\@?^(YH@PR"35S=?/H-$XPZK?VN4BL
M&&]]IV6M>DK-9&M6.G1=:2XEX?"?< MGCF;"-BF^PALL> S;A<>P[*F9<U?Q
MM&ICX4C9JJ;S6M:D=;+"-5F%'/+YP-__:F)K<LQ39-^Y@/.TLDNC>&>J7 DO
MNKWJ//1UJ"4RQ+"V^5=3&D147-%?PK'>X )3*6XM16,M(Z\F&7\C_-U]B XA
MFJ>XZ>']W5Z[>6BU.\=6N]O=GR4]_/\:+21#4;;L4>_G] 0]9PBW\*4$1H)%
MY+,'5QZ[+6"Q*E\':4/_7&UK*CQ!&WC^F3]5&,O)SY7V>+4\1$E9+:\T^3_8
M-LD?,-XK89RZ0HAM.:%/V^HUNU:S<YS#72RR#S-7<;YXO])M[6YO6P^MX_:1
M==P]W,RV5M5!U37,_/=_\V6%GGF/E FKTS)+RN J3L+6-$D165VRPK_! B.
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M+__7NX--93G?\!7KPE>L=O_7E>U<$(.Q4=!7QL5#JP1U_0\:%UNCJA+T#;#
ML^_2WM&AU>H=U54%U6I#7Z1[JFYH]_#0.EH09KYRG;(>:(1(8IEO<:+=<RAV
M<@TVFC5\ TOL#EAB)C/NU9"R0UH6/)-,FIGN/K8ZQVVKTUKUE;G+"<(=$((E
M\!!K%((CZZ1]9/76FB7>U%U;#&A09&-O<(9%S/0J^>NRK@8S!+#0@UPO8.'-
MA%\)6&$]F[TF?XU5SB\4X'A%O%R[T8ABR<[0[44[0Y\%/C)>,+_M5S?Z?D;]
M<_!?5?NMS'A$?7JMI"9A(%LL3<+$6=2RRPI/2PI]?@*[(^I+=H]N%W6/I@=5
MD^F:$D=>J&;(KA_!<>1NR-2;;!S$\ /\R9LF.1^MG0GEA;2E8=Y(EO,0%H?[
MG$2QZ 9L1P^RC32W^TQ:BN*KW7A"9X6ZS%DFO#^FJ8QL['G6=T2SE O1@^RC
M0TTA@W!J7OK1!"L/<63"P84W_K2>K*UXOWB]>O59$&(E$K[H.G1&[F1TSGW:
M9M29=9N%'4Z*>\9@V[?0Q9X1 ]EQC1J4N)$A%Y5:L-H^S)^8QN\<SW4>G2BU
M9ZYZ6A!Q>U*],R?N&CV7>IB(YZZ?+C,CXZU>@QM7K/BNWFTFS26;(;>/%KRA
M+VPWI)JXJZ$Z^Y?)T6?NRZIW=:6'U>?6QND8-!_4(&I&IC:E6E[>N]PB;<E&
ML>W21K&+"GA-+VYL,S&$J9J/4EXU/:\:3XC6]M3@U>5VERX^E7NY<O?1*?([
MIR]C:0<P7S3VDCW&MK2B52JN,+=N,CXG+;\MT3X5.RR$P;,[(G)G;M(5AE,7
MVY:)+M6A([I=)#UF\;*AH>/G[FR/[O/HP7&P3_0XA*>%L$SF8.*('A8N4M$'
M87P0.^'(\(EU^M5<53MZ2766;-W97K1U)ZR7]MPP\.&?W.1.G-\E>WDN^MSZ
M7%U?'33$O:EQB2W9!V8R3?,&8\QV.'B[NTINC,5/0<F#7B"V-;V%/BM_PQ@$
M#CL7PO%@)Y+; [!L4J\;[!1R-XGIDU,G%MTOW4=L^Y'(;"1EUC)=<"JI R,^
MP1X$8VHVPGT5N0.!B5=-B#ZL;*7I%UZ&R1VG^C&E&SLOK&IK>'JRQZ&R3KX$
M[Q76CEN1RDZD']VH#^XHW+V5=;' E51[6$T4\)>KVW.CTS OOUS>8@>[ZV\?
M/EV>F5<7%^=?+[_\]@J5[H(J=@GAJ:E&O/*-SW8(QO41MA!LG5BI^ N&Q":C
M$75 PM^+=2EL\$L-@&=&L;"'W[*):4(LL;'PD=H67U/C(B[2A^G2GXJA7JKX
M_A #6,5M>O'#V)N).MNY_0HAN<[QLNFM&QM;@="$KO%=,LU5H;BVU6P4C1YS
MS]_@&PUSCHI,#^3#)')])XI@M^\00(;Q8G"0X,E!6/"W=^_/[?Z#@2^2L5**
MH0:^UO$NW8C'']!?17MA<T]X9$)\?N=?"T=LOV%>^28+8ZLMI=&E9?<=WH$G
M-WZ@?M7DZ3V%+ERDLGU.KE<R1E</D.HLYE:&HH^?;PXGGI>6<Y)=[$$]&+C4
M?\>;(\DG+Y#D9/M3\(J(I?O2OX5%B?BM,^6Y8_7*Q/E;1IR-^>+<WD5Q1H$S
MT])B8I _]H2O_@ ;YX1Z*_%9XI@^WJU6H]O4FL3I'2!MQ<!E[D4.PBACQSS:
M;^2M^5GF6+V,+S ,Y$6:OO_7/XVJ<8J*G8GO<GYCY2[?[1^IRW?KK<OWEN3S
MQSAH;YW 7U4G\!_S:-3" YYW$A>)G( 5]P@>WS7<5!1T6C9H4N$Y&XR75)8_
M"HX<-LSKKY?_AN-L7G\Z/:-#O:VPR$MZ7;\@!K*8&-2A,?2-.YIXL>T[P23R
MI@8ZDYSP@VEA%$/XC25!#O88;\;@^08AN;;G=NA-/[CAX,P>(W,/]V4'QVO@
M($P%W ;IE+!S>7\?.O?8VA5>--L9VP7WLM?J%CJ7AA",G),)TT)7O-GZVVQ7
M\W!I%/AZ7$U]/MP6/+59RK&L&A@Z61:LI4WO#.,K"-WBH$S?<1^=P=7<O>,R
M5:M5BM6:=1'@P$L']!'4?.A2".5JJ \#,_OJ5"AY-[H8FC@\,C/"\L)3TVH=
M6B?=3OJI17$C(Q\W,E<8-Y(C#*.2P6+ )1U/.FKCENB_24W"PK<SS*%[;'4/
MVYF5>W)"?6%$(WA=&[4ZUF'W6'[-*/O:W.6O=@2.VB1B,D2CC57%!HV9L4$5
M"Q1?I8,L0X'ED4/QZ5SH,#4,\5?#C>3F2F:0BE$B/Q&*K&K+1HW,\JB1418U
M(LCD. P0)AJ9PS 8T6X6[#B("^,>X\)OE,7C9=<H_$RJ<U3#N$PA;TR5!D4\
MB^?$F)^4L5]3"_[2$7)5HE+]FL/P5LGX(E @\EAE!-/U//,.#J3 =0[A9-+'
MM.;L\HL\.=$&?D];;_[\?R8N0WHH&FV/Q_!IVF_/?MJW2)3R[\??PAEGA> 1
MC$?KNB5']Q2$\8,'2S$G[UHWQUT8BY6<K45<AZ^.A[FB:SN,I]HE$2WA0L@[
M:(%'UBG[VFV87\\_@7_QT;P^_7K[AWG[]?3+S>G9[>75EYL?.@'[<HEJ"]C7
M<M)8@^46\-^ E)?!BO$5H:56 Q9<9O<[+Y"<=ETA )<^&"J/#OJ*:#P?IQW=
MQ'B<[=2UEB3A%^^YEJ^9Z9-VK:,2UT:21.SAV"7PEP^(L!R4;5F"/4X9@3!V
M(VT"5W/^TLNP2N</#*U*WE^[V&O7G*2NS*W/NMH/VZE=T@B\9%-7S2-\]UXW
M*1G5A@Z16,R!^,;<N,=A*@G=6F#U"L:GRH<_.GT/_J=8LK+EPOG6DHI^9)@3
M$=-!0(3&2R)<"ET(:4RF')040@OLUFCB$7@0K.H%5F6Q:%#1NO!QF!W[L4[*
MH 7I0P5&,DV!4;SDM26K0:5AQMKFM@)(4/5YNG[?FPP*0A*3,7HBLR?96=,D
M976\,\"SYX!RP)=?!.'0<>?1<I1./-\/<,@/A%LO&W<0/AC,%'U>1-"6HG,R
M494G52C(?O9 !EA,>"S\<PQ7+_C6 <-R$ZA')-5W9G\88-L//(_AN=[4")[F
M':S#I=HI\&Z<^@.-$(5' 7N#23G[/HE('K2UM8>[U $-G5_TG\LNI>*#)??(
M'L8(?ID1"-BSX0$C_)>^A -W0(LO[W8#U7;:S1:N_BS G_.,1T(^.Q_H^RK+
M9FS<D,1_U^ T\'PM3&>L+DR'F.HLE&Q]B*Z-G]&,\..=XP>F%_CWX \4GMR9
MR*77[R>4FCG="J!(L,?B,/"N[F(;_I0V?-;@A!R^P GIU-4)04MAMH;GX@FX
M>;&>0I/QOA/BOIB>.\(#1=7WM#GP-E1R>$?AZH'FLK# $&:%=TSD>!Z5>Z3?
M)KQI$PL[/(L3!_#S6+RLV_RY>'CL-#EVZ+GP.Q'YGL+/FI)6:&H1W"R.M!HR
M8#D@"\,760$]4:F<$7ZJ9I0Z6",9X?R8A" R?VJU4P%KO!)$H!H6"XU809,]
M]C -8:1-]@@-U2"\MWWW+ULL:NCT.74@?Z5"K)[[W=D7Z8,I:%U<>+H@!O8T
MDA%DV^PT#[0_X-! 6](\'+\/OS5XR4H"T?"R_+YP)'@$<H!/G;%+M*]\?\S>
M(*-T@RQ:7MYI BB#AGU ]B]0\EC_0](9$9B.LP(E3TD#[3GZ#FL)J_B?B3O@
M#QF@L^[Q-6)[G^&^]I$Q F2,7AJ!U(-WPR(N+C86&'8PZ";'0'>)@4'/E0</
MCIB\SHGQR8#1JU?*(M929P@I,RP]BJX&.0X#V.1XNO&"5R9;WC:/TB8C6-T7
M7!Z']8E]RF2.0J>PW5G+(&@5KJ+MA41[+Q"H;EVMD5*D4.8&Q]^YPD4:LXL4
MI.!"98548^$MC97\SL4$'2T;8%T $#0G6G)\5.R.9!%!1N4JJL/>+F.![AV?
MHK!X)P:(E5 9[ODHH*.MHX".CV8Q-A6 #:@*2AA3LW!N1A8R$A4]$FU-M"&)
MB%4^ENOLZ$4BPE!Z?-B.3^(_ @H2&5K*OB#P0*ZP?Q JSG-6K,PV-<6D?A)R
M0FN2S!9,\9MW=N1&;- AF 3-.0Q H5>-E"/PKJG2IV@9P:,(9R%B8LE$%#8H
M"(75!*(%S@D=?N&*J$4K^)KFZ91Y,$:!!Y./P!2#&]@$UJU>LCVE4^*K(=U)
ML[6?F*T_B FWR1OVZ 4W;*\^)MOI8 2"%1'[WJ-CP(<?\8JX<)Q:6FV[)D7'
M+Y"BH[K::?\.[AW/P+G"10V?^_3IVJ(,S7#H>J[(T'P.&[Q9]&F+. J%=L7+
M18\):/&;PH#-;-V(2OEV A>RK]QKW9>'*Y.!92/[.^CW1QL<=P%+Y&^I4!;;
M'0S-M%/'!O0X'1NZIV3X'>Y,K/&%5>T[,)M8T&85?GTR'@>868$U$"_%6U&
MZ 1P#]:<[ASXWX;\E+YH@3F&[]!JFFKM#5C[><;>TC91B5#?P T("_ ;+]>I
M/TCK&,%I&5W K/2C\#N8\_H39W0S+(F_HZDX@JD]4. #1"5*=D8MF62TM-"R
M8&LC))0B[LL0# ".OHD CORZM(O@$+#4_A&$W\TS-YX:(R<.@W$ NXLB'CJV
ME5A'\#P3[(?PGE&^F<W!@X%DFO!AS[&CF"C4[,<@) &$'PBVJRAJ A'I9GF
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MBPI^CM:>52-Z^"/5B';>:D1WH:AO]59$;S$K8A4P3&GSG=/=+KWLST2[;MZ
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MM&"[^;?/_*M3^7GZ=>MO^XSE^^SVP^#1CF++O/3[#<NPS8^.9S]A^K ?A..
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M,Q+!G"9"*A!AM>)EJ4\X7(LH8'R90E_(Q(!3;7P2!1\ST>F+."%\?2+SNS-
M?T,A8X3:^ 5"(7/':THD4![0  ;4I_&"2CAOU3'C;1-("B&+<&J+PZ5^)IEB
M-*U6" _ N?=7A"\IAH]CEJ8:]"Z& O &0ATH\5<(/_>58529XO9I4 ?&\S&?
M),3/_8-V+XK1@"@<8#Q@/EX%L*"1N*M7*RLJZ6*-A9*8/+TFR62:$:Y "=A1
M8)E-K<"ZWA0)1*+][)IOC#092X ND0O":=J8WD=T#;:O,Y]SL8[S1%WMD^%
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M&4)09!K%V7W-$S,QYJ\9)L^[$EC>RNCH@5$#MQG6)ZG>#EQ,)_P(EW:#<5B
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MSF&<-SMX5^R3KDN,);;$^%X.5L4[G 2L,]>F03PJ,:;8Z:HZORP?\#NZ$(E
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MMSWFOJ9L4'5\5O6G8UR%%I@1.^[ F5\1S_FL6Q_QGNPR>R5!5#9K%0'#1VR
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M/5-\6,0#ZO7[TA5L#[$3N)CV>X@+(3H.<0,?.R!J#HN$BQU>:1OGM5N^F]Y
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M9+U'XL* Z)+X:1_U[?6.X[[1,I_.?=]L.8R@AHKD]YI&PX'O=H"2[TIO?UW
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MY:*NRL/NP%Y624S:\(%TJLT92;VUU$QO3ZYF4=6>M.38ZJMC721U).22H=5
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M4'I>F;G-\:SQ0].MH7?_1$*,2B&"EM0[06+7KT>,S 1%F(GJ_P-02P,$%
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M%MT:/<!2"!5F4U-:T#&&V6C%/Y6<2YJ4V6*Y$U/%M(?&.R_Y%6?>?8CS<-8
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M8Q6 10-5Q@DBT=S;2>*@'FPCAYTZ"4#I)Q'-4)0>5#,U]7A!@LTP0JA\/X;
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M\BGO=Y<;7=Q.XEY,KNIIW\U:T-'$^M<E?LE.0S)2Q,A:D7!R#INQ=9I<;1'
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M'L6G$6I1E?J[)H@Q_36LV23,N\"B5<^\)'DEOV.WL=BD+U9$S25+(^\@][^
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MN+(AW<2CIIA\Y!: ^RS0C7 &VW>FP/_U542.YXZS^GL;NQS-KB$U\"XS.HA
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ML;Q,,4/)3\D\M=*V:S]N]O?K#@.+!RXI/G<R@2D'JJZ"ENG.>\$S0T([W*8
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MK;=)>I<N@@/QFE4P+2!=#787&S0+%V"=>;0P6$5I@PMU%R%K6/!;AF,T>UB
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MHGR>*$( PK(:& ]FE=^QU.)8>U#40E@"8&1C%17K$P]<U0)0V*\5\.3"58U
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M5F&K[H/:TU))4G;?VRTA4-*@+-V.*QGUE@]-;2@N-OE_,56B*('=CN@:]H3
M99K+24NC-_.$F*M2Y&"Q7<X@K^55DFU?P'V'V)SM2>@$/MA(5(GPOK-:[:G&
M5.[RM94I*D6D'QWL/=!?-&7EB@AL[04)4U;BB([&%&K..B_;;("IKLWCLCJJ
M:KO?&3L;]K.8]MT" F_L.P$K,#98EFV"3JM;F[LEBG<#$Z(IEWLKU-[=!&N0
M#)N\"9*V[E=?(AC*&%HQ2'9=R4H!";*AMS.)!:Q8[04B5ZC0(HS B0P6&BG&
M/Z<<39J^=!1JK:/@,$0E&VVMY:FERL"<IW,-Q"['I4^L6'9!89179ZE_Q"Y%
M>33;%M&+LKORXT-F?/6*-4Z1D1'!.XP(&6/D N#%B3_7,' "%P9S(2'4?'[
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M _.98-&4@"\1>ZA>MZ]=+D,SFO]5A4OV6EG! HFLKSH "CY5!;P])54AZO9
M:I2;-"6VP;6"*6=ZO;S_F;"8 GOCI3CYY>U/NC@94JK7#@G'Z!'@R890DR13
MHUS]N<UL.\5*Y1I>6*J+Z?LL1S5!\(<[=MIB=HB(-.O+WUBZ7[7C_=["]<6=
MI3IES3&(TS;W3_RJ7EF%+ZP%%07/Z=+Z+-5\;:G@G;]-?"Z<IITSFJL@!<[J
M*#)GXLPJ4K> 94:]U@*PI:25O*M?KJ4S\ [@.<!;<F2\$^Z7-AR32HY7+,[J
MLVZQ::*I*Q<'RZ$;[3H&Z4BA;"\LLWU/*G%93>2K5M=JF>EJ0G*!H3<'K$:.
M#%&PIGN/KEO"0M5];S<N5,_5VG7;+)DI;66379ZJ4/7%BE6R2CT_H67[IWV"
M#/9PJD1F^=K6H,$-$JPR:CH$8JYDD(_(:KVFLA3T>\L':TF:WT=R^3 *;P/9
M@V\NYR8Y;4+@76R2A\.;@+(+D% L2" 'T=8#N>"S$Q.!)(MLYW[OD<G\A@N'
MF#FA:[!9>?66D*L(PRS=QP>>%S?K<OPT 2ZO?%<.%@PC-4(Y,#^**R8!7N@+
M[6DXPJ]F,^"&E,H%Z]MX$SPX3RS9..K"0:[&W0,[*\]/.W'SC,ZL^V.X0-ZN
M-^3H,:"P%W!5-2A;9_L-$>1],<,2[-36?TKUA,U.B315*I\M=VKFE*W%V*/-
MW<0[]>QN'5LZ]>M8XG(<>$EG^YD3Z3ZJ/AS)C>RRD>F](XK$LR"R :MFA%?"
MT1<CN\\<75G9JL[3RR!L4VZ4T@!LE<%KB$WG:^E#2Z2@&]:"9OQVJC7:J8
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M<V-A;FAO;&0N:'1M4$L! A0#%     @ ;ZMX4HF1_ZCL    0@,  !L
M         ( !==4! &8Q,&LR,#(P97@R,5]T=7-C86YH;VQD+FAT;5!+ 0(4
M Q0    ( &^K>%+>N:OB20<  ,PI   =              "  9K6 0!F,3!K
M,C R,&5X,S$M,5]T=7-C86YH;VQD+FAT;5!+ 0(4 Q0    ( &^K>%+.$F^
M0@<  !,J   =              "  1[> 0!F,3!K,C R,&5X,S$M,E]T=7-C
M86YH;VQD+FAT;5!+ 0(4 Q0    ( &^K>%)1SMX@$ 0  & 2   ;
M      "  9OE 0!F,3!K,C R,&5X,S)?='5S8V%N:&]L9"YH=&U02P$"% ,4
M    " !OJWA21[>D\/8?  !:F@  '               @ 'DZ0$ 9C$P:S(P
M,C!E>#0M-5]T=7-C86YH;VQD+FAT;5!+ 0(4 Q0    ( &^K>%(@AWVX7Q
M $BF   1              "  10* @!T:&-B+3(P,C Q,C,Q+GAS9%!+ 0(4
M Q0    ( &^K>%(9]4H3, D  *Q8   5              "  :(: @!T:&-B
M+3(P,C Q,C,Q7V-A;"YX;6Q02P$"% ,4    " !OJWA2D-B_NS\N  !>Q@(
M%0              @ $%) ( =&AC8BTR,#(P,3(S,5]D968N>&UL4$L! A0#
M%     @ ;ZMX4N%B!1K0:0  "#D% !4              ( !=U(" '1H8V(M
M,C R,#$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( &^K>%*"MSYP#BX  #7< @ 5
M              "  7J\ @!T:&-B+3(P,C Q,C,Q7W!R92YX;6Q02P4&
/  P # !- P  N^H"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
